0001606498-24-000084.txt : 20241030 0001606498-24-000084.hdr.sgml : 20241030 20241030161720 ACCESSION NUMBER: 0001606498-24-000084 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 88 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241030 DATE AS OF CHANGE: 20241030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AVANOS MEDICAL, INC. CENTRAL INDEX KEY: 0001606498 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464987888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36440 FILM NUMBER: 241410581 BUSINESS ADDRESS: STREET 1: 5405 WINDWARD PARKWAY STREET 2: SUITE 100 SOUTH CITY: ALPHARETTA STATE: GA ZIP: 30004 BUSINESS PHONE: 844-428-2667 MAIL ADDRESS: STREET 1: 5405 WINDWARD PARKWAY STREET 2: SUITE 100 SOUTH CITY: ALPHARETTA STATE: GA ZIP: 30004 FORMER COMPANY: FORMER CONFORMED NAME: Avanos Medical, Inc. DATE OF NAME CHANGE: 20180702 FORMER COMPANY: FORMER CONFORMED NAME: Halyard Health, Inc. DATE OF NAME CHANGE: 20140424 10-Q 1 avns-20240930.htm 10-Q avns-20240930
000160649812/312024Q3FALSE1P1Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesavns:segmentxbrli:pure00016064982024-01-012024-09-3000016064982024-10-2300016064982024-07-012024-09-3000016064982023-07-012023-09-3000016064982023-01-012023-09-3000016064982024-09-3000016064982023-12-310001606498us-gaap:CommonStockMember2024-09-300001606498us-gaap:CommonStockMember2023-09-300001606498us-gaap:AdditionalPaidInCapitalMember2024-06-300001606498us-gaap:AdditionalPaidInCapitalMember2023-06-300001606498us-gaap:AdditionalPaidInCapitalMember2023-12-310001606498us-gaap:AdditionalPaidInCapitalMember2022-12-310001606498us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001606498us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001606498us-gaap:AdditionalPaidInCapitalMember2024-01-012024-09-300001606498us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300001606498us-gaap:AdditionalPaidInCapitalMember2024-09-300001606498us-gaap:AdditionalPaidInCapitalMember2023-09-300001606498us-gaap:RetainedEarningsMember2024-06-300001606498us-gaap:RetainedEarningsMember2023-06-300001606498us-gaap:RetainedEarningsMember2023-12-310001606498us-gaap:RetainedEarningsMember2022-12-310001606498us-gaap:RetainedEarningsMember2024-07-012024-09-300001606498us-gaap:RetainedEarningsMember2023-07-012023-09-300001606498us-gaap:RetainedEarningsMember2024-01-012024-09-300001606498us-gaap:RetainedEarningsMember2023-01-012023-09-300001606498us-gaap:RetainedEarningsMember2024-09-300001606498us-gaap:RetainedEarningsMember2023-09-300001606498us-gaap:TreasuryStockCommonMember2024-06-300001606498us-gaap:TreasuryStockCommonMember2023-06-300001606498us-gaap:TreasuryStockCommonMember2023-12-310001606498us-gaap:TreasuryStockCommonMember2022-12-310001606498us-gaap:TreasuryStockCommonMember2024-07-012024-09-300001606498us-gaap:TreasuryStockCommonMember2023-07-012023-09-300001606498us-gaap:TreasuryStockCommonMember2024-01-012024-09-300001606498us-gaap:TreasuryStockCommonMember2023-01-012023-09-300001606498us-gaap:TreasuryStockCommonMember2024-09-300001606498us-gaap:TreasuryStockCommonMember2023-09-300001606498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001606498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001606498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001606498us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001606498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001606498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001606498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001606498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001606498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001606498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-3000016064982023-09-3000016064982022-12-310001606498avns:RHBusinessMember2023-10-022023-10-020001606498avns:RHBusinessMember2023-06-072023-06-070001606498avns:RHBusinessMembersrt:MinimumMember2023-06-072023-06-070001606498avns:RHBusinessMembersrt:MaximumMember2023-06-072023-06-070001606498us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMemberavns:RHBusinessMember2024-09-300001606498us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMemberavns:RHBusinessMember2023-12-310001606498us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMemberavns:RHBusinessMember2024-07-012024-09-300001606498us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMemberavns:RHBusinessMember2023-07-012023-09-300001606498us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMemberavns:RHBusinessMember2024-01-012024-09-300001606498us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMemberavns:RHBusinessMember2023-01-012023-09-300001606498avns:PostDivestitureRestructuringPlanMembersrt:MinimumMember2024-09-300001606498avns:PostDivestitureRestructuringPlanMembersrt:MaximumMember2024-09-300001606498avns:PostDivestitureRestructuringPlanMember2024-07-012024-09-300001606498avns:PostDivestitureRestructuringPlanMember2024-01-012024-09-3000016064982023-01-012023-01-310001606498avns:TransformationProcessMembersrt:MaximumMember2023-01-310001606498avns:ProgramManagementConsultingAndEmployeeRetentionMembersrt:MinimumMember2024-09-300001606498avns:ProgramManagementConsultingAndEmployeeRetentionMembersrt:MaximumMember2024-09-300001606498avns:ManufacturingAndSupplyChainImprovementsMembersrt:MinimumMember2024-09-300001606498avns:ManufacturingAndSupplyChainImprovementsMembersrt:MaximumMember2024-09-300001606498avns:OrganizationalDesignAlignmentAndOtherRelatedActivitiesMembersrt:MinimumMember2024-09-300001606498avns:OrganizationalDesignAlignmentAndOtherRelatedActivitiesMembersrt:MaximumMember2024-09-300001606498avns:ProgramManagementConsultingAndEmployeeRetentionMember2024-07-012024-09-300001606498avns:ProgramManagementConsultingAndEmployeeRetentionMember2024-01-012024-09-300001606498avns:ProgramManagementConsultingAndEmployeeRetentionMember2023-07-012023-09-300001606498avns:ProgramManagementConsultingAndEmployeeRetentionMember2023-01-012023-09-300001606498avns:ProgramManagementConsultingAndEmployeeRetentionExpensesAndEmployeeSeveranceAndBenefitsMember2024-01-012024-09-300001606498avns:ProgramManagementConsultingAndEmployeeRetentionExpensesAndEmployeeSeveranceAndBenefitsMember2024-07-012024-09-300001606498avns:ProgramManagementConsultingAndEmployeeRetentionExpensesAndEmployeeSeveranceAndBenefitsMember2024-09-300001606498us-gaap:EmployeeSeveranceMemberavns:MultiYearRestructuringPlanInitialPhaseMember2023-12-310001606498us-gaap:EmployeeSeveranceMemberavns:MultiYearRestructuringPlanInitialPhaseMember2024-01-012024-09-300001606498us-gaap:EmployeeSeveranceMemberavns:MultiYearRestructuringPlanInitialPhaseMember2024-09-300001606498avns:DirosTechnologyIncMember2023-07-242023-07-240001606498avns:DirosTechnologyIncMember2023-06-172023-06-170001606498avns:DirosTechnologyIncMember2023-07-240001606498avns:DirosTechnologyIncMember2024-07-012024-09-300001606498avns:DirosTechnologyIncMember2024-01-012024-09-300001606498avns:DirosTechnologyIncMember2023-07-012023-09-300001606498avns:DirosTechnologyIncMember2023-01-012023-09-3000016064982023-06-172024-09-300001606498avns:DirosTechnologyIncMemberus-gaap:TrademarksAndTradeNamesMember2023-07-242023-07-240001606498avns:DirosTechnologyIncMemberus-gaap:CustomerRelationshipsMember2023-07-242023-07-240001606498avns:DirosTechnologyIncMemberus-gaap:TechnologyBasedIntangibleAssetsMember2023-07-242023-07-240001606498avns:AllowanceForCreditLossDoubtfulAccountsMember2024-09-300001606498avns:AllowanceForCreditLossDoubtfulAccountsMember2023-12-310001606498avns:AllowanceForCreditLossSalesDiscountsMember2024-09-300001606498avns:AllowanceForCreditLossSalesDiscountsMember2023-12-310001606498us-gaap:LandMember2024-09-300001606498us-gaap:LandMember2023-12-310001606498us-gaap:BuildingMember2024-09-300001606498us-gaap:BuildingMember2023-12-310001606498us-gaap:MachineryAndEquipmentMember2024-09-300001606498us-gaap:MachineryAndEquipmentMember2023-12-310001606498us-gaap:ConstructionInProgressMember2024-09-300001606498us-gaap:ConstructionInProgressMember2023-12-310001606498us-gaap:TrademarksMember2024-09-300001606498us-gaap:TrademarksMember2023-12-310001606498us-gaap:PatentsMember2024-09-300001606498us-gaap:PatentsMember2023-12-310001606498us-gaap:OtherIntangibleAssetsMember2024-09-300001606498us-gaap:OtherIntangibleAssetsMember2023-12-310001606498us-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-09-300001606498us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-09-300001606498us-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310001606498us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001606498us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:RevolvingCreditFacilityMember2024-09-300001606498us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:RevolvingCreditFacilityMember2024-09-300001606498us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:RevolvingCreditFacilityMember2023-12-310001606498us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:RevolvingCreditFacilityMember2023-12-310001606498us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberavns:TermLoansMember2024-09-300001606498us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberavns:TermLoansMember2024-09-300001606498us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberavns:TermLoansMember2023-12-310001606498us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberavns:TermLoansMember2023-12-310001606498us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-09-300001606498us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-09-300001606498us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310001606498us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001606498us-gaap:RevolvingCreditFacilityMemberus-gaap:UnsecuredDebtMember2024-09-300001606498us-gaap:RevolvingCreditFacilityMemberus-gaap:UnsecuredDebtMember2023-12-310001606498avns:TermLoanFacilityMemberus-gaap:UnsecuredDebtMember2024-09-300001606498avns:TermLoanFacilityMemberus-gaap:UnsecuredDebtMember2023-12-310001606498avns:CreditAgreementMember2022-06-240001606498avns:TermLoanFacilityMemberus-gaap:SecuredDebtMember2022-06-242022-06-240001606498avns:TermLoanFacilityMemberus-gaap:SecuredDebtMember2022-06-240001606498avns:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2022-06-242022-06-240001606498avns:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2022-06-240001606498avns:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:LetterOfCreditMemberus-gaap:LineOfCreditMember2022-06-240001606498avns:VariableRateComponentOneMemberavns:CreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMember2022-06-242022-06-240001606498avns:VariableRateComponentOneMemberavns:CreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MaximumMember2022-06-242022-06-240001606498avns:VariableRateComponentTwoMemberavns:CreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMember2022-06-242022-06-240001606498avns:VariableRateComponentTwoMemberavns:CreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MaximumMember2022-06-242022-06-240001606498avns:CreditAgreementMemberus-gaap:FederalFundsEffectiveSwapRateMember2022-06-242022-06-240001606498avns:VariableRateComponentThreeMemberavns:CreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrMember2022-06-242022-06-240001606498avns:CreditAgreementMemberus-gaap:BaseRateMembersrt:MinimumMember2022-06-242022-06-240001606498avns:CreditAgreementMemberus-gaap:BaseRateMembersrt:MaximumMember2022-06-242022-06-240001606498avns:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MinimumMember2022-06-242022-06-240001606498avns:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MaximumMember2022-06-242022-06-240001606498avns:TermLoanFacilityMemberus-gaap:SecuredDebtMember2024-09-300001606498avns:DebtInstrumentPeriodicPaymentFirstEightQuartersMember2024-01-012024-09-300001606498avns:DebtInstrumentPeriodicPaymentSubsequentToFirstEightQuartersMember2024-01-012024-09-300001606498avns:TermLoanFacilitiesMemberus-gaap:UnsecuredDebtMember2024-01-012024-09-300001606498us-gaap:RevolvingCreditFacilityMemberus-gaap:UnsecuredDebtMember2024-01-012024-09-300001606498us-gaap:LetterOfCreditMember2024-09-300001606498us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001606498us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310001606498us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001606498us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-09-300001606498us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-09-300001606498us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-09-300001606498us-gaap:AccumulatedTranslationAdjustmentMember2024-09-300001606498us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-09-300001606498us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-09-300001606498us-gaap:EmployeeStockOptionMember2024-07-012024-09-300001606498us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001606498us-gaap:EmployeeStockOptionMember2024-01-012024-09-300001606498us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001606498us-gaap:RestrictedStockUnitsRSUMember2024-07-012024-09-300001606498us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001606498us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-09-300001606498us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001606498us-gaap:PerformanceSharesMember2024-07-012024-09-300001606498us-gaap:PerformanceSharesMember2023-07-012023-09-300001606498us-gaap:PerformanceSharesMember2024-01-012024-09-300001606498us-gaap:PerformanceSharesMember2023-01-012023-09-300001606498avns:EmployeeStockPurchaseProgramMember2024-07-012024-09-300001606498avns:EmployeeStockPurchaseProgramMember2023-07-012023-09-300001606498avns:EmployeeStockPurchaseProgramMember2024-01-012024-09-300001606498avns:EmployeeStockPurchaseProgramMember2023-01-012023-09-3000016064982021-07-062021-07-060001606498us-gaap:ForeignExchangeForwardMember2024-09-300001606498us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001606498avns:DigestiveHealthMember2024-07-012024-09-300001606498avns:DigestiveHealthMember2023-07-012023-09-300001606498avns:DigestiveHealthMember2024-01-012024-09-300001606498avns:DigestiveHealthMember2023-01-012023-09-300001606498avns:SurgicalPainAndRecoveryMember2024-07-012024-09-300001606498avns:SurgicalPainAndRecoveryMember2023-07-012023-09-300001606498avns:SurgicalPainAndRecoveryMember2024-01-012024-09-300001606498avns:SurgicalPainAndRecoveryMember2023-01-012023-09-300001606498avns:InterventionalPainMember2024-07-012024-09-300001606498avns:InterventionalPainMember2023-07-012023-09-300001606498avns:InterventionalPainMember2024-01-012024-09-300001606498avns:InterventionalPainMember2023-01-012023-09-300001606498avns:PainManagementAndRecoveryMember2024-07-012024-09-300001606498avns:PainManagementAndRecoveryMember2023-07-012023-09-300001606498avns:PainManagementAndRecoveryMember2024-01-012024-09-300001606498avns:PainManagementAndRecoveryMember2023-01-012023-09-3000016064982023-07-282023-07-2800016064982023-07-2800016064982023-10-012023-12-3100016064982024-01-012024-03-3100016064982024-03-3100016064982024-04-012024-06-3000016064982024-06-30


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2024
OR
☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________  
Commission file number 001-36440
avanoslogo.jpg
AVANOS MEDICAL, INC.
(Exact name of registrant as specified in its charter)
Delaware46-4987888
(State or other jurisdiction of incorporation)(I.R.S. Employer Identification No.)
5405 Windward Parkway
Suite 100 South
Alpharetta,Georgia30004
(Address of principal executive offices)(Zip code)
Registrant’s telephone number, including area code: (844) 428-2667
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of exchange on which registered
Common Stock - $0.01 Par ValueAVNSNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer☒Accelerated filer☐
Non-accelerated filer☐Emerging growth company☐
Smaller reporting company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes  ☐    No  ☒
As of October 23, 2024, there were 45,956,997 shares of the registrant’s common stock outstanding.    


Table of Contents


2


Information Concerning Forward-Looking Statements
This Quarterly Report on Form 10-Q (this “Form 10-Q”) contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are included throughout this Form 10-Q, including in the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements include all statements that do not relate solely to historical or current facts, and can generally be identified by the use of words such as “may,” “believe,” “will,” “expect,” “intend,” “predict,” “potential,” “project,” “estimate,” “anticipate,” “plan,” or “continue” and similar expressions, among others. The matters discussed in these forward-looking statements are based on the current plans and expectations of our management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements. These factors include, but are not limited to:
•general economic conditions, particularly in the United States;
•weakening of economic conditions that could adversely affect the level of demand for our products;
•pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for our products;
•fluctuations in global equity and fixed-income markets;
•our ability to successfully execute on or achieve the expected benefits of our restructuring initiative;
•supply chain issues and inflationary pressures;
•a resurgence of the ongoing COVID-19 pandemic;
•the competitive environment;
•the loss of current customers or the inability to obtain new customers;
•cybersecurity threats, including breaches of or cyberattacks on our information systems;
•the ongoing regional conflicts between Russia and Ukraine and in the Middle East;
•concentration of our manufacturing operations in Mexico;
•financial conditions affecting the banking system and the potential threats to the solvency of commercial banks
•litigation and enforcement actions;
•disruption in the supply of raw materials or the distribution of finished goods;
•price fluctuations in key commodities;
•fluctuations in currency exchange rates;
•changes in governmental regulations that are applicable to our business;
•our ability to realize the intended benefits of our restructuring initiatives or our divestiture, acquisition or merger transactions;
•changes in asset valuations, including write-downs of assets such as inventory, accounts receivable or other assets for impairment or other reasons; and
•any other matters described in Item 1A - “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”) and Part II, Item 1A - “Risk Factors” in this Form 10-Q.
You are cautioned not to unduly rely on such forward-looking statements when evaluating the information in this Form 10-Q. Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of our management and expressed in good faith, and is believed to have a reasonable basis. There can be no assurance that any such expectation or belief will be achieved or accomplished.
Any forward-looking statement made in this Form 10-Q speaks only as of the date of this report. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable securities laws.
3
PART I – FINANCIAL INFORMATION
Item 1.     Financial Statements
AVANOS MEDICAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS
(in millions, except per share amounts)
(Unaudited)
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Net Sales$170.4 $171.3 $508.2 $500.0 
Cost of products sold77.5 75.8 224.9 215.3 
Gross Profit92.9 95.5 283.3 284.7 
Research and development7.2 6.1 20.5 20.4 
Selling and general expenses74.3 78.7 238.8 260.5 
Other (income) expense, net(0.6)9.5 1.7 10.8 
Operating Income (Loss)
12.0 1.2 22.3 (7.0)
Interest income0.7 0.9 4.3 1.9 
Interest expense(3.2)(4.7)(9.4)(11.7)
Income (Loss) Before Income Taxes9.5 (2.6)17.2 (16.8)
Income tax provision(3.6)(6.2)(6.5)(4.1)
Income (Loss) from Continuing Operations5.9 (8.8)10.7 (20.9)
(Loss) Income from discontinued operations, net of tax(1.6)5.1 (5.5)(51.4)
Net Income (Loss)$4.3 $(3.7)$5.2 $(72.3)
Basic Earnings (Loss) Per Share
Continuing operations$0.13 $(0.19)$0.23 $(0.45)
Discontinued operations(0.03)0.11 (0.12)(1.10)
Basic Earnings (Loss) Per Share$0.10 $(0.08)$0.11 $(1.55)
Diluted Earnings (Loss) Per Share
Continuing operations$0.12 $(0.19)$0.23 $(0.45)
Discontinued operations(0.03)0.11 (0.12)(1.10)
Diluted Earnings (Loss) Per Share$0.09 $(0.08)$0.11 $(1.55)

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
4
AVANOS MEDICAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in millions)
(Unaudited)
 Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Net Income (Loss)$4.3 $(3.7)$5.2 $(72.3)
Other Comprehensive Income (Loss), Net of Tax
Unrealized currency translation adjustments0.3 (4.6)(8.0)2.8 
Defined benefit plans0.1 — (0.1)— 
Cash flow hedges0.2 — (1.8)— 
Total Other Comprehensive Income (Loss), Net of Tax0.6 (4.6)(9.9)2.8 
Comprehensive Income (Loss)$4.9 $(8.3)$(4.7)$(69.5)

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.


5
AVANOS MEDICAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions, except share data)
(Unaudited)
September 30,
2024		December 31,
2023
ASSETS
Current Assets
Cash and cash equivalents$89.0 $87.7 
Accounts receivable, net of allowances131.9 142.8 
Inventories161.9 163.2 
Prepaid and other current assets15.9 28.8 
Assets held for sale73.9 64.5 
Total Current Assets472.6 487.0 
Property, Plant and Equipment, net109.5 117.2 
Operating Lease Right-of-Use Assets26.5 26.8 
Goodwill795.1 796.1 
Other Intangible Assets, net220.1 239.5 
Deferred Tax Assets6.6 6.5 
Other Assets25.8 19.3 
TOTAL ASSETS$1,656.2 $1,692.4 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Current portion of long-term debt$9.4 $8.6 
Current portion of operating lease liabilities13.7 12.8 
Trade accounts payable54.2 56.3 
Accrued expenses82.7 93.2 
Liabilities held for sale52.9 63.7 
Total Current Liabilities212.9 234.6 
Long-Term Debt152.6 159.4 
Operating Lease Liabilities26.5 28.3 
Deferred Tax Liabilities23.9 23.8 
Other Long-Term Liabilities10.6 10.0 
Total Liabilities426.5 456.1 
Commitments and Contingencies
Stockholders’ Equity
Preferred stock - $0.01 par value - authorized 20,000,000 shares, none issued
— — 
Common stock - $0.01 par value - authorized 300,000,000 shares, 45,954,931 outstanding as of September 30, 2024 and 46,174,337 outstanding as of December 31, 2023
0.5 0.5 
Additional paid-in capital1,674.7 1,663.6 
Accumulated deficit(309.7)(314.9)
Treasury stock(98.9)(85.9)
Accumulated other comprehensive loss(36.9)(27.0)
Total Stockholders’ Equity1,229.7 1,236.3 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$1,656.2 $1,692.4 

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
6
AVANOS MEDICAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
(in millions)
(Unaudited)
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Common Stock$0.5 $0.5 $0.5 $0.5 
Additional Paid-in Capital, beginning of period1,671.5 1,654.9 1,663.6 1,646.4 
Exercise or redemption of share-based awards0.6 0.9 1.1 1.5 
Stock-based compensation expense2.6 3.9 10.0 11.8 
Additional Paid-in Capital, end of period1,674.7 1,659.7 1,674.7 1,659.7 
Accumulated Deficit, beginning of period(314.0)(321.7)(314.9)(253.1)
Net income (loss)4.3 (3.7)5.2 (72.3)
Accumulated Deficit, end of period(309.7)(325.4)(309.7)(325.4)
Treasury Stock, beginning of period(98.5)(70.5)(85.9)(66.8)
Purchases of treasury stock(0.4)(9.2)(13.0)(12.9)
Treasury Stock, end of period(98.9)(79.7)(98.9)(79.7)
Accumulated Other Comprehensive Loss, beginning of period(37.5)(28.4)(27.0)(35.8)
Other comprehensive income (loss), net of tax0.6 (4.6)(9.9)2.8 
Accumulated Other Comprehensive Loss, end of period(36.9)(33.0)(36.9)(33.0)
Total Stockholders’ Equity, end of period$1,229.7 $1,222.1 $1,229.7 $1,222.1 

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.


7
AVANOS MEDICAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED CASH FLOW STATEMENTS
(in millions)
(Unaudited)
Nine Months Ended September 30,
20242023
Operating Activities
Net income (loss)$5.2 $(72.3)
Depreciation and amortization34.4 34.6 
Stock-based compensation expense10.0 11.8 
Goodwill impairment— 59.1 
Net loss on asset dispositions and impairments0.4 1.1 
Changes in operating assets and liabilities, net of acquisition:
Accounts receivable(6.9)30.0 
Inventories(5.9)(6.6)
Prepaid expenses and other assets7.7 0.2 
Accounts payable(1.2)(16.0)
Accrued expenses(3.7)(19.7)
Deferred income taxes and other2.8 (2.5)
Cash Provided by Operating Activities42.8 19.7 
Investing Activities
Capital expenditures(13.0)(11.9)
Proceeds from RH Divestiture post-closing settlement2.1 — 
Acquisition of assets and investments in businesses— (47.5)
Investment in Note Receivable(9.0)— 
Cash Used in Investing Activities(19.9)(59.4)
Financing Activities
Secured debt repayments(6.3)(3.1)
Revolving credit facility proceeds20.0 55.0 
Revolving credit facility repayments(20.0)(20.0)
Purchases of treasury stock(12.7)(12.9)
Proceeds from the exercise of stock options1.1 1.5 
Payment of contingent consideration liabilities(3.8)— 
Cash (Used in) Provided by Financing Activities(21.7)20.5 
Effect of Exchange Rate Changes on Cash and Cash Equivalents0.1 (1.4)
Increase (Decrease) in Cash and Cash Equivalents1.3 (20.6)
Cash and Cash Equivalents - Beginning of Period87.7 127.7 
Cash and Cash Equivalents - End of Period$89.0 $107.1 

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

8
AVANOS MEDICAL, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Accounting Policies
Background and Basis of Presentation
Avanos Medical, Inc. is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today’s most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio. References herein to “Avanos,” “the Company,” “we,” “our” and “us” refer to Avanos Medical, Inc. and its consolidated subsidiaries.
Interim Financial Statements
We prepared the accompanying unaudited condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and the instructions to the Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements, and the condensed consolidated financial statements in this Form 10-Q should be read in conjunction with the Form 10-K. Our unaudited interim condensed consolidated financial statements contain all necessary material adjustments, which are of a normal and recurring nature, to fairly state our financial condition, results of operations and cash flows for the periods presented.
Use of Estimates
Preparation of our condensed consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Estimates are used in accounting for, among other things, certain amounts included in discontinued operations, certain amounts included in assets and liabilities held for sale, distributor rebate accruals, future cash flows associated with impairment testing for goodwill and long-lived assets, loss contingencies, and deferred tax assets and potential income tax assessments. Actual results could differ from these estimates, and the effect of any change could be material to our financial statements. Changes in these estimates are recorded when known.
Goodwill
We test goodwill for impairment annually or more frequently whenever events or circumstances more likely than not indicate that the fair value of the reporting unit may be below its carrying value. We operate as a single reportable operating segment with one reporting unit. The fair value of our reporting unit is estimated using a combination of income (discounted cash flow analysis) and market approaches. The income approach is dependent upon several assumptions regarding future periods such as sales growth and a terminal growth rate. A weighted average cost of capital (“WACC”) was used to discount future estimated cash flows to their present values. The WACC was based on externally observable data considering market participants’ cost of equity and debt, optimal capital structure and risk factors specific to us. The market approach estimates the value of our company using a market capitalization methodology.
We determined that the fair value of our reporting unit exceeded the net carrying amount in our most recent goodwill impairment test on July 1, 2024. However, there can be no assurance that the assumptions and estimates made for purposes of the annual goodwill impairment test will prove to be accurate. Volatility in the equity and debt markets, or increases in interest rates, could result in a higher discount rate. Changes in sales volumes, selling prices and costs of goods sold, and increases in interest rates could cause changes in our forecasted cash flows. Unfavorable changes in any of the factors described above, as well as a decline in our stock price, could result in a goodwill impairment charge in the future.
Hedging and Derivatives
All derivative instruments are recorded as assets or liabilities on the balance sheet at fair value. Changes in the fair value of
derivatives are either recorded in the income statement or other comprehensive income, as appropriate. The effective portion of
the gain or loss on derivatives designated as cash flow hedges is included in other comprehensive income in the period that
changes in fair value occur, and is reclassified to income in the same period that the hedged item affects income. Our policies allow the use of derivatives for risk management purposes and prohibit their use for speculation. Our policies also prohibit the use of any leveraged derivative instrument. Consistent with our policies, foreign currency derivative instruments are entered into with major financial institutions. At inception, we formally designate certain derivatives as cash flow hedges and establish how the effectiveness of these hedges will be assessed and measured. This process links the derivatives to the transactions they are hedging. See Note 11, “Derivative Financial Instruments,” for disclosures about derivative instruments and hedging activities.
9
Recently Adopted Accounting Pronouncements
Effective January 1, 2023, we adopted ASU No. 2021-08, Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. This ASU pertains to acquired revenue contracts with customers in a business combination and addresses diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. Adoption of this ASU did not have a material effect on our financial position, results of operations or cash flows.
Recently Issued Accounting Pronouncements
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes: Improvement to Income Tax Disclosures. This ASU pertains to disaggregation of income tax disclosures and enhances annual income tax disclosures to address investor requests for more information about the tax risks and opportunities present in an entity’s worldwide operations. The two primary enhancements disaggregate existing income tax disclosures related to the effective tax rate reconciliation and income taxes paid, and requires entities to disclose a tabular reconciliation of expected tax and reported tax on income from continuing operations using both percentages and amounts, broken out into specific categories with certain reconciling items at or above 5% of the expected tax further broken out by nature and/or jurisdiction. Additionally, this ASU requires disclosure around income taxes paid (net of refunds received) broken out between federal, state, local and foreign, and income taxes paid (net of refunds received) to an individual jurisdiction when greater than 5% of total income taxes paid. This ASU will be effective for annual periods beginning after December 15, 2024, with early adoption permitted. Adoption of this ASU is not expected to have a material effect on our financial position, results of operations or cash flows.
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting: Improvements to Reportable Segment Disclosures. This ASU enhances segment reporting under Topic 280 by expanding the breadth and frequency of segment disclosures, and aims to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. This ASU will be effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of this ASU will require us to expand our current disclosures around significant expenses and disclose an aggregate amount and composition of other segment items related to our single operating segment. On an annual basis, this ASU will require us to disclose the Chief Operating Decision Maker’s (CODM) title and position, as well as how the CODM uses each reported measure of segment profit or loss to assess performance and allocate resources to the segment. We will retrospectively adopt this ASU in the fiscal period ending December 31, 2024 as required by ASU No. 2023-07.
In August 2023, the FASB issued ASU No. 2023-05, Business Combinations: Joint Venture Formations. This ASU is intended to address diversity in practice regarding accounting and provide decision-useful information related to contributions made to joint ventures and requires entities that qualify as either a joint venture or a corporate joint venture to apply a new basis of accounting upon the formation of the joint venture. Specifically, the ASU provides that a joint venture or a corporate joint venture must initially measure its assets and liabilities at fair value on the formation date. This ASU will be effective for all newly formed joint venture entities with a formation date on or after January 1, 2025, with early adoption permitted. Joint ventures formed prior to the adoption date may elect to apply the new guidance retrospectively back to their original formation date. Adoption of this ASU is not expected to have a material effect on our financial position, results of operations or cash flows.
Note 2.     Discontinued Operations
On June 7, 2023, we entered into a Purchase Agreement (“the Purchase Agreement”) by and among us and certain of our affiliates and SunMed Group Holdings, LLC (“Buyer”) pursuant to which Buyer agreed to purchase substantially all of the assets primarily relating to or primarily used in our Respiratory Health (“RH”) business (the “RH Divestiture”). On October 2, 2023, we closed the RH Divestiture for a total purchase price of $110 million in cash, subject to certain adjustments as provided in the Purchase Agreement based on the indebtedness and inventory transferred to Buyer at the closing and the chargebacks assumed by Buyer but that would otherwise have been payable by the Company and its subsidiaries on or after October 2, 2023 to distributors of the Company’s RH products located in the United States (the “Initial Closing”).
The RH Divestiture represents a key component of Avanos’ ongoing three-year transformation process, and is aimed at accelerating the Company’s efforts to focus its portfolio on markets where it is well positioned to succeed.
At or before the closing of the RH Divestiture, we and Buyer entered into various transition services agreements pursuant to which we, Buyer and each company’s respective affiliates provide to each other various transitional services, including, but not limited to, product manufacturing and distribution, facilities, order fulfillment, invoicing, quality assurance, regulatory support, audit support and other services. The services generally commenced on the closing date of the Divestiture and terminate no later than one to three years thereafter.
10
We have also entered into distribution agreements with Buyer under which we will remain a limited risk distributor for RH products on Buyer’s behalf for sales outside of the United States. As a result, we had $6.6 million of RH products included in “Prepaid expenses and other current assets” in the accompanying consolidated balance sheet as of September 30, 2024, compared to $11.9 million as of December 31, 2023. While our agreements with Buyer allows for limited risk distributor (“LRD”) arrangements for up to three years from the date of the Purchase Agreement, we expect the LRD arrangements to terminate by the end of this year.
As a result of the RH Divestiture, the results of operations from our RH business are reported as “Net (Loss) Income from discontinued operations, net of tax” and the related assets and liabilities are classified as “held for sale” in the condensed consolidated financial statements.
Pursuant to an agreement under which we provide manufacturing services for the Buyer, certain manufacturing facilities and equipment did not transfer to the Buyer upon the Initial Closing, and remained in “Assets Held for Sale” as of September 30, 2024 with a corresponding liability representing our obligation to transfer the manufacturing facilities and equipment to the buyer at a later date. Likewise, the results of operations from these manufacturing operations continue to be classified as “Net Loss from discontinued operations, net of tax. On October 1, 2024, we finalized the RH Divestiture and completed the transfer of the manufacturing facilities and equipment to Buyer. Accordingly, we expect to finalize adjustments to our pretax loss on discontinued operations in the fourth quarter of 2024.
The following table summarizes the financial results of our discontinued operations for all periods presented herein (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Net Sales$10.5 $31.1 $41.0 $93.9 
Cost of products sold15.9 19.9 47.4 57.8 
Gross Profit(5.4)11.2 (6.4)36.1 
Research and development— 0.2 — 0.8 
Selling and general expenses— 4.2 — 11.9 
Pretax loss on classification as discontinued operations— — — 72.3 
Other (income) expense, net(3.2)0.1 1.1 0.3 
(Loss) Income from discontinued operations before income taxes(2.2)6.7 (7.5)(49.2)
Income tax benefit (provision) from discontinued operations
0.6 (1.6)2.0 (2.2)
Net (Loss) Income from discontinued operations, net of tax$(1.6)$5.1 $(5.5)$(51.4)
(Loss) Earnings Per Share
Basic$(0.03)$0.11 $(0.12)$(1.10)
Diluted$(0.03)$0.11 $(0.12)$(1.10)
In accordance with accounting principles generally accepted in the United States (“GAAP”), only expenses specifically identifiable and related to a business to be disposed may be allocated to discontinued operations. Accordingly, the cost of products sold, research and development, selling and general expenses and other expense, net in discontinued operations include expenses incurred directly to solely support our respiratory health business.
11
Details on assets and liabilities classified as held for sale in the accompanying consolidated balance sheets are presented in the following table (in millions):
September 30, 2024December 31, 2023
Assets held for sale - discontinued operations
Inventories$28.2 $17.5 
Property, Plant and Equipment, net43.0 43.9 
Operating Lease Right-of-Use Assets2.7 3.1 
Total assets classified as held for sale$73.9 $64.5 
Liabilities held for sale - discontinued operations
Current Portion of Operating Lease Liabilities$0.7 $0.8 
Accrued expenses51.3 61.3 
Non-Current Operating Lease Liability0.9 1.6 
Total liabilities held for sale - discontinued operations$52.9 $63.7 

Assets and liabilities held for sale as of September 30, 2024 were classified as current since we expect the RH Divestiture to be completed within one year.

The following table provides operating and investing cash flow information for our discontinued operations (in millions):
Nine Months Ended September 30,
20242023
Operating Activities:
Depreciation and amortization$— $2.6 
Stock-based compensation expense— 0.1 
Investing Activities:
Capital expenditures0.6 3.1 

Note 3.    Restructuring Activities
Post-RH Divestiture Restructuring Plan
During 2024, we initiated a post-RH Divestiture restructuring plan (the “Plan”). The Plan is intended to align our organizational structure, distribution and operational footprint with our remaining business. We expect the Plan will be substantially complete by the end of 2025 and currently expect to incur between $10.0 million and $11.0 million of cash expenses, primarily for employee termination benefits. In the three and nine months ended September 30, 2024, we incurred $2.3 million and $6.4 million, respectively, of costs related to the Plan. These costs were included in “Cost of products sold” and “Selling and general expenses” in the accompanying condensed consolidated income statements.
Transformation Process
In January 2023, we initiated a three-year restructuring initiative intended to align the Company under a single commercial organization, rationalize our product portfolio, undertake additional cost management activities to enhance the Company’s operating profitability and pursue efficient capital allocation strategies (the “Transformation Process”). The RH Divestiture represents a key component of the three-year Transformation Process. We expect the Transformation Process will be substantially complete by the end of 2025.
We expect to incur up to $30.0 million of cash expenses in connection with the Transformation Process, consisting of between $9.0 million and $12.0 million of program management consulting and employee retention expenses; between $8.0 million and $11.0 million of expenses associated with manufacturing and supply chain improvements and portfolio rationalization; and the remainder for expenses associated with organization design and alignment and other related activities. These amounts include between $6.0 million and $8.0 million of employee severance and benefits costs.
In the three and nine months ended September 30, 2024, we incurred expenses of $0.7 million and $5.2 million, respectively, primarily related to employee severance and benefits costs in connection with the Transformation Process, compared to $4.3 million and $23.0 million in the three and nine months ended September 30, 2023. These costs were included in “Cost of products sold” and “Selling and general expenses” in the accompanying condensed consolidated income statements. Plan-to-
12
date we have incurred expenses of $33.4 million in connection with the Transformation Process, which includes $28.1 million of cash expenses.
Restructuring Liability
Our liability for costs associated with our restructuring initiatives as of September 30, 2024 is summarized below (in millions):
As of September 30, 2024
Beginning balance$2.3 
Restructuring and transformation costs, excluding non-cash charges10.3 
Payments and adjustments, net(9.2)
Ending balance$3.4 

Note 4.    Business Acquisition
Diros Technology
On June 17, 2023 we entered into a definitive agreement to acquire Diros Technology Inc. (“Diros”), a leading manufacturer of innovative radiofrequency ablation (“RFA”) products used to treat chronic pain conditions. On July 24, 2023, we closed the acquisition of Diros. The total purchase price paid in connection with our acquisition of Diros was $53.0 million, consisting of $2.5 million in cash paid upon entry into the definitive agreement and $50.5 million in cash paid at closing (subject to certain working capital and other adjustments), with up to an additional $7.0 million payable in contingent cash consideration based on achievement of certain performance objectives defined in the purchase agreement (the “Diros Acquisition”). The purchase price for the Diros Acquisition was funded by proceeds from our Revolving Credit Facility. The accompanying condensed consolidated income statement includes $4.6 million and $14.4 million of net sales from Diros for the three and nine months ended September 30, 2024, respectively. The accompanying condensed consolidated income statement includes $2.4 million of net sales from Diros since the acquisition date for the three and nine months ended September 30, 2023. In the three and nine months ended September 30, 2024, we incurred $1.5 million and $2.1 million of costs in connection with the Diros Acquisition, compared to $0.6 million and $0.9 million of costs in the three and nine months ended September 30, 2023, respectively. These costs are included in “Selling and general expenses,” In the nine months ended September 30, 2024, we made contingent consideration payments of $4.6 million and to date we have made contingent consideration payments of $6.1 million.
Under the acquisition method of accounting for business combinations, the purchase price paid is allocated to the underlying net assets in proportion to their respective fair values. Any excess of the purchase price over the estimated fair values is recorded as goodwill. Fair values of assets acquired and liabilities assumed are being determined using discounted cash flow analyses and the fair value of the contingent consideration is being estimated using a Monte Carlo simulation. Assumptions supporting the estimated fair values are based on facts and circumstances that existed on the valuation date. The purchase price allocation is shown in the table below (in millions):
Current assets, net of cash acquired
$7.5 
Current liabilities, excluding contingent consideration
(7.0)
Contingent consideration
(5.3)
Other noncurrent liabilities, net(0.5)
Deferred tax liabilities
(8.1)
Identifiable intangible assets
29.6 
Goodwill
33.4 
Total$49.6 
13
The identifiable intangible assets relating to the Diros Acquisition include the following (in millions, except years):
Identifiable Intangible Asset AmountWeighted Average Useful Lives (Years)
Trade names and trademarks
$2.9 15
Customer relationships
21.2 14
Developed technology and other
5.5 13
Total$29.6 
Note 5.    Supplemental Balance Sheet Information
Accounts Receivable
Accounts receivable consist of the following (in millions):
September 30, 2024December 31, 2023
Accounts receivable$137.3 $134.0 
Income tax receivable— 14.1 
Allowances and doubtful accounts:
Doubtful accounts(4.8)(5.1)
Sales discounts(0.6)(0.2)
Accounts receivable, net$131.9 $142.8 
Losses on receivables are estimated based on known troubled accounts and historical experience. Receivables are considered impaired and written off when it is probable that payments due will not be collected. Allowance for doubtful accounts was $0.1 million for the three months ended September 30, 2024 and $0.2 million for the nine months ended September 30, 2024, compared to a net benefit of $0.4 million and an expense of $0.2 million for the three and nine months ended September 30, 2023, respectively.
Inventories
Inventories at the lower of cost (determined on the FIFO method) or net realizable value consists of the following (in millions):
September 30, 2024December 31, 2023
Raw materials$47.4 $50.3 
Work in process23.219.8
Finished goods87.988.5
Supplies and other3.44.6
Total Inventory$161.9 $163.2 
We incurred $2.8 million and $4.3 million of expense for inventory write-offs and obsolescence in the three and nine months ended September 30, 2024, compared to $2.0 million and $6.3 million in the three and nine months ended September 30, 2023, respectively.

Property, Plant and Equipment
Property, plant and equipment consists of the following (in millions):
September 30, 2024December 31, 2023
Land$1.2 $1.3 
Buildings and leasehold improvements41.3 38.0 
Machinery and equipment185.4 182.8 
Construction in progress18.8 18.0 
246.7 240.1 
Less accumulated depreciation(137.2)(122.9)
Total$109.5 $117.2 
Depreciation expense was $5.3 million and $15.6 million for the three and nine months ended September 30, 2024,
14
respectively, compared to $4.8 million and $14.2 million for the three and nine months ended September 30, 2023, respectively.
Goodwill and Intangible Assets
The changes in the carrying amount of goodwill are as follows (in millions):
Goodwill
Balance, December 31, 2023$796.1 
Currency translation adjustment(1.0)
Balance, September 30, 2024$795.1 
Intangible assets subject to amortization consist of the following (in millions):
September 30, 2024December 31, 2023
Gross
Carrying
Amount		Accumulated
Amortization		Net Carrying AmountGross
Carrying
Amount		Accumulated
Amortization		Net Carrying Amount
Trademarks$41.6 $(29.7)$11.9 $42.0 $(28.8)$13.2 
Patents and acquired technologies248.5 (179.2)69.3 248.6 (171.9)76.7 
Other207.7 (68.8)138.9 207.7 (58.1)149.6 
Total$497.8 $(277.7)$220.1 $498.3 $(258.8)$239.5 
Amortization expense for intangible assets is included in “Cost of products sold” and “Selling and general expenses” and was $6.4 million and $18.8 million for the three and nine months ended September 30, 2024, respectively, compared to $6.2 million and $17.8 million for the three and nine months ended September 30, 2023, respectively. As of September 30, 2024 we had unrealized currency translation adjustments of $0.3 million related to our acquired intangibles from the acquisition of Diros.
Amortization expense for the remainder of 2024, the following four years and thereafter is estimated as follows (in millions):
Amount
Remainder of 2024$6.7 
202525.0 
202624.5 
202722.8 
202822.6 
Thereafter118.5 
Total$220.1 

Accrued Expenses
Accrued expenses consist of the following (in millions):
September 30, 2024December 31, 2023
Accrued rebates and customer incentives$23.6 $17.7 
Accrued salaries and wages29.8 31.5 
Accrued taxes and other6.2 16.7 
Other23.1 27.3 
Total$82.7 $93.2 
15

Other Long-Term Liabilities
Other long-term liabilities consist of the following (in millions):
September 30, 2024December 31, 2023
Accrued compensation and benefits$6.7 $5.9 
Other3.9 4.1 
Total$10.6 $10.0 
Note 6.    Fair Value Information
The following fair value information is based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels in the hierarchy used to measure fair value are:
Level 1: Unadjusted quoted prices in active markets accessible at the reporting date for identical assets and liabilities.
Level 2: Quoted prices for similar assets or liabilities in active markets. Quoted prices for identical or similar assets and liabilities in markets that are not considered active or financial instruments for which all significant inputs are observable, either directly or indirectly.
Level 3: Prices or valuations that require inputs that are significant to the valuation and are unobservable.
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The following table includes the fair value of our financial instruments for which disclosure of fair value is required (in millions):
September 30, 2024December 31, 2023
Fair Value
Hierarchy
Level		Carrying
Amount		Estimated
Fair
Value		Carrying
Amount		Estimated
Fair
Value
Assets
Cash and cash equivalents1$89.0 $89.0 $87.7 $87.7 
Liabilities
Revolving Credit Facility2$50.0 $50.0 $50.0 $50.0 
Term Loan Facility2112.0 112.0 118.0 118.0 
Contingent consideration related to acquisition3— — 5.3 5.3 
Cash equivalents are recorded at cost, which approximates fair value due to their short-term nature. The fair value of amounts borrowed under our Revolving Credit Facility and Term Loan Facility approximates carrying value because borrowings are subject to a variable rate as described in Note 7, “Debt”.
Note 7.     Debt
As of September 30, 2024 and December 31, 2023, our respective debt balances were as follows (in millions):
Weighted-Average Interest RateMaturitySeptember 30, 2024December 31, 2023
Revolving Credit Facility6.83 %2027$50.0 $50.0 
Term Loan Facility6.81 %2027112.5 118.8 
162.5 168.8 
Unamortized debt issuance costs(0.5)(0.8)
Current portion of long-term debt(9.4)(8.6)
Total Long-Term Debt, net$152.6 $159.4 

On June 24, 2022, we entered into a credit agreement (the “Credit Agreement”) with certain lenders which established credit facilities in an aggregate principal amount of $500.0 million, consisting of a five-year senior secured term loan of $125.0 million (the “Term Loan Facility”) and a five-year senior secured revolving credit facility allowing borrowings of up to $375.0 million, with a letter of credit sub-facility in an amount of $75.0 million (the “Revolving Credit Facility”). All obligations under the Credit Agreement and certain hedging agreements and cash management arrangements thereunder are: (i) guaranteed by each of the Company’s direct and indirect, existing and future, material wholly owned domestic subsidiaries (“Guarantors”) and
16
(ii) secured by a first priority lien on substantially all the assets of the Company and the Guarantors. The Credit Agreement contains an accordion feature that allows us to incur incremental term loans under the Term Loan Facility or under new term loan facilities or to increase the amount of the commitments under the Revolving Credit Facility, including through the establishment of one or more tranches under the Revolving Credit Facility. The Credit Agreement will mature on June 24, 2027.
Borrowings under the Term Loan Facility and Revolving Credit Facility bear interest at our option at either: (i) an adjusted term secured overnight financing rate (“SOFR”), plus a margin ranging between 1.50% to 2.00% per annum, depending on our consolidated total leverage ratio; (ii) an adjusted daily simple SOFR rate, plus a margin ranging between 1.50% to 2.00% per annum, depending on our consolidated total leverage ratio; or (iii) a base rate (calculated as the greatest of (a) the prime rate, (b) the NYFRB rate (being the greater of the federal funds effective rate or the overnight bank funding rate) plus 0.50%, and (c) the one month adjusted term SOFR rate plus 1.00%), plus a margin ranging between 0.50% to 1.00% per annum, depending on our consolidated total leverage ratio. The unused portion of the Revolving Credit Facility will be subject to a commitment fee ranging between 0.20% to 0.25% per annum, depending on our consolidated total leverage ratio. Unamortized debt discount and issuance costs are being amortized to interest expense over the life of the Term Loan Facility using the interest method, resulting in an effective interest rate of 7.1% as of September 30, 2024.
The Credit Agreement requires compliance with certain customary operational and financial covenants. As of September 30, 2024, we were in compliance with these covenants. In addition, the Credit Agreement contains certain other customary limitations on our ability to, among other things: incur additional indebtedness; pay dividends on or repurchase or redeem our capital stock; make loans, investments and acquisitions; sell, transfer or otherwise dispose of assets; guarantee other obligations; create or grant liens; and enter into certain types of transactions with affiliates. Notwithstanding such limitations, the Credit Agreement allows us to pay dividends, repurchase stock and make investments up to an “Available Amount,” as defined in the Credit Agreement, provided no event of default has occurred and certain financial ratios have been achieved on a pro forma basis. We are permitted to prepay all or a portion of the Term Loan Facility and the Revolving Credit Facility at any time without premium or penalty.
Debt Payments
The Credit Agreement requires quarterly principal installment payments on the Term Loan Facility of 10% of the total principal borrowed for the first eight quarters following funding and then quarterly installment payments of 20% of the total principal borrowed, at which time the remaining unpaid principal amount of the Term Loan Facility is due and payable by the Company upon the maturity date of June 24, 2027. The current portion of the Term Loan Facility is $9.4 million. Interest is payable quarterly. We have the right to voluntarily prepay the Term Loan Facility in accordance with the terms of the Credit Agreement. Interest is payable at the same rates set forth above for the Revolving Credit Facility.
During the nine months ended September 30, 2024, we repaid $6.3 million of the Term Loan Facility. During the nine months ended September 30, 2024, we borrowed $20.0 million and repaid $20.0 million of the Revolving Credit Facility. As of September 30, 2024, we had letters of credit outstanding of $6.3 million.
As of September 30, 2024, the aggregate amounts of long-term debt that will mature during each of the next four years are as follows (in millions):
Amount
Remainder of 2024$2.3 
20259.4 
202610.2 
2027140.6 
2028— 
Total$162.5 
17
Note 8.    Accumulated Other Comprehensive Income
The changes in the components of Accumulated Other Comprehensive Income (“AOCI”), net of tax, are as follows (in millions):
Unrealized Currency
Translation		Cash Flow
Hedges		Defined Benefit
Plans		Accumulated
Other
Comprehensive Loss
Balance, December 31, 2023$(27.0)$— $— $(27.0)
Other comprehensive loss(8.0)(1.8)(0.1)(9.9)
Balance, September 30, 2024$(35.0)$(1.8)$(0.1)$(36.9)
The net changes in the components of AOCI, including the tax effect, are as follows (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Unrealized currency translation$0.3 $(4.6)$(8.0)$2.8 
Defined benefit pension plans
0.1 — (0.1)— 
Defined benefit pension plans, net of tax
0.1 — (0.1)— 
Cash flow hedges0.7 — (1.3)— 
Tax effect(0.5)— (0.5)— 
Cash flow hedges, net of tax0.2 — (1.8)— 
Change in AOCI
$0.6 $(4.6)$(9.9)$2.8 
Note 9.     Stock-Based Compensation
Stock-based compensation expense is included in “Cost of products sold,” “Research and development,” and “Sales and general expenses.” Stock-based compensation expense for the three and nine months ended September 30, 2024 and 2023 is shown in the table below (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Stock options$— $— $— $0.3 
Time-based restricted share units2.7 2.5 7.6 7.9 
Performance-based restricted share units(0.1)1.3 2.3 3.4 
Employee stock purchase plan— 0.1 0.1 0.2 
Total stock-based compensation$2.6 $3.9 $10.0 $11.8 
Note 10.    Commitments and Contingencies
Legal Matters
We are subject to various legal proceedings, claims and governmental inspections, audits or investigations pertaining to issues such as contract disputes, product liability, tax matters, patents and trademarks, advertising, governmental regulations, employment and other matters. Under the terms of the distribution agreement we entered into with Kimberly-Clark Corporation (“Kimberly-Clark”) prior to our 2014 spin-off from Kimberly-Clark, legal proceedings, claims and other liabilities that are primarily related to our business are our responsibility and we are obligated to indemnify and hold Kimberly-Clark harmless for such matters.
Government Investigation
In June 2015, we were served with a subpoena from the Department of Veterans Affairs Office of the Inspector General (“VA OIG”) seeking information related to the design, manufacture, testing, sale and promotion of MicroCool and other surgical gowns produced by the Company. In July 2015, we became aware that the VA OIG subpoena and an earlier VA OIG subpoena served on Kimberly-Clark requesting information about gown sales to the federal government were related to a United States Department of Justice (“DOJ”) investigation. In May 2016, April 2017 and September 2018, we received additional subpoenas from the DOJ seeking further information related to the Company’s surgical gowns.
18
On July 6, 2021, we entered into a Deferred Prosecution Agreement (“DPA”) with the DOJ that resolved their criminal investigation related to our MicroCool surgical gowns. Pursuant to the terms of the DPA, in July 2021 the Company made a payment of $22.2 million. The DPA term expired on July 7, 2024. Under the DPA, the DOJ has up to six months following the term’s expiration to seek dismissal of the case.
Patent Litigation
We operate in an industry characterized by extensive patent litigation. Competitors may claim that our products infringe upon their intellectual property. Resolution of patent litigation or other intellectual property claims is typically time consuming and costly and can result in significant damage awards and injunctions that could prevent the manufacture and sale of the affected products or require us to make significant royalty payments in order to continue selling the affected products.
At any given time, we may be involved as either a plaintiff or a defendant in a number of patent infringement actions, the outcomes of which may not be known for prolonged periods of time.
General
While we maintain general and professional liability, product liability and other insurance, our insurance policies may not cover all of these matters and may not fully cover liabilities arising out of these matters. In addition, we may be obligated to indemnify our directors and officers against these matters.
We record provisions in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. For any matters that are reasonably possible to result in loss and for which no possible loss or range of loss is disclosed in this Form 10-Q, management has determined that it is unable to estimate the possible loss or range of loss because, in each case, at least the following facts applied: (a) the matter is at an early stage of the proceedings; (b) the damages are indeterminate, unspecified or determined to be immaterial; and (c) significant factual issues have yet to be resolved. At present, although the results of litigation and claims cannot be predicted with certainty, we believe that the ultimate resolution of any pending legal proceeding to which we are a party will not have a material adverse effect on our business, financial condition, results of operations or liquidity.
Environmental Compliance
We are subject to federal, state and local environmental protection laws and regulations with respect to our business operations. We believe we are operating in compliance with, or are taking action aimed at ensuring compliance with, these laws and regulations. None of our compliance obligations with environmental protection laws and regulations, individually or in the aggregate, is expected to have a material adverse effect on our business, financial condition, results of operations or liquidity.
Note 11.     Derivative Financial Instruments
During the second quarter of 2024, we began to enter into derivative instruments to hedge a portion of forecasted cash flows denominated in Mexican pesos. The derivative instruments used to manage these exposures are designated and qualify as cash flow hedges. The derivative liability for foreign exchange contracts was $2.1 million as of September 30, 2024 and is included in the condensed consolidated balance sheet in accrued expenses.
The effective portion of the gain or loss on a derivative instrument is initially recorded in AOCI, net of related income taxes, and recognized in earnings in the same period that the hedged exposure affects earnings. The loss recognized in earnings was not material in the three and nine months ended September 30, 2024. As of September 30, 2024, the aggregate notional values of outstanding foreign currency swap contracts designated as cash flow hedges were $17.8 million.
Note 12.    Earnings Per Share (“EPS”)
Basic EPS is calculated by dividing net income by the weighted average number of common shares outstanding during each period. Diluted earnings per share is calculated by dividing net income by the number of common shares outstanding and the effect of all dilutive common stock equivalents outstanding during each period, as determined using the treasury stock method.
19
The calculation of basic and diluted earnings (loss) per share for the three and nine months ended September 30, 2024 and 2023 is set forth in the following table (in millions, except per share amounts):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Net income (loss) from continuing operations
$5.9 $(8.8)$10.7 $(20.9)
Net (loss) income from discontinued operations(1.6)5.1 (5.5)(51.4)
Net income (loss)$4.3 $(3.7)$5.2 $(72.3)
Weighted Average Shares Outstanding:
Basic weighted average shares outstanding46.0 46.8 46.0 46.7 
Dilutive effect of stock options and restricted share unit awards0.6 — 0.5 — 
Diluted weighted average shares outstanding46.6 46.8 46.5 46.7 
Earnings (Loss) Per Share
Basic:
    Continuing Operations$0.13 $(0.19)$0.23 $(0.45)
    Discontinued Operations(0.03)0.11 (0.12)(1.10)
Basic Earnings (Loss) Per Share$0.10 $(0.08)$0.11 $(1.55)
Diluted:
    Continuing Operations$0.12 $(0.19)$0.23 $(0.45)
    Discontinued Operations(0.03)0.11 (0.12)(1.10)
Diluted Earnings (Loss) Per Share$0.09 $(0.08)$0.11 $(1.55)
Restricted share units (“RSUs”) contain provisions allowing for the equivalent of any dividends paid on common stock during the restricted period to be reinvested into additional RSUs at the then fair market value of the common stock on the date the dividends are paid. Such awards are to be included in the EPS calculation under the two-class method. Currently, we do not anticipate any cash dividends for the foreseeable future and our outstanding RSU awards are not material in comparison to our weighted average shares outstanding. Accordingly, all EPS amounts reflect shares as if they were fully vested and the disclosures associated with the two-class method are not presented herein.
For the three and nine months ended September 30, 2024, $1.0 million and $1.3 million of potentially dilutive stock options and RSU awards were excluded from the computation of earnings per share as their effect would have been anti-dilutive.
Note 13.     Business and Products Information
We conduct our business in one operating and reportable segment that provides our medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico.
20
Avanos develops, manufactures and markets its recognized brands globally and holds leading market positions in multiple categories across its portfolio. Our management evaluates net sales by product category within our single reportable segment as follows (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Digestive Health$98.2 $95.0 $290.6 $276.8 
Pain Management and Recovery:
Surgical pain and recovery30.3 34.1 93.8 103.6 
Interventional pain41.9 42.2 123.8 119.6 
Total Pain Management and Recovery72.2 76.3 217.6 223.2 
Total Net Sales$170.4 $171.3 $508.2 $500.0 
Digestive Health is a portfolio of products such as our MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions.
Pain Management and Recovery is a portfolio of products including:
•Surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and
•Interventional pain solutions, which provide minimally invasive pain relief therapies, such as our COOLIEF pain therapy, OrthogenRx’s knee osteoarthritis HA pain relief injection products and Diros’ RFA products used to treat chronic pain conditions.
Liabilities for estimated returns, rebates and incentives are presented in the table below (in millions):
September 30, 2024December 31, 2023
Accrued rebates$13.7 $10.4 
Accrued customer incentives9.9 7.3 
Accrued rebates and customer incentives23.6 17.7 
Accrued sales returns(a)
0.1 0.1 
Total estimated liabilities$23.7 $17.8 
__________________________________________________
(a)Accrued sales returns are included in “Other” in the accrued expenses table in Note 5, “Supplemental Balance Sheet Information”.
Due to the nature of our business, we receive purchase orders for products under supply agreements which are normally fulfilled within three to four weeks. Our performance obligations under purchase orders are satisfied and revenue is recognized at a point in time, which is upon shipment or upon delivery of our products, depending on shipping terms. Accordingly, we normally do not have transactions that give rise to material unfulfilled performance obligations.
Note 14.     Share Repurchase Program
On July 28, 2023, the Board of Directors approved a new one-year program under which we may repurchase up to $25.0 million of our common stock. Repurchases under this program will be made from time to time at management’s discretion on the open market or through privately negotiated transactions in compliance with Rule 10b-18 under the Exchange Act, subject to market conditions, applicable legal requirements and other relevant factors. We have established a pre-arranged trading plan under Rule 10b5-1 of the Exchange Act in connection with this share repurchase program. This share repurchase program does not obligate us to purchase any particular amount of common stock and may be suspended, modified or discontinued by us without prior notice. In the third quarter of 2023, we repurchased $9.2 million of our common stock and during the fourth quarter of 2023, we repurchased an additional $5.8 million of our common stock.
For the nine months ended September 30, 2024, our repurchases of our common stock were as summarized in the table below.
Shares RepurchasedAggregate Purchase Price
(in millions)		Average Price per ShareAmount Remaining in
Program for Purchase
(in millions)
# of SharesProgram to Date
First quarter of 2024342,680 1,085,333 $6.7 $19.45 $3.3 
Second quarter of 2024169,571 1,254,904 $3.3 $19.67 $— 
21
In addition to the share repurchase program, we withheld 140,539 shares of common stock for $2.7 million in taxes associated with stock-based compensation transactions for the nine months ended September 30, 2024.
22
Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations
Introduction
Avanos is a medical technology company focused on delivering clinically superior medical device solutions that help patients get back to the things that matter. We are committed to addressing some of today’s most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio.
This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to provide investors with an understanding of our recent performance, and should be read in conjunction with the condensed consolidated financial statements contained in Item 1, “Financial Statements” in this Form 10-Q and our audited consolidated financial statements and related notes included in the Form 10-K. This MD&A contains forward-looking statements. Refer to “Information Concerning Forward-Looking Statements” at the beginning of this Form 10-Q for an explanation of these types of statements.
The following will be discussed and analyzed:
•Restructuring Activities;
•Divestiture of the Respiratory Health Business;
•Discontinued Operations;
•Business Acquisition;
•Results of Operations and Related Information;
•Liquidity and Capital Resources; and
•Critical Accounting Policies and Use of Estimates.
Restructuring Activities
Post-RH Divestiture Restructuring Plan
During 2024, we initiated a restructuring plan (the “Plan”) following the divestiture of our Respiratory Health (“RH”) business in the fourth quarter of 2023 (the “RH Divestiture”). The Plan is intended to align our organizational structure and operational footprint with our remaining business. We expect the Plan will be substantially complete by the end of 2025 and currently expect to incur between $10.0 million to $11.0 million of cash expenses, primarily for employee termination benefits. In the three and nine months ended September 30, 2024, we incurred $2.3 million and $6.4 million, respectively, of costs related to the Plan. These costs were included in “Selling and general expenses” in the accompanying condensed consolidated income statements.
Transformation Process
In January 2023, we initiated a three-year restructuring initiative pursuant to which we plan to: (i) combine our Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management & Recovery product categories; (ii) rationalize our product portfolio including certain low-margin, low-growth product categories through targeted divestitures; (iii) undertake additional cost management activities to enhance the Company’s operating profitability; and (iv) pursue efficient capital allocation strategies, including through acquisitions that meet the Company’s strategic and financial criteria (the “Transformation Process”).
By 2025, we expect total gross savings of between $45.0 million and $55.0 million compared to 2022, most of which will be achieved in 2024. We expect the Transformation Process will be substantially complete by the end of 2025.
We expect to incur up to $30.0 million of cash expenses in connection with the Transformation Process, consisting of between $9.0 million and $12.0 million of program management consulting and employee retention expenses, between $8.0 million and $11.0 million of expenses associated with manufacturing and supply chain improvements and portfolio rationalization; and the remainder for expenses associated with organization design and alignment and other related activities. These amounts include between $6.0 million and $8.0 million of employee severance and benefits costs. The accompanying condensed consolidated income statements for the three and nine months ended September 30, 2024 include costs of $0.7 million and $5.2 million, respectively, incurred in connection with the Transformation Process in “Selling and general expenses.”
Divestiture
On October 2, 2023, we closed the sale of our RH business to SunMed Group Holdings, LLC (“Buyer”) for a total purchase price of $110 million in cash, subject to certain adjustments as provided in the Purchase Agreement based on the indebtedness
23
and inventory transferred to Buyer at the closing and the chargebacks assumed by Buyer but that would otherwise have been payable by the Company and its subsidiaries on or after October 2, 2023 to distributors of the Company’s RH products located in the United States.
The RH Divestiture represents a key component of the Transformation Process, and is aimed at accelerating the Company’s efforts to focus its portfolio on markets where it is well positioned to succeed.
In conjunction with the RH Divestiture, we and Buyer entered into various transition services agreements pursuant to which we, Buyer and each company’s respective affiliates will provide to each other various transitional services, including, but not limited to, product manufacturing and distribution, facilities, order fulfillment, invoicing, quality assurance, regulatory support, audit support and other services. The services generally commenced on the closing date of the RH Divestiture and terminate no later than one to three years thereafter.
On October 1, 2024, we finalized the RH Divestiture and completed the transfer of certain manufacturing facilities and equipment that had not transferred to Buyer upon the Initial Closing. Accordingly, we expect to finalize adjustments to our pretax loss on discontinued operations in the fourth quarter of 2024.
Discontinued Operations
As a result of the RH Divestiture, the results of operations from our RH business are reported as “(Loss) Income from discontinued operations, net of tax” and the related assets and liabilities are classified as “held for sale” in the condensed consolidated financial statements. Net sales from discontinued operations were $10.5 million and $41.0 million in the three and nine months ended September 30, 2024, compared to $31.1 million and $93.9 million in the three and nine months ended September 30, 2023.
Business Acquisition
On June 17, 2023 we entered into a definitive agreement to acquire Diros Technology Inc. (“Diros”), a leading manufacturer of innovative radiofrequency ablation (“RFA”) products used to treat chronic pain conditions. On July 24, 2023, we closed the acquisition of Diros for approximately $53.0 million, consisting of $2.5 million cash paid upon entry into the definitive agreement and $50.5 million in cash paid at closing (subject to certain working capital and other adjustments), with an additional $7.0 million payable in contingent cash consideration based on achievement of certain performance objectives defined in the purchase agreement (the “Diros Acquisition”). The purchase price for the Diros Acquisition was funded by proceeds from our Revolving Credit Facility.
See Note 4, “Business Acquisition” in Item 1 of this Form 10-Q for further details regarding the acquisition.
Results of Operations and Related Information
Use of Non-GAAP Measures
In this section, we present “Adjusted operating profit,” which is a profitability measure that is not calculated in accordance with accounting principles generally accepted in the United States (“GAAP”) and is therefore referred to as non-GAAP financial measure. We provide this non-GAAP measure because we use it to measure our operational performance and provide greater insight into our ongoing business operations. This measure is not intended to be, and should not be, considered separately from, or an alternative to, the most directly comparable GAAP financial measures. A reconciliation of the non-GAAP measure to the most directly comparable GAAP financial measures is provided below under “Adjusted operating profit.”
24
Net Sales
Our net sales are summarized in the following table for the three and nine months ended September 30, 2024 and 2023 (in millions):
Three Months Ended
September 30,		Nine Months Ended
September 30,
20242023Change20242023Change
Digestive Health$98.2 $95.0 3.4 %$290.6 $276.8 5.0 %
Pain Management and Recovery:
Surgical pain and recovery30.3 34.1 (11.1)%93.8 103.6 (9.5)%
Interventional pain41.9 42.2 (0.7)%123.8 119.6 3.5 %
Total Pain Management and Recovery72.2 76.3 (5.4)%217.6 223.2 (2.5)%
Total Net Sales$170.4 $171.3 (0.5)%$508.2 $500.0 1.6 %
TotalVolumePricing/MixCurrency
Other(a)
Net sales - percentage change QTD(0.5)%2.4 %(2.9)%(0.1)%0.1 %
Net sales - percentage changeYTD1.6 %3.6 %(1.9)%(0.1)%— %
______________________________
(a)Other includes rounding.
Product Category Descriptions
Digestive Health is a portfolio of products such as our MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions.
Pain Management and Recovery is a portfolio of products including:
•Surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and
•Interventional pain solutions, which provide minimally invasive pain relief therapies, such as our COOLIEF pain therapy, OrthogenRx’s knee osteoarthritis hyaluronic acid (“HA”) pain relief injection products and Diros’ RFA products used to treat chronic pain conditions.
Third Quarter of 2024 Compared to Third Quarter of 2023
For the three months ended September 30, 2024, net sales were $170.4 million, a decrease of 0.5% compared to the prior year period due to lower demand for our surgical pain products and lower demand and pricing for our HA products. This was partially offset by continued strong demand and volume in our Digestive Health portfolio, primarily from our NeoMed neonatal and pediatric feeding solutions, as well as continued demand for our Game Ready products and increased demand for Trident.
First Nine Months of 2024 Compared to the First Nine Months of 2023
For the nine months ended September 30, 2024, net sales were $508.2 million, an increase of 1.6% compared to the prior year period, primarily due to continued strong demand and volume in our Digestive Health portfolio and Game Ready products and increased demand for Trident. This was partially offset by lower demand and pricing for our HA products.
Net Sales by Geographic Region
Net sales by region is presented in the table below (in millions):
 Three Months Ended September 30,Nine Months Ended September 30,
20242023
Change
20242023
Change
North America$134.3 $136.4 (1.5)%$403.0 $401.0 0.5 %
Europe, Middle East and Africa23.2 20.9 11.0 69.7 61.1 14.1 
Asia Pacific and Latin America12.9 14.0 (7.9)35.5 37.9 (6.3)
Total net sales$170.4 $171.3 (0.5)%$508.2 $500.0 1.6 %
25
Gross Profit (in millions)
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Net sales$170.4 $171.3 $508.2 $500.0 
Cost of products sold77.5 75.8 224.9 215.3 
Gross profit92.9 95.5 283.3 284.7 
Gross profit margin54.5 %55.8 %55.7 %56.9 %
Third Quarter of 2024 Compared to Third Quarter of 2023
For the three months ended September 30, 2024 compared to the prior year period, gross profit margin decreased primarily due to costs related to our restructuring initiatives and plant separation costs associated with the RH Divestiture, partially offset by favorable volume and product mix.
First Nine Months of 2024 Compared to the First Nine Months of 2023
For the nine months ended September 30, 2024 compared to the prior year period, gross profit margin decreased primarily due to costs related to our restructuring initiatives and plant separation costs associated with the RH Divestiture along with unfavorable pricing for our HA products, slightly offset by overall favorable product mix.

Research and Development (in millions)
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Research and development$7.2 $6.1 $20.5 $20.4 
Percentage of net sales4.2 %3.6 %4.0 %4.1 %
Research and development consists primarily of compensation for personnel and expenses for product trial costs, outside laboratory and license fees, the cost of laboratory equipment and facilities and asset write-offs for equipment associated with unsuccessful product launches. Research and development has historically ranged between 4% and 6% of net sales.
Selling and General Expenses (in millions)
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Selling and general expenses$74.3 $78.7 $238.8 $260.5 
Percentage of net sales43.6 %45.9 %47.0 %52.1 %
Selling and general expenses decreased in both the three and nine months ended September 30, 2024, as compared to the prior year periods, driven by savings realized from the execution on the Transformation Process and disciplined spending.
Other (Income) Expense, net (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Other (income) expense, net$(0.6)$9.5 $1.7 $10.8 
Percentage of net sales(0.4)%5.5 %0.3 %2.2 %
Other income was $0.6 million for the three months ended September 30, 2024 and other expense, net was $1.7 million for the nine months ended September 30, 2024, compared to other expense, net of $9.5 million and $10.8 million in the three and nine months ended September 30, 2023, respectively.
26
Operating Profit (in millions)
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Operating profit (loss)$12.0 $1.2 $22.3 $(7.0)
Operating profit margin7.0 %0.7 %4.4 %(1.4)%
The items previously described drove operating profit to $12.0 million and $22.3 million for the three and nine months ended September 30, 2024, respectively, compared to operating profit of $1.2 million and operating loss of $7.0 million for the three and nine months ended September 30, 2023, respectively.
Adjusted Operating Profit
A reconciliation of adjusted operating profit, a non-GAAP measure, to operating profit (loss) is provided in the table below (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Operating profit (loss), as reported (GAAP)
$12.0 $1.2 $22.3 $(7.0)
Acquisition and integration-related charges1.6 0.6 4.1 2.4 
Restructuring and transformation charges0.7 4.3 5.2 23.0 
Post-RH Divestiture transition charges
0.7 — 2.2 — 
Post-RH Divestiture restructuring
2.3 — 6.4 — 
Divestiture related— 1.4 — 5.1 
EU MDR Compliance1.6 0.8 4.4 2.8 
Litigation and legal
— 8.5 — 8.5 
Intangibles amortization6.4 6.2 18.8 17.8 
Adjusted operating profit (non-GAAP)$25.3 $23.0 $63.4 $52.6 

The items noted in the table above are described below:
Acquisition and integration-related charges: Acquisition and integration-related charges were $1.6 million and $0.6 million for the three months ended September 30, 2024 and 2023 respectively, and $4.1 million and $2.4 million for the nine months ended September 30, 2024 and 2023, respectively. Expenses in the three and nine months ended September 30, 2024 were driven by the acquisition of Diros and expenses in the three and nine months ended September 30, 2023 were related to our acquisition of OrthogenRx, Inc.
Restructuring and transformation charges: In January 2023, we initiated the Transformation Process, a three-year restructuring initiative intended to align the Company under a single commercial organization, rationalize our product portfolio, undertake additional cost management activities to enhance the Company’s operating profitability and pursue efficient capital allocation strategies. In the three and nine months ended September 30, 2024 we incurred $0.7 million and $5.2 million, respectively, of expenses related to the Transformation Process, primarily for employee severance and benefits costs. In the three and nine months ended September 30, 2023 we incurred $4.3 million and $23.0 million, respectively, of expenses related to the Transformation Process, which consisted of costs associated with program management consulting and employee retention expenses and employee severance and benefits costs.
Post-RH Divestiture transition charges: In conjunction with the divestiture of our RH business, we incurred professional services fees, equipment write-offs and incremental labor charges of approximately $0.7 million and $2.2 million for the three and nine months ended September 30, 2024, respectively.
Post-RH Divestiture restructuring charges: We initiated a post-RH Divestiture restructuring plan intended to align our organizational structure and operational footprint with our remaining business. In the three and nine months ended September 30, 2024, we incurred expenses of $2.3 million and $6.4 million, respectively, related to the Plan, which primarily consisted of employee severance and benefits costs.
Divestiture-Related Charges: In conjunction with the divestiture of our RH business, we incurred accounting, legal and other professional fees of approximately $1.4 million and $5.1 million for the three and nine months ended September 30, 2023.
EU MDR Compliance: The European Union Medical Device Regulation (the “EU MDR”) brings significant new requirements for our medical devices sold in the European Union. Incremental costs associated with EU MDR compliance are primarily
27
related to re-certification of our products under the enhanced standards. We incurred $1.6 million and $4.4 million of costs for EU MDR compliance for the three and nine months ended September 30, 2024, respectively, and $0.8 million and $2.8 million of costs for EU MDR compliance for the three and nine months ended September 30, 2023, respectively. In early 2023, the deadlines for compliance were extended after compliance was proceeding slower than expected by the European Commission due to a number of factors including insufficient capacity for timely issuance of device certifications under the new requirements. We expect the activities associated with EU MDR compliance will be substantially complete by the end of 2025.
Litigation and legal: We incurred no costs for litigation matters in the three and nine months ended September 30, 2024. In the three and nine months ended September 30, 2023, we accrued $8.5 million for litigation matters. This expense was for a settlement related to a customer claim and is included in “Other expense, net”.
Intangibles amortization: Intangibles amortization is related primarily to intangibles acquired in business acquisitions and was $6.4 million and $18.8 million for the three and nine months ended September 30, 2024, respectively, and $6.2 million and $17.8 million for the three and nine months ended September 30, 2023, respectively.
Interest Expense
Interest expense consists of interest accrued and amortization of debt issuance costs on our revolving credit facility net of interest capitalized on long-term capital projects. See Note 7, “Debt” in Item 1 of this Form 10-Q. Interest expense was $3.2 million and $9.4 million for the three and nine months ended September 30, 2024, respectively, compared to $4.7 million and $11.7 million in the three and nine months ended September 30, 2023, respectively. Our outstanding debt balances, net of unamortized discounts, were $162.0 million and $168.0 million as of September 30, 2024 and December 31, 2023, respectively.

Income Taxes
The income tax provision was $3.6 million and $6.5 million, respectively, in the three and nine months ended September 30, 2024, compared to an income tax provision of $6.2 million and $4.1 million in the three and nine months ended September 30, 2023, respectively. Our effective tax rate was 37.9% and 37.8% in the three and nine months ended September 30, 2024, respectively. For the three and nine months ended September 30, 2023, our effective tax rate was (238.5)% and (24.4)%, respectively.
Liquidity and Capital Resources
General
Our primary sources of liquidity are cash on hand provided by operating activities and amounts available with our Revolving Credit Facility under our Credit Agreement. We expect our operating cash flow will be sufficient to meet our working capital requirements and fund capital expenditures in the next twelve months. In addition, with our borrowing capacity, we expect to have the ability to fund capital expenditures and other investments necessary to grow our business for the foreseeable future for both our domestic and international operations.
As of September 30, 2024, $43.0 million of our $89.0 million of cash and cash equivalents was held by foreign subsidiaries. We consider the undistributed earnings of our foreign subsidiaries to be indefinitely reinvested overseas and currently do not have plans to repatriate such earnings. We do not expect restrictions on repatriation of cash held outside of the United States to have a material effect on our overall liquidity, financial condition or results of operations for the foreseeable future.
Cash and cash equivalents increased by $1.3 million to $89.0 million as of September 30, 2024, compared to $87.7 million as of December 31, 2023. The increase was primarily driven by $42.8 million of cash provided by operations and $20.0 million in proceeds from our revolving credit facility. This was partially offset by $13.0 million of capital expenditures, a 9.0 million investment in a note receivable, payments of $6.3 million on our term loan, payments of $20.0 million on our revolving credit facility and $12.7 million used to repurchase shares of our common stock.
In the prior year, cash and cash equivalents decreased by $20.6 million to $107.1 million as of September 30, 2023. The decrease was primarily driven by $47.5 million used to purchase Diros, $11.9 million of capital expenditures, payments of $20.0 million on our revolving credit facility and $12.9 million used to repurchase shares of our common stock. This was partially offset by $19.7 million of cash generated from operating activities and $55.0 million in proceeds from our revolving credit facility.
Long-Term Debt
On June 24, 2022, we entered into a credit agreement (the “Credit Agreement”) with certain lenders which established credit facilities in an aggregate principal amount of $500.0 million, consisting of a five-year senior secured term loan of $125.0 million (the “Term Loan Facility”) and a five-year senior secured revolving credit facility allowing borrowings of up to $375.0 million, with a letter of credit sub-facility in an amount of $75.0 million (the “Revolving Credit Facility”). All obligations under the Credit Agreement and certain hedging agreements and cash management arrangements thereunder are: (i) guaranteed by
28
each of the Company’s direct and indirect, existing and future, material wholly owned domestic subsidiaries (“Guarantors”) and (ii) secured by a first priority lien on substantially all the assets of the Company and the Guarantors. The Credit Agreement contains an accordion feature that allows us to incur incremental term loans under the Term Loan Facility or under new term loan facilities or to increase the amount of the commitments under the Revolving Credit Facility, including through the establishment of one or more tranches under the Revolving Credit Facility. The Credit Agreement will mature on June 24, 2027.
Borrowings under the Term Loan Facility and Revolving Credit Facility bear interest at our option at either: (i) an adjusted term secured overnight financing rate (“SOFR”), plus a margin ranging between 1.50% to 2.00% per annum, depending on our consolidated total leverage ratio; (ii) an adjusted daily simple SOFR rate, plus a margin ranging between 1.50% to 2.00% per annum, depending on our consolidated total leverage ratio; or (iii) a base rate (calculated as the greatest of (a) the prime rate, (b) the NYFRB rate (being the greater of the federal funds effective rate or the overnight bank funding rate) plus 0.50%, and (c) the one month adjusted term SOFR rate plus 1.00%), plus a margin ranging between 0.50% to 1.00% per annum, depending on our consolidated total leverage ratio. The unused portion of the Revolving Credit Facility will be subject to a commitment fee ranging between 0.20% to 0.25% per annum, depending on our consolidated total leverage ratio.
The Credit Agreement requires compliance with certain customary operational and financial covenants. As of September 30, 2024, we were in compliance with these covenants. In addition, the Credit Agreement contains certain other customary limitations on our ability to, among other things: incur additional indebtedness; pay dividends on or repurchase or redeem our capital stock; make loans, investments and acquisitions; sell, transfer or otherwise dispose of assets; guarantee other obligations; create or grant liens; and enter into certain types of transactions with affiliates. Notwithstanding such limitations, the Credit Agreement allows us to pay dividends, repurchase stock and make investments up to an “Available Amount,” as defined in the Credit Agreement, provided no event of default has occurred and certain financial ratios have been achieved on a pro forma basis.
See Note 7, “Debt” in Item 1 of this Form 10-Q for further details regarding our debt agreements.

Critical Accounting Policies and Use of Estimates
Our financial statements are prepared by applying certain accounting policies. See Note 1, “Accounting Policies” in Item 8, “Financial Statements and Supplementary Data” in the Form 10-K, which describes our most significant accounting policies. In addition, our critical accounting policies and estimates are presented under the caption “Critical Accounting Policies and Use of Estimates” in Item 7, “Management's Discussion and Analysis of Financial Condition and Results of Operation” in the Form 10-K. Certain of these policies require management to make estimates or assumptions that may prove inaccurate or be subject to variations that may significantly affect our reported results and financial position for the period or in future periods. Management views these policies as critical accounting policies. See Note 1, “Accounting Policies” in Item 1 of this Form 10-Q for updates to our critical accounting policies and a discussion of recent accounting pronouncements. In the three and nine months ended September 30, 2024, there were no significant changes to our critical accounting estimates from those disclosed in Item 7, “Management's Discussion and Analysis of Financial Condition and Results of Operation” in the Form 10-K.

Item 3.    Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes regarding our market risk position from the information provided under Item 7A – “Quantitative and Qualitative Disclosures About Market Risk” in the Form 10-K.

Item 4.    Controls and Procedures
With the participation of management, our Chief Executive Officer (principal executive officer) and our Senior Vice President, and Chief Financial Officer (principal financial officer) carried out an evaluation, pursuant to Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and our Senior Vice President and Chief Financial Officer concluded that our disclosure controls and procedures were operating effectively as of September 30, 2024.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting that occurred during the three months ended September 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
29
PART II – OTHER INFORMATION

Item 1.    Legal Proceedings
We are subject to various legal proceedings, claims and governmental inspections, audits or investigations pertaining to issues such as contract disputes, product liability, tax matters, patents and trademarks, advertising, governmental regulations, employment and other matters. At present, although the results of litigation and claims cannot be predicted with certainty, we believe that the ultimate resolution of any pending legal proceeding to which we are a party will not have a material adverse effect on our business, financial condition, results of operations or liquidity.

Item 1A.    Risk Factors
There have been no material changes to the risk factors described in Part I, Item 1A, “Risk Factors,” of the Form 10-K, except as follows:
We are subject to political, economic and regulatory risks associated with doing business outside of the United States.
Most of our manufacturing facilities are located outside the United States in Mexico. In addition, we use contract manufacturers outside the United States from time to time and source many of our raw materials and components from foreign suppliers, including suppliers in China and Mexico. We distribute and sell our products globally. In 2023, approximately 20% of our net sales were generated outside of North America and we expect this percentage will grow over time. Our operations outside of the United States are subject to risks that are inherent in conducting business internationally, including compliance with both United States and foreign laws and regulations that apply to our international operations. These laws and regulations include robust data privacy requirements, labor relations laws that may impede employer flexibility, tax laws, anti-competition regulations, import, customs and trade restrictions, export requirements, economic sanction laws, environmental, health and safety laws, anti-bribery laws such as the U.S. Foreign Corrupt Practices Act and similar anti-bribery laws in other jurisdictions. Given the high level of complexity of these laws, there is a risk that some provisions may be violated inadvertently or through fraudulent or negligent behavior of individual employees, our failure to comply with certain formal documentation requirements or otherwise. In addition, these laws are subject to changes, which may require additional resources or make it more difficult for us to comply with these laws. Violations of the laws and regulations governing our international operations could result in fines or criminal sanctions against us, our officers or our employees, and prohibitions on the conduct of our business. Any such violations could include prohibitions on our ability to manufacture or distribute our products in one or more countries and could have a material adverse effect on our reputation, our brand, our international expansion efforts, our ability to attract and retain employees, our business, results of operations, financial condition and cash flows. Our success depends, in part, on our ability to anticipate and prevent or mitigate these risks and manage difficulties as they arise.
We are subject to tariffs and taxes in the United States and numerous foreign jurisdictions, and we may be subject to trade protection measures that are being contemplated or implemented by the United States and other governments around the world, as well as potential disruptions in trade agreements, such as the exit of the United Kingdom from the EU. For example, during 2024 the United States announced increased tariffs on a Chinese-sourced component of certain of our products. While we have received an extension on the effectiveness of such tariffs, we are exploring options to identify a longer-term solution to such tariffs (although there can be no assurance that we will succeed in such efforts). In addition, changes in the United States government following the 2024 presidential and congressional elections may result in changes to United States trade policies and tariffs, and may cause other countries to react to such changes.
These developments, measures and disruptions may result in new or higher tariffs, import-export restrictions and taxes. Changes in, or revised interpretations of import-export laws or international trade agreements, along with new or increased tariffs, trade restrictions or taxation on income earned or goods manufactured outside the United States may have a material adverse effect on our business, financial condition, results of operations and cash flows.
In addition to the foregoing, engaging in international business inherently involves a number of other difficulties and risks, including:
•different local medical practices, product preferences and product requirements,
•price and currency controls and exchange rate fluctuations,
•cost and availability of international shipping channels,
•longer payment cycles in certain countries other than the United States,
•minimal or diminished protection of intellectual property in certain countries,
30
•uncertainties regarding judicial systems, including difficulties in enforcing agreements through certain non-U.S. legal systems,
•political instability and actual or anticipated military or political conflicts, expropriation of assets, economic instability and the impact on interest rates, inflation and the credit worthiness of our customers, and
•difficulties and costs of staffing and managing non-U.S. operations
These risks and difficulties, individually or in the aggregate, could have a material adverse effect on our business, results of operations, financial condition and cash flows.
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds
Not applicable

Item 3.    Defaults Upon Senior Securities
Not applicable

Item 4.    Mine Safety Disclosures
Not applicable

Item 5.    Other Information
On October 29, 2024, the Compensation Committee of the Board of Directors approved an amendment to the Company’s Executive Severance Plan (the “Executive Severance Plan”) pursuant to which the payout multiple payable to Executive Participants (as that term is defined in the Executive Severance Plan) under the Executive Severance Plan (other than the Company’s Chief Executive Officer) following a Qualified Termination of Employment (as that term is defined in the Executive Severance Plan) has been increased from one and one-half to two times the sum of the Executive Participant’s annual base salary and target full annual cash incentive award for the year in which the Qualified Termination of Employment occurs. The other elements of the cash payment to which Executive Participants would be entitled under the Executive Severance Plan upon a Qualified Termination of Employment remain unchanged.

31
Item 6.     Exhibits

(a)Exhibits
Exhibit
Number		Description
101.INSXBRL Instance Document - The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
* Management contracts, compensatory plans or arrangements
** The certifications attached as Exhibit 32(a) and 32(b) that accompany this Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Avanos Medical, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-Q, irrespective of any general incorporation language contained in such filing.
32
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
AVANOS MEDICAL, INC.
(Registrant)
October 30, 2024By: /s/ Warren J. Machan
 Warren J. Machan
 Interim Chief Financial Officer
 (Principal Financial Officer)
October 30, 2024By:/s/ John J. Hurley
John J. Hurley
Controller
(Principal Accounting Officer)

33
 EX-4.1 2 avns3q2024from10qex41.htm FIRST AMENDMENT TO CREDIT AGREEMENT Document

Exhibit 4.1
FIRST AMENDMENT TO CREDIT AGREEMENT

This FIRST AMENDMENT TO CREDIT AGREEMENT (this “First Amendment”) dated as of June 26, 2024, is by and among AVANOS MEDICAL, INC., a Delaware corporation (the “Borrower”), THE LENDERS PARTY HERETO and JPMORGAN CHASE BANK, N.A., as Administrative Agent for the Lenders (in such capacity “Agent”).

WHEREAS, the Borrower, the Guarantors, the Lenders party thereto and the Agent entered into that certain Credit Agreement dated as of June 24, 2022 (as amended and in effect immediately prior to the effectiveness of this First Amendment, the “Credit Agreement”; the Credit Agreement, as amended by this First Amendment, the “Amended Credit Agreement”);

WHEREAS, the Agent, the Required Lenders and the Borrower seek to modify certain terms and provisions of the Credit Agreement as set forth herein; and
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by the parties hereto, the parties hereto hereby agree as follows:
Section 1. Definitions. Capitalized terms used in this First Amendment and not otherwise defined herein shall have the respective meanings given such terms in the Amended Credit Agreement.

Section 2. Specific Amendment to Credit Agreement. Section 7.05(j) of the Credit Agreement is hereby restated in its entirety as follows:

(j) the repurchase, redemption or other acquisition for value of Equity Interests of the Borrower; provided that the aggregate Restricted Payments made under this Section 7.05(j) do not exceed (i) repurchases, redemptions and acquisitions to be made pursuant to the stock redemption program that was commenced prior to the Closing Date plus (ii) $75,000,000 during the term of this Agreement;

Section 3. Conditions Precedent. The effectiveness of this First Amendment is subject to the satisfaction of each of the following conditions (the date such conditions are satisfied is referred to herein as the “First Amendment Effective Date”):

(a) Receipt by the Agent of counterparts of this First Amendment duly executed by the Borrower and Required Lenders;

(b) Payment of all reasonable fees, costs and expenses of the Agent invoiced at least one Business Day prior to the First Amendment Effective Date including, without limitation, the fees and expenses set forth in Section 7 hereof.

Section 4. Representations. The Borrower represents and warrants to the Agent and the Lenders party hereto that:
(a) Authorization. The Borrower has full power, authority and legal right to make, deliver and perform all of its respective obligations hereunder and under the Amended Credit Agreement, and to enter into this First Amendment. This First Amendment has been duly executed and delivered on behalf of the Borrower. The Amended Credit Agreement constitutes a legal, valid and binding obligation of each Loan Party enforceable against such Loan Party in accordance with its terms, except as enforceability may be limited by Debtor Relief Laws and by general principles of equity.


Exhibit 4.1
(b) Compliance with Laws, etc. The execution and delivery by the Borrower of this First Amendment and performance by each Loan Party of the Amended Credit Agreement do not (i) contravene the terms of any such Person’s Organizational Documents, (ii) conflict with or result in any breach or contravention of, or the creation of any Lien under (other than as permitted by Section 7.01 of the Amended Credit Agreement) (x) any material order, injunction, writ or decree of any Governmental Authority or any arbitral award to which such Person or its property is subject or (y) any material agreement to which such Person is a party or (iii) violate any material Law; except with respect to any conflict, breach, violation or contravention referred to in clause (ii) or (iii), to the extent that such conflict, breach, violation or contravention would not reasonably be expected to have a Material Adverse Effect.

(c) No Default. No Default or Event of Default has occurred and is continuing as of the date hereof nor will exist immediately after giving effect to this First Amendment.

Section 5. Reaffirmation of Representations; Liens and Obligations of Loan Parties. Without limiting Section 4 hereof, the Borrower hereby (i) certifies that as of the date hereof, the representations and warranties of the Loan Parties contained in the Loan Documents are true and correct in all material respects (except to the extent that such representations and warranties specifically refer to an earlier date, in which case they are true and correct as of such earlier date), (ii) ratifies and reaffirms the Liens granted to the Agent for the benefit of the Lenders under the Amended Credit Agreement and each other Loan Document and confirms and agrees that such Liens hereafter secure all of the Obligations and (iii) acknowledges and reaffirms its Obligations and its continuing obligations owing to the Agent and the Lenders under each of the Loan Documents including, without limitation, the Security Agreement. By executing this First Amendment, the Borrower hereby acknowledges, consents and agrees that all of the Loan Parties’ obligations and liabilities under the Guaranty contained in the Amended Credit Agreement, contingent or otherwise, remain in full force and effect, and that the execution and delivery of this First Amendment shall not alter, amend, reduce or modify its obligations and liability under the Guaranty or any of the other Loan Documents to which it is a party except as expressly set forth herein.

Section 6. Certain References; Effect.

(a) Each reference to the Credit Agreement in any of the Loan Documents shall be deemed to be a reference to the Amended Credit Agreement. This First Amendment shall be deemed to be a “Loan Document” under the Amended Credit Agreement.

(b) Except as expressly herein amended, the terms and conditions of the Credit Agreement and the other Loan Documents remain unchanged and continue to be in full force and effect. The Amended Credit Agreement is hereby ratified and confirmed in all respects. The Agent and the Lenders reserve all rights, privileges and remedies under the Loan Documents. The consent, acknowledgment and amendments contained herein shall be deemed to have prospective application only, unless otherwise specifically stated herein.

Section 7. Fees and Expenses. The Borrower shall reimburse the Agent upon demand for all reasonable out-of-pocket costs and expenses (including reasonable attorneys’ fees) incurred by the Agent in connection with the preparation, negotiation, and execution of this First Amendment and the other agreements and documents executed and delivered in connection herewith.

Section 8. Entire Agreement. This First Amendment and the other Loan Documents embody the entire agreement between the parties and supersede all prior agreements and understandings, if any, relating to the subject matter hereof. This First Amendment represents the final agreement among the


Exhibit 4.1
parties and may not be contradicted by evidence of prior, contemporaneous or subsequent oral agreements of the parties.

Section 9. Benefits. This First Amendment shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns.

Section 10. GOVERNING LAW. THIS FIRST AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO ANY CONFLICTS PROVISIONS THAT WOULD RESULT IN THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION (OTHER THAN SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW).

Section 11. Effect. Nothing in this First Amendment shall limit, impair or constitute a waiver of the rights, powers or remedies available to the Agent or the Lenders under the Amended Credit Agreement or any other Loan Document.

Section 12. Counterparts. Delivery of an executed counterpart of a signature page of this First Amendment that is an Electronic Signature transmitted by telecopy, emailed .pdf or any other electronic means that reproduces an image of an actual executed signature page shall be effective as delivery of a manually executed counterpart of this First Amendment. The words “execution,” “signed,” “signature,” “delivery,” and words of like import in or relating to this First Amendment shall be deemed to include Electronic Signatures, deliveries or the keeping of records in any electronic form (including deliveries by telecopy, emailed .pdf or any other electronic means that reproduces an image of an actual executed signature page), each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be; provided that nothing herein shall require the Agent to accept Electronic Signatures in any form or format without its prior written consent and pursuant to procedures approved by it; provided further that, without limiting the foregoing, (i) to the extent the Agent has agreed to accept any Electronic Signature, the Agent and each of the Lenders shall be entitled to rely on such Electronic Signature purportedly given by or on behalf of the Borrower or any other Loan Party without further verification thereof and without any obligation to review the appearance or form of any such Electronic Signature and (ii) upon the request of the Agent or any Lender, any Electronic Signature shall be promptly followed by a manually executed counterpart.

[Signatures Commence on Next Page]



Exhibit 4.1
IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to Credit Agreement to be executed as of the date first above written.

Borrower:

AVANOS MEDICAL, INC.

By: /s/ JASON PICKETT
Name: Jason Pickett
Title: Vice President, Tax and Treasurer









Exhibit 4.1
JPMORGAN CHASE BANK, N.A., as Agent and a Lender

By: /s/ HELEN D. DAVIS
Name: Helen D. Davis
Title: Authorized Signer








Exhibit 4.1
MUFG BANK, LTD., as a Lender

By: /s/ DOMINIC YUNG
Name: Dominic Yung
Title: Director







Exhibit 4.1
PNC Bank, National Association, as a Lender

By: /s/ AMY TALIA
Name: Amy Tallia
Title: SVP







Exhibit 4.1
U.S. BANK NATIONAL ASSOCIATION, as a Lender

By: /s/ CHRISTIAN PELLICCI
Name: Christian Pellicci
Title: Assistant Vice President







Exhibit 4.1
ING CAPTIAL LLC, as a Lender

By: /s/ TIM VAN DEN BERG
Name: Tim van den Berg
Title: Director


By: /s/ STEPHEN FARRELLY
Name: Stephen Farrelly
Title: Managing Director






Exhibit 4.1
Regions Bank, as a Lender

By: /s/ JOHN LEVESQUE
Name: John Levesque
Title: Managing Director







Exhibit 4.1
MORGAN STANLEY BANK, N.A., as a Lender

By: /s/ RIKIN PANDYA
Name: Rikin Pandya
Title: Authorized Signatory







Exhibit 4.1
UBS AG, Stamford Branch, as a Lender

By: /s/ Peter Hazoglou
Name: Peter Hazoglou
Title: Authorized Signatory


By: /s/ ANTHONY N. JOSPEH
Name: Anthony N. Joseph
Title: Associate Director



 EX-10.1 3 avns3q2024form10qex101.htm AMENDED AND RESTATED EXECUTIVE SEVERANCE PLAN Document

image_0.jpg
AVANOS MEDICAL, INC.
EXECUTIVE SEVERANCE PLAN
Amended and Restated as of October 29, 2024


1.    Preamble and Statement of Purpose. The purpose of this Plan is to assure the Corporation that it will have the continued dedication of, and the availability of objective advice and counsel from, key executives of the Corporation notwithstanding the possibility, threat or occurrence of a change of control of the Corporation.

In the event the Corporation receives any proposal from a third person concerning a possible business combination with the Corporation, or acquisition of the Corporation’s equity securities, or otherwise considers or pursues a transaction that could lead to a change of control, the Committee believes it imperative that the Corporation and the Board of Directors of the Corporation (the “Board”) be able to rely upon key executives to continue in their positions and be available for advice, if requested, without concern that those individuals might be distracted by the personal uncertainties and risks created by such a possibility.

Should the Corporation receive or consider any such proposal or transaction, in addition to their regular duties, such key executives may be called upon to assist in the assessment of the proposal or transaction, to advise management and the Board as to whether the proposal or transaction would be in the best interests of the Corporation and its stockholders, and to take such other actions as the Board might determine to be appropriate.

2.    Definitions. As used in this Plan, the following terms shall have the following respective meanings.

(a)    Annual Bonus Amount: For any Participant, the target full annual cash incentive awards for the Participant under the Avanos Medical, Inc. Management Achievement Award Program or any successor or additional plan (the “Bonus Program”), for the year in which the Relevant Date occurs, without regard to any otherwise-applicable proration.

(b)    Cause: The term “Cause” shall mean any of the following:

(i)    the commission by the Participant of a felony;

(ii)    the Participant’s dishonesty, habitual neglect or incompetence in the management of the affairs of the Corporation; or

(iii)    the refusal or failure by the Participant to act in accordance with any lawful directive or order of the Corporation, or an act or failure to act


by the Participant which is in bad faith and which is detrimental to the Corporation; or

(iv)    the Participant’s material breach of any employment, severance, restrictive covenant agreement, or similar agreement, with the Corporation or a Subsidiary.

(c)    Change of Control: “Change of Control” means and includes the occurrence of any one of the following events but shall specifically exclude a public offering of any class or series of the Corporation’s equity securities pursuant to a registration statement filed by the Corporation under the Securities Act of 1933:

(i)    during any consecutive 12-month period, individuals who, at the beginning of such period, constitute the Board (the “Incumbent Directors”) cease for any reason to constitute at least a majority of such Board, provided that any person becoming a director after the beginning of such 12-month period and whose election or nomination for election was approved by a vote of at least a majority of the Incumbent Directors then on the Board shall be an Incumbent Director; provided, however, that no individual initially elected or nominated as a director of the Corporation as a result of an actual or threatened election contest with respect to the election or removal of directors (“Election Contest”) or other actual or threatened solicitation of proxies or consents by or on behalf of any Person other than the Board (“Proxy Contest”), including by reason of any agreement intended to avoid or settle any Election Contest or Proxy Contest, shall be deemed an Incumbent Director; or

(ii)    any individual, entity or group, within the meaning of Section 3(a)(9) of the Securities Exchange Act of 1934 (the “Exchange Act”) and as used in Section 13(d)(3) or 14(d)(2) of the Exchange Act (a “Person”), other than a broker, underwriter or financial institution that acquires such shares as part of a firm commitment or similar underwriting or distribution process pursuant to which the subject shares of stock are being held for further distribution (an “Underwriter”), becomes a “Beneficial Owner” under the meaning given such term in Rule 13d-3 of the General Rules and Regulations under the Exchange Act, directly or indirectly, of either (A) 30% or more of the then-outstanding shares of common stock of the Corporation (“Corporation Common Stock”) or (B) securities of the Corporation representing 30% or more of the combined voting power of the Corporation’s then outstanding securities eligible to vote for the election of directors (the “Corporation Voting Securities”); provided, however, that for purposes of this subsection (ii), the following acquisitions of Corporation Common Stock or Corporation Voting Securities shall not constitute a Change of Control: (w) an acquisition directly (or indirectly through Underwriters) from the Corporation, (x) an acquisition by the Corporation or a Subsidiary, (y) an acquisition
-2-


by any employee benefit plan (or related trust) sponsored or maintained by the Corporation or any Subsidiary, or (z) an acquisition pursuant to a Non-Qualifying Transaction (as defined in subsection (iii) below); or

(iii)    the consummation of a reorganization, merger, consolidation, statutory share exchange or similar form of corporate transaction involving the Corporation or a Subsidiary (a “Reorganization”), or the sale or other disposition of all or substantially all of the Corporation’s assets (a “Sale”) or the acquisition of assets or stock of another corporation or other entity (an “Acquisition”), unless immediately following such Reorganization, Sale or Acquisition: (A) all or substantially all of the individuals and entities who were the Beneficial Owners, respectively, of the outstanding Corporation Common Stock and outstanding Corporation Voting Securities immediately prior to such Reorganization, Sale or Acquisition beneficially own, directly or indirectly, more than 50% of, respectively, the then outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the entity resulting from such Reorganization, Sale or Acquisition (including, without limitation, an entity which as a result of such transaction owns the Corporation or all or substantially all of the Corporation’s assets or stock either directly or through one or more subsidiaries, the “Surviving Entity”) in substantially the same proportions as their ownership, immediately prior to such Reorganization, Sale or Acquisition, of the outstanding Corporation Common Stock and the outstanding Corporation Voting Securities, as the case may be, and (B) no person (other than (x) the Corporation or any Subsidiary, (y) the Surviving Entity or its ultimate parent entity, or (z) any employee benefit plan (or related trust) sponsored or maintained by any of the foregoing) is the Beneficial Owner, directly or indirectly, of 30% or more of the total common stock or 30% or more of the total voting power of the outstanding voting securities eligible to elect directors of the Surviving Entity, and (C) at least a majority of the members of the board of directors of the Surviving Entity were Incumbent Directors at the time of the Board’s approval of the execution of the initial agreement providing for such Reorganization, Sale or Acquisition (any Reorganization, Sale or Acquisition which satisfies all of the criteria specified in (A), (B) and (C) above shall be deemed to be a “Non-Qualifying Transaction”); or

(iv)    approval by the stockholders of the Corporation of a complete liquidation or dissolution of the Corporation.

(d)    Code: The Internal Revenue Code of 1986, as amended.

(e)    Committee: The Compensation Committee of the Board.
-3-



(f)    Corporation: Avanos Medical, Inc. and any successor thereto that assumes this Plan pursuant to Section 14 below.

(g)    Discretionary Participant: Any Participant who is not an executive officer of the Corporation.

(h)    Eligible Employee: Those key executives and other officers of the Corporation and its Subsidiaries who are from time to time designated by the Committee as, or who pursuant to criteria established by the Board or the Committee are, eligible to participate in this Plan.

(i)    Equity Plans: The Avanos Medical, Inc. Equity Participation Plan, the Avanos Medical, Inc. 2021 Long Term Incentive Plan, as amended, and any successor or additional plans under which a Participant receives stock options, restricted stock, RSUs (as defined below) or other equity-based compensation.

(j)    Executive Participant: A Participant who is an executive officer of the Corporation.
    
(k)    Excise Tax: The excise tax imposed by Section 4999 of the Code, together with any interest or penalties imposed with respect to such excise tax.

(l)    Fair Market Value: With respect to any publicly traded equity security, the reported closing price of such security on the relevant date as reported on the composite list used by The Wall Street Journal for reporting stock prices, or, if no such sale shall have been made on that day, on the last preceding day on which there was such a sale; and with respect to any other property, the fair market value thereof as determined by the Committee in good faith.

(m)    Good Reason: Termination by the Participant for “Good Reason” shall mean the Separation from Service during the two-year time period following the initial existence (without the Participant’s express written consent) of any one of the following conditions:

(i)     A material diminution in the Participant’s base compensation.

(ii)     A material diminution in the Participant’s authority, duties or responsibilities.

(iii)     A material diminution in the authority, duties, or responsibilities of the supervisor to whom the Participant is required to report, including a requirement that a Participant report to a corporate officer or employee instead of reporting directly to the Board.

(iv)     A material diminution in the budget over which the Participant retains authority.
-4-



(v)    A change, by more than 50 miles, in the geographic location at which the Participant must perform the services.

(vi)    Any other action or inaction that constitutes a material breach by the Corporation of any agreement under which the Participant provides services.

The Participant must provide notice to the Corporation of the existence of any of the above conditions within a period not to exceed 90 days of the initial existence of the condition, upon the notice of which the Corporation must be provided a period of at least 30 days during which it may remedy the condition. In the event the Corporation remedies such condition during such period, “Good Reason” shall not be deemed to exist with respect to such condition.

The Participant’s right to terminate the Participant’s employment for Good Reason shall not be affected by the Participant’s incapacity due to physical or mental illness.

(n)     Multiplier: For the Chief Executive Officer of the Corporation, two and one-half; for an Executive Participant other than the Chief Executive Officer, two, and for a Discretionary Participant, one.

(o)    Net After Tax Receipt: The Value of a Payment, net of all taxes imposed on a Participant with respect thereto under Sections 1 and 4999 of the Code, under Section 3121 of the Code, and any state and local income taxes, determined by applying the highest marginal rate under Section 1 of the Code which applied to the Participant’s taxable income for the immediately preceding taxable year.

(p)    Participant: An Eligible Employee who is designated as a Participant in this Plan by the Committee. The Participants as of October 29, 2024 are provided on Exhibit A to this Plan, which shall be updated from time to time. For purposes of this Plan, the Committee shall be permitted to designate groups of Eligible Employees by job title as Participants without the need to identify any individual Participant by name.

(q)    Payment: Any payment or distribution in the nature of compensation (within the meaning of Section 280G(b)(2) of the Code) to or for the benefit of a Participant, whether paid or payable pursuant to this Plan or otherwise.

(r)    Qualified Termination of Employment: The Participant’s Separation from Service either (i) within the two (2) year period following a Change of Control of the Corporation (A) by the Corporation without Cause or, (B) by the Participant with Good Reason, or (ii) by the Corporation without Cause before a Change of Control, if a Change of Control occurs within one year after such Separation from Service and it is reasonably demonstrated by the Participant that such Separation from Service was at the request of a third party that had taken steps reasonably calculated to effect a Change of Control or otherwise arose in connection with or in anticipation of a Change of Control.

-5-


(s)    Reduced Amount: With respect to a Participant, the greatest aggregate amount of Separation Payments which (a) is less than the sum of all Separation Payments and (b) results in aggregate Net After Tax Receipts which are equal to or greater than the Net After Tax Receipts which would result if the Participant were paid the sum of all Separation Payments.

(t)    Relevant Date: In the case of a Qualified Termination of Employment as described in clause (ii) of the definition of “Qualified Termination of Employment,” the date of such Qualified Termination of Employment and, in all other cases, the date of the Change of Control.

(u)    RSUs. Time-based restricted share units and/or performance-based restricted share units.

(v)    Separation from Service: Termination of employment with the Corporation or a Subsidiary. A Separation from Service also will be deemed to have occurred if the Participant’s services with the Corporation or a Subsidiary is reduced to an annual rate that is 20 percent or less of the services rendered, on average, during the immediately preceding three years of employment (or if employed less than three years, such lesser period). A Separation from Service shall not be deemed to have occurred where a Participant transfers employment between the Company and a Subsidiary or between Subsidiaries.

(w)    Separation Payment: With respect to a Participant, a Payment paid or payable to the Participant pursuant to this Plan (disregarding Section 11 of this Plan).

(x)    Severance Period: For an Executive Participant, the period of two years beginning on the date of the Qualified Termination of Employment

(y)    Subsidiary: Any domestic or foreign corporation at least twenty percent (20%) of whose shares normally entitled to vote in electing directors is owned directly or indirectly by the Corporation or by other Subsidiaries, provided, however, that “at least fifty percent (50%)” shall replace “at least twenty percent (20%)” where there is not a legitimate business criteria for using such lower percentage.

(z)    Value: With respect to a Payment, the economic present value of a Payment as of the date of the change of control for purposes of Section 280G of the Code, as determined by the Accounting Firm using the discount rate required by Section 280G(d)(4) of the Code.

3.    Participation. An Eligible Employee shall become a Participant on the date he or she is designated as a Participant by the Committee, or such other time as the Committee may determine in its discretion. A Participant shall cease to be a Participant in the Plan upon the earlier of (i) the Participant’s Separation from Service that is not a Qualified Termination of Employment, or (ii) the termination of the Plan in accordance with its terms.

4.    Separation from Service of Participants. Nothing in this Plan shall be deemed to entitle a Participant to continued employment with the Corporation and its Subsidiaries,
-6-


and the rights of the Corporation to terminate a Participant’s service shall continue as fully as though this Plan were not in effect, provided that any Qualified Termination of Employment shall entitle the Participant to the benefits herein provided. In addition, nothing in this Plan shall be deemed to entitle a Participant under this Plan to any rights, or to payments under this Plan, with respect to any plan or program in which the Participant was not a participant prior to a Qualified Termination of Employment.

5.     Payments Upon Qualified Termination of Employment. In the event of a Qualified Termination of Employment of a Participant, a lump sum cash payment shall be made to such Participant as compensation for services rendered, in an amount or amounts (subject to any applicable payroll or other taxes required to be withheld) equal to the sum of the amounts specified in subsections (a) through (e) below (the “Severance Payments”):

(a)     Salary Plus Incentive Compensation. A lump sum amount equal to the Multiplier times the sum of (a) the Participant’s annual base salary at the rate in effect immediately prior to the Relevant Date or, if higher, immediately before the Qualified Termination of Employment and (b) the Annual Bonus Amount.

        (b)    Prorated Final Year Bonus. If the Qualified Termination of Employment occurs after March 31 of a given year, a lump sum amount equal to (i) the annual cash incentive award that would have been payable to the Participant, for the year in which the Qualified Termination of Employment occurs, under the Bonus Program in which the Participant was a participant on the Relevant Date if the Participant had remained employed for the entire for the entire calendar year, and assuming that performance was achieved at the target level of performance, multiplied by (ii) a fraction, the numerator of which is the number of days worked by the Participant during such final year and the denominator of which is 365.

(c)    Stock Options. All stock options that were granted to the Participant under any of the Equity Plans, including but not limited to any substitute plans adopted prior to the Relevant Date (or any successor or additional plan), and were outstanding both on the Relevant Date and immediately before the Qualified Termination of Employment, shall vest and become exercisable and the Qualified Termination of Employment of the Participant shall be deemed a “Retirement” for purposes of exercising the stock options under the terms of the Equity Plans and the applicable award agreements.

(d)    RSUs. All RSUs that were granted to the Participant under any of the Equity Plans, including but not limited to any substitute plans adopted prior to the Relevant Date (or any successor or additional plan), and were outstanding both on the Relevant Date and immediately before the Qualified Termination of Employment, shall become fully vested upon the Qualified Termination of Employment. For purposes of any RSU subject to performance conditions, such RSU will be deemed earned at the target level.

(e)    Employer Portion of Retirement Plan Benefits. With respect to an Executive Participant only, a lump sum amount equal to the Participant’s maximum matching contribution under the Avanos Medical, Inc. 401(k) Plan (the “401(k) Plan”) (or any successor or additional plans) and the Avanos Medical, Inc. Supplemental Retirement 401(k) Plan (or any successor or additional plans) (individually the “Supplemental 401(k)
-7-


Plan” and collectively, the “Retirement Benefit Plans”) to which the Participant would have been entitled if he or she had remained employed by the Corporation for the Severance Period at the rate of annual compensation specified in Section 5(a) above except that the Annual Bonus Amount shall be treated as earned for the year in which separation occurred and the balance of the Severance Period and no award actually earned in, and paid for, the year in which termination occurred shall be considered.

    (f)    Medical and Dental Benefits. A lump sum amount equal to (a) the amount of the monthly premiums that the Participant would be required to pay, if he or she elected “COBRA” continuation coverage under the medical and dental plans of the Corporation in which the Participant was participating immediately before the Qualified Termination of Employment, based upon the premium rates in effect as of the date of the Qualified Termination of Employment, times (b) the Multiplier, times (c) twelve.

The Severance Payments shall be made within 60 days following the later of the date of the Qualified Termination of Employment or the date of the Change of Control, subject to Section 16. Notwithstanding anything in this Section 5 to the contrary, any amounts which are payable under this Plan with respect to amounts which the Participant would have been entitled to receive under a deferred compensation plan required to meet the requirements of Section 409A of the Code and the regulations promulgated thereunder, shall be payable at the dates and in such amounts as would have been payable to the Participant under the terms of the deferred compensation plan.

6.    Separation Agreement and Release. No Participant shall be entitled to receive Severance Benefits hereunder unless such Participant executes a Separation Agreement and Full and Final Release of Claims (the “Separation Agreement”), in the form attached hereto as Exhibit B, within the period specified for such individual therein and such Participant does not revoke such Separation Agreement in writing within the 7-day period following the date on which it is executed. The Employer shall provide the Separation Agreement to the Participant promptly following the date of the Qualified Termination of Employment.

6.    No Payments on Other Termination of Employment. In the event a Participant’s employment terminates in any way that does not constitute a Qualified Termination of Employment, no benefits shall be payable to the Participant under this Plan.

7.    Other Terms and Conditions. Where appearing in this Plan, the masculine shall include the feminine and the plural shall include the singular, unless the context clearly indicates otherwise.

8.    Non-Assignability. Each Participant’s rights under this Plan shall be non-transferable except by will or by the laws of descent and distribution.

9.    Unfunded Plan. The Plan shall be unfunded. Neither the Corporation nor the Board shall be required to segregate any assets that may at any time be represented by benefits under the Plan. Neither the Corporation nor the Board shall be deemed to be a trustee of any amounts to be paid under the Plan. Any liability of the Corporation to any Participant with respect to any benefit shall be based solely upon any contractual obligations created by the Plan; no such obligation shall be deemed to be secured by any pledge or any encumbrance on any property of the Corporation.
-8-



10.    Certain Reduction of Payments by the Corporation.

(a)    Anything in this Plan to the contrary notwithstanding, in the event a reputable certified public accounting firm designated by the Corporation (the “Accounting Firm”) shall determine that receipt of all Payments would subject a Participant to tax under Section 4999 of the Code, it shall determine whether some amount of Payments would meet the definition of a “Reduced Amount.” If the Accounting Firm determines that there is a Reduced Amount, the aggregate Payments shall be reduced to such Reduced Amount. The reduction of the Payments, if applicable, shall be made by first reducing cash Payments and then, to the extent necessary, reducing those Payments having the next highest ratio of Parachute Value to actual present value of such Payments as of the date of the Change of Control, as determined by the Accounting Firm. For purposes of this Section 11, present value shall be determined in accordance with Section 280G(d)(4) of the Code, and the “Parachute Value” of a Payment means the present value as of the date of the change of control of the portion of such Payment that constitutes a “parachute payment” under Section 280G(b)(2) of the Code, as determined by the Accounting Firm for purposes of determining whether and to what extent the Excise Tax will apply to such Payment. All fees payable to the Accounting Firm with respect to this Section 11 shall be paid solely by the Corporation.

(b)    If the Accounting Firm determines that aggregate Separation Payments should be reduced to the Reduced Amount, the Corporation shall promptly give the Participant notice to that effect and a copy of the detailed calculation thereof. All determinations made by the Accounting Firm under this Section 11 shall be binding upon the Corporation and the Participant and shall be made as promptly as practicable. Following such determination, the Corporation shall pay to or distribute for the benefit of the Participant such Separation Payments as are then due to the Participant under Section 5 of this Plan and shall promptly pay to or distribute for the benefit of the Participant in the future such Separation Payments as become due to the Participant under this Plan. Notwithstanding the prior sentence, such determination by the Accounting Firm shall be made within 60 days of the later of the Qualified Termination of Employment of the Participant or the date of the Change of Control.

(c)    While it is the intention of the Corporation to reduce the amounts payable or distributable to a Participant hereunder only if the aggregate Net After Tax Receipts to the Participant would thereby be increased, as a result of the uncertainty in the application of Section 4999 of the Code at the time of the initial determination by the Accounting Firm hereunder, it is possible that amounts will have been paid or distributed by the Corporation to or for the benefit of a Participant pursuant to this Plan which should not have been so paid or distributed (“Overpayment”) or that additional amounts which will have not been paid or distributed by the Corporation to or for the benefit of a Participant pursuant to this Plan could have been so paid or distributed (“Underpayment”), in each case, consistent with the calculation of the Reduced Amount hereunder. In the event that the Accounting Firm determines that an Overpayment has been made, based upon the assertion of a deficiency by the Internal Revenue Service against the Corporation or the Participant which the Accounting Firm believes has a high probability of success, the Participant shall repay any such benefit to the Corporation together with interest at the applicable federal rate provided for in Section 7872(f)(2) of the Code; provided, however, that no such interest
-9-


shall be deemed to have been incurred and no amount shall be payable by a Participant to the Corporation if and to the extent such repayment would not either reduce the amount on which the Participant is subject to tax under Section 1 and Section 4999 of the Code or generate a refund of such taxes. In the event that the Accounting Firm, based upon controlling precedent or substantial authority, determines that an Underpayment has occurred, any such Underpayment shall be promptly paid by the Corporation to or for the benefit of the Participant together with interest at the applicable federal rate provided for in Section 7872(f)(2) of the Code, but no later than March 15 of the year after the year in which the Underpayment is determined to exist, which is when the legally binding right to such Underpayment arises. Notwithstanding anything in this Plan to the contrary, the payment will be conditioned upon the Overpayment or Underpayment meeting the requirements of Section 409A of the Code and the regulations promulgated thereunder.

11.    No Duty to Mitigate. In no event shall any Participant be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Participant under any of the provisions of this Plan, and such amounts shall not be reduced whether or not the Participant obtains other employment.

12.    Termination and Amendment of this Plan. The Committee shall have the power at any time, in its discretion, to amend, abandon or terminate this Plan, in whole or in part, except that no such amendment, abandonment or termination shall adversely affect the rights of, or the benefits payable to, any Participant under the Plan unless such amendment, abandonment or termination is agreed to in a writing signed by the Participant and the Corporation. Notwithstanding the foregoing, the Committee may modify the Plan at any time without the Participants' consent to comply with the requirements of Section 409A of the Code and any other rule, regulation, or statute, as determined by the Committee in its sole and absolute discretion.

13.    Successors. The Corporation shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of its business and/or assets to assume expressly and agree to perform this Plan in the same manner and to the same extent that the Corporation would be required to perform them if no such succession had taken place.

14.    Interpretation of the Plan. The Committee shall have sole and absolute authority to interpret and construe the terms of this Plan. Any interpretations, rules, decisions, or constructions by the Committee shall be final and binding on all Participants.

15.    Tax Treatment. The Participant shall be solely responsible for tax consequences of any payment under the Plan. It is intended that the payments and benefits provided under the Plan shall either be exempt from the application of, or comply with, the requirements of Section 409A of the Code. The Plan shall be construed in a manner that effects such intent. Nevertheless, the tax treatment of the benefits provided under the Plan is not warranted or guaranteed. Neither the Corporation nor its respective directors, officers, employees or advisers (other than in his or her capacity as a Participant) shall be held liable for any taxes, interest, penalties or other monetary amounts owed by any Participant or other taxpayer as a result of the Plan.

-10-


Notwithstanding anything in the Plan to the contrary, to the extent that any amount or benefit that would constitute non-exempt “deferred compensation” for purposes of Section 409A of the Code (“Non-Exempt Deferred Compensation”) would otherwise be payable or distributable under the Plan by reason of the occurrence of the Participant’s termination of employment, such Non-Exempt Deferred Compensation will not be payable or distributable to the Participant by reason of such circumstance unless the circumstances giving rise to such termination of employment meet any description or definition of “separation from service” in Section 409A of the Code and applicable regulations (without giving effect to any elective provisions that may be available under such definition). If this provision prevents the payment or distribution of any Non-Exempt Deferred Compensation, such payment or distribution shall be made on the date, if any, on which an event occurs that constitutes a Section 409A-compliant “separation from service.” Each payment of Severance Benefits pursuant to this Plan shall be considered a separate payment, as described in Treas. Reg. Section 1.409A-2(b)(2), for purposes of Section 409A of the Code.

Whenever in this Plan a payment or benefit is conditioned on the Participant’s execution of a Separation Agreement, the Separation Agreement must be executed and all revocation periods shall have expired in accordance with terms set forth therein, but in no case later than sixty (60) days after the date of the Qualified Termination of Employment; failing which such payment or benefit shall be forfeited. If such payment or benefit constitutes Non-Exempt Deferred Compensation, then such payment or benefit (including any installment payments) that would have otherwise been payable during such 60-day period shall be accumulated and paid on the 60th day after the date of the Qualified Termination of Employment provided such release shall have been executed and such revocation periods shall have expired. If such payment or benefit is exempt from Section 409A of the Code, the Corporation may elect to make or commence payment at any time during such 60-day period.

17.    Indemnification. If litigation shall be brought by a Participant to enforce any provision contained in this Plan and at least one claim in such litigation is adjudicated in the Participant’s favor, the Corporation hereby agrees to indemnify the Participant for the Participant’s reasonable attorney's fees and disbursements incurred in such litigation, and hereby agrees to pay prejudgment interest on any money judgment obtained by the Participant calculated at Citibank's (or any successor entity) prime rate of interest in effect from time to time from the date that payment(s) to the Participant should have been made under this Plan. The reimbursement of an attorney's fees and disbursements incurred in such litigation will be made on or before the last day of the calendar year following the calendar year in which the expense was incurred.

18.    Payment Obligations Absolute. The Corporation's obligation to pay a Participant the Severance Benefits provided in this Plan shall be absolute and unconditional and shall not be affected by any circumstances, including without limitation, any set-off, counterclaim, recoupment, defense or other right which the Corporation may have against the Participant or anyone else. All amounts payable by the Corporation hereunder shall be paid without notice or demand.

19.    Effective Date. This Plan became effective on November 1, 2014, was amended and restated on October 26, 2016, and was further amended and restated on October 25, 2017, October 27, 2020, March 4, 2022, February 14, 2023 and October 29, 2024.
-11-



Exhibit A

AVANOS MEDICAL, INC.
Executive Severance Plan
As of October 29, 2024


List of Participants

NameType of Participant
Michael GreinerExecutive Participant*
Mojirade JamesExecutive Participant
Kerr HolbrookExecutive Participant
Sig DelgadoExecutive Participant
Scott GalovanExecutive Participant
Vinny SastriExecutive Participant
Chip ZimlikiExecutive Participant
John CatoExecutive Participant
Katrine KubisExecutive Participant

                        
* Mr. Greiner was appointed to the position of Interim Chief Executive Officer on October 28, 2024. He will remain an Executive Participant for purposes of the Plan while he remains in that position.





Exhibit B

AVANOS MEDICAL, INC.

SEPARATION AGREEMENT AND
FULL AND FINAL RELEASE OF CLAIMS

    This Separation Agreement and Full and Final Release of Claims (“Agreement”) is made and entered into between _____________ (“Executive”) and Avanos Medical, Inc., a Delaware corporation (the “Corporation”)

1.    SEPARATION FROM EMPLOYMENT. Executive’s employment is being terminated and Executive’s last day on the payroll is ______, 20__ (the “Separation Date”).

2.    SEVERANCE PLAN. Executive agrees and understands that the consideration described in Paragraph 2 of this Agreement is provided through the Avanos Medical, Inc. Amended and Restated Executive Severance Plan (the “Plan”), which also requires the execution of this Agreement as a condition to the payment of benefits under the Plan.

3.    CONSIDERATION. In consideration of Executive’s decision to enter into this Agreement, following the Corporation’s receipt of this Agreement executed by the Executive and the expiration of the seven (7) day period within which the Executive may revoke Executive’s acceptance of this Agreement as explained below (and provided Executive has not exercised such right of revocation), the Corporation will provide Executive with the following:

(1)A lump sum separation payment in the aggregate amount of $____, less ordinary tax withholding and all required deductions, which amount is the sum of (i) $____ in satisfaction of the severance payment pursuant to Section 5(a) of the Plan, (ii) $____ in satisfaction of the prorated final year bonus pursuant to Section 5(b) of the Plan, (iii) $____ in satisfaction of the retirement plan benefits pursuant to Section 5(d) of the Plan, and (iv) $____ in satisfaction of the medical and dental benefits pursuant to Section 5(e) of the Plan.

(2)Any outstanding and unvested stock options held by Executive shall be fully vested and exercisable, and Executive’s termination of employment shall be treated as a retirement for purposes of exercising the stock options under the terms of the relevant equity incentive plans and award agreements. [NOTE: this applies only with respect to stock options that are outstanding on both the Relevant Date (as defined in the Plan) and immediately before the Executive’s termination of employment.]

(3)Any outstanding and unvested time-based restricted share units and/or performance-based restricted share units held by Executive shall be fully vested, with any performance-based restricted share unit being deemed earned at the target level. [NOTE: this applies only with respect to RSUs that are outstanding
-1-

on both the Relevant Date as defined in the Plan) and immediately before the Executive’s termination of employment.]

Executive further acknowledges that tax withholdings may be applied to the above payments as determined by the Corporation in its sole discretion. Executive agrees that, except for the amounts withheld, Executive shall be fully responsible for paying any taxes, interest, penalties, or other amounts due on the above payments and the Corporation makes no representation as to the tax treatment of any consideration under this Agreement. All above payments will be made as soon as administratively feasible after the Separation Date or the date this Agreement becomes final and binding, whichever is later.

4.    VACATION PAY. Whether or not Executive executes this Agreement, Executive will be paid for any unused vacation due to Executive according to the Corporation’s vacation policy currently in effect and as required by law.

    5.    FULL AND FINAL RELEASE. In consideration of the payments being provided to Executive above, Executive, for Executive, Executive’s attorneys, heirs, executors, administrators, successors and assigns, fully, finally and forever releases and discharges the Corporation, all parent, subsidiary, related and affiliated companies, as well as its and their successors, assigns, officers, owners, directors, agents, representatives, attorneys, and employees (all of whom are referred to throughout this Agreement as the “Released Parties”), of and from all claims, demands, actions, causes of action, suits, damages, losses, and expenses, whether known or unknown, of any and every nature whatsoever, as a result of actions or omissions occurring through the execution date of this Agreement. Specifically included in this waiver and release are, among other things, any and all claims of alleged employment discrimination, either as a result of the separation of Executive’s employment or otherwise, any claims under any severance pay plan of the Released Parties, the Age Discrimination in Employment Act, the Older Workers Benefit Protection Act, Title VII of the Civil Rights Act of 1964, the Family and Medical Leave Act (FMLA), the Americans with Disabilities Act, the Worker Adjustment and Retraining Notification (WARN) Act, the Uniformed Services Employment and Reemployment Rights Act (USERRA), the Ledbetter Fair Pay Act, the Genetic Information Nondiscrimination Act of 2008, the Internal Revenue Code (IRC), the US tax code, the Employee Retirement Income Security Act (ERISA), any other federal, state or local statute, rule, ordinance, or regulation, as well as any claims for alleged wrongful discharge, negligent or intentional infliction of emotional distress, breach of contract, fraud, defamation, or any other unlawful behavior, the existence of which is specifically denied by the Released Parties.

Executive hereby expressly waives all rights Executive might have under any laws including, without limitation, Section 1542 of the Civil Code of the State of California, which states as follows:

A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by Executive must have materially affected his or her settlement with the debtor.

-2-

Thus, notwithstanding the provisions of any law, including without limitation, Section 1542 of the Civil Code of the State of California, and for the purpose of implementing a full and complete release and discharge of the Released Parties, Executive expressly acknowledges that this Agreement is intended to include in its effect, without limitation, all claims that Executive does not know or suspect to exist in Executive’s favor at the time Executive executes this Agreement, and that this Agreement contemplates the extinguishment of any such claims.

The above release does not waive any rights or claims that (a) may arise after the date on which Executive executes this Agreement; (b) cannot lawfully be released under applicable law, including, but not limited to, unemployment benefits and workers’ compensation claims, (c) constitute an award to Executive from or by a Government Agency for providing information. In addition, nothing in this Agreement is intended to waive any vested right that Executive may have under any pension, 401(k) plan or other benefit plan provided by the Released Parties, and nothing in this Agreement shall prohibit Executive from enforcing such rights.

6.    NON-INTERFERENCE. Nothing in this Agreement shall be construed to prohibit Executive from filing a charge or participating in any investigation or proceeding before any federal, state or local agency or commission including, but not limited to, the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, and the Securities and Exchange Commission (collectively, “Government Agencies”). In addition, nothing in this Agreement shall limit Executive’s ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Corporation. This Agreement does not limit Executive’s right to receive an award for information provided to any Government Agencies regarding any violation of any Securities and Exchange Commission regulation or financial fraud or misconduct. Notwithstanding the foregoing, to the maximum extent permitted by law, Executive waives Executive’s right to recover damages as a result of any charge or lawsuit filed by Executive or by anyone else on Executive’s behalf, including a class or collective action, whether or not Executive is named in such proceeding. Furthermore, pursuant to the federal Defend Trade Secrets Act of 2016, Executive shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (1) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney, in each case, solely for the purpose of reporting or investigating a suspected violation of law or (2) in a complaint or other document filed in a lawsuit or proceeding, if such filings are made under seal.

7.    NO OTHER CLAIMS. Executive understands that Executive is releasing claims about which Executive may not know anything at the time Executive executes this Agreement. Executive represents and warrants that Executive has (a) filed no claims, lawsuits, charges, grievances, or causes of action of any kind against the Released Parties and, to the best of the Executive’s knowledge, Executive possesses no such claims (including Fair Labor Standards Act (“FLSA”) and worker’s compensation claims) that Executive has not already disclosed to the Released Parties; (b) received any and all compensation (including overtime compensation), meal periods, and rest periods to which Executive may have been entitled, and
-3-

Executive is not currently aware of any facts or circumstances constituting a violation by the Released Parties of the FLSA or other applicable wage, hour, meal period, and/or rest period laws that Executive has not already disclosed to the Released Parties; and (c) not suffered any work-related injury or illness within the twelve (12) months preceding Executive’s execution of this Agreement, and Executive is not currently aware of any facts or circumstances that would give rise to a worker’s compensation claim against the Released Parties that Executive has not already disclosed to the Released Parties.

8.    DUTY TO COOPERATE.  Executive agrees to be available on a reasonable basis to assist the Released Parties with any investigation, claim, suit, or other proceeding that is pending or threatened by or against the Released Parties. Executive further agrees to promptly inform the Corporation’s General Counsel if Executive is requested to: (a) testify in connection with or otherwise become involved in any claim against the Released Parties; or (b) assist with or participate in any investigation of the Released Parties. The Corporation’s General Counsel may be contacted via mail at the following address: General Counsel, Avanos Medical, Inc., 5405 Windward Parkway, Alpharetta, Georgia 30004.

9.    RESTRICTIVE COVENANTS. Executive acknowledges and agrees that he or she has received good and valuable consideration for entering into this Agreement. Executive acknowledges and agrees that he or she has been provided and entrusted with Confidential Information (as that term is defined below), including highly confidential customer information that is subject to extensive measures to maintain its secrecy within the Corporation, is not known in the trade or disclosed to the public, and would materially harm the Corporation’s legitimate business interests if it was disclosed or used in violation of this Agreement. Executive also acknowledges and agrees that he or she has been provided and entrusted with access to the Corporation’s customer and employee relationships and goodwill. Executive further acknowledges and agrees that the Corporation’s Confidential Information, customer and employee relationships, and goodwill are valuable assets of the Corporation and are legitimate business interests that are properly subject to protection through the covenants contained in this Agreement.

(i)    Potential Unfair Competition. Executive acknowledges and agrees that as a result of his or her employment with the Corporation, his or her knowledge of and access to Confidential Information, and his or her relationships with the Corporation’s customers and employees, Executive would have an unfair competitive advantage if Executive were to engage in activities in violation of this Agreement.

(ii)    No Undue Hardship. Executive acknowledges and agrees that he or she possesses marketable skills and abilities that will enable him or her to find suitable employment without violating the covenants set forth in this Agreement.

(iii)    Voluntary Execution. Executive acknowledges and affirms that he or she is executing this Agreement voluntarily, that he or she has read this Agreement carefully and had a full and reasonable opportunity to consider this Agreement (including an
-4-

opportunity to consult with legal counsel), and that he or she has not been pressured or in any way coerced, threatened or intimidated into signing this Agreement.

(iv)    Restriction on Disclosure and Use of Confidential Information. Executive agrees that Executive shall not, directly or indirectly, use any Confidential Information on Executive’s own behalf or on behalf of any Person other than the Corporation, or reveal, divulge, or disclose any Confidential Information to any Person not expressly authorized by the Corporation to receive such Confidential Information. This obligation shall remain in effect for as long as the information or materials in question retain their status as Confidential Information. Executive further agrees that he or she shall fully cooperate with the Corporation in maintaining the Confidential Information to the extent permitted by law. The parties acknowledge and agree that this Agreement is not intended to, and does not, alter either the Corporation’s rights or Executive’s obligations under any state or federal statutory or common law regarding trade secrets and unfair trade practices. Anything herein to the contrary notwithstanding, Executive shall not be restricted from disclosing information that is required to be disclosed by law, court order or other valid and appropriate legal process; provided, however, that in the event such disclosure is required by law, Executive shall provide the Corporation with prompt notice of such requirement so that the Corporation may seek an appropriate protective order prior to any such required disclosure by Executive.

For purposes of this Agreement, “Confidential Information” means any and all data and information relating to the Corporation, its activities, business, or clients that (i) was disclosed to Executive or of which Executive became aware as a consequence of his or her employment with the Corporation; (ii) has value to the Corporation; and (iii) is not generally known outside of the Corporation. “Confidential Information” shall include, but is not limited to the following types of information regarding, related to, or concerning the Corporation: trade secrets; financial plans and data; management planning information; business plans; operational methods; market studies; marketing plans or strategies; pricing information; product development techniques or plans; customer lists; customer files, data and financial information; details of customer contracts; current and anticipated customer requirements; identifying and other information pertaining to business referral sources; past, current and planned research and development; computer aided systems, software, strategies and programs; business acquisition plans; management organization and related information (including, without limitation, data and other information concerning the compensation and benefits paid to officers, directors, employees and management); personnel and compensation policies; new personnel acquisition plans; and other similar information. “Confidential Information” also includes combinations of information or materials which individually may be generally known outside of the Corporation, but for which the nature, method, or procedure for combining such information or materials is not generally known outside of the Corporation. In addition to data and information relating to the Corporation, “Confidential Information” also includes any and all data and information relating to or concerning a third party that otherwise meets the definition set forth above, that was provided or made available to the Corporation by such third party, and that the
-5-

Corporation has a duty or obligation to keep confidential. This definition shall not limit any definition of “confidential information” or any equivalent term under state or federal law. “Confidential Information” shall not include information that has become generally available to the public by the act of one who has the right to disclose such information without violating any right or privilege of the Corporation.

(v)    Non-Solicitation of Protected Customers. Executive agrees that during the two (2) year period following the Separation Date, he or she shall not, without the prior written consent of the Corporation, directly or indirectly, on his or her own behalf or as a principal, owner, employee, representative or agent of any Person, solicit, divert, take away, or attempt to solicit, divert, or take away a Protected Customer for the purpose of engaging in, providing, or selling any activities, products, or services of the type conducted, authorized, offered, or provided by the Corporation as of the Separation Date, or during the two (2) years immediately prior to such date.

For purposes of this Agreement, “Protected Customer” means any person or entity to whom the Corporation has sold its products or services or actively solicited to sell its products or services, and with whom Executive has had Material Contact on behalf of the Corporation during his or her employment with the Corporation, and “Material Contact” means contact between Executive and a customer or potential customer of the Corporation (i) with whom or which Executive had dealings on behalf of the Corporation; (ii) whose dealings with the Corporation were coordinated or supervised by Executive; (iii) about whom Executive obtained Confidential Information in the ordinary course of business as a result of his or her employment with the Corporation; or (iv) who receives products or services of the Corporation, the sale or provision of which results or resulted in compensation, commissions, or earnings for Executive within the two (2) years prior to the Separation Date.

(vi)    Non-Recruitment of Employees. Executive agrees that during the two (2) year period following the Separation Date, he or she shall not, without the prior written consent of the Corporation, directly or indirectly, whether on his or her own behalf or as a principal, owner, employee, representative or agent of any person or entity, solicit or induce or attempt to solicit or induce any employee of the Corporation to terminate his or her employment relationship with the Corporation or to enter into employment with Executive or any other person or entity.

(vii)    Rights and Remedies Upon Breach. The parties specifically acknowledge and agree that the remedy at law for any breach of the covenants provided in this Section 9 (the “Restrictive Covenants”) will be inadequate, and that in the event Executive breaches, or threatens to breach, any of the Restrictive Covenants, the Corporation shall have the right and remedy, without the necessity of proving actual damage or posting any bond, to enjoin, preliminarily and permanently, Executive from violating or threatening to violate the Restrictive Covenants and to have the Restrictive Covenants specifically enforced by any court of competent jurisdiction, it being agreed that any breach or threatened breach of the Restrictive Covenants would cause irreparable injury to the
-6-

Corporation and that money damages would not provide an adequate remedy to the Corporation. Executive understands and agrees that if he or she violates any of the obligations set forth in the Restrictive Covenants, the period of restriction applicable to each obligation violated shall cease to run during the pendency of any litigation over such violation, provided that such litigation was initiated during the period of restriction. Such rights and remedies shall be in addition to, and not in lieu of, any other rights and remedies available to the Corporation at law or in equity. Executive understands and agrees that, if the parties become involved in legal action regarding the enforcement of the Restrictive Covenants and if the Corporation prevails in such legal action, the Corporation will be entitled, in addition to any other remedy, to recover from Executive its reasonable costs and attorneys’ fees incurred in enforcing such covenants. The Corporation’s ability to enforce its rights under the Restrictive Covenants or applicable law against Executive shall not be impaired in any way by the existence of a claim or cause of action on the part of Executive based on, or arising out of, this Agreement or any other event or transaction.

(viii)    Severability and Modification of Covenants. Executive acknowledges and agrees that each of the Restrictive Covenants is reasonable and valid in time and scope and in all other respects. The parties agree that it is their intention that the Restrictive Covenants be enforced in accordance with their terms to the maximum extent permitted by law. Each of the Restrictive Covenants shall be considered and construed as a separate and independent covenant. Should any part or provision of any of the Restrictive Covenants be held invalid, void, or unenforceable, such invalidity, voidness, or unenforceability shall not render invalid, void, or unenforceable any other part or provision of this Agreement or such Restrictive Covenant. If any of the provisions of the Restrictive Covenants should ever be held by a court of competent jurisdiction to exceed the scope permitted by the applicable law, such provision or provisions shall be automatically modified to such lesser scope as such court may deem just and proper for the reasonable protection of the Corporation’s legitimate business interests and may be enforced by the Corporation to that extent in the manner described above and all other provisions of this Agreement shall be valid and enforceable.

10.    NON-DISPARAGEMENT. Executive agrees that Executive has not and will not (including during the time period while this Agreement was under consideration by Executive) make any defamatory or maliciously disparaging statements about the Released Parties, the Released Parties’ products or services, or the Released Parties’ representatives or employees to current, former or prospective customers or suppliers, to the media, or to other members of the public.   Nothing in this Agreement shall be deemed to preclude Executive from providing truthful testimony or information pursuant to subpoena, court order, or similar legal process, or from providing truthful information to government or regulatory agencies.

11.    NON-ADMISSION OF LIABILITY OR WRONGFUL CONDUCT. This Agreement shall not be construed as an admission by the Released Parties of any liability or acts of wrongdoing or discrimination, nor shall it be considered to be evidence of such liability, wrongdoing, or discrimination.
-7-


12.    TERMINATION OF EMPLOYMENT RELATIONSHIP. Except as set forth above, Executive and the Released Parties agree as a matter of intent that this Agreement terminates all aspects of the employment relationship between them.

    13.    CONFIDENTIALITY. The nature and terms of this Agreement are strictly confidential and they have not been and shall not be disclosed by Executive at any time to any person other than Executive’s lawyer, Executive’s accountant, Executive’s immediate family, or the Securities and Exchange Commission without the prior written consent of an officer of the Corporation, except as necessary in any legal proceedings directly related to the provisions and terms of this Agreement, to prepare and file income tax forms, or pursuant to court order after reasonable notice to the Corporation.

    14.    RETURN OF COMPANY PROPERTY.  Executive understands and agrees that all Company Information and Business Ideas (as defined in the Confidentiality, Nonsolicitation and Assignment of Business Ideas Agreement) is the exclusive property of the Corporation and that Executive has no rights in or to the Company Information upon the termination of employment. Executive represents that Executive has delivered to the Corporation:

(a) all originals and electronic and paper copies of all documents and records that may contain Company Information, regardless of where such documents and records are stored including, but not limited to, on USB drives, external hard drives, and/or any cloud-based storage (for which Executive provided any necessary passwords);

(b) property of any nature that relates to Company Information or Business Ideas, including, but not limited to, business activities, customers or prospective customers of the Corporation, whether prepared by Executive or others; and

(c) property of any nature whatsoever that was in Executive’s possession, custody or control, and that is the property of the Corporation (e.g., cellular phones, credit cards, computer or other equipment)

Executive further represents that, after returning any electronic copies of documents, records or data to the Corporation, Executive has deleted any remaining electronic versions from personal electronic devices (e.g., personal computers, phones, tablets).

Executive has provided to the Corporation a signed declaration stating that all Company Information, documents, data and other property has been returned and all Company Information and electronic data has been deleted from personal electronic devices (e.g., personal computers, phones, tablets).

    15.    CHOICE OF FORUM AND GOVERNING LAW. This Agreement shall be governed and construed as to both substantive and procedural matters in accordance with the
-8-

laws of the State of Georgia, without regard to the conflict of laws principles thereof. Executive agrees that any claim or dispute Executive may have against the Corporation or the Released Parties that is released by, or relates to the enforceability of, this Agreement must be resolved by a court located in Fulton County, Georgia. Executive agrees to submit to personal jurisdiction and venue in the Superior Court of Fulton County, State of Georgia for the purpose of litigating all such claims or disputes.
16.    SEVERABILITY. The provisions of this Agreement are severable, and if any part of this Agreement is found by a court of law to be unenforceable, the remainder of the Agreement will continue to be valid and effective.

17.    ENTIRE AGREEMENT.  This Agreement sets forth the entire agreement between Executive and the Corporation concerning the subject matter of this Agreement and Executive’s employment with and separation from the Corporation and the events leading thereto and associated therewith.  Any prior agreements between or directly involving Executive and any of the Released Parties concerning the subject matter of this Agreement and Executive’s relationship with the Corporation are superseded by the terms of this Agreement and thus are rendered null and void with the exception of any noncompetition, confidentiality, nonsolicitation and/or assignment of business ideas agreements or any prior agreements between the parties related to inventions, business ideas, and confidentiality of corporate information, which remain intact, including, but not limited to, those provided to Executive with this Agreement.

    18.    NO OTHER PROMISES. Executive affirms that the only consideration for Executive signing this Agreement is that set forth in Paragraph 2, that no other promise or agreement of any kind has been made to or with Executive by any person or entity to cause Executive to execute this document, and that Executive fully understands the meaning and intent of this Agreement, including but not limited to, its final and binding effect.

    19.    REVIEW AND REVOCATION PERIODS. Executive acknowledges that Executive is hereby advised to consult with an attorney before signing this Agreement. Executive further acknowledges that Executive has been given [CHOOSE, depending on age of employee and whether part of group termination program:] twenty-one (21) or forty-five (45) days from the time that Executive receives this Agreement to consider whether to sign it. If Executive has signed this Agreement before the end of this [CHOOSE:] twenty-one (21) or forty-five (45) day period, it is because Executive freely chose to do so after carefully considering its terms. Finally, Executive shall have seven (7) days from the date Executive signs this Agreement to revoke this Agreement by delivering written notice within the seven (7) day period to the following Corporation contact:
General Counsel
Avanos Medical, Inc.
5405 Windward Parkway
Alpharetta, Georgia 30004

-9-

If Executive does not revoke this Agreement, this Agreement will become effective and irrevocable by Executive on the eighth day after Executive has executed it. If Executive elects not to sign this Agreement within [CHOOSE:] twenty-one (21) or forty-five (45) days from the date that Executive receives this Agreement or if the Executive revokes the Agreement during the foregoing applicable revocation period, this Agreement shall not become effective and the offer to enter into this Agreement shall terminate and expire automatically.

[DELETE PARAGRAPH 20 AND RENUMBER PARAGRAPH 21 & 22 UNLESS EMPLOYEE IS AGE 40+ AND PART OF GROUP TERMINATION PROGRAM]     

    20.    REDUCTION-IN-FORCE. Pursuant to the Age Discrimination in Employment Act, additional information regarding the employment termination program that resulted in Executive’s separation is contained in Exhibit A.

21.    LEGALLY BINDING AGREEMENT. Executive understands and acknowledges that this Agreement is final and binding following the seven (7) day revocation period provided in this Agreement.

22.    REPRESENTATION AND WARRANTY OF UNDERSTANDING. By signing below, Executive represents and warrants that Executive: (a) has carefully read and understands the terms of this Agreement; (b) is entering into this Agreement knowingly, voluntarily and of Executive’s own free will; and (c) understands its terms and significance and intends to abide by its provisions without exception.



Date:                                                
                        Executive Name

                
                    
                        AVANOS MEDICAL, INC.


Date:                        By:                        
                    

-10-
 EX-31.A 4 avns3q2024form10qex31a.htm SECTION 302 CEO CERTIFICATION Document

Exhibit 31(a)
CERTIFICATIONS


I, Michael C. Greiner, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Avanos Medical, Inc. (the “registrant”);
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: October 30, 2024/s/ Michael C. Greiner
Michael C. Greiner
Interim Chief Executive Officer (Principal Executive Officer)




 EX-31.B 5 avns3q2024form10qex31b.htm SECTION 302 CFO CERTIFICATION Document

Exhibit 31(b)
CERTIFICATIONS


I, Warren J. Machan, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Avanos Medical, Inc. (the “registrant”);
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: October 30, 2024/s/ Warren J. Machan
Warren J. Machan
Interim Chief Financial Officer (Principal Financial Officer)


 EX-32.A 6 avns3q2024form10qex32a.htm SECTION 906 CEO CERTIFICATION Document

Exhibit 32(a)

Certification of Chief Executive Officer
Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code


I, Michael C. Greiner, Interim Chief Executive Officer of Avanos Medical, Inc., certify that, to my knowledge:
(1)the Form 10-Q, filed with the Securities and Exchange Commission on October 30, 2024 (“accompanied report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the accompanied report fairly presents, in all material respects, the financial condition and results of operations of Avanos Medical, Inc.

Date: October 30, 2024/s/ Michael C. Greiner
Michael C. Greiner
Interim Chief Executive Officer (Principal Executive Officer)



 EX-32.B 7 avns3q2024form10qex32b.htm SECTION 906 CFO CERTIFICATION Document

Exhibit 32(b)

Certification of Chief Financial Officer
Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code


I, Warren J. Machan, Interim Chief Financial Officer of Avanos Medical, Inc., certify that, to my knowledge:
(1)the Form 10-Q, filed with the Securities and Exchange Commission on October 30, 2024 (“accompanied report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the accompanied report fairly presents, in all material respects, the financial condition and results of operations of Avanos Medical, Inc.

Date: October 30, 2024/s/ Warren J. Machan
Warren J. Machan
Interim Chief Financial Officer (Principal Financial Officer)



 EX-101.SCH 8 avns-20240930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 9952151 - Statement - CONDENSED CONSOLIDATED INCOME STATEMENTS link:presentationLink link:calculationLink link:definitionLink 9952152 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 9952153 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 9952154 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952155 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 9952156 - Statement - CONDENSED CONSOLIDATED CASH FLOW STATEMENTS link:presentationLink link:calculationLink link:definitionLink 9952157 - Disclosure - Accounting Policies link:presentationLink link:calculationLink link:definitionLink 9952158 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 9952159 - Disclosure - Restructuring Activities link:presentationLink link:calculationLink link:definitionLink 9952160 - Disclosure - Business Acquisition link:presentationLink link:calculationLink link:definitionLink 9952161 - Disclosure - Supplemental Balance Sheet Information link:presentationLink link:calculationLink link:definitionLink 9952162 - Disclosure - Fair Value Information link:presentationLink link:calculationLink link:definitionLink 9952163 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 9952164 - Disclosure - Accumulated Other Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 9952165 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 9952166 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 9952167 - Disclosure - Derivative Financial Instruments link:presentationLink link:calculationLink link:definitionLink 9952168 - Disclosure - Earnings Per Share ("EPS") link:presentationLink link:calculationLink link:definitionLink 9952169 - Disclosure - Business and Products Information link:presentationLink link:calculationLink link:definitionLink 9952170 - Disclosure - Share Repurchase Program link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Discontinued Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Restructuring Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Business Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Supplemental Balance Sheet Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Fair Value Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Accumulated Other Comprehensive Income (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Earnings Per Share ("EPS") (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Business and Products Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Share Repurchase Program (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Accounting Policies - Narratives (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Discontinued Operations - Narratives (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Discontinued Operations - Schedule of Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Discontinued Operations - Schedule of Balance Sheet (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Discontinued Operations- Schedule of Cashflow (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Restructuring Activities - Narratives (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Restructuring Activities - Accrual and Payment Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Business Acquisition - Narratives (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Business Acquisition - Purchase Price Allocation (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Business Acquisition - Identifiable Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Supplemental Balance Sheet Information - Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Supplemental Balance Sheet Information - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Supplemental Balance Sheet Information - Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Supplemental Balance Sheet Information - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Supplemental Balance Sheet Information - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Supplemental Balance Sheet Information - Estimated Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Supplemental Balance Sheet Information - Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Supplemental Balance Sheet Information - Other Long-Term Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Fair Value Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Debt - Summary of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Debt - Narratives (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Debt - Maturities of Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Accumulated Other Comprehensive Income - Changes During the Period (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Accumulated Other Comprehensive Income - Net Changes in Components of AOCI, Including Tax Effect (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Derivative Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - Earnings Per Share ("EPS") (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - Business and Products Information - Narratives (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Business and Products Information - Net Sales by Product Category (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - Business and Products Information - Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - Business and Products Information - Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - Share Repurchase Program - Narratives (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - Share Repurchase Program - Summary of Treasury Stock (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 avns-20240930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 avns-20240930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 avns-20240930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Fed funds effective rate overnight index rate swap Fed Funds Effective Rate Overnight Index Swap Rate [Member] Digestive Health Digestive Health [Member] Digestive Health Interventional pain Interventional pain [Member] Interventional pain Work in process Inventory, Work in Process, Gross Statistical Measurement [Domain] Statistical Measurement [Domain] Amount Remaining in Program for Purchase (in millions) Share Repurchase Program, Remaining Authorized, Amount Cover page. Cover [Abstract] Increase (Decrease) in Cash and Cash Equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Trading Symbol Trading Symbol Derivative [Line Items] Derivative [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] First Eight Quarters Debt Instrument, Periodic Payment, First Eight Quarters [Member] Debt Instrument, Periodic Payment, First Eight Quarters Investing Activities: Cash Provided By (Used In) Investing Activities, Discontinued Operations [Abstract] Cash Provided By (Used In) Investing Activities, Discontinued Operations [Abstract] Disposal Group Name [Domain] Disposal Group Name [Domain] Accounts receivable Increase (Decrease) in Accounts Receivable Total estimated liabilities Liabilities For Estimated Rebates And Incentives, Net Liabilities For Estimated Rebates And Incentives, Net Derivative [Table] Derivative [Table] Hedging Relationship [Domain] Hedging Relationship [Domain] Fair Value Information Fair Value Disclosures [Text Block] Proceeds from the exercise of stock options Proceeds from Stock Options Exercised Effective interest rate (as percent) Line of Credit Facility, Interest Rate at Period End Land Land [Member] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three Variable rate component three Variable Rate Component Three [Member] Variable Rate Component Three Commitments and Contingencies Legal Matters and Contingencies [Text Block] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Operating Lease Liabilities Operating Lease, Liability, Noncurrent Cash flow hedging Cash Flow Hedging [Member] Property, Plant and Equipment, net Disposal Group, Including Discontinued Operation, Property, Plant and Equipment SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Inventory, Net Inventory, Net [Abstract] Dilutive effect of stock options and restricted share unit awards (in shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Other Assets Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Gross Carrying Amount Finite-Lived Intangible Assets, Gross Schedule of Finite-Lived Intangible Assets [Table] Intangible Asset, Finite-Lived [Table] Shares Repurchased (in shares) Treasury Stock, Shares, Acquired Cash Provided by Operating Activities Net Cash Provided by (Used in) Operating Activities Patents and acquired technologies Patents [Member] Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Treasury Stock Treasury Stock, Common [Member] Accrued taxes and other Taxes Payable, Current Summary of Changes in the Components of Accumulated Other Comprehensive Income Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Senior Secured Term Loan Secured Debt [Member] Income tax receivable Income Taxes Receivable Equity Components [Axis] Equity Components [Axis] Restructuring Type [Axis] Restructuring Type [Axis] Transition services agreement, term (in years) Transition Services Agreement, Term Transition Services Agreement, Term Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Proceeds from RH Divestiture post-closing settlement Proceeds from divestiture of businesses Proceeds from Divestiture of Businesses Use of Estimates Use of Estimates, Policy [Policy Text Block] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Diluted Earnings (Loss) Per Share Earnings Per Share, Diluted [Abstract] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Entity Small Business Entity Small Business Summary of Accrual and Payment Activity Restructuring and Related Costs [Table Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Identifiable Intangible Asset Amount Finite-Lived Intangible Assets Acquired Accounts receivable, net Receivables, Net, Current Value of common stock repurchased Stock Repurchased During Period, Value Defined benefit pension plans Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent Accrued expenses Total Accrued Liabilities, Current Dilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Payments and adjustments, net Payments for Restructuring Payment of contingent consideration liabilities Payment for Contingent Consideration Liability, Operating and Financing Activities Payment for Contingent Consideration Liability, Operating and Financing Activities Credit Facility [Domain] Credit Facility [Domain] Cash and Cash Equivalents - Beginning of Period Cash and Cash Equivalents - End of Period Cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Current Assets Assets, Current [Abstract] Goodwill Beginning balance Ending balance Goodwill Surgical pain and recovery Surgical Pain And Recovery [Member] Surgical Pain And Recovery Allowances and doubtful accounts Accounts Receivable, Allowance for Credit Loss Stock repurchase program, authorized amount Share Repurchase Program, Authorized, Amount Income (Loss) from Continuing Operations Net income (loss) from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Shares repurchased, program to date (in shares) Treasury Stock, Common, Shares Term of restructuring initiative (in years) Restructuring Plan, Term Restructuring Plan, Term Product and Service [Domain] Product and Service [Domain] Stock options Share-Based Payment Arrangement, Option [Member] Foreign exchange forward Foreign Exchange Forward [Member] Goodwill [Roll Forward] Goodwill [Roll Forward] Depreciation expense Depreciation Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Comprehensive Income (Loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Revolving credit facility repayments Repayment of credit facility Repayments of Lines of Credit Security Exchange Name Security Exchange Name Basis spread on variable rate (as percent) Debt Instrument, Basis Spread on Variable Rate Award Type [Axis] Award Type [Axis] Currency translation adjustment Goodwill, Foreign Currency Translation Gain (Loss) Basic Earnings (Loss) Per Share Earnings (Loss) Per Share Earnings Per Share, Basic [Abstract] Total Inventory Inventory, Gross Property, Plant and Equipment, net Total Property, Plant and Equipment, Net Total Liabilities Liabilities Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Four Finite-Lived Intangible Asset, Expected Amortization, after Year Four Total Pain Management and Recovery Pain Management And Recovery [Member] Pain Management And Recovery Number of reporting units Number of Reporting Units Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Research and development Research and Development Expense Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Weighted Average Useful Lives (Years) Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Revolving Credit Facility Revolving Credit Facility [Member] Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Current portion of operating lease liabilities Operating Lease, Liability, Current Borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Total assets classified as held for sale Disposal Group, Including Discontinued Operation, Assets Derivative liability Derivative Liability Summary of Class of Treasury Stock Class of Treasury Stock [Table Text Block] Depreciation and amortization Depreciation and Amortization, Discontinued Operations Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, plant and equipment, gross Property, Plant and Equipment, Gross Accounts receivable, net of allowances Accounts Receivable, after Allowance for Credit Loss Debt Instrument [Line Items] Debt Instrument [Line Items] Debt Instrument, Periodic Payment [Domain] Debt Instrument, Periodic Payment [Domain] Debt Instrument, Periodic Payment [Domain] Goodwill Goodwill and Intangible Assets, Policy [Policy Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Background and Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Diluted weighted average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Costs expected to incur Restructuring and Related Cost, Expected Cost Other Comprehensive Income (Loss), Net of Tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Remainder of 2024 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Organizational Design Alignment and Other Related Activities Organizational Design Alignment And Other Related Activities [Member] Organizational Design Alignment And Other Related Activities Total Stockholders’ Equity Beginning balance Ending balance Equity, Attributable to Parent Net Sales Disposal Group, Including Discontinued Operation, Revenue Hedging Designation [Domain] Hedging Designation [Domain] Interest expense Interest Expense, Nonoperating Accrued salaries and wages Accrued Salaries, Current Summary of Changes in the Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Payment of contingent consideration liabilities Payment for Contingent Consideration Liability, Financing Activities Letters of credit outstanding Letters of Credit Outstanding, Amount Selling and general expenses Selling, General and Administrative Expense Total Other Comprehensive Income (Loss), Net of Tax Other comprehensive income (loss), net of tax Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Long-Term Debt Total Long-Term Debt, net Long-Term Debt Document Fiscal Period Focus (Q1,Q2,Q3,FY) Document Fiscal Period Focus 2028 Long-Term Debt, Maturity, Year Four Business acquisition, transaction costs Business Combination, Acquisition Related Costs Liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities, Current Accounts receivable Accounts Receivable, before Allowance for Credit Loss, Current 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two ASSETS Assets [Abstract] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Document Type Document Type Derivative Contract [Domain] Derivative Contract [Domain] Line of credit facility, commitment fee percentage Line of Credit Facility, Commitment Fee Percentage Average Price Per Share (in dollars per share) Shares Acquired, Average Cost Per Share Contingent consideration Business Combination, Contingent Consideration, Liability, Noncurrent Current Portion of Operating Lease Liabilities Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Current Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Current Summary of Estimated Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Maximum Maximum [Member] Amortization expense for intangible assets Amortization of Intangible Assets Doubtful accounts Allowance For Credit Loss, Doubtful Accounts [Member] Allowance For Credit Loss, Doubtful Accounts [Member] Net Carrying Amount Finite-Lived Intangible Assets, Net Trade accounts payable Accounts Payable, Current Accounting Policies [Abstract] Accounting Policies [Abstract] Unamortized debt issuance costs Debt Instrument, Unamortized Discount Business Acquisition Business Combination Disclosure [Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Senior Secured Revolving Credit Facility Senior Secured Revolving Credit Facility [Member] Senior Secured Revolving Credit Facility Statistical Measurement [Axis] Statistical Measurement [Axis] Stock-based compensation expense Share-Based Compensation Expense, Discontinued Operations Share-Based Compensation Expense, Discontinued Operations Income (Loss) Before Income Taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Accrued rebates Accrued Rebates Accrued Rebates Award Type [Domain] Award Type [Domain] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Summary of Financial Results of Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Goodwill impairment Goodwill, Impairment Loss Total Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract] Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract] Deferred Tax Assets Deferred Income Tax Assets, Net Additional Paid-in Capital Additional Paid-in Capital [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Summary of Accounts Receivable Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Customer relationships Customer Relationships [Member] Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Diluted Earnings (Loss) Per Share (in dollars per share) Earnings Per Share, Diluted Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Summary of Calculation of Basic and Diluted Earnings Per Share Schedule of Weighted Average Number of Shares [Table Text Block] Post-RH Divestiture Restructuring Plan Post-Divestiture Restructuring Plan [Member] Post-Divestiture Restructuring Plan Entity Interactive Data Current Entity Interactive Data Current Type of Restructuring [Domain] Type of Restructuring [Domain] (Loss) Income from discontinued operations, net of tax Net (Loss) Income from discontinued operations, net of tax Net (loss) income from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Number of operating segments Number of Operating Segments Variable Rate Component [Domain] Variable Rate Component [Domain] Variable Rate Component [Domain] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Unrealized currency translation adjustments Unrealized Gain (Loss), Foreign Currency Transaction, before Tax Employee severance and benefits Employee Severance [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Program Management Consulting and Employee Retention Program Management Consulting And Employee Retention [Member] Program Management Consulting And Employee Retention Restructuring Activities Restructuring and Related Activities Disclosure [Text Block] Disposed of by sale Discontinued Operations, Held-for-Sale or Disposed of by Sale [Member] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Defined Benefit Plans Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Secured debt repayments Repayments of Secured Debt Inventories Disposal Group, Including Discontinued Operation, Inventory Income tax provision Income Tax Expense (Benefit) Derivative, notional amount Derivative, Notional Amount Net Sales Total Net Sales Revenue from Contract with Customer, Excluding Assessed Tax Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Inventory obsolescence Inventory Write-down Cash Used in Investing Activities Net Cash Provided by (Used in) Investing Activities Operating Income (Loss) Operating Income (Loss) Accumulated Other Comprehensive Income AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Variable Rate [Domain] Variable Rate [Domain] Business Acquisition [Line Items] Business Acquisition [Line Items] Number of reportable segments Number of Reportable Segments TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity Deferred income taxes and other Other Operating Activities, Cash Flow Statement Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Additional paid-in capital Additional Paid in Capital Hedging Designation [Axis] Hedging Designation [Axis] Derivative Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Term Loan Facility Term Loans [Member] Term Loans Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Interest income Investment Income, Interest Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Summary of Maturities of Long-Term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Research and development Disposal Group, Including Discontinued Operations, Research And Development Expense Disposal Group, Including Discontinued Operations, Research And Development Expense Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Cash Flow Hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Inventories Inventory, Net Total liabilities held for sale - discontinued operations Disposal Group, Including Discontinued Operation, Liabilities Discontinued operations- basic (in dollars per share) Basic (in dollars per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share Product and Service [Axis] Product and Service [Axis] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity Address, State or Province Entity Address, State or Province Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Statement [Line Items] Statement [Line Items] Derivative Instruments and Hedging Activities Disclosure [Abstract] Assets held for sale Disposal Group, Including Discontinued Operation, Assets, Current Summary of Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Consideration transferred Business Combination, Consideration Transferred Diros Technology Inc Diros Technology Inc [Member] Diros Technology Inc LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Costs incurred Restructuring and Related Cost, Incurred Cost Minimum Minimum [Member] Estimated Fair Value Estimate of Fair Value Measurement [Member] Subsequent To First Eight Quarters Debt Instrument, Periodic Payment, Subsequent To First Eight Quarters [Member] Debt Instrument, Periodic Payment, Subsequent To First Eight Quarters Quarterly installment payments (as percent) Debt Instrument, Periodic Payment, Percent Debt Instrument, Periodic Payment, Percent Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Operating Lease Right-of-Use Assets Operating Lease, Right-of-Use Asset Accrued expenses Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current Provision (reversal) for doubtful accounts Accounts Receivable, Credit Loss Expense (Reversal) Other noncurrent liabilities, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Derivative Instrument [Axis] Derivative Instrument [Axis] Total Long-Term Debt, net Total Long-Term Debt, Gross Variable rate component two Variable Rate Component Two [Member] Variable Rate Component Two Earnings Per Share (“EPS”) Earnings Per Share [Text Block] Exercise or redemption of share-based awards Stock Issued During Period, Value, Stock Options Exercised Continuing operations- basic (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Restructuring Plan [Axis] Restructuring Plan [Axis] Operating Activities: Cash Provided By (Used In) Operating Activities, Discontinued Operations [Abstract] Cash Provided By (Used In) Operating Activities, Discontinued Operations [Abstract] Debt instrument, term (in years) Debt Instrument, Term Accounts payable Increase (Decrease) in Accounts Payable, Trade 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Revolving credit facility proceeds Proceeds from Lines of Credit Trade names and trademarks Trademarks and Trade Names [Member] Buildings and leasehold improvements Building [Member] Variable Rate [Axis] Variable Rate [Axis] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Other Intangible Assets, net Intangible Assets, Net (Excluding Goodwill) Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Disposal Group Name [Axis] Disposal Group Name [Axis] Treasury stock Treasury Stock, Common, Value Remainder of 2024 Long-Term Debt, Maturity, Remainder of Fiscal Year Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] Assets Assets, Fair Value Disclosure [Abstract] Capital expenditures Capital Expenditure, Discontinued Operations Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Gross Profit Disposal Group, Including Discontinued Operation, Gross Profit (Loss) Discontinued operations- diluted (in dollars per share) Diluted (in dollars per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share Local Phone Number Local Phone Number Deferred Tax Liabilities Deferred Income Tax Liabilities, Net Changes in operating assets and liabilities, net of acquisition: Increase (Decrease) in Operating Capital [Abstract] Secured overnight financing rate (SOFR) Secured Overnight Financing Rate (SOFR) [Member] Term Loan Facility Term Loan Facility [Member] Term Loan Facility [Member] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Summary of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Common Stock Common Stock [Member] Tax effect Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Line of Credit Line of Credit [Member] Entity Emerging Growth Company Entity Emerging Growth Company Weighted-Average Interest Rate Long-Term Debt, Weighted Average Interest Rate, at Point in Time Segment Reporting [Abstract] Segment Reporting [Abstract] Acquisition of assets and investments in businesses Acquisition Of Assets And Investments In Businesses Acquisition Of Assets And Investments In Businesses Shares withheld for tax withholding obligation (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Entity Central Index Key Entity Central Index Key Summary of Inventories Schedule of Inventory, Current [Table Text Block] Cost of products sold Disposal Group, Including Discontinued Operation, Costs of Goods Sold Unrealized Currency Translation Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Discontinued Operations and Disposal Groups [Abstract] Discontinued Operations and Disposal Groups [Abstract] Share Repurchase Program Equity [Text Block] Equity Component [Domain] Equity Component [Domain] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Business and Products Information Segment Reporting Disclosure [Text Block] Current portion of long-term debt Current portion of long-term debt Long-Term Debt, Current Maturities Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Other (income) expense, net Disposal Group, Including Discontinued Operation, Other Expense (Income) Disposal Group, Including Discontinued Operation, Other Expense (Income) Entity Shell Company Entity Shell Company Measurement Basis [Axis] Measurement Basis [Axis] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Unsecured debt Unsecured Debt [Member] Statement [Table] Statement [Table] Estimated Amortization Expense Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract] City Area Code City Area Code Term Loan Facilities Term Loan Facilities [Member] Term Loan Facilities Income tax benefit (provision) from discontinued operations Discontinued Operation, Tax Effect of Discontinued Operation Current Liabilities Liabilities, Current [Abstract] (Loss) Income from discontinued operations before income taxes Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax Hedging and Derivatives Derivatives, Methods of Accounting, Hedging Derivatives [Policy Text Block] Repurchase program period (in years) Share Repurchase Program, Period in Force Future estimated payments Contingent consideration related to acquisition Business Combination, Contingent Consideration, Liability Disposal Group Classification [Domain] Disposal Group Classification [Domain] Stock issued, value, stock options exercised, net of tax benefit (expense) Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense) Capital expenditures Payments to Acquire Productive Assets Level 1 Fair Value, Inputs, Level 1 [Member] Net loss on asset dispositions and impairments Gain (Loss) on Disposition of Assets Total Current Assets Assets, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Accrued expenses Increase (Decrease) in Accrued Liabilities Purchases of treasury stock Payments for Repurchase of Common Stock 2027 Long-Term Debt, Maturity, Year Three Multi-year restructuring plan, initial phase Multi-Year Restructuring Plan, Initial Phase [Member] Multi-Year Restructuring Plan, Initial Phase [Member] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] Identifiable intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Other Other Intangible Assets [Member] (Loss) Earnings Per Share Earnings Per Share [Abstract] Equity [Abstract] Equity [Abstract] Current assets, net of cash acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Accumulated deficit Retained Earnings (Accumulated Deficit) Selling and general expenses Disposal Group, Including Discontinued Operation, Selling And General Expense Disposal Group, Including Discontinued Operation, Selling And General Expense Inventories Increase (Decrease) in Inventories Summary of Debt Balances Schedule of Debt [Table Text Block] Accrued rebates and customer incentives Accrued Rebates And Incentives Accrued Rebates And Incentives 2026 Long-Term Debt, Maturity, Year Two Summary of Identifiable Intangible Assets Asset Acquisition [Table Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Cash (Used in) Provided by Financing Activities Net Cash Provided by (Used in) Financing Activities Performance-based restricted share units Performance Shares [Member] Credit Facility [Axis] Credit Facility [Axis] Amendment Flag Amendment Flag Long-term debt, fair value Long-Term Debt, Fair Value Carrying Amount Reported Value Measurement [Member] Entity Registrant Name Entity Registrant Name Payments to acquire businesses, gross Payments to Acquire Businesses, Gross Supplies and other Other Inventory, Supplies, Gross Depreciation and amortization Depreciation, Depletion and Amortization Gross Profit Gross Profit Unrealized currency translation adjustments Unrealized currency translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Machinery and equipment Machinery and Equipment [Member] Accrued sales returns Accrued sales returns Accrued sales returns Level 2 Fair Value, Inputs, Level 2 [Member] Debt Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Stockholders’ Equity Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Sales discounts Allowance For Credit Loss, Sales Discounts [Member] Allowance For Credit Loss, Sales Discounts [Member] Face amount of debt Debt Instrument, Face Amount Summary of Net Sales by Product Category Disaggregation of Revenue [Table Text Block] Developed technology and other Technology-Based Intangible Assets [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Summary of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Restructuring and Related Costs [Table] Restructuring Cost [Table] Accrued rebates and customer incentives Accrued Rebates And Customer Incentives Accrued Rebates And Customer Incentives Title of 12(b) Security Title of 12(b) Security Common stock - $0.01 par value - authorized 300,000,000 shares, 45,954,931 outstanding as of September 30, 2024 and 46,174,337 outstanding as of December 31, 2023 Common Stock, Value, Issued Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Manufacturing and Supply Chain Improvements Manufacturing And Supply Chain Improvements [Member] Manufacturing And Supply Chain Improvements Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Non-Current Operating Lease Liability Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Noncurrent Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Noncurrent Pretax loss on classification as discontinued operations Discontinued Operation, Amount of Adjustment to Prior Period Gain (Loss) on Disposal, before Income Tax Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Raw materials Inventory, Raw Materials, Gross Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Investment in Note Receivable Payments to Acquire Notes Receivable Preferred stock - $0.01 par value - authorized 20,000,000 shares, none issued Preferred Stock, Value, Issued Finished goods Inventory, Finished Goods, Gross Fair Value Measurement [Domain] Fair Value Measurement [Domain] Basic Earnings (Loss) Per Share (in dollars per share) Earnings Per Share, Basic Variable Rate Component [Axis] Variable Rate Component [Axis] Variable Rate Component Trademarks Trademarks [Member] Designated as hedging instrument Designated as Hedging Instrument [Member] Total Current Liabilities Liabilities, Current Weighted Average Shares Outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] TOTAL ASSETS Assets 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One Cost of products sold Cost of Goods and Services Sold Other Long-Term Liabilities Total Other Liabilities, Noncurrent Commitments and Contingencies Commitments and Contingencies Other Other Sundry Liabilities, Noncurrent 2025 Long-Term Debt, Maturity, Year One Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Entity Address, City or Town Entity Address, City or Town Accrued customer incentives Accrued incentives Accrued incentives Summary of Purchase Price Allocation Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Total stock-based compensation Share-Based Payment Arrangement, Expense Discontinued Operations Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Net Income (Loss) Net Income (Loss) Net income (loss) Net income (loss) Net Income (Loss) Attributable to Parent Other (income) expense, net Other Operating Income (Expense), Net Summary of Fair Value of Financial Instruments Fair Value, by Balance Sheet Grouping [Table Text Block] Current liabilities, excluding contingent consideration Business Combination, Liability, Current, Excluding Contingent Consideration Business Combination, Liability, Current, Excluding Contingent Consideration Restructuring and transformation costs, excluding non-cash charges Restructuring Charges And Accrual Adjustment Restructuring Charges And Accrual Adjustment Transformation process term (in years) Divestiture, Term Of Transformation Process Divestiture, Term Of Transformation Process Accumulated Other Comprehensive Income Comprehensive Income (Loss) Note [Text Block] Business Acquisition [Axis] Business Acquisition [Axis] Summary of Intangible Assets Subject to Amortization Schedule of Finite-Lived Intangible Assets [Table Text Block] Program Management Consulting and Employee Retention Expenses And Employee Severance and Benefits Program Management Consulting And Employee Retention Expenses And Employee Severance And Benefits [Member] Program Management Consulting And Employee Retention Expenses And Employee Severance And Benefits Entity File Number Entity File Number Liabilities Liabilities, Fair Value Disclosure [Abstract] Document Fiscal Year Focus Document Fiscal Year Focus Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Purchases of treasury stock Aggregate Purchase Price (in millions) Treasury Stock, Value, Acquired, Cost Method Entity Address, Address Line Two Entity Address, Address Line Two Employee stock purchase plan Employee Stock Purchase Program [Member] Employee Stock Purchase Program Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Effect of Exchange Rate Changes on Cash and Cash Equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Other Other Accrued Liabilities, Current Restructuring Plan [Domain] Restructuring Plan [Domain] Operating Lease Right-of-Use Assets Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Assets Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Assets Document Period End Date Document Period End Date Cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent Base rate Base Rate [Member] Accrued compensation and benefits Accrued Compensation Benefits Accrued Compensation Benefits Supplemental Balance Sheet Information Supplemental Balance Sheet Disclosures [Text Block] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Debt Instrument, Periodic Payment [Axis] Debt Instrument, Periodic Payment [Axis] Debt Instrument, Periodic Payment Continuing operations- diluted (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Variable rate component one Variable Rate Component One [Member] Variable Rate Component One Prepaid and other current assets Prepaid Expense and Other Assets, Current RH Business RH Business [Member] RH Business Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report Defined benefit plans Defined benefit pension plans, net of tax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Current Reporting Status Entity Current Reporting Status Accumulated Deficit Retained Earnings [Member] Summary of Other Long-Term Liabilities Other Noncurrent Liabilities [Table Text Block] Credit Agreement Credit Agreement [Member] Credit Agreement Basic weighted average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Time-based restricted share units Restricted Stock Units (RSUs) [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Loss contingency accrual, payments Loss Contingency Accrual, Payments Construction in progress Construction in Progress [Member] Entity Filer Category Entity Filer Category Beginning balance Ending balance Restructuring Reserve Transformation Process Transformation Process [Member] Transformation Process Letter of Credit Letter of Credit [Member] Cash flow hedges Cash flow hedges, net of tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent EX-101.PRE 12 avns-20240930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 13 avns-20240930_g1.jpg begin 644 avns-20240930_g1.jpg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end GRAPHIC 14 image_0.jpg begin 644 image_0.jpg MB5!.1PT*&@H -24A$4@ %[M76EL'$=VKC>D>-_W38J'1-VW+,GR6K:UMA-O[&"#++!K M8)$ B_P(D""_\C,P_#\(]D?^Q AVL\B?+) X\>W8D6W).JW[MBA2O"G>ATA1 M),6I?*^[IZ=GIGLX,U);E/:5!@3%J7Y5]57UUZ]?O?>*M-9*BB @" @"@H"? M" 3\%"ZR!0%!0! 0!!@!8JWV-_4Q8!#_Q=)WC=_#A4)_-__D^%;'U/04 N%N ME8WZVBG3;B*L?*_4HM5HG,Y$=IOK>W8F8H!F9R)> QY+9^+!:*'A.OP4.Q,U M_*@1.;YU60#.A1%?3@B91Q(2A4S4VHC31-2<.J2/@V6;GGD70&]SP)M&@(B5FLSA'%?.O=&1!Q&SXV&JH%?,O-5084"@:(L+ZO[4VIVW#'CD4)0+3-/ MY5OG%EIK M([BL1WI4,!B>7_>%:H #'J< 53:HVE8JKV&>!64O/E S$WJX3_?>4K-FSWGM M1@!E_R^F,RPS(U.55-+:C511RZR]O*3F9M7XB!ZXHP=[U!*@B\0B[3Q(08G8]+&G&&[QA%ZIV)$N*" MS)KWWA6J-1;C,TRU>66TZ\]IPV%F!Q[ILK[^I?[VMVII/DP*SCL:U%Q8%7CS M'YB=36RZS^DO_UG=GPXSIMMM0\U[U(XWJ&XS5P-K#'<%/_VUNC?F3K5$M.*9WD+5:WW'"H4 M/?#CW(2"EFI<0J6-5+]M!6C04&T[5;>K'+Q6%ZJ,;#UX0SU<\+J*BFM498LJ MKK+JYQ91XS957*W2,Q*= ]!35JYU>7$5M>T*;']9K5P,L_I=9-;#2 Q0 ,#FDL,)/_BS_6--+!UP.'?ZJ*RE86*#6> M!@2$:I^&64JYCUD%5+E>%519U@.60U1HO4ZN&B[KVDYJ>L.OEEJFG7 M"M;#PBI5UL3$9ZIFB_=UQVE^Q?8J->NIK#["RIF52W7M*K\DE;&R)EY&>]^@ MFA;#(O$X2G8>;=I'!]^BUJVJN)QYT(N:\7=0<'DM;=Y'S[]!;7$?2U#GMSQ' M6_>IJGJV_+H6"(2JFU>@QH;4DN?CZG$,4F3\< @(U?YP6#^!EO+*5.,NR^IJ M-P_%MG(=J[=QZ+;GO)J=L%Y=L_((&BC(U+3VNA6JW4A%U59#2P_TR!TU,:"6 M'[K7!AO6MK,.&UF@V%)A98H;0C"/5#31[M=52?4C[%.%.I2111OV!G:]0@WK M5:9A#D8!ZPW=T==.Z3/_JT]^HL_^G_[^O)X8L88)?LPO!L_2WL-4WQJ-N3W2 MHE):MXTJZJP*R\MZ:EQ?/:-/?:&/?Z[/'=/=M]3FMF1G)A"@=7NI_3EH MN(^X@T^-&VGK"]@$LP@1]M/1?GWQ:/#49_KX1_KXA_K;#_GGB8_UJ4_US;/8 M'[/,Q# .M&RFYUY5A26N<%%U$Y54LJ$ !;::Z7%]^HC^]E-]]!-][&/^Y?CG MP7-']8T+^N07>G*,;<%2G@D$A&J?B6ET'41.,94WJX+*D%+V@+=L>KC!;EUO\>[.:G"2JIHMGP/L%,$.V_W!4^>!0LV;:>"!0G8&Z(]5K0K:<Z[Y:>&(;#@QX=U)U7]8E/]-?OZVNGU10V (U'2V8V;=E/S9O9ZAI3 MV($A,V107EJ IX'^]A/=TZ$G1_7TA+[;QQKNUQ_I8Y_JSNOLOR'E64% J/99 MFZXYV5+*[!R+&GIM/LE*BYS@1?&$]M/&4QZ?]:E@W"HZ._R!##9$4G] MU8& 4.WJF(?'W@MP*#P':C99@K4.7OI0]UY0#PPZP+?P3&C>%V?''W2I)_K5 MHN&]!$,DV+;E.7:YC2J!-&K99VV(X2MXX/9>]J0)L$Q5FRJIL5P%8-7MNQ$\ M^9^VDQ;!L%#>F+0- 0P(]S)VDC4ZNW8;;3A 936IF!%@A=A\@#UGS3([%>RX MH"]^$^%&%C-9&G8 .'M]?\$:.!X_,->6PQ@2XQ%Q_QYWU2S8>:MOH'MN MCWUAB, GA(!0[1,"WN=FJ1B16]K$9NLWYJ%FAJZPZJK$BJA3F8R7&M;5O0TR.ZYY*G3 AI/Q 6,CFDNLZI ML1XU?,?:7$((67D#P8R05%FXKP=NZ^[+UALWF*YM%^WXL>LK?#S!>!(4E%!E MHV5+!7+#?>K2L4043#WV=+@RVHC;P]M\&7GI+ MP;# 06)2GED$A&J?T:FM6J6'NO.$FI_6@U11R!OGG<=L*E\B95Z^WVZSI=&-'L1/#(ORMPM^GV '?7ENVT MZ]7D;!'I:ZBRB75,T^J"\+/Q(3TVF- 2P?[5^+#N[[0K(P:,$&@;6?10C^JY MI>Z%&!FAS(4EM.>EP,__)O"G?TE;L:=7G%!S4NEI0T"H]FF;L43Z"S:L:*/B M4+SU\I*^?5PMW%-SDTR=,W=9!@>&YA <9F,] >PF0)J@3CM.#*X+\#3("VEJ M[$^:QU3+W&04.'C=[?#T\0(O-VSA8 JX-* @#'>T1TW=A?LM.^&"U\QG "(% MX(J ?;.D"L>G]01/?J"F1UD.3*[%%=2^C]IV)\&VT&J+*Q0>*F:9F]'38TGL M3.-M.O J ME5JA>DEA()57,P)"M:MY=E+M&TP'I;!X&M8#Q".,=ZNQ+G8J"#Y4(YUZ)*1Y M@8^:]W,B B_G?'B2PN7+5FS!SXT[PLX#8&J8#DKJK'T>!->.]>B[CCVNJ.XS M+^\/*]%CO>IN)_<*>NC$D,;FF&D7AE$"OK$(9TBJ@*4QTEO?Z9NGU M017UM/LU;)1Y>KE&-0%#;5:VC89&",:#R+P*<;O$]6&*M0MBR-BFJM*Q=G5?<9M8!0>MXUTD@! [, .[T:MW=Y,SLJF$E;W IVQCC$UBZE M#0H?TV(+!P8XV[+]P7C=ALH,]IP9=1<$ BVL4/6;+5[F;"_=>MBT3ACQ:9UG MV1O!I)W""FK<8BF_<0"(?4+,306O'M6]U]4#8V<_,X<]9'<>YBPS<7PM["; MU\B2$RYPXT@@85BR4X2P!5ALSW^C3WRNSWZENVZP/<'VPUN#)T0M;3] S[_* M&1)B-]:2;4[JKPX$A&I7QSP\QEX@&+=J@\HS7L!!KWC][SK%^JQ9[H,0[ZCI M(>N_2!H KR]X<7D5Y$,8[K1)D(FUIAV1$,=OW!&FJ=$N#:JUM]>C!.84 M4,TZE5]JD9=I/;!Y&:_\W9?4O7&+<;(QA&:%1%PIA(X-=>GK)_1@IV7'@-5B MYV%JV9Z0IZT.:JBE(;8E.,::V7 2+%!CD5K!+E!RO>+E,%XC2"SXY7_IHQ\% MSQ_CP+#Q84XT8Q;DHUF_C?:]S#D0;(-&@MV0:JL2 :':53DMC] IPF87J-!, MO )OJLE^??=66&G":_[4@.Z_'&ZA81M'#7@I?AIO]P[%MGH#0;$%&Y8V MB'EY[TF-]X5Y!L9T8A)YKN::R^;*$6G:FI%1J MW7D>;*LFC<2/G' GG],CP%76MBE[P6N8,AR!'@54A#R-B295(*2)80^S$"0S MDTCZ%6\F^4%X3W]_27_V'_K#WP41-M:'IUHH$A=^%)MV437>.>+FT'F$I2*7 M_I ("-7^D&C[WQ:8!>97;#V9979,]9Y#XL2(AA&8T'_%)A0J:T+NKF@O+N<% M4&P=T5\$XVQ9HT)NL'J$_(;>K_'NC[P'V))R+=C9+ZJB>MO)-Z@&;B@X[4:5 M.Q?55"@Q+K3@MCV)VEBCY"P91MO+7]FY6JAZ+6U]454TK# !#Y?T722*70@% M;F0B<2+[)"12X$N Y+..S%YZ=$"[1BBX2=/P7D!@+CCWYD7;01BO#M30H@J* M$FE?ZJQR!(1J5_D$)=,]=BK(H[H=*MNZ.?6]4=W]7;0(#NCJ8TY/Z4'KAE[5H8=$ZU4--.&'Q%3K55TWU4]#<<&1[I8I[2B*C8[V!D.L6T% M7H8-(;+ \4LC L+T0X #&7+[DZS+)A@3CR8$+=.1VF(=@$D"W!:PL( M.S9SD[K[O)WZA/-X(7(,P;AV0=)%9DGW3E-I?5BEY5SC%S6LM+%!K@ALA4^" MK=AR>JT#AM-N"D6KL3Y]Z2L]T!'R(T[LY![LUUT]'HY$R"D(M&REW8?C[ZH1 M4M9N/8"LM7:&;]UW&QEJU();&LE,*,N5JL#-?Q:8P.;@S.9E9B*7\O0C(+/X M],^A/0)0[?I#X:C6J0$U=,U]9P8LC"!=**HFWR&A(K+-AHY=<$'DP3W=<3*\ MMP8W,AQL8\7R:\0L<-;$D/] ].5P5T"L;:G#JMM]D7? 8@N4R@'8<$/Q;-B+ MY]"R!')XN\XA6P.Z]8G_5G/3X5?R%6<;MNSNZ[K_EN6V!:MQ<45@[VNT_X_9 MX3>6]6!1K6FF%]Y"X3S;6K>?>&>B.A!GO-XUTS(XZ<&>GW.: E,_A:%V=ISR2MD:6[;6^ FS MK/FSGO,KPFX G1&502A+#PC!N^,FS<5T .D%EN:I[0#S.!_WXO"" C=UGE$@ MXFBJ#0FI:J%U!ZC*/)Y LR5TM(>P55563XC!+6\T?EH?=@@K;R(SE2U:P5CZ MX LU[G!LL,12/N^;P2V,:\)W#;MJ-T]%+F/BQ\S<-"Y@>VO4[A;O*!XRLMD:O&R\V:#R921+_3>#U$*=<9X/B'0SK_\=M>Z+SCB#4+2/_Y'9 M%JZLL2."TK?K37P4KR,.%X@ GP];=(2*Z7.?ZE/O@TG-J^TCI*BF ME5[]%3486VU(A=5Q-OA^I,9@3@>B$@I*Z95?4BM,V [/K?G9Y5__-2[T&&PF MDLX@-7@X92U$H<]C@\B@R!P*$H=C >VU1/LLW:H I30KFOZV =\#J/3TPN= M09V*NL";?T%09DU?".C=2'1[MQ]^M5!=";ENJY!0HMIZ*N"%8V0P^,'O=,]M M*V)-SA9[FL\6$ZW69* G^TB,KSXDT#?H4]!2=_Z,^&R;4'VXE.:74T&EZP?9 MOCD-@ET9>U8+LVKH>Z1*<$<#I(GH,CCA.C/.P(R+G;=3O^?XA6C;J]&-W&+: M=(C#>2UK@\$X<.1"D$+X4PYZM3]6D)O]8$!L:]]U#@"SY">CU3([:X[X0M1O M237Q2;>A\*TX6BVNPK@X)'<1?K($@C83P>!:G+-044>U+:R6UJRETFKVO37] M7F$K &-V7F'30?=-%S32 JS)XM P= .& GZ92(-P9+"ENF9J@,!&=C8P>XC7 MB-F9X)FO]&V$8S@CUE+3LQ)80A;@B==,^:[Y ]5JQ58;J>P]I?]+SZ+"6O:H M33FZ"41:6$WPL?4JP8>Z]R*?:F['-;&B]P![7!PEX?RC0P)5KV/GL$?(646E MM3 O)!=*$#,$?>>*OG%*CP\F8;2%IGSMI#[^@>ZZHJ9&C5/6/7;]..ONG!KI MUU=.Z&\_TK>ON$/X\"$H6'_S@;Y^5HT.,8&Z"L0?8<& []>5,SC_)IPJX2E= MF=+M$ *BU3X36FT!(EGW4'D;GVB0\H>/7YSGT#(O'1^28>?%AAB;7(V&P+SG M_D=-]AM4ZZ*M4/L+.%B!H-+B[3OES_T9-B#,3CK?/RBW$,<^PN;+8F&[@+]! MQ[G(^SJR/V,#;"#&63@(!L,E8-)S7Q@OYMY*%BP XW>Q2X8M,@Y/P"C,P\.A MD3W2V)5*81LKJ!:\:6M;3ENM>1T,DJCJD,/?&4/&!A=G$\?O,?L8[G8WM^T.1+C>FS#2.(1MMBY=W!%\1J$V/]!A*KIMA.LS9QJ!@SH;-MQK9 M'5MA-.","NGI[)6%X-J1/MV+@Q=AO5TV>-.^,G(@49W!RP<,!7 1@R$"]EDD M3@2/8S\-L;E]G6SGG3=UWB@A$?>P;;8.-1JSQA+LC-GEV+DV)]';/.K^E$I* MCNM>2$J=":-AS8"!AFMGDKK9$^J,8UX\AK_FO7=E6\Q<9T_YMAB[!$0Y8+H1 M7_BFBE2.[-N)M3;PIC?[H!4V33J$\SF#YO5N+9INH=%W5 +LYB0[7 ^ESR"R M\!UEV#JQ[65,'[Y G<@ BEBJ9910W^@_)%G;5@EW!F80?) !TD0 VC%:9-T6 M*=-"E)T4NZ'_$(C]24;)& 7 ?&CHME8>!J':\#J(S_M"M5Y/RWCL%A>UB =[ M,2?4P<:C\K[H9O?54Y25&LM2#>;@+LZ%C%&T6K#-.Q\!COOA=6DU\02P."@" @" C5RAH0! 0!0( MI0%!0! 0!(1J90T( H* (. [ D*UOD,L#0@"@H @(%0K:T 0$ 0$ =\1$*KU M'6)I0! 0! 0!H5I9 X* (" (^(Z 4*WO$$L#@H @( B0QNGS4@0!04 0$ 3\ 81.#_ =LYW8/EFT;] $E%3D2N0F"" end XML 16 R1.htm IDEA: XBRL DOCUMENT v3.24.3
Cover - shares
 9 Months Ended
Sep. 30, 2024
Oct. 23, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2024  
Document Transition Report false  
Entity File Number 001-36440  
Entity Registrant Name AVANOS MEDICAL, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 46-4987888  
Entity Address, Address Line One 5405 Windward Parkway  
Entity Address, Address Line Two Suite 100 South  
Entity Address, City or Town Alpharetta,  
Entity Address, State or Province GA  
Entity Address, Postal Zip Code 30004  
City Area Code (844)  
Local Phone Number 428-2667  
Title of 12(b) Security Common Stock - $0.01 Par Value  
Trading Symbol AVNS  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Emerging Growth Company false  
Entity Small Business false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   45,956,997
Entity Central Index Key 0001606498  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus (Q1,Q2,Q3,FY) Q3  
Amendment Flag false  
XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED INCOME STATEMENTS - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net Sales $ 170.4 $ 171.3 $ 508.2 $ 500.0
Cost of products sold 77.5 75.8 224.9 215.3
Gross Profit 92.9 95.5 283.3 284.7
Research and development 7.2 6.1 20.5 20.4
Selling and general expenses 74.3 78.7 238.8 260.5
Other (income) expense, net (0.6) 9.5 1.7 10.8
Operating Income (Loss) 12.0 1.2 22.3 (7.0)
Interest income 0.7 0.9 4.3 1.9
Interest expense (3.2) (4.7) (9.4) (11.7)
Income (Loss) Before Income Taxes 9.5 (2.6) 17.2 (16.8)
Income tax provision (3.6) (6.2) (6.5) (4.1)
Income (Loss) from Continuing Operations 5.9 (8.8) 10.7 (20.9)
(Loss) Income from discontinued operations, net of tax (1.6) 5.1 (5.5) (51.4)
Net Income (Loss) $ 4.3 $ (3.7) $ 5.2 $ (72.3)
Basic Earnings (Loss) Per Share        
Continuing operations- basic (in dollars per share) $ 0.13 $ (0.19) $ 0.23 $ (0.45)
Discontinued operations- basic (in dollars per share) (0.03) 0.11 (0.12) (1.10)
Basic Earnings (Loss) Per Share (in dollars per share) 0.10 (0.08) 0.11 (1.55)
Diluted Earnings (Loss) Per Share        
Continuing operations- diluted (in dollars per share) 0.12 (0.19) 0.23 (0.45)
Discontinued operations- diluted (in dollars per share) (0.03) 0.11 (0.12) (1.10)
Diluted Earnings (Loss) Per Share (in dollars per share) $ 0.09 $ (0.08) $ 0.11 $ (1.55)
XML 18 R3.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Statement of Comprehensive Income [Abstract]        
Net Income (Loss) $ 4.3 $ (3.7) $ 5.2 $ (72.3)
Other Comprehensive Income (Loss), Net of Tax        
Unrealized currency translation adjustments 0.3 (4.6) (8.0) 2.8
Defined benefit plans 0.1 0.0 (0.1) 0.0
Cash flow hedges 0.2 0.0 (1.8) 0.0
Total Other Comprehensive Income (Loss), Net of Tax 0.6 (4.6) (9.9) 2.8
Comprehensive Income (Loss) $ 4.9 $ (8.3) $ (4.7) $ (69.5)
XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 89.0 $ 87.7
Accounts receivable, net of allowances 131.9 142.8
Inventories 161.9 163.2
Prepaid and other current assets 15.9 28.8
Assets held for sale 73.9 64.5
Total Current Assets 472.6 487.0
Property, Plant and Equipment, net 109.5 117.2
Operating Lease Right-of-Use Assets 26.5 26.8
Goodwill 795.1 796.1
Other Intangible Assets, net 220.1 239.5
Deferred Tax Assets 6.6 6.5
Other Assets 25.8 19.3
TOTAL ASSETS 1,656.2 1,692.4
Current Liabilities    
Current portion of long-term debt 9.4 8.6
Current portion of operating lease liabilities 13.7 12.8
Trade accounts payable 54.2 56.3
Accrued expenses 82.7 93.2
Liabilities held for sale 52.9 63.7
Total Current Liabilities 212.9 234.6
Long-Term Debt 152.6 159.4
Operating Lease Liabilities 26.5 28.3
Deferred Tax Liabilities 23.9 23.8
Other Long-Term Liabilities 10.6 10.0
Total Liabilities 426.5 456.1
Commitments and Contingencies
Stockholders’ Equity    
Preferred stock - $0.01 par value - authorized 20,000,000 shares, none issued 0.0 0.0
Common stock - $0.01 par value - authorized 300,000,000 shares, 45,954,931 outstanding as of September 30, 2024 and 46,174,337 outstanding as of December 31, 2023 0.5 0.5
Additional paid-in capital 1,674.7 1,663.6
Accumulated deficit (309.7) (314.9)
Treasury stock (98.9) (85.9)
Accumulated other comprehensive loss (36.9) (27.0)
Total Stockholders’ Equity 1,229.7 1,236.3
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 1,656.2 $ 1,692.4
XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 20,000,000 20,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 300,000,000 300,000,000
Common stock, shares outstanding (in shares) 45,954,931 46,174,337
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2022     $ 1,646.4 $ (253.1) $ (66.8) $ (35.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise or redemption of share-based awards     1.5      
Stock-based compensation expense     11.8      
Net income (loss) $ (72.3)     (72.3)    
Purchases of treasury stock         (12.9)  
Other comprehensive income (loss), net of tax 2.8         2.8
Ending balance at Sep. 30, 2023 1,222.1 $ 0.5 1,659.7 (325.4) (79.7) (33.0)
Beginning balance at Jun. 30, 2023     1,654.9 (321.7) (70.5) (28.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise or redemption of share-based awards     0.9      
Stock-based compensation expense     3.9      
Net income (loss) (3.7)     (3.7)    
Purchases of treasury stock         (9.2)  
Other comprehensive income (loss), net of tax (4.6)         (4.6)
Ending balance at Sep. 30, 2023 1,222.1 0.5 1,659.7 (325.4) (79.7) (33.0)
Beginning balance at Dec. 31, 2023 1,236.3   1,663.6 (314.9) (85.9) (27.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise or redemption of share-based awards     1.1      
Stock-based compensation expense     10.0      
Net income (loss) 5.2     5.2    
Purchases of treasury stock         (13.0)  
Other comprehensive income (loss), net of tax (9.9)         (9.9)
Ending balance at Sep. 30, 2024 1,229.7 0.5 1,674.7 (309.7) (98.9) (36.9)
Beginning balance at Jun. 30, 2024     1,671.5 (314.0) (98.5) (37.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise or redemption of share-based awards     0.6      
Stock-based compensation expense     2.6      
Net income (loss) 4.3     4.3    
Purchases of treasury stock         (0.4)  
Other comprehensive income (loss), net of tax 0.6         0.6
Ending balance at Sep. 30, 2024 $ 1,229.7 $ 0.5 $ 1,674.7 $ (309.7) $ (98.9) $ (36.9)
XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED CASH FLOW STATEMENTS - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Operating Activities    
Net income (loss) $ 5.2 $ (72.3)
Depreciation and amortization 34.4 34.6
Stock-based compensation expense 10.0 11.8
Goodwill impairment 0.0 59.1
Net loss on asset dispositions and impairments 0.4 1.1
Changes in operating assets and liabilities, net of acquisition:    
Accounts receivable (6.9) 30.0
Inventories (5.9) (6.6)
Prepaid expenses and other assets 7.7 0.2
Accounts payable (1.2) (16.0)
Accrued expenses (3.7) (19.7)
Deferred income taxes and other 2.8 (2.5)
Cash Provided by Operating Activities 42.8 19.7
Investing Activities    
Capital expenditures (13.0) (11.9)
Proceeds from RH Divestiture post-closing settlement 2.1 0.0
Acquisition of assets and investments in businesses 0.0 (47.5)
Investment in Note Receivable (9.0) 0.0
Cash Used in Investing Activities (19.9) (59.4)
Financing Activities    
Secured debt repayments (6.3) (3.1)
Revolving credit facility proceeds 20.0 55.0
Revolving credit facility repayments (20.0) (20.0)
Purchases of treasury stock (12.7) (12.9)
Proceeds from the exercise of stock options 1.1 1.5
Payment of contingent consideration liabilities (3.8) 0.0
Cash (Used in) Provided by Financing Activities (21.7) 20.5
Effect of Exchange Rate Changes on Cash and Cash Equivalents 0.1 (1.4)
Increase (Decrease) in Cash and Cash Equivalents 1.3 (20.6)
Cash and Cash Equivalents - Beginning of Period 87.7 127.7
Cash and Cash Equivalents - End of Period $ 89.0 $ 107.1
XML 23 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Accounting Policies
 9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Accounting Policies Accounting Policies
Background and Basis of Presentation
Avanos Medical, Inc. is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today’s most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio. References herein to “Avanos,” “the Company,” “we,” “our” and “us” refer to Avanos Medical, Inc. and its consolidated subsidiaries.
Interim Financial Statements
We prepared the accompanying unaudited condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and the instructions to the Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements, and the condensed consolidated financial statements in this Form 10-Q should be read in conjunction with the Form 10-K. Our unaudited interim condensed consolidated financial statements contain all necessary material adjustments, which are of a normal and recurring nature, to fairly state our financial condition, results of operations and cash flows for the periods presented.
Use of Estimates
Preparation of our condensed consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Estimates are used in accounting for, among other things, certain amounts included in discontinued operations, certain amounts included in assets and liabilities held for sale, distributor rebate accruals, future cash flows associated with impairment testing for goodwill and long-lived assets, loss contingencies, and deferred tax assets and potential income tax assessments. Actual results could differ from these estimates, and the effect of any change could be material to our financial statements. Changes in these estimates are recorded when known.
Goodwill
We test goodwill for impairment annually or more frequently whenever events or circumstances more likely than not indicate that the fair value of the reporting unit may be below its carrying value. We operate as a single reportable operating segment with one reporting unit. The fair value of our reporting unit is estimated using a combination of income (discounted cash flow analysis) and market approaches. The income approach is dependent upon several assumptions regarding future periods such as sales growth and a terminal growth rate. A weighted average cost of capital (“WACC”) was used to discount future estimated cash flows to their present values. The WACC was based on externally observable data considering market participants’ cost of equity and debt, optimal capital structure and risk factors specific to us. The market approach estimates the value of our company using a market capitalization methodology.
We determined that the fair value of our reporting unit exceeded the net carrying amount in our most recent goodwill impairment test on July 1, 2024. However, there can be no assurance that the assumptions and estimates made for purposes of the annual goodwill impairment test will prove to be accurate. Volatility in the equity and debt markets, or increases in interest rates, could result in a higher discount rate. Changes in sales volumes, selling prices and costs of goods sold, and increases in interest rates could cause changes in our forecasted cash flows. Unfavorable changes in any of the factors described above, as well as a decline in our stock price, could result in a goodwill impairment charge in the future.
Hedging and Derivatives
All derivative instruments are recorded as assets or liabilities on the balance sheet at fair value. Changes in the fair value of
derivatives are either recorded in the income statement or other comprehensive income, as appropriate. The effective portion of
the gain or loss on derivatives designated as cash flow hedges is included in other comprehensive income in the period that
changes in fair value occur, and is reclassified to income in the same period that the hedged item affects income. Our policies allow the use of derivatives for risk management purposes and prohibit their use for speculation. Our policies also prohibit the use of any leveraged derivative instrument. Consistent with our policies, foreign currency derivative instruments are entered into with major financial institutions. At inception, we formally designate certain derivatives as cash flow hedges and establish how the effectiveness of these hedges will be assessed and measured. This process links the derivatives to the transactions they are hedging. See Note 11, “Derivative Financial Instruments,” for disclosures about derivative instruments and hedging activities.
Recently Adopted Accounting Pronouncements
Effective January 1, 2023, we adopted ASU No. 2021-08, Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. This ASU pertains to acquired revenue contracts with customers in a business combination and addresses diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. Adoption of this ASU did not have a material effect on our financial position, results of operations or cash flows.
Recently Issued Accounting Pronouncements
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes: Improvement to Income Tax Disclosures. This ASU pertains to disaggregation of income tax disclosures and enhances annual income tax disclosures to address investor requests for more information about the tax risks and opportunities present in an entity’s worldwide operations. The two primary enhancements disaggregate existing income tax disclosures related to the effective tax rate reconciliation and income taxes paid, and requires entities to disclose a tabular reconciliation of expected tax and reported tax on income from continuing operations using both percentages and amounts, broken out into specific categories with certain reconciling items at or above 5% of the expected tax further broken out by nature and/or jurisdiction. Additionally, this ASU requires disclosure around income taxes paid (net of refunds received) broken out between federal, state, local and foreign, and income taxes paid (net of refunds received) to an individual jurisdiction when greater than 5% of total income taxes paid. This ASU will be effective for annual periods beginning after December 15, 2024, with early adoption permitted. Adoption of this ASU is not expected to have a material effect on our financial position, results of operations or cash flows.
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting: Improvements to Reportable Segment Disclosures. This ASU enhances segment reporting under Topic 280 by expanding the breadth and frequency of segment disclosures, and aims to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. This ASU will be effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of this ASU will require us to expand our current disclosures around significant expenses and disclose an aggregate amount and composition of other segment items related to our single operating segment. On an annual basis, this ASU will require us to disclose the Chief Operating Decision Maker’s (CODM) title and position, as well as how the CODM uses each reported measure of segment profit or loss to assess performance and allocate resources to the segment. We will retrospectively adopt this ASU in the fiscal period ending December 31, 2024 as required by ASU No. 2023-07.
In August 2023, the FASB issued ASU No. 2023-05, Business Combinations: Joint Venture Formations. This ASU is intended to address diversity in practice regarding accounting and provide decision-useful information related to contributions made to joint ventures and requires entities that qualify as either a joint venture or a corporate joint venture to apply a new basis of accounting upon the formation of the joint venture. Specifically, the ASU provides that a joint venture or a corporate joint venture must initially measure its assets and liabilities at fair value on the formation date. This ASU will be effective for all newly formed joint venture entities with a formation date on or after January 1, 2025, with early adoption permitted. Joint ventures formed prior to the adoption date may elect to apply the new guidance retrospectively back to their original formation date. Adoption of this ASU is not expected to have a material effect on our financial position, results of operations or cash flows.
XML 24 R9.htm IDEA: XBRL DOCUMENT v3.24.3
Discontinued Operations
 9 Months Ended
Sep. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations Discontinued Operations
On June 7, 2023, we entered into a Purchase Agreement (“the Purchase Agreement”) by and among us and certain of our affiliates and SunMed Group Holdings, LLC (“Buyer”) pursuant to which Buyer agreed to purchase substantially all of the assets primarily relating to or primarily used in our Respiratory Health (“RH”) business (the “RH Divestiture”). On October 2, 2023, we closed the RH Divestiture for a total purchase price of $110 million in cash, subject to certain adjustments as provided in the Purchase Agreement based on the indebtedness and inventory transferred to Buyer at the closing and the chargebacks assumed by Buyer but that would otherwise have been payable by the Company and its subsidiaries on or after October 2, 2023 to distributors of the Company’s RH products located in the United States (the “Initial Closing”).
The RH Divestiture represents a key component of Avanos’ ongoing three-year transformation process, and is aimed at accelerating the Company’s efforts to focus its portfolio on markets where it is well positioned to succeed.
At or before the closing of the RH Divestiture, we and Buyer entered into various transition services agreements pursuant to which we, Buyer and each company’s respective affiliates provide to each other various transitional services, including, but not limited to, product manufacturing and distribution, facilities, order fulfillment, invoicing, quality assurance, regulatory support, audit support and other services. The services generally commenced on the closing date of the Divestiture and terminate no later than one to three years thereafter.
We have also entered into distribution agreements with Buyer under which we will remain a limited risk distributor for RH products on Buyer’s behalf for sales outside of the United States. As a result, we had $6.6 million of RH products included in “Prepaid expenses and other current assets” in the accompanying consolidated balance sheet as of September 30, 2024, compared to $11.9 million as of December 31, 2023. While our agreements with Buyer allows for limited risk distributor (“LRD”) arrangements for up to three years from the date of the Purchase Agreement, we expect the LRD arrangements to terminate by the end of this year.
As a result of the RH Divestiture, the results of operations from our RH business are reported as “Net (Loss) Income from discontinued operations, net of tax” and the related assets and liabilities are classified as “held for sale” in the condensed consolidated financial statements.
Pursuant to an agreement under which we provide manufacturing services for the Buyer, certain manufacturing facilities and equipment did not transfer to the Buyer upon the Initial Closing, and remained in “Assets Held for Sale” as of September 30, 2024 with a corresponding liability representing our obligation to transfer the manufacturing facilities and equipment to the buyer at a later date. Likewise, the results of operations from these manufacturing operations continue to be classified as “Net Loss from discontinued operations, net of tax. On October 1, 2024, we finalized the RH Divestiture and completed the transfer of the manufacturing facilities and equipment to Buyer. Accordingly, we expect to finalize adjustments to our pretax loss on discontinued operations in the fourth quarter of 2024.
The following table summarizes the financial results of our discontinued operations for all periods presented herein (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Net Sales$10.5 $31.1 $41.0 $93.9 
Cost of products sold15.9 19.9 47.4 57.8 
Gross Profit(5.4)11.2 (6.4)36.1 
Research and development— 0.2 — 0.8 
Selling and general expenses— 4.2 — 11.9 
Pretax loss on classification as discontinued operations— — — 72.3 
Other (income) expense, net(3.2)0.1 1.1 0.3 
(Loss) Income from discontinued operations before income taxes(2.2)6.7 (7.5)(49.2)
Income tax benefit (provision) from discontinued operations
0.6 (1.6)2.0 (2.2)
Net (Loss) Income from discontinued operations, net of tax$(1.6)$5.1 $(5.5)$(51.4)
(Loss) Earnings Per Share
Basic$(0.03)$0.11 $(0.12)$(1.10)
Diluted$(0.03)$0.11 $(0.12)$(1.10)
In accordance with accounting principles generally accepted in the United States (“GAAP”), only expenses specifically identifiable and related to a business to be disposed may be allocated to discontinued operations. Accordingly, the cost of products sold, research and development, selling and general expenses and other expense, net in discontinued operations include expenses incurred directly to solely support our respiratory health business.
Details on assets and liabilities classified as held for sale in the accompanying consolidated balance sheets are presented in the following table (in millions):
September 30, 2024December 31, 2023
Assets held for sale - discontinued operations
Inventories$28.2 $17.5 
Property, Plant and Equipment, net43.0 43.9 
Operating Lease Right-of-Use Assets2.7 3.1 
Total assets classified as held for sale$73.9 $64.5 
Liabilities held for sale - discontinued operations
Current Portion of Operating Lease Liabilities$0.7 $0.8 
Accrued expenses51.3 61.3 
Non-Current Operating Lease Liability0.9 1.6 
Total liabilities held for sale - discontinued operations$52.9 $63.7 

Assets and liabilities held for sale as of September 30, 2024 were classified as current since we expect the RH Divestiture to be completed within one year.

The following table provides operating and investing cash flow information for our discontinued operations (in millions):
Nine Months Ended September 30,
20242023
Operating Activities:
Depreciation and amortization$— $2.6 
Stock-based compensation expense— 0.1 
Investing Activities:
Capital expenditures0.6 3.1 
XML 25 R10.htm IDEA: XBRL DOCUMENT v3.24.3
Restructuring Activities
 9 Months Ended
Sep. 30, 2024
Restructuring and Related Activities [Abstract]  
Restructuring Activities Restructuring Activities
Post-RH Divestiture Restructuring Plan
During 2024, we initiated a post-RH Divestiture restructuring plan (the “Plan”). The Plan is intended to align our organizational structure, distribution and operational footprint with our remaining business. We expect the Plan will be substantially complete by the end of 2025 and currently expect to incur between $10.0 million and $11.0 million of cash expenses, primarily for employee termination benefits. In the three and nine months ended September 30, 2024, we incurred $2.3 million and $6.4 million, respectively, of costs related to the Plan. These costs were included in “Cost of products sold” and “Selling and general expenses” in the accompanying condensed consolidated income statements.
Transformation Process
In January 2023, we initiated a three-year restructuring initiative intended to align the Company under a single commercial organization, rationalize our product portfolio, undertake additional cost management activities to enhance the Company’s operating profitability and pursue efficient capital allocation strategies (the “Transformation Process”). The RH Divestiture represents a key component of the three-year Transformation Process. We expect the Transformation Process will be substantially complete by the end of 2025.
We expect to incur up to $30.0 million of cash expenses in connection with the Transformation Process, consisting of between $9.0 million and $12.0 million of program management consulting and employee retention expenses; between $8.0 million and $11.0 million of expenses associated with manufacturing and supply chain improvements and portfolio rationalization; and the remainder for expenses associated with organization design and alignment and other related activities. These amounts include between $6.0 million and $8.0 million of employee severance and benefits costs.
In the three and nine months ended September 30, 2024, we incurred expenses of $0.7 million and $5.2 million, respectively, primarily related to employee severance and benefits costs in connection with the Transformation Process, compared to $4.3 million and $23.0 million in the three and nine months ended September 30, 2023. These costs were included in “Cost of products sold” and “Selling and general expenses” in the accompanying condensed consolidated income statements. Plan-to-
date we have incurred expenses of $33.4 million in connection with the Transformation Process, which includes $28.1 million of cash expenses.
Restructuring Liability
Our liability for costs associated with our restructuring initiatives as of September 30, 2024 is summarized below (in millions):
As of September 30, 2024
Beginning balance$2.3 
Restructuring and transformation costs, excluding non-cash charges10.3 
Payments and adjustments, net(9.2)
Ending balance$3.4 
XML 26 R11.htm IDEA: XBRL DOCUMENT v3.24.3
Business Acquisition
 9 Months Ended
Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Business Acquisition Business Acquisition
Diros Technology
On June 17, 2023 we entered into a definitive agreement to acquire Diros Technology Inc. (“Diros”), a leading manufacturer of innovative radiofrequency ablation (“RFA”) products used to treat chronic pain conditions. On July 24, 2023, we closed the acquisition of Diros. The total purchase price paid in connection with our acquisition of Diros was $53.0 million, consisting of $2.5 million in cash paid upon entry into the definitive agreement and $50.5 million in cash paid at closing (subject to certain working capital and other adjustments), with up to an additional $7.0 million payable in contingent cash consideration based on achievement of certain performance objectives defined in the purchase agreement (the “Diros Acquisition”). The purchase price for the Diros Acquisition was funded by proceeds from our Revolving Credit Facility. The accompanying condensed consolidated income statement includes $4.6 million and $14.4 million of net sales from Diros for the three and nine months ended September 30, 2024, respectively. The accompanying condensed consolidated income statement includes $2.4 million of net sales from Diros since the acquisition date for the three and nine months ended September 30, 2023. In the three and nine months ended September 30, 2024, we incurred $1.5 million and $2.1 million of costs in connection with the Diros Acquisition, compared to $0.6 million and $0.9 million of costs in the three and nine months ended September 30, 2023, respectively. These costs are included in “Selling and general expenses,” In the nine months ended September 30, 2024, we made contingent consideration payments of $4.6 million and to date we have made contingent consideration payments of $6.1 million.
Under the acquisition method of accounting for business combinations, the purchase price paid is allocated to the underlying net assets in proportion to their respective fair values. Any excess of the purchase price over the estimated fair values is recorded as goodwill. Fair values of assets acquired and liabilities assumed are being determined using discounted cash flow analyses and the fair value of the contingent consideration is being estimated using a Monte Carlo simulation. Assumptions supporting the estimated fair values are based on facts and circumstances that existed on the valuation date. The purchase price allocation is shown in the table below (in millions):
Current assets, net of cash acquired
$7.5 
Current liabilities, excluding contingent consideration
(7.0)
Contingent consideration
(5.3)
Other noncurrent liabilities, net(0.5)
Deferred tax liabilities
(8.1)
Identifiable intangible assets
29.6 
Goodwill
33.4 
Total$49.6 
The identifiable intangible assets relating to the Diros Acquisition include the following (in millions, except years):
Identifiable Intangible Asset AmountWeighted Average Useful Lives (Years)
Trade names and trademarks
$2.9 15
Customer relationships
21.2 14
Developed technology and other
5.5 13
Total$29.6 
XML 27 R12.htm IDEA: XBRL DOCUMENT v3.24.3
Supplemental Balance Sheet Information
 9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplemental Balance Sheet Information Supplemental Balance Sheet Information
Accounts Receivable
Accounts receivable consist of the following (in millions):
September 30, 2024December 31, 2023
Accounts receivable$137.3 $134.0 
Income tax receivable— 14.1 
Allowances and doubtful accounts:
Doubtful accounts(4.8)(5.1)
Sales discounts(0.6)(0.2)
Accounts receivable, net$131.9 $142.8 
Losses on receivables are estimated based on known troubled accounts and historical experience. Receivables are considered impaired and written off when it is probable that payments due will not be collected. Allowance for doubtful accounts was $0.1 million for the three months ended September 30, 2024 and $0.2 million for the nine months ended September 30, 2024, compared to a net benefit of $0.4 million and an expense of $0.2 million for the three and nine months ended September 30, 2023, respectively.
Inventories
Inventories at the lower of cost (determined on the FIFO method) or net realizable value consists of the following (in millions):
September 30, 2024December 31, 2023
Raw materials$47.4 $50.3 
Work in process23.219.8
Finished goods87.988.5
Supplies and other3.44.6
Total Inventory$161.9 $163.2 
We incurred $2.8 million and $4.3 million of expense for inventory write-offs and obsolescence in the three and nine months ended September 30, 2024, compared to $2.0 million and $6.3 million in the three and nine months ended September 30, 2023, respectively.

Property, Plant and Equipment
Property, plant and equipment consists of the following (in millions):
September 30, 2024December 31, 2023
Land$1.2 $1.3 
Buildings and leasehold improvements41.3 38.0 
Machinery and equipment185.4 182.8 
Construction in progress18.8 18.0 
246.7 240.1 
Less accumulated depreciation(137.2)(122.9)
Total$109.5 $117.2 
Depreciation expense was $5.3 million and $15.6 million for the three and nine months ended September 30, 2024,
respectively, compared to $4.8 million and $14.2 million for the three and nine months ended September 30, 2023, respectively.
Goodwill and Intangible Assets
The changes in the carrying amount of goodwill are as follows (in millions):
Goodwill
Balance, December 31, 2023$796.1 
Currency translation adjustment(1.0)
Balance, September 30, 2024$795.1 
Intangible assets subject to amortization consist of the following (in millions):
September 30, 2024December 31, 2023
Gross
Carrying
Amount		Accumulated
Amortization		Net Carrying AmountGross
Carrying
Amount		Accumulated
Amortization		Net Carrying Amount
Trademarks$41.6 $(29.7)$11.9 $42.0 $(28.8)$13.2 
Patents and acquired technologies248.5 (179.2)69.3 248.6 (171.9)76.7 
Other207.7 (68.8)138.9 207.7 (58.1)149.6 
Total$497.8 $(277.7)$220.1 $498.3 $(258.8)$239.5 
Amortization expense for intangible assets is included in “Cost of products sold” and “Selling and general expenses” and was $6.4 million and $18.8 million for the three and nine months ended September 30, 2024, respectively, compared to $6.2 million and $17.8 million for the three and nine months ended September 30, 2023, respectively. As of September 30, 2024 we had unrealized currency translation adjustments of $0.3 million related to our acquired intangibles from the acquisition of Diros.
Amortization expense for the remainder of 2024, the following four years and thereafter is estimated as follows (in millions):
Amount
Remainder of 2024$6.7 
202525.0 
202624.5 
202722.8 
202822.6 
Thereafter118.5 
Total$220.1 

Accrued Expenses
Accrued expenses consist of the following (in millions):
September 30, 2024December 31, 2023
Accrued rebates and customer incentives$23.6 $17.7 
Accrued salaries and wages29.8 31.5 
Accrued taxes and other6.2 16.7 
Other23.1 27.3 
Total$82.7 $93.2 
Other Long-Term Liabilities
Other long-term liabilities consist of the following (in millions):
September 30, 2024December 31, 2023
Accrued compensation and benefits$6.7 $5.9 
Other3.9 4.1 
Total$10.6 $10.0 
XML 28 R13.htm IDEA: XBRL DOCUMENT v3.24.3
Fair Value Information
 9 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value Information Fair Value Information
The following fair value information is based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels in the hierarchy used to measure fair value are:
Level 1: Unadjusted quoted prices in active markets accessible at the reporting date for identical assets and liabilities.
Level 2: Quoted prices for similar assets or liabilities in active markets. Quoted prices for identical or similar assets and liabilities in markets that are not considered active or financial instruments for which all significant inputs are observable, either directly or indirectly.
Level 3: Prices or valuations that require inputs that are significant to the valuation and are unobservable.
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The following table includes the fair value of our financial instruments for which disclosure of fair value is required (in millions):
September 30, 2024December 31, 2023
Fair Value
Hierarchy
Level		Carrying
Amount		Estimated
Fair
Value		Carrying
Amount		Estimated
Fair
Value
Assets
Cash and cash equivalents1$89.0 $89.0 $87.7 $87.7 
Liabilities
Revolving Credit Facility2$50.0 $50.0 $50.0 $50.0 
Term Loan Facility2112.0 112.0 118.0 118.0 
Contingent consideration related to acquisition3— — 5.3 5.3 
Cash equivalents are recorded at cost, which approximates fair value due to their short-term nature. The fair value of amounts borrowed under our Revolving Credit Facility and Term Loan Facility approximates carrying value because borrowings are subject to a variable rate as described in Note 7, “Debt”.
XML 29 R14.htm IDEA: XBRL DOCUMENT v3.24.3
Debt
 9 Months Ended
Sep. 30, 2024
Debt Disclosure [Abstract]  
Debt Debt
As of September 30, 2024 and December 31, 2023, our respective debt balances were as follows (in millions):
Weighted-Average Interest RateMaturitySeptember 30, 2024December 31, 2023
Revolving Credit Facility6.83 %2027$50.0 $50.0 
Term Loan Facility6.81 %2027112.5 118.8 
162.5 168.8 
Unamortized debt issuance costs(0.5)(0.8)
Current portion of long-term debt(9.4)(8.6)
Total Long-Term Debt, net$152.6 $159.4 

On June 24, 2022, we entered into a credit agreement (the “Credit Agreement”) with certain lenders which established credit facilities in an aggregate principal amount of $500.0 million, consisting of a five-year senior secured term loan of $125.0 million (the “Term Loan Facility”) and a five-year senior secured revolving credit facility allowing borrowings of up to $375.0 million, with a letter of credit sub-facility in an amount of $75.0 million (the “Revolving Credit Facility”). All obligations under the Credit Agreement and certain hedging agreements and cash management arrangements thereunder are: (i) guaranteed by each of the Company’s direct and indirect, existing and future, material wholly owned domestic subsidiaries (“Guarantors”) and
(ii) secured by a first priority lien on substantially all the assets of the Company and the Guarantors. The Credit Agreement contains an accordion feature that allows us to incur incremental term loans under the Term Loan Facility or under new term loan facilities or to increase the amount of the commitments under the Revolving Credit Facility, including through the establishment of one or more tranches under the Revolving Credit Facility. The Credit Agreement will mature on June 24, 2027.
Borrowings under the Term Loan Facility and Revolving Credit Facility bear interest at our option at either: (i) an adjusted term secured overnight financing rate (“SOFR”), plus a margin ranging between 1.50% to 2.00% per annum, depending on our consolidated total leverage ratio; (ii) an adjusted daily simple SOFR rate, plus a margin ranging between 1.50% to 2.00% per annum, depending on our consolidated total leverage ratio; or (iii) a base rate (calculated as the greatest of (a) the prime rate, (b) the NYFRB rate (being the greater of the federal funds effective rate or the overnight bank funding rate) plus 0.50%, and (c) the one month adjusted term SOFR rate plus 1.00%), plus a margin ranging between 0.50% to 1.00% per annum, depending on our consolidated total leverage ratio. The unused portion of the Revolving Credit Facility will be subject to a commitment fee ranging between 0.20% to 0.25% per annum, depending on our consolidated total leverage ratio. Unamortized debt discount and issuance costs are being amortized to interest expense over the life of the Term Loan Facility using the interest method, resulting in an effective interest rate of 7.1% as of September 30, 2024.
The Credit Agreement requires compliance with certain customary operational and financial covenants. As of September 30, 2024, we were in compliance with these covenants. In addition, the Credit Agreement contains certain other customary limitations on our ability to, among other things: incur additional indebtedness; pay dividends on or repurchase or redeem our capital stock; make loans, investments and acquisitions; sell, transfer or otherwise dispose of assets; guarantee other obligations; create or grant liens; and enter into certain types of transactions with affiliates. Notwithstanding such limitations, the Credit Agreement allows us to pay dividends, repurchase stock and make investments up to an “Available Amount,” as defined in the Credit Agreement, provided no event of default has occurred and certain financial ratios have been achieved on a pro forma basis. We are permitted to prepay all or a portion of the Term Loan Facility and the Revolving Credit Facility at any time without premium or penalty.
Debt Payments
The Credit Agreement requires quarterly principal installment payments on the Term Loan Facility of 10% of the total principal borrowed for the first eight quarters following funding and then quarterly installment payments of 20% of the total principal borrowed, at which time the remaining unpaid principal amount of the Term Loan Facility is due and payable by the Company upon the maturity date of June 24, 2027. The current portion of the Term Loan Facility is $9.4 million. Interest is payable quarterly. We have the right to voluntarily prepay the Term Loan Facility in accordance with the terms of the Credit Agreement. Interest is payable at the same rates set forth above for the Revolving Credit Facility.
During the nine months ended September 30, 2024, we repaid $6.3 million of the Term Loan Facility. During the nine months ended September 30, 2024, we borrowed $20.0 million and repaid $20.0 million of the Revolving Credit Facility. As of September 30, 2024, we had letters of credit outstanding of $6.3 million.
As of September 30, 2024, the aggregate amounts of long-term debt that will mature during each of the next four years are as follows (in millions):
Amount
Remainder of 2024$2.3 
20259.4 
202610.2 
2027140.6 
2028— 
Total$162.5 
XML 30 R15.htm IDEA: XBRL DOCUMENT v3.24.3
Accumulated Other Comprehensive Income
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income
The changes in the components of Accumulated Other Comprehensive Income (“AOCI”), net of tax, are as follows (in millions):
Unrealized Currency
Translation		Cash Flow
Hedges		Defined Benefit
Plans		Accumulated
Other
Comprehensive Loss
Balance, December 31, 2023$(27.0)$— $— $(27.0)
Other comprehensive loss(8.0)(1.8)(0.1)(9.9)
Balance, September 30, 2024$(35.0)$(1.8)$(0.1)$(36.9)
The net changes in the components of AOCI, including the tax effect, are as follows (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Unrealized currency translation$0.3 $(4.6)$(8.0)$2.8 
Defined benefit pension plans
0.1 — (0.1)— 
Defined benefit pension plans, net of tax
0.1 — (0.1)— 
Cash flow hedges0.7 — (1.3)— 
Tax effect(0.5)— (0.5)— 
Cash flow hedges, net of tax0.2 — (1.8)— 
Change in AOCI
$0.6 $(4.6)$(9.9)$2.8 
XML 31 R16.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Stock-based compensation expense is included in “Cost of products sold,” “Research and development,” and “Sales and general expenses.” Stock-based compensation expense for the three and nine months ended September 30, 2024 and 2023 is shown in the table below (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Stock options$— $— $— $0.3 
Time-based restricted share units2.7 2.5 7.6 7.9 
Performance-based restricted share units(0.1)1.3 2.3 3.4 
Employee stock purchase plan— 0.1 0.1 0.2 
Total stock-based compensation$2.6 $3.9 $10.0 $11.8 
XML 32 R17.htm IDEA: XBRL DOCUMENT v3.24.3
Commitments and Contingencies
 9 Months Ended
Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Legal Matters
We are subject to various legal proceedings, claims and governmental inspections, audits or investigations pertaining to issues such as contract disputes, product liability, tax matters, patents and trademarks, advertising, governmental regulations, employment and other matters. Under the terms of the distribution agreement we entered into with Kimberly-Clark Corporation (“Kimberly-Clark”) prior to our 2014 spin-off from Kimberly-Clark, legal proceedings, claims and other liabilities that are primarily related to our business are our responsibility and we are obligated to indemnify and hold Kimberly-Clark harmless for such matters.
Government Investigation
In June 2015, we were served with a subpoena from the Department of Veterans Affairs Office of the Inspector General (“VA OIG”) seeking information related to the design, manufacture, testing, sale and promotion of MicroCool and other surgical gowns produced by the Company. In July 2015, we became aware that the VA OIG subpoena and an earlier VA OIG subpoena served on Kimberly-Clark requesting information about gown sales to the federal government were related to a United States Department of Justice (“DOJ”) investigation. In May 2016, April 2017 and September 2018, we received additional subpoenas from the DOJ seeking further information related to the Company’s surgical gowns.
On July 6, 2021, we entered into a Deferred Prosecution Agreement (“DPA”) with the DOJ that resolved their criminal investigation related to our MicroCool surgical gowns. Pursuant to the terms of the DPA, in July 2021 the Company made a payment of $22.2 million. The DPA term expired on July 7, 2024. Under the DPA, the DOJ has up to six months following the term’s expiration to seek dismissal of the case.
Patent Litigation
We operate in an industry characterized by extensive patent litigation. Competitors may claim that our products infringe upon their intellectual property. Resolution of patent litigation or other intellectual property claims is typically time consuming and costly and can result in significant damage awards and injunctions that could prevent the manufacture and sale of the affected products or require us to make significant royalty payments in order to continue selling the affected products.
At any given time, we may be involved as either a plaintiff or a defendant in a number of patent infringement actions, the outcomes of which may not be known for prolonged periods of time.
General
While we maintain general and professional liability, product liability and other insurance, our insurance policies may not cover all of these matters and may not fully cover liabilities arising out of these matters. In addition, we may be obligated to indemnify our directors and officers against these matters.
We record provisions in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. For any matters that are reasonably possible to result in loss and for which no possible loss or range of loss is disclosed in this Form 10-Q, management has determined that it is unable to estimate the possible loss or range of loss because, in each case, at least the following facts applied: (a) the matter is at an early stage of the proceedings; (b) the damages are indeterminate, unspecified or determined to be immaterial; and (c) significant factual issues have yet to be resolved. At present, although the results of litigation and claims cannot be predicted with certainty, we believe that the ultimate resolution of any pending legal proceeding to which we are a party will not have a material adverse effect on our business, financial condition, results of operations or liquidity.
Environmental Compliance
We are subject to federal, state and local environmental protection laws and regulations with respect to our business operations. We believe we are operating in compliance with, or are taking action aimed at ensuring compliance with, these laws and regulations. None of our compliance obligations with environmental protection laws and regulations, individually or in the aggregate, is expected to have a material adverse effect on our business, financial condition, results of operations or liquidity.
XML 33 R18.htm IDEA: XBRL DOCUMENT v3.24.3
Derivative Financial Instruments
 9 Months Ended
Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
During the second quarter of 2024, we began to enter into derivative instruments to hedge a portion of forecasted cash flows denominated in Mexican pesos. The derivative instruments used to manage these exposures are designated and qualify as cash flow hedges. The derivative liability for foreign exchange contracts was $2.1 million as of September 30, 2024 and is included in the condensed consolidated balance sheet in accrued expenses.
The effective portion of the gain or loss on a derivative instrument is initially recorded in AOCI, net of related income taxes, and recognized in earnings in the same period that the hedged exposure affects earnings. The loss recognized in earnings was not material in the three and nine months ended September 30, 2024. As of September 30, 2024, the aggregate notional values of outstanding foreign currency swap contracts designated as cash flow hedges were $17.8 million.
XML 34 R19.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings Per Share ("EPS")
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Earnings Per Share (“EPS”) Earnings Per Share (“EPS”)
Basic EPS is calculated by dividing net income by the weighted average number of common shares outstanding during each period. Diluted earnings per share is calculated by dividing net income by the number of common shares outstanding and the effect of all dilutive common stock equivalents outstanding during each period, as determined using the treasury stock method.
The calculation of basic and diluted earnings (loss) per share for the three and nine months ended September 30, 2024 and 2023 is set forth in the following table (in millions, except per share amounts):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Net income (loss) from continuing operations
$5.9 $(8.8)$10.7 $(20.9)
Net (loss) income from discontinued operations(1.6)5.1 (5.5)(51.4)
Net income (loss)$4.3 $(3.7)$5.2 $(72.3)
Weighted Average Shares Outstanding:
Basic weighted average shares outstanding46.0 46.8 46.0 46.7 
Dilutive effect of stock options and restricted share unit awards0.6 — 0.5 — 
Diluted weighted average shares outstanding46.6 46.8 46.5 46.7 
Earnings (Loss) Per Share
Basic:
    Continuing Operations$0.13 $(0.19)$0.23 $(0.45)
    Discontinued Operations(0.03)0.11 (0.12)(1.10)
Basic Earnings (Loss) Per Share$0.10 $(0.08)$0.11 $(1.55)
Diluted:
    Continuing Operations$0.12 $(0.19)$0.23 $(0.45)
    Discontinued Operations(0.03)0.11 (0.12)(1.10)
Diluted Earnings (Loss) Per Share$0.09 $(0.08)$0.11 $(1.55)
Restricted share units (“RSUs”) contain provisions allowing for the equivalent of any dividends paid on common stock during the restricted period to be reinvested into additional RSUs at the then fair market value of the common stock on the date the dividends are paid. Such awards are to be included in the EPS calculation under the two-class method. Currently, we do not anticipate any cash dividends for the foreseeable future and our outstanding RSU awards are not material in comparison to our weighted average shares outstanding. Accordingly, all EPS amounts reflect shares as if they were fully vested and the disclosures associated with the two-class method are not presented herein.
For the three and nine months ended September 30, 2024, $1.0 million and $1.3 million of potentially dilutive stock options and RSU awards were excluded from the computation of earnings per share as their effect would have been anti-dilutive.
XML 35 R20.htm IDEA: XBRL DOCUMENT v3.24.3
Business and Products Information
 9 Months Ended
Sep. 30, 2024
Segment Reporting [Abstract]  
Business and Products Information Business and Products Information
We conduct our business in one operating and reportable segment that provides our medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico.
Avanos develops, manufactures and markets its recognized brands globally and holds leading market positions in multiple categories across its portfolio. Our management evaluates net sales by product category within our single reportable segment as follows (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Digestive Health$98.2 $95.0 $290.6 $276.8 
Pain Management and Recovery:
Surgical pain and recovery30.3 34.1 93.8 103.6 
Interventional pain41.9 42.2 123.8 119.6 
Total Pain Management and Recovery72.2 76.3 217.6 223.2 
Total Net Sales$170.4 $171.3 $508.2 $500.0 
Digestive Health is a portfolio of products such as our MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions.
Pain Management and Recovery is a portfolio of products including:
•Surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and
•Interventional pain solutions, which provide minimally invasive pain relief therapies, such as our COOLIEF pain therapy, OrthogenRx’s knee osteoarthritis HA pain relief injection products and Diros’ RFA products used to treat chronic pain conditions.
Liabilities for estimated returns, rebates and incentives are presented in the table below (in millions):
September 30, 2024December 31, 2023
Accrued rebates$13.7 $10.4 
Accrued customer incentives9.9 7.3 
Accrued rebates and customer incentives23.6 17.7 
Accrued sales returns(a)
0.1 0.1 
Total estimated liabilities$23.7 $17.8 
__________________________________________________
(a)Accrued sales returns are included in “Other” in the accrued expenses table in Note 5, “Supplemental Balance Sheet Information”.
Due to the nature of our business, we receive purchase orders for products under supply agreements which are normally fulfilled within three to four weeks. Our performance obligations under purchase orders are satisfied and revenue is recognized at a point in time, which is upon shipment or upon delivery of our products, depending on shipping terms. Accordingly, we normally do not have transactions that give rise to material unfulfilled performance obligations.
XML 36 R21.htm IDEA: XBRL DOCUMENT v3.24.3
Share Repurchase Program
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Share Repurchase Program Share Repurchase Program
On July 28, 2023, the Board of Directors approved a new one-year program under which we may repurchase up to $25.0 million of our common stock. Repurchases under this program will be made from time to time at management’s discretion on the open market or through privately negotiated transactions in compliance with Rule 10b-18 under the Exchange Act, subject to market conditions, applicable legal requirements and other relevant factors. We have established a pre-arranged trading plan under Rule 10b5-1 of the Exchange Act in connection with this share repurchase program. This share repurchase program does not obligate us to purchase any particular amount of common stock and may be suspended, modified or discontinued by us without prior notice. In the third quarter of 2023, we repurchased $9.2 million of our common stock and during the fourth quarter of 2023, we repurchased an additional $5.8 million of our common stock.
For the nine months ended September 30, 2024, our repurchases of our common stock were as summarized in the table below.
Shares RepurchasedAggregate Purchase Price
(in millions)		Average Price per ShareAmount Remaining in
Program for Purchase
(in millions)
# of SharesProgram to Date
First quarter of 2024342,680 1,085,333 $6.7 $19.45 $3.3 
Second quarter of 2024169,571 1,254,904 $3.3 $19.67 $— 
In addition to the share repurchase program, we withheld 140,539 shares of common stock for $2.7 million in taxes associated with stock-based compensation transactions for the nine months ended September 30, 2024.
XML 37 R22.htm IDEA: XBRL DOCUMENT v3.24.3
Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Background and Basis of Presentation
Background and Basis of Presentation
Avanos Medical, Inc. is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today’s most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio. References herein to “Avanos,” “the Company,” “we,” “our” and “us” refer to Avanos Medical, Inc. and its consolidated subsidiaries.
Interim Financial Statements
We prepared the accompanying unaudited condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and the instructions to the Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements, and the condensed consolidated financial statements in this Form 10-Q should be read in conjunction with the Form 10-K. Our unaudited interim condensed consolidated financial statements contain all necessary material adjustments, which are of a normal and recurring nature, to fairly state our financial condition, results of operations and cash flows for the periods presented.
Use of Estimates
Use of Estimates
Preparation of our condensed consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Estimates are used in accounting for, among other things, certain amounts included in discontinued operations, certain amounts included in assets and liabilities held for sale, distributor rebate accruals, future cash flows associated with impairment testing for goodwill and long-lived assets, loss contingencies, and deferred tax assets and potential income tax assessments. Actual results could differ from these estimates, and the effect of any change could be material to our financial statements. Changes in these estimates are recorded when known.
Goodwill
Goodwill
We test goodwill for impairment annually or more frequently whenever events or circumstances more likely than not indicate that the fair value of the reporting unit may be below its carrying value. We operate as a single reportable operating segment with one reporting unit. The fair value of our reporting unit is estimated using a combination of income (discounted cash flow analysis) and market approaches. The income approach is dependent upon several assumptions regarding future periods such as sales growth and a terminal growth rate. A weighted average cost of capital (“WACC”) was used to discount future estimated cash flows to their present values. The WACC was based on externally observable data considering market participants’ cost of equity and debt, optimal capital structure and risk factors specific to us. The market approach estimates the value of our company using a market capitalization methodology.
We determined that the fair value of our reporting unit exceeded the net carrying amount in our most recent goodwill impairment test on July 1, 2024. However, there can be no assurance that the assumptions and estimates made for purposes of the annual goodwill impairment test will prove to be accurate. Volatility in the equity and debt markets, or increases in interest rates, could result in a higher discount rate. Changes in sales volumes, selling prices and costs of goods sold, and increases in interest rates could cause changes in our forecasted cash flows. Unfavorable changes in any of the factors described above, as well as a decline in our stock price, could result in a goodwill impairment charge in the future.
Hedging and Derivatives
Hedging and Derivatives
All derivative instruments are recorded as assets or liabilities on the balance sheet at fair value. Changes in the fair value of
derivatives are either recorded in the income statement or other comprehensive income, as appropriate. The effective portion of
the gain or loss on derivatives designated as cash flow hedges is included in other comprehensive income in the period that
changes in fair value occur, and is reclassified to income in the same period that the hedged item affects income. Our policies allow the use of derivatives for risk management purposes and prohibit their use for speculation. Our policies also prohibit the use of any leveraged derivative instrument. Consistent with our policies, foreign currency derivative instruments are entered into with major financial institutions. At inception, we formally designate certain derivatives as cash flow hedges and establish how the effectiveness of these hedges will be assessed and measured. This process links the derivatives to the transactions they are hedging.
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements
Recently Adopted Accounting Pronouncements
Effective January 1, 2023, we adopted ASU No. 2021-08, Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. This ASU pertains to acquired revenue contracts with customers in a business combination and addresses diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. Adoption of this ASU did not have a material effect on our financial position, results of operations or cash flows.
Recently Issued Accounting Pronouncements
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes: Improvement to Income Tax Disclosures. This ASU pertains to disaggregation of income tax disclosures and enhances annual income tax disclosures to address investor requests for more information about the tax risks and opportunities present in an entity’s worldwide operations. The two primary enhancements disaggregate existing income tax disclosures related to the effective tax rate reconciliation and income taxes paid, and requires entities to disclose a tabular reconciliation of expected tax and reported tax on income from continuing operations using both percentages and amounts, broken out into specific categories with certain reconciling items at or above 5% of the expected tax further broken out by nature and/or jurisdiction. Additionally, this ASU requires disclosure around income taxes paid (net of refunds received) broken out between federal, state, local and foreign, and income taxes paid (net of refunds received) to an individual jurisdiction when greater than 5% of total income taxes paid. This ASU will be effective for annual periods beginning after December 15, 2024, with early adoption permitted. Adoption of this ASU is not expected to have a material effect on our financial position, results of operations or cash flows.
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting: Improvements to Reportable Segment Disclosures. This ASU enhances segment reporting under Topic 280 by expanding the breadth and frequency of segment disclosures, and aims to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. This ASU will be effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of this ASU will require us to expand our current disclosures around significant expenses and disclose an aggregate amount and composition of other segment items related to our single operating segment. On an annual basis, this ASU will require us to disclose the Chief Operating Decision Maker’s (CODM) title and position, as well as how the CODM uses each reported measure of segment profit or loss to assess performance and allocate resources to the segment. We will retrospectively adopt this ASU in the fiscal period ending December 31, 2024 as required by ASU No. 2023-07.
In August 2023, the FASB issued ASU No. 2023-05, Business Combinations: Joint Venture Formations. This ASU is intended to address diversity in practice regarding accounting and provide decision-useful information related to contributions made to joint ventures and requires entities that qualify as either a joint venture or a corporate joint venture to apply a new basis of accounting upon the formation of the joint venture. Specifically, the ASU provides that a joint venture or a corporate joint venture must initially measure its assets and liabilities at fair value on the formation date. This ASU will be effective for all newly formed joint venture entities with a formation date on or after January 1, 2025, with early adoption permitted. Joint ventures formed prior to the adoption date may elect to apply the new guidance retrospectively back to their original formation date. Adoption of this ASU is not expected to have a material effect on our financial position, results of operations or cash flows.
XML 38 R23.htm IDEA: XBRL DOCUMENT v3.24.3
Discontinued Operations (Tables)
 9 Months Ended
Sep. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Summary of Financial Results of Discontinued Operations
The following table summarizes the financial results of our discontinued operations for all periods presented herein (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Net Sales$10.5 $31.1 $41.0 $93.9 
Cost of products sold15.9 19.9 47.4 57.8 
Gross Profit(5.4)11.2 (6.4)36.1 
Research and development— 0.2 — 0.8 
Selling and general expenses— 4.2 — 11.9 
Pretax loss on classification as discontinued operations— — — 72.3 
Other (income) expense, net(3.2)0.1 1.1 0.3 
(Loss) Income from discontinued operations before income taxes(2.2)6.7 (7.5)(49.2)
Income tax benefit (provision) from discontinued operations
0.6 (1.6)2.0 (2.2)
Net (Loss) Income from discontinued operations, net of tax$(1.6)$5.1 $(5.5)$(51.4)
(Loss) Earnings Per Share
Basic$(0.03)$0.11 $(0.12)$(1.10)
Diluted$(0.03)$0.11 $(0.12)$(1.10)
Details on assets and liabilities classified as held for sale in the accompanying consolidated balance sheets are presented in the following table (in millions):
September 30, 2024December 31, 2023
Assets held for sale - discontinued operations
Inventories$28.2 $17.5 
Property, Plant and Equipment, net43.0 43.9 
Operating Lease Right-of-Use Assets2.7 3.1 
Total assets classified as held for sale$73.9 $64.5 
Liabilities held for sale - discontinued operations
Current Portion of Operating Lease Liabilities$0.7 $0.8 
Accrued expenses51.3 61.3 
Non-Current Operating Lease Liability0.9 1.6 
Total liabilities held for sale - discontinued operations$52.9 $63.7 
The following table provides operating and investing cash flow information for our discontinued operations (in millions):
Nine Months Ended September 30,
20242023
Operating Activities:
Depreciation and amortization$— $2.6 
Stock-based compensation expense— 0.1 
Investing Activities:
Capital expenditures0.6 3.1 
XML 39 R24.htm IDEA: XBRL DOCUMENT v3.24.3
Restructuring Activities (Tables)
 9 Months Ended
Sep. 30, 2024
Restructuring and Related Activities [Abstract]  
Summary of Accrual and Payment Activity
Our liability for costs associated with our restructuring initiatives as of September 30, 2024 is summarized below (in millions):
As of September 30, 2024
Beginning balance$2.3 
Restructuring and transformation costs, excluding non-cash charges10.3 
Payments and adjustments, net(9.2)
Ending balance$3.4 
XML 40 R25.htm IDEA: XBRL DOCUMENT v3.24.3
Business Acquisition (Tables)
 9 Months Ended
Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Summary of Purchase Price Allocation The purchase price allocation is shown in the table below (in millions):
Current assets, net of cash acquired
$7.5 
Current liabilities, excluding contingent consideration
(7.0)
Contingent consideration
(5.3)
Other noncurrent liabilities, net(0.5)
Deferred tax liabilities
(8.1)
Identifiable intangible assets
29.6 
Goodwill
33.4 
Total$49.6 
Summary of Identifiable Intangible Assets
The identifiable intangible assets relating to the Diros Acquisition include the following (in millions, except years):
Identifiable Intangible Asset AmountWeighted Average Useful Lives (Years)
Trade names and trademarks
$2.9 15
Customer relationships
21.2 14
Developed technology and other
5.5 13
Total$29.6 
XML 41 R26.htm IDEA: XBRL DOCUMENT v3.24.3
Supplemental Balance Sheet Information (Tables)
 9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Summary of Accounts Receivable
Accounts receivable consist of the following (in millions):
September 30, 2024December 31, 2023
Accounts receivable$137.3 $134.0 
Income tax receivable— 14.1 
Allowances and doubtful accounts:
Doubtful accounts(4.8)(5.1)
Sales discounts(0.6)(0.2)
Accounts receivable, net$131.9 $142.8 
Summary of Inventories
Inventories at the lower of cost (determined on the FIFO method) or net realizable value consists of the following (in millions):
September 30, 2024December 31, 2023
Raw materials$47.4 $50.3 
Work in process23.219.8
Finished goods87.988.5
Supplies and other3.44.6
Total Inventory$161.9 $163.2 
Summary of Property, Plant and Equipment
Property, plant and equipment consists of the following (in millions):
September 30, 2024December 31, 2023
Land$1.2 $1.3 
Buildings and leasehold improvements41.3 38.0 
Machinery and equipment185.4 182.8 
Construction in progress18.8 18.0 
246.7 240.1 
Less accumulated depreciation(137.2)(122.9)
Total$109.5 $117.2 
Summary of Changes in the Carrying Amount of Goodwill
The changes in the carrying amount of goodwill are as follows (in millions):
Goodwill
Balance, December 31, 2023$796.1 
Currency translation adjustment(1.0)
Balance, September 30, 2024$795.1 
Summary of Intangible Assets Subject to Amortization
Intangible assets subject to amortization consist of the following (in millions):
September 30, 2024December 31, 2023
Gross
Carrying
Amount		Accumulated
Amortization		Net Carrying AmountGross
Carrying
Amount		Accumulated
Amortization		Net Carrying Amount
Trademarks$41.6 $(29.7)$11.9 $42.0 $(28.8)$13.2 
Patents and acquired technologies248.5 (179.2)69.3 248.6 (171.9)76.7 
Other207.7 (68.8)138.9 207.7 (58.1)149.6 
Total$497.8 $(277.7)$220.1 $498.3 $(258.8)$239.5 
Summary of Estimated Amortization Expense
Amortization expense for the remainder of 2024, the following four years and thereafter is estimated as follows (in millions):
Amount
Remainder of 2024$6.7 
202525.0 
202624.5 
202722.8 
202822.6 
Thereafter118.5 
Total$220.1 
Summary of Accrued Expenses
Accrued expenses consist of the following (in millions):
September 30, 2024December 31, 2023
Accrued rebates and customer incentives$23.6 $17.7 
Accrued salaries and wages29.8 31.5 
Accrued taxes and other6.2 16.7 
Other23.1 27.3 
Total$82.7 $93.2 
Liabilities for estimated returns, rebates and incentives are presented in the table below (in millions):
September 30, 2024December 31, 2023
Accrued rebates$13.7 $10.4 
Accrued customer incentives9.9 7.3 
Accrued rebates and customer incentives23.6 17.7 
Accrued sales returns(a)
0.1 0.1 
Total estimated liabilities$23.7 $17.8 
__________________________________________________
(a)Accrued sales returns are included in “Other” in the accrued expenses table in Note 5, “Supplemental Balance Sheet Information”.
Summary of Other Long-Term Liabilities
Other long-term liabilities consist of the following (in millions):
September 30, 2024December 31, 2023
Accrued compensation and benefits$6.7 $5.9 
Other3.9 4.1 
Total$10.6 $10.0 
XML 42 R27.htm IDEA: XBRL DOCUMENT v3.24.3
Fair Value Information (Tables)
 9 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
Summary of Fair Value of Financial Instruments The following table includes the fair value of our financial instruments for which disclosure of fair value is required (in millions):
September 30, 2024December 31, 2023
Fair Value
Hierarchy
Level		Carrying
Amount		Estimated
Fair
Value		Carrying
Amount		Estimated
Fair
Value
Assets
Cash and cash equivalents1$89.0 $89.0 $87.7 $87.7 
Liabilities
Revolving Credit Facility2$50.0 $50.0 $50.0 $50.0 
Term Loan Facility2112.0 112.0 118.0 118.0 
Contingent consideration related to acquisition3— — 5.3 5.3 
XML 43 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Debt (Tables)
 9 Months Ended
Sep. 30, 2024
Debt Disclosure [Abstract]  
Summary of Debt Balances
As of September 30, 2024 and December 31, 2023, our respective debt balances were as follows (in millions):
Weighted-Average Interest RateMaturitySeptember 30, 2024December 31, 2023
Revolving Credit Facility6.83 %2027$50.0 $50.0 
Term Loan Facility6.81 %2027112.5 118.8 
162.5 168.8 
Unamortized debt issuance costs(0.5)(0.8)
Current portion of long-term debt(9.4)(8.6)
Total Long-Term Debt, net$152.6 $159.4 
Summary of Maturities of Long-Term Debt
As of September 30, 2024, the aggregate amounts of long-term debt that will mature during each of the next four years are as follows (in millions):
Amount
Remainder of 2024$2.3 
20259.4 
202610.2 
2027140.6 
2028— 
Total$162.5 
XML 44 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Accumulated Other Comprehensive Income (Tables)
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Summary of Changes in the Components of Accumulated Other Comprehensive Income
The changes in the components of Accumulated Other Comprehensive Income (“AOCI”), net of tax, are as follows (in millions):
Unrealized Currency
Translation		Cash Flow
Hedges		Defined Benefit
Plans		Accumulated
Other
Comprehensive Loss
Balance, December 31, 2023$(27.0)$— $— $(27.0)
Other comprehensive loss(8.0)(1.8)(0.1)(9.9)
Balance, September 30, 2024$(35.0)$(1.8)$(0.1)$(36.9)
The net changes in the components of AOCI, including the tax effect, are as follows (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Unrealized currency translation$0.3 $(4.6)$(8.0)$2.8 
Defined benefit pension plans
0.1 — (0.1)— 
Defined benefit pension plans, net of tax
0.1 — (0.1)— 
Cash flow hedges0.7 — (1.3)— 
Tax effect(0.5)— (0.5)— 
Cash flow hedges, net of tax0.2 — (1.8)— 
Change in AOCI
$0.6 $(4.6)$(9.9)$2.8 
XML 45 R30.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-Based Compensation Expense
Stock-based compensation expense is included in “Cost of products sold,” “Research and development,” and “Sales and general expenses.” Stock-based compensation expense for the three and nine months ended September 30, 2024 and 2023 is shown in the table below (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Stock options$— $— $— $0.3 
Time-based restricted share units2.7 2.5 7.6 7.9 
Performance-based restricted share units(0.1)1.3 2.3 3.4 
Employee stock purchase plan— 0.1 0.1 0.2 
Total stock-based compensation$2.6 $3.9 $10.0 $11.8 
XML 46 R31.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings Per Share ("EPS") (Tables)
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Summary of Calculation of Basic and Diluted Earnings Per Share
The calculation of basic and diluted earnings (loss) per share for the three and nine months ended September 30, 2024 and 2023 is set forth in the following table (in millions, except per share amounts):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Net income (loss) from continuing operations
$5.9 $(8.8)$10.7 $(20.9)
Net (loss) income from discontinued operations(1.6)5.1 (5.5)(51.4)
Net income (loss)$4.3 $(3.7)$5.2 $(72.3)
Weighted Average Shares Outstanding:
Basic weighted average shares outstanding46.0 46.8 46.0 46.7 
Dilutive effect of stock options and restricted share unit awards0.6 — 0.5 — 
Diluted weighted average shares outstanding46.6 46.8 46.5 46.7 
Earnings (Loss) Per Share
Basic:
    Continuing Operations$0.13 $(0.19)$0.23 $(0.45)
    Discontinued Operations(0.03)0.11 (0.12)(1.10)
Basic Earnings (Loss) Per Share$0.10 $(0.08)$0.11 $(1.55)
Diluted:
    Continuing Operations$0.12 $(0.19)$0.23 $(0.45)
    Discontinued Operations(0.03)0.11 (0.12)(1.10)
Diluted Earnings (Loss) Per Share$0.09 $(0.08)$0.11 $(1.55)
XML 47 R32.htm IDEA: XBRL DOCUMENT v3.24.3
Business and Products Information (Tables)
 9 Months Ended
Sep. 30, 2024
Segment Reporting [Abstract]  
Summary of Net Sales by Product Category Our management evaluates net sales by product category within our single reportable segment as follows (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Digestive Health$98.2 $95.0 $290.6 $276.8 
Pain Management and Recovery:
Surgical pain and recovery30.3 34.1 93.8 103.6 
Interventional pain41.9 42.2 123.8 119.6 
Total Pain Management and Recovery72.2 76.3 217.6 223.2 
Total Net Sales$170.4 $171.3 $508.2 $500.0 
Summary of Accrued Expenses
Accrued expenses consist of the following (in millions):
September 30, 2024December 31, 2023
Accrued rebates and customer incentives$23.6 $17.7 
Accrued salaries and wages29.8 31.5 
Accrued taxes and other6.2 16.7 
Other23.1 27.3 
Total$82.7 $93.2 
Liabilities for estimated returns, rebates and incentives are presented in the table below (in millions):
September 30, 2024December 31, 2023
Accrued rebates$13.7 $10.4 
Accrued customer incentives9.9 7.3 
Accrued rebates and customer incentives23.6 17.7 
Accrued sales returns(a)
0.1 0.1 
Total estimated liabilities$23.7 $17.8 
__________________________________________________
(a)Accrued sales returns are included in “Other” in the accrued expenses table in Note 5, “Supplemental Balance Sheet Information”.
XML 48 R33.htm IDEA: XBRL DOCUMENT v3.24.3
Share Repurchase Program (Tables)
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Summary of Class of Treasury Stock
For the nine months ended September 30, 2024, our repurchases of our common stock were as summarized in the table below.
Shares RepurchasedAggregate Purchase Price
(in millions)		Average Price per ShareAmount Remaining in
Program for Purchase
(in millions)
# of SharesProgram to Date
First quarter of 2024342,680 1,085,333 $6.7 $19.45 $3.3 
Second quarter of 2024169,571 1,254,904 $3.3 $19.67 $— 
XML 49 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Accounting Policies - Narratives (Details)
 9 Months Ended
Sep. 30, 2024
segment
Accounting Policies [Abstract]  
Number of operating segments 1
Number of reporting units 1
XML 50 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Discontinued Operations - Narratives (Details) - USD ($)
$ in Millions
 9 Months Ended
Oct. 02, 2023
Jun. 07, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Proceeds from divestiture of businesses     $ 2.1 $ 0.0  
Prepaid and other current assets     15.9   $ 28.8
RH Business          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Proceeds from divestiture of businesses $ 110.0        
Transformation process term (in years)   3 years      
RH Business | Disposed of by sale          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Prepaid and other current assets     $ 6.6   $ 11.9
RH Business | Minimum          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Transition services agreement, term (in years)   1 year      
RH Business | Maximum          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Transition services agreement, term (in years)   3 years      
XML 51 R36.htm IDEA: XBRL DOCUMENT v3.24.3
Discontinued Operations - Schedule of Income (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]        
Net (Loss) Income from discontinued operations, net of tax $ (1.6) $ 5.1 $ (5.5) $ (51.4)
(Loss) Earnings Per Share        
Basic (in dollars per share) $ (0.03) $ 0.11 $ (0.12) $ (1.10)
Diluted (in dollars per share) $ (0.03) $ 0.11 $ (0.12) $ (1.10)
RH Business | Disposed of by sale        
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]        
Net Sales $ 10.5 $ 31.1 $ 41.0 $ 93.9
Cost of products sold 15.9 19.9 47.4 57.8
Gross Profit (5.4) 11.2 (6.4) 36.1
Research and development 0.0 0.2 0.0 0.8
Selling and general expenses 0.0 4.2 0.0 11.9
Pretax loss on classification as discontinued operations 0.0 0.0 0.0 72.3
Other (income) expense, net (3.2) 0.1 1.1 0.3
(Loss) Income from discontinued operations before income taxes (2.2) 6.7 (7.5) (49.2)
Income tax benefit (provision) from discontinued operations 0.6 (1.6) 2.0 (2.2)
Net (Loss) Income from discontinued operations, net of tax $ (1.6) $ 5.1 $ (5.5) $ (51.4)
(Loss) Earnings Per Share        
Basic (in dollars per share) $ (0.03) $ 0.11 $ (0.12) $ (1.10)
Diluted (in dollars per share) $ (0.03) $ 0.11 $ (0.12) $ (1.10)
XML 52 R37.htm IDEA: XBRL DOCUMENT v3.24.3
Discontinued Operations - Schedule of Balance Sheet (Details) - RH Business - Disposed of by sale - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Inventories $ 28.2 $ 17.5
Property, Plant and Equipment, net 43.0 43.9
Operating Lease Right-of-Use Assets 2.7 3.1
Total assets classified as held for sale 73.9 64.5
Current Portion of Operating Lease Liabilities 0.7 0.8
Accrued expenses 51.3 61.3
Non-Current Operating Lease Liability 0.9 1.6
Total liabilities held for sale - discontinued operations $ 52.9 $ 63.7
XML 53 R38.htm IDEA: XBRL DOCUMENT v3.24.3
Discontinued Operations- Schedule of Cashflow (Details) - Disposed of by sale - RH Business - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Operating Activities:    
Depreciation and amortization $ 0.0 $ 2.6
Stock-based compensation expense 0.0 0.1
Investing Activities:    
Capital expenditures $ 0.6 $ 3.1
XML 54 R39.htm IDEA: XBRL DOCUMENT v3.24.3
Restructuring Activities - Narratives (Details) - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended 9 Months Ended
Jun. 07, 2023
Jan. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]            
Term of restructuring initiative (in years)   3 years        
RH Business            
Restructuring Cost and Reserve [Line Items]            
Transformation process term (in years) 3 years          
Post-RH Divestiture Restructuring Plan            
Restructuring Cost and Reserve [Line Items]            
Costs incurred     $ 2.3   $ 6.4  
Post-RH Divestiture Restructuring Plan | Minimum            
Restructuring Cost and Reserve [Line Items]            
Costs expected to incur     10.0   10.0  
Post-RH Divestiture Restructuring Plan | Maximum            
Restructuring Cost and Reserve [Line Items]            
Costs expected to incur     11.0   11.0  
Transformation Process | Maximum            
Restructuring Cost and Reserve [Line Items]            
Costs expected to incur   $ 30.0        
Program Management Consulting and Employee Retention            
Restructuring Cost and Reserve [Line Items]            
Costs incurred     0.7 $ 4.3 5.2 $ 23.0
Program Management Consulting and Employee Retention | Minimum            
Restructuring Cost and Reserve [Line Items]            
Costs expected to incur     9.0   9.0  
Program Management Consulting and Employee Retention | Maximum            
Restructuring Cost and Reserve [Line Items]            
Costs expected to incur     12.0   12.0  
Manufacturing and Supply Chain Improvements | Minimum            
Restructuring Cost and Reserve [Line Items]            
Costs expected to incur     8.0   8.0  
Manufacturing and Supply Chain Improvements | Maximum            
Restructuring Cost and Reserve [Line Items]            
Costs expected to incur     11.0   11.0  
Organizational Design Alignment and Other Related Activities | Minimum            
Restructuring Cost and Reserve [Line Items]            
Costs expected to incur     6.0   6.0  
Organizational Design Alignment and Other Related Activities | Maximum            
Restructuring Cost and Reserve [Line Items]            
Costs expected to incur     8.0   8.0  
Program Management Consulting and Employee Retention Expenses And Employee Severance and Benefits            
Restructuring Cost and Reserve [Line Items]            
Costs expected to incur     28.1   28.1  
Costs incurred     $ 33.4   $ 33.4  
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.24.3
Restructuring Activities - Accrual and Payment Activity (Details) - Employee severance and benefits - Multi-year restructuring plan, initial phase
$ in Millions
 9 Months Ended
Sep. 30, 2024
USD ($)
Restructuring Reserve [Roll Forward]  
Beginning balance $ 2.3
Restructuring and transformation costs, excluding non-cash charges 10.3
Payments and adjustments, net (9.2)
Ending balance $ 3.4
XML 56 R41.htm IDEA: XBRL DOCUMENT v3.24.3
Business Acquisition - Narratives (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended 15 Months Ended
Jul. 24, 2023
Jun. 17, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Business Acquisition [Line Items]              
Net Sales     $ 170.4 $ 171.3 $ 508.2 $ 500.0  
Payment of contingent consideration liabilities         4.6   $ 6.1
Diros Technology Inc              
Business Acquisition [Line Items]              
Consideration transferred $ 53.0            
Payments to acquire businesses, gross 50.5 $ 2.5          
Future estimated payments $ 7.0            
Net Sales     4.6 2.4 14.4 2.4  
Business acquisition, transaction costs     $ 1.5 $ 0.6 $ 2.1 $ 0.9  
XML 57 R42.htm IDEA: XBRL DOCUMENT v3.24.3
Business Acquisition - Purchase Price Allocation (Details) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Jul. 24, 2023
Business Acquisition [Line Items]      
Goodwill $ 795.1 $ 796.1  
Diros Technology Inc      
Business Acquisition [Line Items]      
Current assets, net of cash acquired     $ 7.5
Current liabilities, excluding contingent consideration     (7.0)
Contingent consideration     (5.3)
Other noncurrent liabilities, net     (0.5)
Deferred tax liabilities     (8.1)
Identifiable intangible assets     29.6
Goodwill     33.4
Total     $ 49.6
XML 58 R43.htm IDEA: XBRL DOCUMENT v3.24.3
Business Acquisition - Identifiable Intangible Assets (Details) - Diros Technology Inc
$ in Millions
Jul. 24, 2023
USD ($)
Business Acquisition [Line Items]  
Identifiable Intangible Asset Amount $ 29.6
Trade names and trademarks  
Business Acquisition [Line Items]  
Identifiable Intangible Asset Amount $ 2.9
Weighted Average Useful Lives (Years) 15 years
Customer relationships  
Business Acquisition [Line Items]  
Identifiable Intangible Asset Amount $ 21.2
Weighted Average Useful Lives (Years) 14 years
Developed technology and other  
Business Acquisition [Line Items]  
Identifiable Intangible Asset Amount $ 5.5
Weighted Average Useful Lives (Years) 13 years
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.24.3
Supplemental Balance Sheet Information - Accounts Receivable (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]          
Accounts receivable $ 137.3   $ 137.3   $ 134.0
Income tax receivable 0.0   0.0   14.1
Accounts receivable, net 131.9   131.9   142.8
Provision (reversal) for doubtful accounts 0.1 $ (0.4) 0.2 $ 0.2  
Doubtful accounts          
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]          
Allowances and doubtful accounts (4.8)   (4.8)   (5.1)
Sales discounts          
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]          
Allowances and doubtful accounts $ (0.6)   $ (0.6)   $ (0.2)
XML 60 R45.htm IDEA: XBRL DOCUMENT v3.24.3
Supplemental Balance Sheet Information - Inventories (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Inventory, Net          
Raw materials $ 47.4   $ 47.4   $ 50.3
Work in process 23.2   23.2   19.8
Finished goods 87.9   87.9   88.5
Supplies and other 3.4   3.4   4.6
Total Inventory 161.9   161.9   $ 163.2
Inventory obsolescence $ 2.8 $ 2.0 $ 4.3 $ 6.3  
XML 61 R46.htm IDEA: XBRL DOCUMENT v3.24.3
Supplemental Balance Sheet Information - Property, Plant and Equipment (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Property, Plant and Equipment [Line Items]          
Property, plant and equipment, gross $ 246.7   $ 246.7   $ 240.1
Less accumulated depreciation (137.2)   (137.2)   (122.9)
Total 109.5   109.5   117.2
Depreciation expense 5.3 $ 4.8 15.6 $ 14.2  
Land          
Property, Plant and Equipment [Line Items]          
Property, plant and equipment, gross 1.2   1.2   1.3
Buildings and leasehold improvements          
Property, Plant and Equipment [Line Items]          
Property, plant and equipment, gross 41.3   41.3   38.0
Machinery and equipment          
Property, Plant and Equipment [Line Items]          
Property, plant and equipment, gross 185.4   185.4   182.8
Construction in progress          
Property, Plant and Equipment [Line Items]          
Property, plant and equipment, gross $ 18.8   $ 18.8   $ 18.0
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.24.3
Supplemental Balance Sheet Information - Goodwill (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2024
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 796.1
Currency translation adjustment (1.0)
Ending balance $ 795.1
XML 63 R48.htm IDEA: XBRL DOCUMENT v3.24.3
Supplemental Balance Sheet Information - Intangible Assets (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Amount $ 497.8   $ 497.8   $ 498.3
Accumulated Amortization (277.7)   (277.7)   (258.8)
Net Carrying Amount 220.1   220.1   239.5
Amortization expense for intangible assets 6.4 $ 6.2 18.8 $ 17.8  
Unrealized currency translation adjustments     (0.3)    
Trademarks          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Amount 41.6   41.6   42.0
Accumulated Amortization (29.7)   (29.7)   (28.8)
Net Carrying Amount 11.9   11.9   13.2
Patents and acquired technologies          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Amount 248.5   248.5   248.6
Accumulated Amortization (179.2)   (179.2)   (171.9)
Net Carrying Amount 69.3   69.3   76.7
Other          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Amount 207.7   207.7   207.7
Accumulated Amortization (68.8)   (68.8)   (58.1)
Net Carrying Amount $ 138.9   $ 138.9   $ 149.6
XML 64 R49.htm IDEA: XBRL DOCUMENT v3.24.3
Supplemental Balance Sheet Information - Estimated Amortization Expense (Details) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Estimated Amortization Expense    
Remainder of 2024 $ 6.7  
2025 25.0  
2026 24.5  
2027 22.8  
2028 22.6  
Thereafter 118.5  
Net Carrying Amount $ 220.1 $ 239.5
XML 65 R50.htm IDEA: XBRL DOCUMENT v3.24.3
Supplemental Balance Sheet Information - Accrued Expenses (Details) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued rebates and customer incentives $ 23.6 $ 17.7
Accrued salaries and wages 29.8 31.5
Accrued taxes and other 6.2 16.7
Other 23.1 27.3
Total $ 82.7 $ 93.2
XML 66 R51.htm IDEA: XBRL DOCUMENT v3.24.3
Supplemental Balance Sheet Information - Other Long-Term Liabilities (Details) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued compensation and benefits $ 6.7 $ 5.9
Other 3.9 4.1
Total $ 10.6 $ 10.0
XML 67 R52.htm IDEA: XBRL DOCUMENT v3.24.3
Fair Value Information (Details) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Dec. 31, 2022
Assets        
Cash and cash equivalents $ 89.0 $ 87.7 $ 107.1 $ 127.7
Level 1 | Carrying Amount        
Assets        
Cash and cash equivalents 89.0 87.7    
Level 1 | Estimated Fair Value        
Assets        
Cash and cash equivalents 89.0 87.7    
Level 2 | Carrying Amount | Revolving Credit Facility        
Liabilities        
Long-term debt, fair value 50.0 50.0    
Level 2 | Carrying Amount | Term Loan Facility        
Liabilities        
Long-term debt, fair value 112.0 118.0    
Level 2 | Estimated Fair Value | Revolving Credit Facility        
Liabilities        
Long-term debt, fair value 50.0 50.0    
Level 2 | Estimated Fair Value | Term Loan Facility        
Liabilities        
Long-term debt, fair value 112.0 118.0    
Level 3 | Carrying Amount        
Liabilities        
Contingent consideration related to acquisition 0.0 5.3    
Level 3 | Estimated Fair Value        
Liabilities        
Contingent consideration related to acquisition $ 0.0 $ 5.3    
XML 68 R53.htm IDEA: XBRL DOCUMENT v3.24.3
Debt - Summary of Debt (Details) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Total Long-Term Debt, net $ 162.5 $ 168.8
Unamortized debt issuance costs (0.5) (0.8)
Current portion of long-term debt (9.4) (8.6)
Total Long-Term Debt, net $ 152.6 159.4
Revolving Credit Facility | Unsecured debt    
Debt Instrument [Line Items]    
Weighted-Average Interest Rate 6.83%  
Total Long-Term Debt, net $ 50.0 50.0
Term Loan Facility | Unsecured debt    
Debt Instrument [Line Items]    
Weighted-Average Interest Rate 6.81%  
Total Long-Term Debt, net $ 112.5 $ 118.8
XML 69 R54.htm IDEA: XBRL DOCUMENT v3.24.3
Debt - Narratives (Details) - USD ($)
 9 Months Ended
Jun. 24, 2022
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Debt Instrument [Line Items]        
Current portion of long-term debt   $ 9,400,000   $ 8,600,000
Repayment of credit facility   20,000,000.0 $ 20,000,000.0  
Revolving credit facility proceeds   $ 20,000,000.0 $ 55,000,000.0  
First Eight Quarters        
Debt Instrument [Line Items]        
Quarterly installment payments (as percent)   10.00%    
Subsequent To First Eight Quarters        
Debt Instrument [Line Items]        
Quarterly installment payments (as percent)   20.00%    
Letter of Credit        
Debt Instrument [Line Items]        
Letters of credit outstanding   $ 6,300,000    
Unsecured debt | Revolving Credit Facility        
Debt Instrument [Line Items]        
Repayment of credit facility   20,000,000.0    
Unsecured debt | Term Loan Facilities        
Debt Instrument [Line Items]        
Repayment of credit facility   $ 6,300,000    
Credit Agreement        
Debt Instrument [Line Items]        
Borrowing capacity $ 500,000,000.0      
Credit Agreement | Secured overnight financing rate (SOFR) | Variable rate component three        
Debt Instrument [Line Items]        
Basis spread on variable rate (as percent) 1.00%      
Credit Agreement | Fed funds effective rate overnight index rate swap        
Debt Instrument [Line Items]        
Basis spread on variable rate (as percent) 0.50%      
Credit Agreement | Minimum | Secured overnight financing rate (SOFR) | Variable rate component one        
Debt Instrument [Line Items]        
Basis spread on variable rate (as percent) 1.50%      
Credit Agreement | Minimum | Secured overnight financing rate (SOFR) | Variable rate component two        
Debt Instrument [Line Items]        
Basis spread on variable rate (as percent) 1.50%      
Credit Agreement | Minimum | Base rate        
Debt Instrument [Line Items]        
Basis spread on variable rate (as percent) 0.50%      
Credit Agreement | Maximum | Secured overnight financing rate (SOFR) | Variable rate component one        
Debt Instrument [Line Items]        
Basis spread on variable rate (as percent) 2.00%      
Credit Agreement | Maximum | Secured overnight financing rate (SOFR) | Variable rate component two        
Debt Instrument [Line Items]        
Basis spread on variable rate (as percent) 2.00%      
Credit Agreement | Maximum | Base rate        
Debt Instrument [Line Items]        
Basis spread on variable rate (as percent) 1.00%      
Term Loan Facility | Senior Secured Term Loan        
Debt Instrument [Line Items]        
Debt instrument, term (in years) 5 years      
Face amount of debt $ 125,000,000.0      
Effective interest rate (as percent)   7.10%    
Senior Secured Revolving Credit Facility | Line of Credit | Revolving Credit Facility        
Debt Instrument [Line Items]        
Borrowing capacity $ 375,000,000.0      
Debt instrument, term (in years) 5 years      
Senior Secured Revolving Credit Facility | Line of Credit | Revolving Credit Facility | Minimum        
Debt Instrument [Line Items]        
Line of credit facility, commitment fee percentage 0.20%      
Senior Secured Revolving Credit Facility | Line of Credit | Revolving Credit Facility | Maximum        
Debt Instrument [Line Items]        
Line of credit facility, commitment fee percentage 0.25%      
Senior Secured Revolving Credit Facility | Line of Credit | Letter of Credit        
Debt Instrument [Line Items]        
Borrowing capacity $ 75,000,000.0      
XML 70 R55.htm IDEA: XBRL DOCUMENT v3.24.3
Debt - Maturities of Long-Term Debt (Details) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Debt Disclosure [Abstract]    
Remainder of 2024 $ 2.3  
2025 9.4  
2026 10.2  
2027 140.6  
2028 0.0  
Total $ 162.5 $ 168.8
XML 71 R56.htm IDEA: XBRL DOCUMENT v3.24.3
Accumulated Other Comprehensive Income - Changes During the Period (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance     $ 1,236.3  
Other comprehensive loss $ 0.6 $ (4.6) (9.9) $ 2.8
Ending balance 1,229.7 1,222.1 1,229.7 1,222.1
Unrealized Currency Translation        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance     (27.0)  
Other comprehensive loss     (8.0)  
Ending balance (35.0)   (35.0)  
Cash Flow Hedges        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance     0.0  
Other comprehensive loss     (1.8)  
Ending balance (1.8)   (1.8)  
Defined Benefit Plans        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance     0.0  
Other comprehensive loss     (0.1)  
Ending balance (0.1)   (0.1)  
Accumulated Other Comprehensive Loss        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance (37.5) (28.4) (27.0) (35.8)
Other comprehensive loss 0.6 (4.6) (9.9) 2.8
Ending balance $ (36.9) $ (33.0) $ (36.9) $ (33.0)
XML 72 R57.htm IDEA: XBRL DOCUMENT v3.24.3
Accumulated Other Comprehensive Income - Net Changes in Components of AOCI, Including Tax Effect (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Equity [Abstract]        
Unrealized currency translation $ 0.3 $ (4.6) $ (8.0) $ 2.8
Defined benefit pension plans 0.1 0.0 (0.1) 0.0
Defined benefit pension plans, net of tax 0.1 0.0 (0.1) 0.0
Cash flow hedges 0.7 0.0 (1.3) 0.0
Tax effect (0.5) 0.0 (0.5) 0.0
Cash flow hedges, net of tax 0.2 0.0 (1.8) 0.0
Total Other Comprehensive Income (Loss), Net of Tax $ 0.6 $ (4.6) $ (9.9) $ 2.8
XML 73 R58.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation $ 2.6 $ 3.9 $ 10.0 $ 11.8
Stock options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation 0.0 0.0 0.0 0.3
Time-based restricted share units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation 2.7 2.5 7.6 7.9
Performance-based restricted share units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation (0.1) 1.3 2.3 3.4
Employee stock purchase plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation $ 0.0 $ 0.1 $ 0.1 $ 0.2
XML 74 R59.htm IDEA: XBRL DOCUMENT v3.24.3
Commitments and Contingencies (Details)
$ in Millions
Jul. 06, 2021
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Loss contingency accrual, payments $ 22.2
XML 75 R60.htm IDEA: XBRL DOCUMENT v3.24.3
Derivative Financial Instruments (Details) - Foreign exchange forward
$ in Millions
Sep. 30, 2024
USD ($)
Derivative [Line Items]  
Derivative liability $ 2.1
Cash flow hedging | Designated as hedging instrument  
Derivative [Line Items]  
Derivative, notional amount $ 17.8
XML 76 R61.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings Per Share ("EPS") (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Earnings Per Share [Abstract]        
Net income (loss) from continuing operations $ 5.9 $ (8.8) $ 10.7 $ (20.9)
Net (loss) income from discontinued operations (1.6) 5.1 (5.5) (51.4)
Net Income (Loss) $ 4.3 $ (3.7) $ 5.2 $ (72.3)
Weighted Average Shares Outstanding:        
Basic weighted average shares outstanding (in shares) 46.0 46.8 46.0 46.7
Dilutive effect of stock options and restricted share unit awards (in shares) 0.6 0.0 0.5 0.0
Diluted weighted average shares outstanding (in shares) 46.6 46.8 46.5 46.7
Earnings (Loss) Per Share        
Continuing operations- basic (in dollars per share) $ 0.13 $ (0.19) $ 0.23 $ (0.45)
Discontinued operations- basic (in dollars per share) (0.03) 0.11 (0.12) (1.10)
Basic Earnings (Loss) Per Share (in dollars per share) 0.10 (0.08) 0.11 (1.55)
Diluted Earnings (Loss) Per Share        
Continuing operations- diluted (in dollars per share) 0.12 (0.19) 0.23 (0.45)
Discontinued operations- diluted (in dollars per share) (0.03) 0.11 (0.12) (1.10)
Diluted Earnings (Loss) Per Share (in dollars per share) $ 0.09 $ (0.08) $ 0.11 $ (1.55)
Dilutive securities excluded from computation of earnings per share (in shares) 1.0   1.3  
XML 77 R62.htm IDEA: XBRL DOCUMENT v3.24.3
Business and Products Information - Narratives (Details)
 9 Months Ended
Sep. 30, 2024
segment
Segment Reporting [Abstract]  
Number of operating segments 1
Number of reportable segments 1
XML 78 R63.htm IDEA: XBRL DOCUMENT v3.24.3
Business and Products Information - Net Sales by Product Category (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disaggregation of Revenue [Line Items]        
Total Net Sales $ 170.4 $ 171.3 $ 508.2 $ 500.0
Digestive Health        
Disaggregation of Revenue [Line Items]        
Total Net Sales 98.2 95.0 290.6 276.8
Total Pain Management and Recovery        
Disaggregation of Revenue [Line Items]        
Total Net Sales 72.2 76.3 217.6 223.2
Surgical pain and recovery        
Disaggregation of Revenue [Line Items]        
Total Net Sales 30.3 34.1 93.8 103.6
Interventional pain        
Disaggregation of Revenue [Line Items]        
Total Net Sales $ 41.9 $ 42.2 $ 123.8 $ 119.6
XML 79 R64.htm IDEA: XBRL DOCUMENT v3.24.3
Business and Products Information - Accrued Liabilities (Details) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Segment Reporting [Abstract]    
Accrued rebates $ 13.7 $ 10.4
Accrued customer incentives 9.9 7.3
Accrued rebates and customer incentives 23.6 17.7
Accrued sales returns 0.1 0.1
Total estimated liabilities $ 23.7 $ 17.8
XML 80 R65.htm IDEA: XBRL DOCUMENT v3.24.3
Share Repurchase Program - Narratives (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jul. 28, 2023
Dec. 31, 2023
Sep. 30, 2023
Sep. 30, 2024
Equity [Abstract]        
Repurchase program period (in years) 1 year      
Stock repurchase program, authorized amount $ 25.0      
Value of common stock repurchased   $ 5.8 $ 9.2  
Shares withheld for tax withholding obligation (in shares)       140,539
Stock issued, value, stock options exercised, net of tax benefit (expense)       $ 2.7
XML 81 R66.htm IDEA: XBRL DOCUMENT v3.24.3
Share Repurchase Program - Summary of Treasury Stock (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Equity [Abstract]    
Shares Repurchased (in shares) 169,571 342,680
Shares repurchased, program to date (in shares) 1,254,904 1,085,333
Aggregate Purchase Price (in millions) $ 3.3 $ 6.7
Average Price Per Share (in dollars per share) $ 19.67 $ 19.45
Amount Remaining in Program for Purchase (in millions) $ 0.0 $ 3.3
EXCEL 82 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 83 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 84 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 86 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.3 html 205 281 1 false 68 0 false 5 false false R1.htm 0000001 - Document - Cover Sheet http://www.avanos.com/role/Cover Cover Cover 1 false false R2.htm 9952151 - Statement - CONDENSED CONSOLIDATED INCOME STATEMENTS Sheet http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS CONDENSED CONSOLIDATED INCOME STATEMENTS Statements 2 false false R3.htm 9952152 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Sheet http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Statements 3 false false R4.htm 9952153 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 4 false false R5.htm 9952154 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 5 false false R6.htm 9952155 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Sheet http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 9952156 - Statement - CONDENSED CONSOLIDATED CASH FLOW STATEMENTS Sheet http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS CONDENSED CONSOLIDATED CASH FLOW STATEMENTS Statements 7 false false R8.htm 9952157 - Disclosure - Accounting Policies Sheet http://www.avanos.com/role/AccountingPolicies Accounting Policies Notes 8 false false R9.htm 9952158 - Disclosure - Discontinued Operations Sheet http://www.avanos.com/role/DiscontinuedOperations Discontinued Operations Notes 9 false false R10.htm 9952159 - Disclosure - Restructuring Activities Sheet http://www.avanos.com/role/RestructuringActivities Restructuring Activities Notes 10 false false R11.htm 9952160 - Disclosure - Business Acquisition Sheet http://www.avanos.com/role/BusinessAcquisition Business Acquisition Notes 11 false false R12.htm 9952161 - Disclosure - Supplemental Balance Sheet Information Sheet http://www.avanos.com/role/SupplementalBalanceSheetInformation Supplemental Balance Sheet Information Notes 12 false false R13.htm 9952162 - Disclosure - Fair Value Information Sheet http://www.avanos.com/role/FairValueInformation Fair Value Information Notes 13 false false R14.htm 9952163 - Disclosure - Debt Sheet http://www.avanos.com/role/Debt Debt Notes 14 false false R15.htm 9952164 - Disclosure - Accumulated Other Comprehensive Income Sheet http://www.avanos.com/role/AccumulatedOtherComprehensiveIncome Accumulated Other Comprehensive Income Notes 15 false false R16.htm 9952165 - Disclosure - Stock-Based Compensation Sheet http://www.avanos.com/role/StockBasedCompensation Stock-Based Compensation Notes 16 false false R17.htm 9952166 - Disclosure - Commitments and Contingencies Sheet http://www.avanos.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 17 false false R18.htm 9952167 - Disclosure - Derivative Financial Instruments Sheet http://www.avanos.com/role/DerivativeFinancialInstruments Derivative Financial Instruments Notes 18 false false R19.htm 9952168 - Disclosure - Earnings Per Share ("EPS") Sheet http://www.avanos.com/role/EarningsPerShareEPS Earnings Per Share ("EPS") Notes 19 false false R20.htm 9952169 - Disclosure - Business and Products Information Sheet http://www.avanos.com/role/BusinessandProductsInformation Business and Products Information Notes 20 false false R21.htm 9952170 - Disclosure - Share Repurchase Program Sheet http://www.avanos.com/role/ShareRepurchaseProgram Share Repurchase Program Notes 21 false false R22.htm 9954471 - Disclosure - Accounting Policies (Policies) Sheet http://www.avanos.com/role/AccountingPoliciesPolicies Accounting Policies (Policies) Policies http://www.avanos.com/role/AccountingPolicies 22 false false R23.htm 9954472 - Disclosure - Discontinued Operations (Tables) Sheet http://www.avanos.com/role/DiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://www.avanos.com/role/DiscontinuedOperations 23 false false R24.htm 9954473 - Disclosure - Restructuring Activities (Tables) Sheet http://www.avanos.com/role/RestructuringActivitiesTables Restructuring Activities (Tables) Tables http://www.avanos.com/role/RestructuringActivities 24 false false R25.htm 9954474 - Disclosure - Business Acquisition (Tables) Sheet http://www.avanos.com/role/BusinessAcquisitionTables Business Acquisition (Tables) Tables http://www.avanos.com/role/BusinessAcquisition 25 false false R26.htm 9954475 - Disclosure - Supplemental Balance Sheet Information (Tables) Sheet http://www.avanos.com/role/SupplementalBalanceSheetInformationTables Supplemental Balance Sheet Information (Tables) Tables http://www.avanos.com/role/SupplementalBalanceSheetInformation 26 false false R27.htm 9954476 - Disclosure - Fair Value Information (Tables) Sheet http://www.avanos.com/role/FairValueInformationTables Fair Value Information (Tables) Tables http://www.avanos.com/role/FairValueInformation 27 false false R28.htm 9954477 - Disclosure - Debt (Tables) Sheet http://www.avanos.com/role/DebtTables Debt (Tables) Tables http://www.avanos.com/role/Debt 28 false false R29.htm 9954478 - Disclosure - Accumulated Other Comprehensive Income (Tables) Sheet http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeTables Accumulated Other Comprehensive Income (Tables) Tables http://www.avanos.com/role/AccumulatedOtherComprehensiveIncome 29 false false R30.htm 9954479 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.avanos.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.avanos.com/role/StockBasedCompensation 30 false false R31.htm 9954480 - Disclosure - Earnings Per Share ("EPS") (Tables) Sheet http://www.avanos.com/role/EarningsPerShareEPSTables Earnings Per Share ("EPS") (Tables) Tables http://www.avanos.com/role/EarningsPerShareEPS 31 false false R32.htm 9954481 - Disclosure - Business and Products Information (Tables) Sheet http://www.avanos.com/role/BusinessandProductsInformationTables Business and Products Information (Tables) Tables http://www.avanos.com/role/BusinessandProductsInformation 32 false false R33.htm 9954482 - Disclosure - Share Repurchase Program (Tables) Sheet http://www.avanos.com/role/ShareRepurchaseProgramTables Share Repurchase Program (Tables) Tables http://www.avanos.com/role/ShareRepurchaseProgram 33 false false R34.htm 9954483 - Disclosure - Accounting Policies - Narratives (Details) Sheet http://www.avanos.com/role/AccountingPoliciesNarrativesDetails Accounting Policies - Narratives (Details) Details 34 false false R35.htm 9954484 - Disclosure - Discontinued Operations - Narratives (Details) Sheet http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails Discontinued Operations - Narratives (Details) Details 35 false false R36.htm 9954485 - Disclosure - Discontinued Operations - Schedule of Income (Details) Sheet http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails Discontinued Operations - Schedule of Income (Details) Details 36 false false R37.htm 9954486 - Disclosure - Discontinued Operations - Schedule of Balance Sheet (Details) Sheet http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails Discontinued Operations - Schedule of Balance Sheet (Details) Details 37 false false R38.htm 9954487 - Disclosure - Discontinued Operations- Schedule of Cashflow (Details) Sheet http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails Discontinued Operations- Schedule of Cashflow (Details) Details 38 false false R39.htm 9954488 - Disclosure - Restructuring Activities - Narratives (Details) Sheet http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails Restructuring Activities - Narratives (Details) Details 39 false false R40.htm 9954489 - Disclosure - Restructuring Activities - Accrual and Payment Activity (Details) Sheet http://www.avanos.com/role/RestructuringActivitiesAccrualandPaymentActivityDetails Restructuring Activities - Accrual and Payment Activity (Details) Details 40 false false R41.htm 9954490 - Disclosure - Business Acquisition - Narratives (Details) Sheet http://www.avanos.com/role/BusinessAcquisitionNarrativesDetails Business Acquisition - Narratives (Details) Details 41 false false R42.htm 9954491 - Disclosure - Business Acquisition - Purchase Price Allocation (Details) Sheet http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails Business Acquisition - Purchase Price Allocation (Details) Details 42 false false R43.htm 9954492 - Disclosure - Business Acquisition - Identifiable Intangible Assets (Details) Sheet http://www.avanos.com/role/BusinessAcquisitionIdentifiableIntangibleAssetsDetails Business Acquisition - Identifiable Intangible Assets (Details) Details 43 false false R44.htm 9954493 - Disclosure - Supplemental Balance Sheet Information - Accounts Receivable (Details) Sheet http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails Supplemental Balance Sheet Information - Accounts Receivable (Details) Details 44 false false R45.htm 9954494 - Disclosure - Supplemental Balance Sheet Information - Inventories (Details) Sheet http://www.avanos.com/role/SupplementalBalanceSheetInformationInventoriesDetails Supplemental Balance Sheet Information - Inventories (Details) Details 45 false false R46.htm 9954495 - Disclosure - Supplemental Balance Sheet Information - Property, Plant and Equipment (Details) Sheet http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails Supplemental Balance Sheet Information - Property, Plant and Equipment (Details) Details 46 false false R47.htm 9954496 - Disclosure - Supplemental Balance Sheet Information - Goodwill (Details) Sheet http://www.avanos.com/role/SupplementalBalanceSheetInformationGoodwillDetails Supplemental Balance Sheet Information - Goodwill (Details) Details 47 false false R48.htm 9954497 - Disclosure - Supplemental Balance Sheet Information - Intangible Assets (Details) Sheet http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails Supplemental Balance Sheet Information - Intangible Assets (Details) Details 48 false false R49.htm 9954498 - Disclosure - Supplemental Balance Sheet Information - Estimated Amortization Expense (Details) Sheet http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails Supplemental Balance Sheet Information - Estimated Amortization Expense (Details) Details 49 false false R50.htm 9954499 - Disclosure - Supplemental Balance Sheet Information - Accrued Expenses (Details) Sheet http://www.avanos.com/role/SupplementalBalanceSheetInformationAccruedExpensesDetails Supplemental Balance Sheet Information - Accrued Expenses (Details) Details 50 false false R51.htm 9954500 - Disclosure - Supplemental Balance Sheet Information - Other Long-Term Liabilities (Details) Sheet http://www.avanos.com/role/SupplementalBalanceSheetInformationOtherLongTermLiabilitiesDetails Supplemental Balance Sheet Information - Other Long-Term Liabilities (Details) Details 51 false false R52.htm 9954501 - Disclosure - Fair Value Information (Details) Sheet http://www.avanos.com/role/FairValueInformationDetails Fair Value Information (Details) Details http://www.avanos.com/role/FairValueInformationTables 52 false false R53.htm 9954502 - Disclosure - Debt - Summary of Debt (Details) Sheet http://www.avanos.com/role/DebtSummaryofDebtDetails Debt - Summary of Debt (Details) Details 53 false false R54.htm 9954503 - Disclosure - Debt - Narratives (Details) Sheet http://www.avanos.com/role/DebtNarrativesDetails Debt - Narratives (Details) Details 54 false false R55.htm 9954504 - Disclosure - Debt - Maturities of Long-Term Debt (Details) Sheet http://www.avanos.com/role/DebtMaturitiesofLongTermDebtDetails Debt - Maturities of Long-Term Debt (Details) Details 55 false false R56.htm 9954505 - Disclosure - Accumulated Other Comprehensive Income - Changes During the Period (Details) Sheet http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeChangesDuringthePeriodDetails Accumulated Other Comprehensive Income - Changes During the Period (Details) Details 56 false false R57.htm 9954506 - Disclosure - Accumulated Other Comprehensive Income - Net Changes in Components of AOCI, Including Tax Effect (Details) Sheet http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeNetChangesinComponentsofAOCIIncludingTaxEffectDetails Accumulated Other Comprehensive Income - Net Changes in Components of AOCI, Including Tax Effect (Details) Details 57 false false R58.htm 9954507 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.avanos.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) Details http://www.avanos.com/role/StockBasedCompensationTables 58 false false R59.htm 9954508 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.avanos.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.avanos.com/role/CommitmentsandContingencies 59 false false R60.htm 9954509 - Disclosure - Derivative Financial Instruments (Details) Sheet http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails Derivative Financial Instruments (Details) Details http://www.avanos.com/role/DerivativeFinancialInstruments 60 false false R61.htm 9954510 - Disclosure - Earnings Per Share ("EPS") (Details) Sheet http://www.avanos.com/role/EarningsPerShareEPSDetails Earnings Per Share ("EPS") (Details) Details http://www.avanos.com/role/EarningsPerShareEPSTables 61 false false R62.htm 9954511 - Disclosure - Business and Products Information - Narratives (Details) Sheet http://www.avanos.com/role/BusinessandProductsInformationNarrativesDetails Business and Products Information - Narratives (Details) Details 62 false false R63.htm 9954512 - Disclosure - Business and Products Information - Net Sales by Product Category (Details) Sheet http://www.avanos.com/role/BusinessandProductsInformationNetSalesbyProductCategoryDetails Business and Products Information - Net Sales by Product Category (Details) Details 63 false false R64.htm 9954513 - Disclosure - Business and Products Information - Accrued Liabilities (Details) Sheet http://www.avanos.com/role/BusinessandProductsInformationAccruedLiabilitiesDetails Business and Products Information - Accrued Liabilities (Details) Details 64 false false R65.htm 9954514 - Disclosure - Share Repurchase Program - Narratives (Details) Sheet http://www.avanos.com/role/ShareRepurchaseProgramNarrativesDetails Share Repurchase Program - Narratives (Details) Details 65 false false R66.htm 9954515 - Disclosure - Share Repurchase Program - Summary of Treasury Stock (Details) Sheet http://www.avanos.com/role/ShareRepurchaseProgramSummaryofTreasuryStockDetails Share Repurchase Program - Summary of Treasury Stock (Details) Details 66 false false All Reports Book All Reports avns-20240930.htm avns-20240930.xsd avns-20240930_cal.xml avns-20240930_def.xml avns-20240930_lab.xml avns-20240930_pre.xml avns-20240930_g1.jpg http://fasb.org/srt/2024 http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 true true JSON 89 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "avns-20240930.htm": { "nsprefix": "avns", "nsuri": "http://www.avanos.com/20240930", "dts": { "inline": { "local": [ "avns-20240930.htm" ] }, "schema": { "local": [ "avns-20240930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "avns-20240930_cal.xml" ] }, "definitionLink": { "local": [ "avns-20240930_def.xml" ] }, "labelLink": { "local": [ "avns-20240930_lab.xml" ] }, "presentationLink": { "local": [ "avns-20240930_pre.xml" ] } }, "keyStandard": 258, "keyCustom": 23, "axisStandard": 21, "axisCustom": 2, "memberStandard": 41, "memberCustom": 26, "hidden": { "total": 7, "http://xbrl.sec.gov/dei/2024": 5, "http://www.avanos.com/20240930": 1, "http://fasb.org/us-gaap/2024": 1 }, "contextCount": 205, "entityCount": 1, "segmentCount": 68, "elementCount": 465, "unitCount": 5, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 741, "http://xbrl.sec.gov/dei/2024": 30, "http://fasb.org/srt/2024": 1 }, "report": { "R1": { "role": "http://www.avanos.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS", "longName": "9952151 - Statement - CONDENSED CONSOLIDATED INCOME STATEMENTS", "shortName": "CONDENSED CONSOLIDATED INCOME STATEMENTS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R3": { "role": "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "longName": "9952152 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:ComprehensiveIncomeNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R4": { "role": "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "longName": "9952153 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "longName": "9952154 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "longName": "9952155 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY", "shortName": "CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-13", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS", "longName": "9952156 - Statement - CONDENSED CONSOLIDATED CASH FLOW STATEMENTS", "shortName": "CONDENSED CONSOLIDATED CASH FLOW STATEMENTS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R8": { "role": "http://www.avanos.com/role/AccountingPolicies", "longName": "9952157 - Disclosure - Accounting Policies", "shortName": "Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.avanos.com/role/DiscontinuedOperations", "longName": "9952158 - Disclosure - Discontinued Operations", "shortName": "Discontinued Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.avanos.com/role/RestructuringActivities", "longName": "9952159 - Disclosure - Restructuring Activities", "shortName": "Restructuring Activities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.avanos.com/role/BusinessAcquisition", "longName": "9952160 - Disclosure - Business Acquisition", "shortName": "Business Acquisition", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.avanos.com/role/SupplementalBalanceSheetInformation", "longName": "9952161 - Disclosure - Supplemental Balance Sheet Information", "shortName": "Supplemental Balance Sheet Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.avanos.com/role/FairValueInformation", "longName": "9952162 - Disclosure - Fair Value Information", "shortName": "Fair Value Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.avanos.com/role/Debt", "longName": "9952163 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncome", "longName": "9952164 - Disclosure - Accumulated Other Comprehensive Income", "shortName": "Accumulated Other Comprehensive Income", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.avanos.com/role/StockBasedCompensation", "longName": "9952165 - Disclosure - Stock-Based Compensation", "shortName": "Stock-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.avanos.com/role/CommitmentsandContingencies", "longName": "9952166 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.avanos.com/role/DerivativeFinancialInstruments", "longName": "9952167 - Disclosure - Derivative Financial Instruments", "shortName": "Derivative Financial Instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.avanos.com/role/EarningsPerShareEPS", "longName": "9952168 - Disclosure - Earnings Per Share (\"EPS\")", "shortName": "Earnings Per Share (\"EPS\")", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.avanos.com/role/BusinessandProductsInformation", "longName": "9952169 - Disclosure - Business and Products Information", "shortName": "Business and Products Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.avanos.com/role/ShareRepurchaseProgram", "longName": "9952170 - Disclosure - Share Repurchase Program", "shortName": "Share Repurchase Program", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.avanos.com/role/AccountingPoliciesPolicies", "longName": "9954471 - Disclosure - Accounting Policies (Policies)", "shortName": "Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.avanos.com/role/DiscontinuedOperationsTables", "longName": "9954472 - Disclosure - Discontinued Operations (Tables)", "shortName": "Discontinued Operations (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.avanos.com/role/RestructuringActivitiesTables", "longName": "9954473 - Disclosure - Restructuring Activities (Tables)", "shortName": "Restructuring Activities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.avanos.com/role/BusinessAcquisitionTables", "longName": "9954474 - Disclosure - Business Acquisition (Tables)", "shortName": "Business Acquisition (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.avanos.com/role/SupplementalBalanceSheetInformationTables", "longName": "9954475 - Disclosure - Supplemental Balance Sheet Information (Tables)", "shortName": "Supplemental Balance Sheet Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.avanos.com/role/FairValueInformationTables", "longName": "9954476 - Disclosure - Fair Value Information (Tables)", "shortName": "Fair Value Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.avanos.com/role/DebtTables", "longName": "9954477 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeTables", "longName": "9954478 - Disclosure - Accumulated Other Comprehensive Income (Tables)", "shortName": "Accumulated Other Comprehensive Income (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.avanos.com/role/StockBasedCompensationTables", "longName": "9954479 - Disclosure - Stock-Based Compensation (Tables)", "shortName": "Stock-Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.avanos.com/role/EarningsPerShareEPSTables", "longName": "9954480 - Disclosure - Earnings Per Share (\"EPS\") (Tables)", "shortName": "Earnings Per Share (\"EPS\") (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.avanos.com/role/BusinessandProductsInformationTables", "longName": "9954481 - Disclosure - Business and Products Information (Tables)", "shortName": "Business and Products Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.avanos.com/role/ShareRepurchaseProgramTables", "longName": "9954482 - Disclosure - Share Repurchase Program (Tables)", "shortName": "Share Repurchase Program (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.avanos.com/role/AccountingPoliciesNarrativesDetails", "longName": "9954483 - Disclosure - Accounting Policies - Narratives (Details)", "shortName": "Accounting Policies - Narratives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportingUnits", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportingUnits", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails", "longName": "9954484 - Disclosure - Discontinued Operations - Narratives (Details)", "shortName": "Discontinued Operations - Narratives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProceedsFromDivestitureOfBusinesses", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-52", "name": "us-gaap:ProceedsFromDivestitureOfBusinesses", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R36": { "role": "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails", "longName": "9954485 - Disclosure - Discontinued Operations - Schedule of Income (Details)", "shortName": "Discontinued Operations - Schedule of Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-58", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R37": { "role": "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails", "longName": "9954486 - Disclosure - Discontinued Operations - Schedule of Balance Sheet (Details)", "shortName": "Discontinued Operations - Schedule of Balance Sheet (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-56", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-56", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails", "longName": "9954487 - Disclosure - Discontinued Operations- Schedule of Cashflow (Details)", "shortName": "Discontinued Operations- Schedule of Cashflow (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-60", "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-60", "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails", "longName": "9954488 - Disclosure - Restructuring Activities - Narratives (Details)", "shortName": "Restructuring Activities - Narratives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-66", "name": "avns:RestructuringPlanTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-66", "name": "avns:RestructuringPlanTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.avanos.com/role/RestructuringActivitiesAccrualandPaymentActivityDetails", "longName": "9954489 - Disclosure - Restructuring Activities - Accrual and Payment Activity (Details)", "shortName": "Restructuring Activities - Accrual and Payment Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-81", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-81", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.avanos.com/role/BusinessAcquisitionNarrativesDetails", "longName": "9954490 - Disclosure - Business Acquisition - Narratives (Details)", "shortName": "Business Acquisition - Narratives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "avns:PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R42": { "role": "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails", "longName": "9954491 - Disclosure - Business Acquisition - Purchase Price Allocation (Details)", "shortName": "Business Acquisition - Purchase Price Allocation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-86", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R43": { "role": "http://www.avanos.com/role/BusinessAcquisitionIdentifiableIntangibleAssetsDetails", "longName": "9954492 - Disclosure - Business Acquisition - Identifiable Intangible Assets (Details)", "shortName": "Business Acquisition - Identifiable Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-84", "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:AssetAcquisitionTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-84", "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:AssetAcquisitionTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails", "longName": "9954493 - Disclosure - Supplemental Balance Sheet Information - Accounts Receivable (Details)", "shortName": "Supplemental Balance Sheet Information - Accounts Receivable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:AccountsReceivableGrossCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-7", "name": "us-gaap:AccountsReceivableGrossCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R45": { "role": "http://www.avanos.com/role/SupplementalBalanceSheetInformationInventoriesDetails", "longName": "9954494 - Disclosure - Supplemental Balance Sheet Information - Inventories (Details)", "shortName": "Supplemental Balance Sheet Information - Inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:InventoryRawMaterials", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-7", "name": "us-gaap:InventoryRawMaterials", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R46": { "role": "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails", "longName": "9954495 - Disclosure - Supplemental Balance Sheet Information - Property, Plant and Equipment (Details)", "shortName": "Supplemental Balance Sheet Information - Property, Plant and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-7", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R47": { "role": "http://www.avanos.com/role/SupplementalBalanceSheetInformationGoodwillDetails", "longName": "9954496 - Disclosure - Supplemental Balance Sheet Information - Goodwill (Details)", "shortName": "Supplemental Balance Sheet Information - Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R48": { "role": "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails", "longName": "9954497 - Disclosure - Supplemental Balance Sheet Information - Intangible Assets (Details)", "shortName": "Supplemental Balance Sheet Information - Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-7", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R49": { "role": "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails", "longName": "9954498 - Disclosure - Supplemental Balance Sheet Information - Estimated Amortization Expense (Details)", "shortName": "Supplemental Balance Sheet Information - Estimated Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccruedExpensesDetails", "longName": "9954499 - Disclosure - Supplemental Balance Sheet Information - Accrued Expenses (Details)", "shortName": "Supplemental Balance Sheet Information - Accrued Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-6", "name": "avns:AccruedRebatesAndCustomerIncentives", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "avns:AccruedRebatesAndCustomerIncentives", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.avanos.com/role/SupplementalBalanceSheetInformationOtherLongTermLiabilitiesDetails", "longName": "9954500 - Disclosure - Supplemental Balance Sheet Information - Other Long-Term Liabilities (Details)", "shortName": "Supplemental Balance Sheet Information - Other Long-Term Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-6", "name": "avns:AccruedCompensationBenefits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "avns:AccruedCompensationBenefits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.avanos.com/role/FairValueInformationDetails", "longName": "9954501 - Disclosure - Fair Value Information (Details)", "shortName": "Fair Value Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-113", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R53": { "role": "http://www.avanos.com/role/DebtSummaryofDebtDetails", "longName": "9954502 - Disclosure - Debt - Summary of Debt (Details)", "shortName": "Debt - Summary of Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R54": { "role": "http://www.avanos.com/role/DebtNarrativesDetails", "longName": "9954503 - Disclosure - Debt - Narratives (Details)", "shortName": "Debt - Narratives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:LongTermDebtCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-150", "name": "avns:DebtInstrumentPeriodicPaymentPercent", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R55": { "role": "http://www.avanos.com/role/DebtMaturitiesofLongTermDebtDetails", "longName": "9954504 - Disclosure - Debt - Maturities of Long-Term Debt (Details)", "shortName": "Debt - Maturities of Long-Term Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeChangesDuringthePeriodDetails", "longName": "9954505 - Disclosure - Accumulated Other Comprehensive Income - Changes During the Period (Details)", "shortName": "Accumulated Other Comprehensive Income - Changes During the Period (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-155", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R57": { "role": "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeNetChangesinComponentsofAOCIIncludingTaxEffectDetails", "longName": "9954506 - Disclosure - Accumulated Other Comprehensive Income - Net Changes in Components of AOCI, Including Tax Effect (Details)", "shortName": "Accumulated Other Comprehensive Income - Net Changes in Components of AOCI, Including Tax Effect (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R58": { "role": "http://www.avanos.com/role/StockBasedCompensationDetails", "longName": "9954507 - Disclosure - Stock-Based Compensation (Details)", "shortName": "Stock-Based Compensation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.avanos.com/role/CommitmentsandContingenciesDetails", "longName": "9954508 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-180", "name": "us-gaap:LossContingencyAccrualPayments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-180", "name": "us-gaap:LossContingencyAccrualPayments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails", "longName": "9954509 - Disclosure - Derivative Financial Instruments (Details)", "shortName": "Derivative Financial Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-181", "name": "us-gaap:DerivativeLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-181", "name": "us-gaap:DerivativeLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.avanos.com/role/EarningsPerShareEPSDetails", "longName": "9954510 - Disclosure - Earnings Per Share (\"EPS\") (Details)", "shortName": "Earnings Per Share (\"EPS\") (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:IncomeLossFromContinuingOperations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R62": { "role": "http://www.avanos.com/role/BusinessandProductsInformationNarrativesDetails", "longName": "9954511 - Disclosure - Business and Products Information - Narratives (Details)", "shortName": "Business and Products Information - Narratives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:NumberOfOperatingSegments", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:NumberOfOperatingSegments", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.avanos.com/role/BusinessandProductsInformationNetSalesbyProductCategoryDetails", "longName": "9954512 - Disclosure - Business and Products Information - Net Sales by Product Category (Details)", "shortName": "Business and Products Information - Net Sales by Product Category (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-183", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "unique": true } }, "R64": { "role": "http://www.avanos.com/role/BusinessandProductsInformationAccruedLiabilitiesDetails", "longName": "9954513 - Disclosure - Business and Products Information - Accrued Liabilities (Details)", "shortName": "Business and Products Information - Accrued Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-6", "name": "avns:AccruedRebates", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "avns:AccruedRebates", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.avanos.com/role/ShareRepurchaseProgramNarrativesDetails", "longName": "9954514 - Disclosure - Share Repurchase Program - Narratives (Details)", "shortName": "Share Repurchase Program - Narratives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-199", "name": "us-gaap:StockRepurchaseProgramPeriodInForce1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-199", "name": "us-gaap:StockRepurchaseProgramPeriodInForce1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.avanos.com/role/ShareRepurchaseProgramSummaryofTreasuryStockDetails", "longName": "9954515 - Disclosure - Share Repurchase Program - Summary of Treasury Stock (Details)", "shortName": "Share Repurchase Program - Summary of Treasury Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-204", "name": "us-gaap:TreasuryStockSharesAcquired", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-204", "name": "us-gaap:TreasuryStockSharesAcquired", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "avns-20240930.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AOCIAttributableToParentNetOfTaxRollForward", "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeChangesDuringthePeriodDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Trade accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r98", "r709" ] }, "us-gaap_AccountsReceivableGrossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableGrossCurrent", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails": { "parentTag": "us-gaap_ReceivablesNetCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable", "label": "Accounts Receivable, before Allowance for Credit Loss, Current", "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r214", "r301", "r663" ] }, "us-gaap_AccountsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNet", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net of allowances", "label": "Accounts Receivable, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r603", "r656", "r718", "r843", "r844" ] }, "avns_AccruedCompensationBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "AccruedCompensationBenefits", "crdr": "credit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationOtherLongTermLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationOtherLongTermLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation and benefits", "label": "Accrued Compensation Benefits", "documentation": "Accrued Compensation Benefits" } } }, "auth_ref": [] }, "avns_AccruedIncentives": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "AccruedIncentives", "crdr": "credit", "calculation": { "http://www.avanos.com/role/BusinessandProductsInformationAccruedLiabilitiesDetails": { "parentTag": "avns_AccruedRebatesAndIncentives", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued customer incentives", "label": "Accrued incentives", "documentation": "Accrued incentives" } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccruedExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses", "totalLabel": "Total", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r101" ] }, "avns_AccruedRebates": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "AccruedRebates", "crdr": "credit", "calculation": { "http://www.avanos.com/role/BusinessandProductsInformationAccruedLiabilitiesDetails": { "parentTag": "avns_AccruedRebatesAndIncentives", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued rebates", "label": "Accrued Rebates", "documentation": "Accrued Rebates" } } }, "auth_ref": [] }, "avns_AccruedRebatesAndCustomerIncentives": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "AccruedRebatesAndCustomerIncentives", "crdr": "credit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued rebates and customer incentives", "label": "Accrued Rebates And Customer Incentives", "documentation": "Accrued Rebates And Customer Incentives" } } }, "auth_ref": [] }, "avns_AccruedRebatesAndIncentives": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "AccruedRebatesAndIncentives", "crdr": "credit", "calculation": { "http://www.avanos.com/role/BusinessandProductsInformationAccruedLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.avanos.com/role/BusinessandProductsInformationAccruedLiabilitiesDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Accrued rebates and customer incentives", "label": "Accrued Rebates And Incentives", "documentation": "Accrued Rebates And Incentives" } } }, "auth_ref": [] }, "us-gaap_AccruedSalariesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedSalariesCurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued salaries and wages", "label": "Accrued Salaries, Current", "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r101", "r664" ] }, "avns_AccruedSalesReturns": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "AccruedSalesReturns", "crdr": "debit", "calculation": { "http://www.avanos.com/role/BusinessandProductsInformationAccruedLiabilitiesDetails_1": { "parentTag": "avns_AccruedRebatesAndIncentives", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued sales returns", "label": "Accrued sales returns", "documentation": "Accrued sales returns" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeChangesDuringthePeriodDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plans", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r6", "r7", "r20", "r31", "r123", "r741", "r742", "r743" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r43", "r208", "r549" ] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeChangesDuringthePeriodDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flow Hedges", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r223", "r230", "r231", "r474", "r666", "r741" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeChangesDuringthePeriodDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r229", "r230", "r511", "r512", "r513", "r514", "r515", "r516" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r30", "r31", "r124", "r215", "r546", "r571", "r572" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeChangesDuringthePeriodDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r229", "r230", "r511", "r512", "r513", "r514", "r515", "r516" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeChangesDuringthePeriodDetails", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "verboseLabel": "Accumulated Other Comprehensive Loss", "terseLabel": "Accumulated Other Comprehensive Loss", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r20", "r31", "r481", "r484", "r524", "r567", "r568", "r741", "r742", "r743", "r751", "r752", "r753", "r754" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeChangesDuringthePeriodDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Currency Translation", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r5", "r20", "r31", "r121", "r122", "r230", "r231", "r512", "r513", "r514", "r515", "r516", "r741" ] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionIdentifiableIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Useful Lives (Years)", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r321", "r659" ] }, "avns_AcquisitionOfAssetsAndInvestmentsInBusinesses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "AcquisitionOfAssetsAndInvestmentsInBusinesses", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition of assets and investments in businesses", "label": "Acquisition Of Assets And Investments In Businesses", "documentation": "Acquisition Of Assets And Investments In Businesses" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r111", "r709", "r878" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r576", "r751", "r752", "r753", "r754", "r812", "r880" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r53", "r54", "r417" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "netLabel": "Total stock-based compensation", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r446", "r450" ] }, "avns_AllowanceForCreditLossDoubtfulAccountsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "AllowanceForCreditLossDoubtfulAccountsMember", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Doubtful accounts", "label": "Allowance For Credit Loss, Doubtful Accounts [Member]", "documentation": "Allowance For Credit Loss, Doubtful Accounts [Member]" } } }, "auth_ref": [] }, "avns_AllowanceForCreditLossSalesDiscountsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "AllowanceForCreditLossSalesDiscountsMember", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales discounts", "label": "Allowance For Credit Loss, Sales Discounts [Member]", "documentation": "Allowance For Credit Loss, Sales Discounts [Member]" } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails": { "parentTag": "us-gaap_ReceivablesNetCurrent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Allowances and doubtful accounts", "label": "Accounts Receivable, Allowance for Credit Loss", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r216", "r302", "r306", "r307", "r309", "r844" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense for intangible assets", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r15", "r318", "r325", "r680" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive securities excluded from computation of earnings per share (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r269" ] }, "us-gaap_AssetAcquisitionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetAcquisitionTableTextBlock", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Identifiable Intangible Assets", "label": "Asset Acquisition [Table Text Block]", "documentation": "Tabular disclosure of asset acquisition." } } }, "auth_ref": [ "r804" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r161", "r173", "r212", "r240", "r273", "r279", "r290", "r293", "r303", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r472", "r475", "r509", "r541", "r608", "r673", "r674", "r709", "r725", "r797", "r798", "r833" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r204", "r218", "r240", "r303", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r472", "r475", "r509", "r709", "r797", "r798", "r833" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current Assets", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsFairValueDisclosureAbstract", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "crdr": "debit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets classified as held for sale", "label": "Disposal Group, Including Discontinued Operation, Assets", "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r3", "r79", "r93", "r144", "r202", "r203" ] }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Assets held for sale", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r79", "r93", "r142", "r144", "r202", "r203" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://www.avanos.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445" ] }, "us-gaap_BaseRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BaseRateMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Base rate", "label": "Base Rate [Member]", "documentation": "Minimum rate investor will accept." } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.avanos.com/role/AccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Background and Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.avanos.com/role/AccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r139" ] }, "us-gaap_BuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BuildingMember", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Buildings and leasehold improvements", "label": "Building [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities." } } }, "auth_ref": [ "r143" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionIdentifiableIntangibleAssetsDetails", "http://www.avanos.com/role/BusinessAcquisitionNarrativesDetails", "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r319", "r320", "r321", "r322", "r323", "r466", "r697", "r698" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionIdentifiableIntangibleAssetsDetails", "http://www.avanos.com/role/BusinessAcquisitionNarrativesDetails", "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r56", "r57", "r319", "r320", "r321", "r322", "r323", "r466", "r697", "r698" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionIdentifiableIntangibleAssetsDetails", "http://www.avanos.com/role/BusinessAcquisitionNarrativesDetails", "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r466" ] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business acquisition, transaction costs", "label": "Business Combination, Acquisition Related Costs", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities." } } }, "auth_ref": [ "r55" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consideration transferred", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r0", "r1", "r19" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionNarrativesDetails", "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future estimated payments", "verboseLabel": "Contingent consideration related to acquisition", "label": "Business Combination, Contingent Consideration, Liability", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r61", "r157", "r469", "r494", "r495", "r496" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "negatedNetLabel": "Contingent consideration", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r61", "r157" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.avanos.com/role/BusinessAcquisition" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition", "label": "Business Combination Disclosure [Text Block]", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r154", "r467" ] }, "avns_BusinessCombinationLiabilityCurrentExcludingContingentConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "BusinessCombinationLiabilityCurrentExcludingContingentConsideration", "crdr": "credit", "calculation": { "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Current liabilities, excluding contingent consideration", "label": "Business Combination, Liability, Current, Excluding Contingent Consideration", "documentation": "Business Combination, Liability, Current, Excluding Contingent Consideration" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "crdr": "debit", "calculation": { "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets, net of cash acquired", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r58" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Deferred tax liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date." } } }, "auth_ref": [ "r58" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Identifiable intangible assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date." } } }, "auth_ref": [ "r58" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "negatedNetLabel": "Other noncurrent liabilities, net", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r58" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r58" ] }, "us-gaap_CapitalExpenditureDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CapitalExpenditureDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capital expenditures", "label": "Capital Expenditure, Discontinued Operations", "documentation": "Amount of capital expenditure attributable to discontinued operations." } } }, "auth_ref": [ "r92" ] }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CarryingReportedAmountFairValueDisclosureMember", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying Amount", "label": "Reported Value Measurement [Member]", "documentation": "Measured as reported on the statement of financial position (balance sheet)." } } }, "auth_ref": [ "r75", "r76" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r37", "r206", "r661" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS", "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and Cash Equivalents - Beginning of Period", "periodEndLabel": "Cash and Cash Equivalents - End of Period", "verboseLabel": "Cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r37", "r136", "r237" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "totalLabel": "Increase (Decrease) in Cash and Cash Equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r136" ] }, "us-gaap_CashFlowHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowHedgingMember", "presentation": [ "http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flow hedging", "label": "Cash Flow Hedging [Member]", "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk." } } }, "auth_ref": [ "r66" ] }, "avns_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperationsAbstract", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investing Activities:", "label": "Cash Provided By (Used In) Investing Activities, Discontinued Operations [Abstract]", "documentation": "Cash Provided By (Used In) Investing Activities, Discontinued Operations [Abstract]" } } }, "auth_ref": [] }, "avns_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperationsAbstract", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Activities:", "label": "Cash Provided By (Used In) Operating Activities, Discontinued Operations [Abstract]", "documentation": "Cash Provided By (Used In) Operating Activities, Discontinued Operations [Abstract]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r106", "r165", "r543", "r594" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r715", "r716", "r717", "r719", "r720", "r721", "r722", "r751", "r752", "r754", "r812", "r876", "r880" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r109" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r109", "r595" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r21", "r109", "r595", "r614", "r880", "r881" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock - $0.01 par value - authorized 300,000,000 shares, 45,954,931 outstanding as of September\u00a030, 2024 and 46,174,337 outstanding as of December\u00a031, 2023", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r109", "r545", "r709" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive Income (Loss)", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r32", "r226", "r228", "r233", "r537", "r554", "r555" ] }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNoteTextBlock", "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income", "label": "Comprehensive Income (Loss) Note [Text Block]", "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income." } } }, "auth_ref": [ "r120", "r232", "r536", "r553" ] }, "us-gaap_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConstructionInProgressMember", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Construction in progress", "label": "Construction in Progress [Member]", "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service." } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS" ], "lang": { "en-us": { "role": { "verboseLabel": "Cost of products sold", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r129", "r130", "r531" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover page.", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "avns_CreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "CreditAgreementMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Agreement", "label": "Credit Agreement [Member]", "documentation": "Credit Agreement" } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditFacilityAxis", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails", "http://www.avanos.com/role/DebtSummaryofDebtDetails", "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r352", "r795" ] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditFacilityDomain", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails", "http://www.avanos.com/role/DebtSummaryofDebtDetails", "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r352", "r795", "r796" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerRelationshipsMember", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionIdentifiableIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer relationships", "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r60", "r776", "r777", "r778", "r779", "r781", "r783", "r786", "r787" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.avanos.com/role/Debt" ], "lang": { "en-us": { "role": { "terseLabel": "Debt", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r149", "r238", "r331", "r332", "r333", "r334", "r335", "r351", "r352", "r362", "r368", "r369", "r370", "r371", "r372", "r373", "r378", "r385", "r386", "r388", "r517" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r26", "r100", "r101", "r162", "r164", "r241", "r363", "r364", "r365", "r366", "r367", "r369", "r374", "r375", "r376", "r377", "r379", "r380", "r381", "r382", "r383", "r384", "r681", "r682", "r683", "r684", "r685", "r708", "r748", "r788", "r789", "r790", "r831", "r832" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basis spread on variable rate (as percent)", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.avanos.com/role/DebtMaturitiesofLongTermDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/DebtMaturitiesofLongTermDebtDetails", "http://www.avanos.com/role/DebtSummaryofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total Long-Term Debt, net", "totalLabel": "Total", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r26", "r164", "r389" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Face amount of debt", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r363", "r517", "r518", "r682", "r683", "r708" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails", "http://www.avanos.com/role/DebtSummaryofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r241", "r363", "r364", "r365", "r366", "r367", "r369", "r374", "r375", "r376", "r377", "r379", "r380", "r381", "r382", "r383", "r384", "r387", "r681", "r682", "r683", "r684", "r685", "r708", "r748", "r831", "r832" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r26", "r241", "r363", "r364", "r365", "r366", "r367", "r369", "r374", "r375", "r376", "r377", "r379", "r380", "r381", "r382", "r383", "r384", "r681", "r682", "r683", "r684", "r685", "r708", "r748", "r788", "r789", "r790", "r831", "r832" ] }, "avns_DebtInstrumentPeriodicPaymentAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "DebtInstrumentPeriodicPaymentAxis", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Periodic Payment [Axis]", "label": "Debt Instrument, Periodic Payment [Axis]", "documentation": "Debt Instrument, Periodic Payment" } } }, "auth_ref": [] }, "avns_DebtInstrumentPeriodicPaymentDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "DebtInstrumentPeriodicPaymentDomain", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Periodic Payment [Domain]", "label": "Debt Instrument, Periodic Payment [Domain]", "documentation": "Debt Instrument, Periodic Payment [Domain]" } } }, "auth_ref": [] }, "avns_DebtInstrumentPeriodicPaymentFirstEightQuartersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "DebtInstrumentPeriodicPaymentFirstEightQuartersMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "First Eight Quarters", "label": "Debt Instrument, Periodic Payment, First Eight Quarters [Member]", "documentation": "Debt Instrument, Periodic Payment, First Eight Quarters" } } }, "auth_ref": [] }, "avns_DebtInstrumentPeriodicPaymentPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "DebtInstrumentPeriodicPaymentPercent", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quarterly installment payments (as percent)", "label": "Debt Instrument, Periodic Payment, Percent", "documentation": "Debt Instrument, Periodic Payment, Percent" } } }, "auth_ref": [] }, "avns_DebtInstrumentPeriodicPaymentSubsequentToFirstEightQuartersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "DebtInstrumentPeriodicPaymentSubsequentToFirstEightQuartersMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent To First Eight Quarters", "label": "Debt Instrument, Periodic Payment, Subsequent To First Eight Quarters [Member]", "documentation": "Debt Instrument, Periodic Payment, Subsequent To First Eight Quarters" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTable", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails", "http://www.avanos.com/role/DebtSummaryofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "Disclosure of information about long-term debt instrument or arrangement." } } }, "auth_ref": [ "r26", "r46", "r47", "r77", "r151", "r152", "r241", "r363", "r364", "r365", "r366", "r367", "r369", "r374", "r375", "r376", "r377", "r379", "r380", "r381", "r382", "r383", "r384", "r387", "r681", "r682", "r683", "r684", "r685", "r708", "r748", "r831", "r832" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, term (in years)", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/DebtSummaryofDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Unamortized debt issuance costs", "label": "Debt Instrument, Unamortized Discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r800", "r830", "r831", "r832" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Tax Assets", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r453", "r454" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Tax Liabilities", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r453", "r454", "r542" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation expense", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r15", "r42" ] }, "us-gaap_DepreciationAndAmortizationDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationAndAmortizationDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation and Amortization, Discontinued Operations", "documentation": "Amount of deprecation and amortization expense attributable to property, plant and equipment and intangible assets of discontinued operations." } } }, "auth_ref": [ "r201", "r747" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r15", "r273", "r284", "r293", "r673", "r674" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r584", "r586", "r600", "r601", "r602", "r604", "r605", "r606", "r607", "r609", "r610", "r611", "r612", "r622", "r623", "r624", "r625", "r628", "r629", "r630", "r631", "r643", "r644", "r649", "r651", "r715", "r717", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r68", "r70", "r71", "r160", "r584", "r586", "r600", "r601", "r602", "r604", "r605", "r606", "r607", "r609", "r610", "r611", "r612", "r622", "r623", "r624", "r625", "r628", "r629", "r630", "r631", "r643", "r644", "r649", "r651", "r665", "r715", "r717", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.avanos.com/role/DerivativeFinancialInstruments" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Financial Instruments", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r159", "r479", "r486" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Axis]", "label": "Hedging Relationship [Axis]", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [ "r22", "r68", "r70" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilities", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liability", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r219", "r220", "r492", "r493", "r501", "r508", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r609", "r611", "r612", "r644", "r645", "r646", "r649", "r650", "r651", "r652", "r665", "r814", "r815", "r816", "r877" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLineItems", "presentation": [ "http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Line Items]", "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r486" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, notional amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r808", "r809" ] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeTable", "presentation": [ "http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Table]", "label": "Derivative [Table]", "documentation": "Disclosure of information about derivative instrument or group of derivative instruments, including, but not limited to, type of derivative instrument, risk being hedged, notional amount, hedge designation, related hedged item, inception date, and maturity date." } } }, "auth_ref": [ "r22", "r63", "r64", "r65", "r67", "r69", "r70", "r72", "r73", "r74", "r486" ] }, "us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativesMethodsOfAccountingHedgingDerivatives", "presentation": [ "http://www.avanos.com/role/AccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging and Derivatives", "label": "Derivatives, Methods of Accounting, Hedging Derivatives [Policy Text Block]", "documentation": "Disclosure of accounting policy for derivatives used in hedging relationships, which may include how gains or losses are recognized and presented in the financial statements, and amortization policies for deferred amounts." } } }, "auth_ref": [ "r478", "r811" ] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Designated as hedging instrument", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r22" ] }, "avns_DigestiveHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "DigestiveHealthMember", "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationNetSalesbyProductCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Digestive Health", "label": "Digestive Health [Member]", "documentation": "Digestive Health" } } }, "auth_ref": [] }, "avns_DirosTechnologyIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "DirosTechnologyIncMember", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionIdentifiableIntangibleAssetsDetails", "http://www.avanos.com/role/BusinessAcquisitionNarrativesDetails", "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diros Technology Inc", "label": "Diros Technology Inc [Member]", "documentation": "Diros Technology Inc" } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationNetSalesbyProductCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r406", "r687", "r688", "r689", "r690", "r691", "r692", "r693" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationNetSalesbyProductCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r406", "r687", "r688", "r689", "r690", "r691", "r692", "r693" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Net Sales by Product Category", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r802" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.avanos.com/role/StockBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r415", "r419", "r447", "r448", "r449", "r700" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax", "crdr": "credit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Pretax loss on classification as discontinued operations", "label": "Discontinued Operation, Amount of Adjustment to Prior Period Gain (Loss) on Disposal, before Income Tax", "documentation": "Amount before tax of an increase (decrease) to a gain (loss) previously reported in discontinued operations in a prior period." } } }, "auth_ref": [ "r27", "r83", "r85" ] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "crdr": "credit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "(Loss) Income from discontinued operations before income taxes", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax", "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r80", "r81", "r82", "r83", "r84", "r90", "r128", "r845" ] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails", "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued operations- basic (in dollars per share)", "verboseLabel": "Basic (in dollars per share)", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share", "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation." } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails", "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Discontinued operations- diluted (in dollars per share)", "terseLabel": "Diluted (in dollars per share)", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share", "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation." } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "crdr": "debit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Income tax benefit (provision) from discontinued operations", "label": "Discontinued Operation, Tax Effect of Discontinued Operation", "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r81", "r82", "r83", "r84", "r90", "r95", "r455", "r459", "r460" ] }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]", "label": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposed of by sale", "label": "Discontinued Operations, Held-for-Sale or Disposed of by Sale [Member]", "documentation": "Component or group of components representing strategic shift that has or will have major effect on operation and financial result, classified as held-for-sale or disposed of by sale, and business and nonprofit activity on acquisition and upon joint venture formation, classified as held-for-sale." } } }, "auth_ref": [ "r10", "r11", "r12" ] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Axis]", "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r202" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Domain]", "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses", "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current", "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r79", "r93", "r142", "r144" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "crdr": "debit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of products sold", "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r91", "r203" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "crdr": "credit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross Profit", "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)", "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r91", "r203" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1", "crdr": "debit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Disposal Group, Including Discontinued Operation, Inventory", "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r3", "r79", "r93", "r144" ] }, "avns_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current Portion of Operating Lease Liabilities", "label": "Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Current", "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Current" } } }, "auth_ref": [] }, "avns_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Current Operating Lease Liability", "label": "Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Noncurrent", "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Noncurrent" } } }, "auth_ref": [] }, "avns_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets", "crdr": "debit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease Right-of-Use Assets", "label": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Assets", "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Assets" } } }, "auth_ref": [] }, "avns_DisposalGroupIncludingDiscontinuedOperationOtherExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherExpenseIncome", "crdr": "debit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other (income) expense, net", "label": "Disposal Group, Including Discontinued Operation, Other Expense (Income)", "documentation": "Disposal Group, Including Discontinued Operation, Other Expense (Income)" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment, net", "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment", "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r3", "r79", "r93", "r144" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "crdr": "credit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Sales", "label": "Disposal Group, Including Discontinued Operation, Revenue", "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r91", "r203" ] }, "avns_DisposalGroupIncludingDiscontinuedOperationSellingAndGeneralExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationSellingAndGeneralExpense", "crdr": "debit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling and general expenses", "label": "Disposal Group, Including Discontinued Operation, Selling And General Expense", "documentation": "Disposal Group, Including Discontinued Operation, Selling And General Expense" } } }, "auth_ref": [] }, "avns_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Disposal Group, Including Discontinued Operations, Research And Development Expense", "documentation": "Disposal Group, Including Discontinued Operations, Research And Development Expense" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]", "label": "Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued Operations", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r78", "r141" ] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails", "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Name [Domain]", "label": "Disposal Group Name [Domain]", "documentation": "Name of disposal group." } } }, "auth_ref": [ "r697", "r698" ] }, "avns_DivestitureTermOfTransformationProcess": { "xbrltype": "durationItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "DivestitureTermOfTransformationProcess", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails", "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transformation process term (in years)", "label": "Divestiture, Term Of Transformation Process", "documentation": "Divestiture, Term Of Transformation Process" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus (Q1,Q2,Q3,FY)", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r729" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r730" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "(Loss) Earnings Per Share", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS", "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Basic Earnings (Loss) Per Share (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r234", "r252", "r253", "r254", "r255", "r256", "r257", "r262", "r264", "r266", "r267", "r268", "r272", "r464", "r471", "r489", "r490", "r538", "r556", "r667" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS", "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic Earnings (Loss) Per Share", "netLabel": "Earnings (Loss) Per Share", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS", "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Diluted Earnings (Loss) Per Share (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r234", "r252", "r253", "r254", "r255", "r256", "r257", "r264", "r266", "r267", "r268", "r272", "r464", "r471", "r489", "r490", "r538", "r556", "r667" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS", "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted Earnings (Loss) Per Share", "label": "Earnings Per Share, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.avanos.com/role/EarningsPerShareEPS" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share (\u201cEPS\u201d)", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r261", "r269", "r270", "r271" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of Exchange Rate Changes on Cash and Cash Equivalents", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r510" ] }, "us-gaap_EmployeeSeveranceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeSeveranceMember", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesAccrualandPaymentActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee severance and benefits", "label": "Employee Severance [Member]", "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.avanos.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options", "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "avns_EmployeeStockPurchaseProgramMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "EmployeeStockPurchaseProgramMember", "presentation": [ "http://www.avanos.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee stock purchase plan", "label": "Employee Stock Purchase Program [Member]", "documentation": "Employee Stock Purchase Program" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r727" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r727" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r727" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r731" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r727" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r727" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r727" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r727" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeChangesDuringthePeriodDetails", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r21", "r200", "r229", "r230", "r231", "r247", "r248", "r249", "r251", "r256", "r258", "r260", "r274", "r304", "r305", "r330", "r404", "r457", "r458", "r461", "r462", "r463", "r465", "r470", "r471", "r480", "r481", "r482", "r483", "r484", "r485", "r488", "r511", "r512", "r513", "r514", "r515", "r516", "r519", "r520", "r524", "r553", "r567", "r568", "r569", "r576", "r634" ] }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EstimateOfFairValueFairValueDisclosureMember", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated Fair Value", "label": "Estimate of Fair Value Measurement [Member]", "documentation": "Measured as an estimate of fair value." } } }, "auth_ref": [ "r376", "r508", "r682", "r683" ] }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByBalanceSheetGroupingTable", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]", "label": "Fair Value, by Balance Sheet Grouping [Table]", "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r75", "r76" ] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://www.avanos.com/role/FairValueInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Fair Value of Financial Instruments", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r75" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r376", "r408", "r409", "r410", "r411", "r412", "r413", "r491", "r493", "r494", "r495", "r496", "r500", "r501", "r502", "r525", "r526", "r527", "r682", "r683", "r694", "r695", "r696", "r702", "r704" ] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Basis [Axis]", "label": "Measurement Basis [Axis]", "documentation": "Information by measurement basis." } } }, "auth_ref": [ "r376", "r682", "r683" ] }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosureItemAmountsDomain", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurement [Domain]", "label": "Fair Value Measurement [Domain]", "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value." } } }, "auth_ref": [ "r376", "r682", "r683" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.avanos.com/role/FairValueInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Information", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r497", "r498", "r499", "r500", "r502", "r503", "r504", "r505", "r506", "r534", "r702", "r705" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r376", "r408", "r413", "r493", "r501", "r525", "r694", "r695", "r696", "r702" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r376", "r408", "r413", "r493", "r494", "r501", "r526", "r682", "r683", "r694", "r695", "r696", "r702" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r376", "r408", "r409", "r410", "r411", "r412", "r413", "r493", "r494", "r495", "r496", "r501", "r527", "r682", "r683", "r694", "r695", "r696", "r702", "r704" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r376", "r408", "r409", "r410", "r411", "r412", "r413", "r491", "r493", "r494", "r495", "r496", "r500", "r501", "r502", "r525", "r526", "r527", "r682", "r683", "r694", "r695", "r696", "r702", "r704" ] }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FederalFundsEffectiveSwapRateMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fed funds effective rate overnight index rate swap", "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]", "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg." } } }, "auth_ref": [ "r810" ] }, "avns_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four", "documentation": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accumulated Amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r210", "r311", "r324", "r680" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r326", "r659", "r680" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Remainder of 2024", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year." } } }, "auth_ref": [ "r882" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r326", "r659", "r680" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r326", "r659", "r680" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r326", "r659", "r680" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionIdentifiableIntangibleAssetsDetails", "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r317", "r319", "r320", "r321", "r323", "r324", "r327", "r328", "r532", "r533", "r659" ] }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated Amortization Expense", "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Carrying Amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r311", "r324", "r533", "r680" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r317", "r324", "r327", "r328", "r329", "r532", "r659", "r680" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionIdentifiableIntangibleAssetsDetails", "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r317", "r319", "r320", "r321", "r323", "r324", "r327", "r328", "r659" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationEstimatedAmortizationExpenseDetails", "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Carrying Amount", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r532", "r783" ] }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinitelivedIntangibleAssetsAcquired1", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionIdentifiableIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Identifiable Intangible Asset Amount", "label": "Finite-Lived Intangible Assets Acquired", "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition." } } }, "auth_ref": [ "r319" ] }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ForeignCurrencyTransactionGainLossUnrealized", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized currency translation adjustments", "label": "Unrealized Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r138", "r616", "r723", "r826", "r827", "r879" ] }, "us-gaap_ForeignExchangeForwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ForeignExchangeForwardMember", "presentation": [ "http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange forward", "label": "Foreign Exchange Forward [Member]", "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate." } } }, "auth_ref": [ "r601", "r606", "r611", "r624", "r630", "r647", "r648", "r649", "r717" ] }, "us-gaap_GainLossOnDispositionOfAssets1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnDispositionOfAssets1", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net loss on asset dispositions and impairments", "label": "Gain (Loss) on Disposition of Assets", "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee." } } }, "auth_ref": [ "r747" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.avanos.com/role/SupplementalBalanceSheetInformationGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r209", "r312", "r535", "r674", "r679", "r703", "r709", "r765", "r772" ] }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "presentation": [ "http://www.avanos.com/role/AccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets." } } }, "auth_ref": [ "r763", "r775" ] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationGoodwillDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Currency translation adjustment", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) asset representing future economic benefit from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r315" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill impairment", "label": "Goodwill, Impairment Loss", "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r15", "r313", "r314", "r316", "r679", "r703" ] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillRollForward", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS" ], "lang": { "en-us": { "role": { "totalLabel": "Gross Profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r125", "r131", "r172", "r240", "r303", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r509", "r669", "r673", "r756", "r758", "r759", "r760", "r761", "r797" ] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r22", "r477" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r22" ] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.avanos.com/role/DerivativeFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Domain]", "label": "Hedging Relationship [Domain]", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [ "r22" ] }, "us-gaap_IncomeLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperations", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS", "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income (Loss) from Continuing Operations", "verboseLabel": "Net income (loss) from continuing operations", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent." } } }, "auth_ref": [ "r62", "r127", "r138", "r252", "r253", "r254", "r255", "r256", "r265", "r268", "r471" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS" ], "lang": { "en-us": { "role": { "totalLabel": "Income (Loss) Before Income Taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r126", "r167", "r172", "r539", "r551", "r669", "r673", "r756", "r758", "r759", "r760", "r761" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS", "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Continuing operations- basic (in dollars per share)", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r127", "r168", "r234", "r250", "r252", "r253", "r254", "r255", "r256", "r264", "r266", "r267", "r464", "r471", "r490", "r538", "r846" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS", "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Continuing operations- diluted (in dollars per share)", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r127", "r234", "r250", "r252", "r253", "r254", "r255", "r256", "r264", "r266", "r267", "r268", "r471", "r490", "r538", "r846" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 }, "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails", "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "(Loss) Income from discontinued operations, net of tax", "totalLabel": "Net (Loss) Income from discontinued operations, net of tax", "netLabel": "Net (loss) income from discontinued operations", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r80", "r81", "r82", "r83", "r84", "r90", "r95", "r158" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails", "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Name [Axis]", "label": "Disposal Group Name [Axis]", "documentation": "Information by name of disposal group." } } }, "auth_ref": [ "r697", "r698" ] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]", "label": "Disposal Groups, Including Discontinued Operations [Table]", "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r18", "r24", "r28", "r79", "r85", "r86", "r87", "r88", "r89", "r94", "r96", "r97", "r145" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Income tax provision", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r175", "r180", "r259", "r260", "r273", "r285", "r293", "r455", "r456", "r459", "r557", "r701" ] }, "us-gaap_IncomeTaxReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxReceivable", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails": { "parentTag": "us-gaap_ReceivablesNetCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax receivable", "label": "Income Taxes Receivable", "documentation": "Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable." } } }, "auth_ref": [ "r734" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayableTrade", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable, Trade", "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses", "label": "Increase (Decrease) in Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities, net of acquisition:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Prepaid expenses and other assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other Intangible Assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r317", "r783", "r785" ] }, "us-gaap_InterestExpenseNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseNonoperating", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest Expense, Nonoperating", "documentation": "Amount of interest expense classified as nonoperating." } } }, "auth_ref": [ "r283", "r745" ] }, "avns_InterventionalPainMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "InterventionalPainMember", "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationNetSalesbyProductCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interventional pain", "label": "Interventional pain [Member]", "documentation": "Interventional pain" } } }, "auth_ref": [] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryFinishedGoods", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationInventoriesDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods", "label": "Inventory, Finished Goods, Gross", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r735" ] }, "us-gaap_InventoryGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryGross", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationInventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total Inventory", "label": "Inventory, Gross", "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r739" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r217", "r662", "r709" ] }, "us-gaap_InventoryNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNetAbstract", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory, Net", "label": "Inventory, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryRawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryRawMaterials", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationInventoriesDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Raw materials", "label": "Inventory, Raw Materials, Gross", "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r737" ] }, "us-gaap_InventoryWorkInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryWorkInProcess", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationInventoriesDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Work in process", "label": "Inventory, Work in Process, Gross", "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r736" ] }, "us-gaap_InventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryWriteDown", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory obsolescence", "label": "Inventory Write-down", "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels." } } }, "auth_ref": [ "r310" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r273", "r282", "r293", "r673", "r744" ] }, "us-gaap_LandMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LandMember", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Land", "label": "Land [Member]", "documentation": "Part of earth's surface not covered by water." } } }, "auth_ref": [ "r803" ] }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LegalMattersAndContingenciesTextBlock", "presentation": [ "http://www.avanos.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Legal Matters and Contingencies [Text Block]", "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies." } } }, "auth_ref": [ "r148" ] }, "us-gaap_LetterOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LetterOfCreditMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letter of Credit", "label": "Letter of Credit [Member]", "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)." } } }, "auth_ref": [] }, "us-gaap_LettersOfCreditOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LettersOfCreditOutstandingAmount", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letters of credit outstanding", "label": "Letters of Credit Outstanding, Amount", "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r26", "r100", "r101", "r102", "r104", "r105", "r106", "r107", "r240", "r303", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r473", "r475", "r476", "r509", "r593", "r668", "r725", "r797", "r833", "r834" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r115", "r166", "r548", "r709", "r749", "r762", "r825" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r102", "r205", "r240", "r303", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r473", "r475", "r476", "r509", "r709", "r797", "r833", "r834" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current Liabilities", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesFairValueDisclosureAbstract", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "Liabilities, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "avns_LiabilitiesForEstimatedRebatesAndIncentivesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "LiabilitiesForEstimatedRebatesAndIncentivesNet", "crdr": "credit", "calculation": { "http://www.avanos.com/role/BusinessandProductsInformationAccruedLiabilitiesDetails_1": { "parentTag": "avns_AccruedRebatesAndIncentives", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total estimated liabilities", "label": "Liabilities For Estimated Rebates And Incentives, Net", "documentation": "Liabilities For Estimated Rebates And Incentives, Net" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "crdr": "credit", "calculation": { "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities held for sale - discontinued operations", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r3", "r79", "r93", "r144", "r202", "r203" ] }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities held for sale", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r79", "r93", "r142", "r144", "r202", "r203" ] }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityCommitmentFeePercentage", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit facility, commitment fee percentage", "label": "Line of Credit Facility, Commitment Fee Percentage", "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective interest rate (as percent)", "label": "Line of Credit Facility, Interest Rate at Period End", "documentation": "The effective interest rate at the end of the reporting period." } } }, "auth_ref": [ "r99", "r103" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r99", "r103" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.avanos.com/role/DebtSummaryofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Debt", "verboseLabel": "Total Long-Term Debt, net", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r26", "r164", "r375", "r390", "r682", "r683", "r708", "r842" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.avanos.com/role/DebtNarrativesDetails", "http://www.avanos.com/role/DebtSummaryofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt", "negatedTerseLabel": "Current portion of long-term debt", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r213" ] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Long-term debt, fair value", "label": "Long-Term Debt, Fair Value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [ "r813", "r814", "r815", "r816" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.avanos.com/role/DebtMaturitiesofLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/DebtMaturitiesofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Long-Term Debt, Maturity, Year One", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r17", "r241", "r380" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://www.avanos.com/role/DebtMaturitiesofLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.avanos.com/role/DebtMaturitiesofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Long-Term Debt, Maturity, Year Four", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r17", "r241", "r380" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://www.avanos.com/role/DebtMaturitiesofLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/DebtMaturitiesofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Long-Term Debt, Maturity, Year Three", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r17", "r241", "r380" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://www.avanos.com/role/DebtMaturitiesofLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/DebtMaturitiesofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Long-Term Debt, Maturity, Year Two", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r17", "r241", "r380" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.avanos.com/role/DebtMaturitiesofLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/DebtMaturitiesofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remainder of 2024", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year." } } }, "auth_ref": [ "r750" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails", "http://www.avanos.com/role/DebtSummaryofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r26", "r788", "r789", "r790" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails", "http://www.avanos.com/role/DebtSummaryofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r26", "r45", "r788", "r789", "r790" ] }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtWeightedAverageInterestRate", "presentation": [ "http://www.avanos.com/role/DebtSummaryofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Interest Rate", "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time", "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time." } } }, "auth_ref": [] }, "us-gaap_LossContingencyAccrualPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyAccrualPayments", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss contingency accrual, payments", "label": "Loss Contingency Accrual, Payments", "documentation": "Amount of cash outflow reducing loss contingency liability." } } }, "auth_ref": [ "r792" ] }, "us-gaap_MachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MachineryAndEquipmentMember", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Machinery and equipment", "label": "Machinery and Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment." } } }, "auth_ref": [] }, "avns_ManufacturingAndSupplyChainImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "ManufacturingAndSupplyChainImprovementsMember", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Manufacturing and Supply Chain Improvements", "label": "Manufacturing And Supply Chain Improvements [Member]", "documentation": "Manufacturing And Supply Chain Improvements" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails", "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails", "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r186", "r187", "r188", "r189", "r190", "r198", "r199", "r347", "r348", "r349", "r350", "r414", "r451", "r496", "r530", "r565", "r566", "r573", "r585", "r586", "r639", "r640", "r641", "r642", "r653", "r657", "r658", "r678", "r686", "r699", "r704", "r705", "r706", "r707", "r711", "r799", "r835", "r836", "r837", "r838", "r839", "r840" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails", "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails", "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r186", "r187", "r188", "r189", "r190", "r198", "r199", "r347", "r348", "r349", "r350", "r414", "r451", "r496", "r530", "r565", "r566", "r573", "r585", "r586", "r639", "r640", "r641", "r642", "r653", "r657", "r658", "r678", "r686", "r699", "r704", "r705", "r706", "r711", "r799", "r835", "r836", "r837", "r838", "r839", "r840" ] }, "avns_MultiYearRestructuringPlanInitialPhaseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "MultiYearRestructuringPlanInitialPhaseMember", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesAccrualandPaymentActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Multi-year restructuring plan, initial phase", "label": "Multi-Year Restructuring Plan, Initial Phase [Member]", "documentation": "Multi-Year Restructuring Plan, Initial Phase [Member]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "totalLabel": "Cash (Used in) Provided by Financing Activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r236" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Financing Activities", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "totalLabel": "Cash Used in Investing Activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r236" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Investing Activities", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "totalLabel": "Cash Provided by Operating Activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r136", "r137", "r138" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Activities", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 }, "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Income (Loss)", "verboseLabel": "Net Income (Loss)", "terseLabel": "Net income (loss)", "netLabel": "Net income (loss)", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r132", "r138", "r169", "r203", "r224", "r227", "r231", "r240", "r250", "r252", "r253", "r254", "r255", "r256", "r259", "r260", "r265", "r303", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r464", "r471", "r490", "r509", "r552", "r617", "r632", "r633", "r723", "r797" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.avanos.com/role/AccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.avanos.com/role/AccountingPoliciesNarrativesDetails", "http://www.avanos.com/role/BusinessandProductsInformationNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r674", "r757" ] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r670", "r677", "r757" ] }, "us-gaap_NumberOfReportingUnits": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfReportingUnits", "presentation": [ "http://www.avanos.com/role/AccountingPoliciesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reporting units", "label": "Number of Reporting Units", "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment." } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS" ], "lang": { "en-us": { "role": { "totalLabel": "Operating Income (Loss)", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r172", "r669", "r756", "r758", "r759", "r760", "r761" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of operating lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r522" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease Liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r522" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease Right-of-Use Assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r521" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "avns_OrganizationalDesignAlignmentAndOtherRelatedActivitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "OrganizationalDesignAlignmentAndOtherRelatedActivitiesMember", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Organizational Design Alignment and Other Related Activities", "label": "Organizational Design Alignment And Other Related Activities [Member]", "documentation": "Organizational Design Alignment And Other Related Activities" } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r101" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other Assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r211" ] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent", "crdr": "debit", "calculation": { "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeNetChangesinComponentsofAOCIIncludingTaxEffectDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeNetChangesinComponentsofAOCIIncludingTaxEffectDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Defined benefit pension plans", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent", "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive (income) loss for defined benefit plan, attributable to parent entity." } } }, "auth_ref": [ "r13", "r20", "r158" ] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 1.0 }, "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeNetChangesinComponentsofAOCIIncludingTaxEffectDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeNetChangesinComponentsofAOCIIncludingTaxEffectDetails", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Defined benefit plans", "negatedTotalLabel": "Defined benefit pension plans, net of tax", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent." } } }, "auth_ref": [ "r6", "r7", "r20", "r123", "r124", "r158" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeNetChangesinComponentsofAOCIIncludingTaxEffectDetails", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized currency translation adjustments", "verboseLabel": "Unrealized currency translation", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r13", "r20", "r158" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 3.0 }, "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeNetChangesinComponentsofAOCIIncludingTaxEffectDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeNetChangesinComponentsofAOCIIncludingTaxEffectDetails", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flow hedges", "totalLabel": "Cash flow hedges, net of tax", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent", "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r221" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeNetChangesinComponentsofAOCIIncludingTaxEffectDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeNetChangesinComponentsofAOCIIncludingTaxEffectDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flow hedges", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent", "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r221" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent", "crdr": "debit", "calculation": { "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeNetChangesinComponentsofAOCIIncludingTaxEffectDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeNetChangesinComponentsofAOCIIncludingTaxEffectDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Tax effect", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent", "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r222" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeChangesDuringthePeriodDetails", "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeNetChangesinComponentsofAOCIIncludingTaxEffectDetails", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Total Other Comprehensive Income (Loss), Net of Tax", "netLabel": "Other comprehensive income (loss), net of tax", "verboseLabel": "Other comprehensive loss", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r13", "r20", "r158", "r225", "r228", "r256" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Other Comprehensive Income (Loss), Net of Tax", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Intangible Assets [Member]", "documentation": "Intangible assets classified as other." } } }, "auth_ref": [ "r680", "r776", "r777", "r778", "r779", "r780", "r781", "r783", "r785", "r786", "r787" ] }, "us-gaap_OtherInventorySupplies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherInventorySupplies", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationInventoriesDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplies and other", "label": "Other Inventory, Supplies, Gross", "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r738" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 }, "http://www.avanos.com/role/SupplementalBalanceSheetInformationOtherLongTermLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.avanos.com/role/SupplementalBalanceSheetInformationOtherLongTermLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Long-Term Liabilities", "totalLabel": "Total", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r105" ] }, "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNoncurrentLiabilitiesTableTextBlock", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Summary of Other Long-Term Liabilities", "label": "Other Noncurrent Liabilities [Table Text Block]", "documentation": "Tabular disclosure of other noncurrent liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherOperatingActivitiesCashFlowStatement", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes and other", "label": "Other Operating Activities, Cash Flow Statement", "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities)." } } }, "auth_ref": [] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other (income) expense, net", "label": "Other Operating Income (Expense), Net", "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "us-gaap_OtherSundryLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherSundryLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationOtherLongTermLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationOtherLongTermLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Sundry Liabilities, Noncurrent", "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date." } } }, "auth_ref": [ "r105", "r163" ] }, "avns_PainManagementAndRecoveryMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "PainManagementAndRecoveryMember", "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationNetSalesbyProductCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total Pain Management and Recovery", "label": "Pain Management And Recovery [Member]", "documentation": "Pain Management And Recovery" } } }, "auth_ref": [] }, "us-gaap_PatentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PatentsMember", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Patents and acquired technologies", "label": "Patents [Member]", "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law." } } }, "auth_ref": [ "r156", "r776", "r777", "r778", "r779", "r781", "r783", "r786", "r787" ] }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payment of contingent consideration liabilities", "label": "Payment for Contingent Consideration Liability, Financing Activities", "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date." } } }, "auth_ref": [ "r9" ] }, "avns_PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment of contingent consideration liabilities", "label": "Payment for Contingent Consideration Liability, Operating and Financing Activities", "documentation": "Payment for Contingent Consideration Liability, Operating and Financing Activities" } } }, "auth_ref": [] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchases of treasury stock", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r134" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesAccrualandPaymentActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments and adjustments, net", "label": "Payments for Restructuring", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r339", "r746" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments to acquire businesses, gross", "label": "Payments to Acquire Businesses, Gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r35", "r468" ] }, "us-gaap_PaymentsToAcquireNotesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireNotesReceivable", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Investment in Note Receivable", "label": "Payments to Acquire Notes Receivable", "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics." } } }, "auth_ref": [ "r34" ] }, "us-gaap_PaymentsToAcquireProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireProductiveAssets", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Capital expenditures", "label": "Payments to Acquire Productive Assets", "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r174", "r805", "r806", "r807" ] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PerformanceSharesMember", "presentation": [ "http://www.avanos.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance-based restricted share units", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Portion at Fair Value Measurement", "label": "Portion at Fair Value Measurement [Member]", "documentation": "Measured at fair value for financial reporting purposes." } } }, "auth_ref": [ "r507" ] }, "avns_PostDivestitureRestructuringPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "PostDivestitureRestructuringPlanMember", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Post-RH Divestiture Restructuring Plan", "label": "Post-Divestiture Restructuring Plan [Member]", "documentation": "Post-Divestiture Restructuring Plan" } } }, "auth_ref": [] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r108", "r392" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r108", "r595" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r108", "r392" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock - $0.01 par value - authorized 20,000,000 shares, none issued", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r108", "r544", "r709" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r740" ] }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromDivestitureOfBusinesses", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS", "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Proceeds from RH Divestiture post-closing settlement", "terseLabel": "Proceeds from divestiture of businesses", "label": "Proceeds from Divestiture of Businesses", "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period." } } }, "auth_ref": [ "r33" ] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS", "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving credit facility proceeds", "label": "Proceeds from Lines of Credit", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r36", "r748" ] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from the exercise of stock options", "label": "Proceeds from Stock Options Exercised", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r8", "r23" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationNetSalesbyProductCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r296", "r531", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r660", "r687", "r710", "r711", "r712", "r713", "r714", "r732", "r793", "r794", "r802", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationNetSalesbyProductCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r296", "r531", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r660", "r687", "r710", "r711", "r712", "r713", "r714", "r732", "r793", "r794", "r802", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875" ] }, "avns_ProgramManagementConsultingAndEmployeeRetentionExpensesAndEmployeeSeveranceAndBenefitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "ProgramManagementConsultingAndEmployeeRetentionExpensesAndEmployeeSeveranceAndBenefitsMember", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Program Management Consulting and Employee Retention Expenses And Employee Severance and Benefits", "label": "Program Management Consulting And Employee Retention Expenses And Employee Severance And Benefits [Member]", "documentation": "Program Management Consulting And Employee Retention Expenses And Employee Severance And Benefits" } } }, "auth_ref": [] }, "avns_ProgramManagementConsultingAndEmployeeRetentionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "ProgramManagementConsultingAndEmployeeRetentionMember", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Program Management Consulting and Employee Retention", "label": "Program Management Consulting And Employee Retention [Member]", "documentation": "Program Management Consulting And Employee Retention" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment, Type [Axis]", "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r16", "r523" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, gross", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r143", "r207", "r550" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Line Items]", "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r523" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 }, "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment, net", "totalLabel": "Total", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r16", "r523", "r540", "r550", "r709" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Property, Plant and Equipment", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r16" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment, Type [Domain]", "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r143", "r523" ] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Provision (reversal) for doubtful accounts", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r235", "r308" ] }, "avns_RHBusinessMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "RHBusinessMember", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofBalanceSheetDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails", "http://www.avanos.com/role/DiscontinuedOperationsScheduleofIncomeDetails", "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "RH Business", "label": "RH Business [Member]", "documentation": "RH Business" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails", "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails", "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r186", "r187", "r188", "r189", "r190", "r198", "r199", "r347", "r348", "r349", "r350", "r407", "r414", "r442", "r443", "r444", "r451", "r496", "r528", "r529", "r530", "r565", "r566", "r573", "r585", "r586", "r639", "r640", "r641", "r642", "r653", "r657", "r658", "r678", "r686", "r699", "r704", "r705", "r706", "r707", "r711", "r717", "r791", "r799", "r815", "r836", "r837", "r838", "r839", "r840" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails", "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails", "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r186", "r187", "r188", "r189", "r190", "r198", "r199", "r347", "r348", "r349", "r350", "r407", "r414", "r442", "r443", "r444", "r451", "r496", "r528", "r529", "r530", "r565", "r566", "r573", "r585", "r586", "r639", "r640", "r641", "r642", "r653", "r657", "r658", "r678", "r686", "r699", "r704", "r705", "r706", "r707", "r711", "r717", "r791", "r799", "r815", "r836", "r837", "r838", "r839", "r840" ] }, "us-gaap_ReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Accounts receivable, net", "label": "Receivables, Net, Current", "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value." } } }, "auth_ref": [ "r709" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract", "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeChangesDuringthePeriodDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income", "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfLinesOfCredit", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS", "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Revolving credit facility repayments", "terseLabel": "Repayment of credit facility", "label": "Repayments of Lines of Credit", "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r135", "r748" ] }, "us-gaap_RepaymentsOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfSecuredDebt", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Secured debt repayments", "label": "Repayments of Secured Debt", "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt." } } }, "auth_ref": [ "r135" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS" ], "lang": { "en-us": { "role": { "verboseLabel": "Research and development", "label": "Research and Development Expense", "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity." } } }, "auth_ref": [ "r452", "r659", "r673", "r841" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.avanos.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Time-based restricted share units", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Activities [Abstract]", "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.avanos.com/role/RestructuringActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Activities", "label": "Restructuring and Related Activities Disclosure [Text Block]", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r336", "r337", "r339", "r342", "r346" ] }, "us-gaap_RestructuringAndRelatedCostExpectedCost1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringAndRelatedCostExpectedCost1", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Costs expected to incur", "label": "Restructuring and Related Cost, Expected Cost", "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost." } } }, "auth_ref": [ "r338", "r341", "r343", "r345" ] }, "us-gaap_RestructuringAndRelatedCostIncurredCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringAndRelatedCostIncurredCost", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Costs incurred", "label": "Restructuring and Related Cost, Incurred Cost", "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost." } } }, "auth_ref": [ "r338", "r341", "r343", "r345" ] }, "avns_RestructuringChargesAndAccrualAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "RestructuringChargesAndAccrualAdjustment", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesAccrualandPaymentActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and transformation costs, excluding non-cash charges", "label": "Restructuring Charges And Accrual Adjustment", "documentation": "Restructuring Charges And Accrual Adjustment" } } }, "auth_ref": [] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesAccrualandPaymentActivityDetails", "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Type [Axis]", "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r338", "r339", "r343", "r344" ] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesAccrualandPaymentActivityDetails", "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Cost and Reserve [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r338", "r339", "r340", "r341", "r343", "r344", "r345" ] }, "us-gaap_RestructuringPlanAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringPlanAxis", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesAccrualandPaymentActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Plan [Axis]", "label": "Restructuring Plan [Axis]", "documentation": "Information by individual restructuring plan." } } }, "auth_ref": [] }, "us-gaap_RestructuringPlanDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringPlanDomain", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesAccrualandPaymentActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Plan [Domain]", "label": "Restructuring Plan [Domain]", "documentation": "Identification of the individual restructuring plans." } } }, "auth_ref": [] }, "avns_RestructuringPlanTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "RestructuringPlanTerm", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term of restructuring initiative (in years)", "label": "Restructuring Plan, Term", "documentation": "Restructuring Plan, Term" } } }, "auth_ref": [] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesAccrualandPaymentActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r339", "r344" ] }, "us-gaap_RestructuringReserveRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringReserveRollForward", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesAccrualandPaymentActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Reserve [Roll Forward]", "label": "Restructuring Reserve [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r112", "r153", "r547", "r570", "r572", "r575", "r596", "r709" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r200", "r247", "r248", "r249", "r251", "r256", "r258", "r260", "r304", "r305", "r330", "r457", "r458", "r461", "r462", "r463", "r465", "r470", "r471", "r480", "r482", "r483", "r485", "r488", "r519", "r520", "r567", "r569", "r576", "r880" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionNarrativesDetails", "http://www.avanos.com/role/BusinessandProductsInformationNetSalesbyProductCategoryDetails", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Net Sales", "netLabel": "Total Net Sales", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r170", "r171", "r273", "r280", "r281", "r289", "r293", "r296", "r298", "r299", "r405", "r406", "r531" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails", "http://www.avanos.com/role/DebtSummaryofDebtDetails", "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Accounts Receivable", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r110", "r116" ] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationTables", "http://www.avanos.com/role/SupplementalBalanceSheetInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Accrued Expenses", "label": "Schedule of Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Changes in the Components of Accumulated Other Comprehensive Income", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r31", "r828", "r829" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionIdentifiableIntangibleAssetsDetails", "http://www.avanos.com/role/BusinessAcquisitionNarrativesDetails", "http://www.avanos.com/role/BusinessAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability." } } }, "auth_ref": [ "r56", "r57", "r466" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.avanos.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Debt Balances", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Financial Results of Discontinued Operations", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r18", "r24", "r28", "r79", "r85", "r86", "r87", "r88", "r89", "r94", "r96", "r97", "r145" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.avanos.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Stock-Based Compensation Expense", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r52" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]", "label": "Intangible Asset, Finite-Lived [Table]", "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset." } } }, "auth_ref": [ "r317", "r324", "r327", "r328", "r329", "r532", "r659", "r680" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Intangible Assets Subject to Amortization", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r680", "r782" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Changes in the Carrying Amount of Goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r679", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Inventories", "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r29", "r117", "r118", "r119" ] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://www.avanos.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Maturities of Long-Term Debt", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r17" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Table]", "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r16", "r523" ] }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Purchase Price Allocation", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree." } } }, "auth_ref": [ "r155" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesAccrualandPaymentActivityDetails", "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Restructuring Cost [Table]", "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve." } } }, "auth_ref": [ "r338", "r339", "r340", "r341", "r343", "r344", "r345" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Accrual and Payment Activity", "label": "Restructuring and Related Costs [Table Text Block]", "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets." } } }, "auth_ref": [ "r44", "r146", "r147" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.avanos.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r416", "r418", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445" ] }, "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfTreasuryStockByClassTextBlock", "presentation": [ "http://www.avanos.com/role/ShareRepurchaseProgramTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Class of Treasury Stock", "label": "Class of Treasury Stock [Table Text Block]", "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock." } } }, "auth_ref": [ "r48", "r49", "r50", "r51" ] }, "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "presentation": [ "http://www.avanos.com/role/EarningsPerShareEPSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Calculation of Basic and Diluted Earnings Per Share", "label": "Schedule of Weighted Average Number of Shares [Table Text Block]", "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Estimated Amortization Expense", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r680", "r784" ] }, "us-gaap_SecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecuredDebtMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Secured Term Loan", "label": "Secured Debt [Member]", "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets." } } }, "auth_ref": [] }, "us-gaap_SecuredOvernightFinancingRateSofrMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecuredOvernightFinancingRateSofrMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Secured overnight financing rate (SOFR)", "label": "Secured Overnight Financing Rate (SOFR) [Member]", "documentation": "Interest rate at which bank can borrow U.S. dollar overnight while posting U.S. Treasury bond as collateral." } } }, "auth_ref": [ "r810" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r726" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r728" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Business and Products Information", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r173", "r273", "r275", "r276", "r277", "r278", "r279", "r286", "r287", "r288", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r299", "r670", "r671", "r672", "r673", "r675", "r676", "r677" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDINCOMESTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Selling and general expenses", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r133" ] }, "avns_SeniorSecuredRevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "SeniorSecuredRevolvingCreditFacilityMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Secured Revolving Credit Facility", "label": "Senior Secured Revolving Credit Facility [Member]", "documentation": "Senior Secured Revolving Credit Facility" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDCASHFLOWSTATEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r14" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.avanos.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r416", "r418", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.avanos.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445" ] }, "avns_ShareBasedCompensationExpenseDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "ShareBasedCompensationExpenseDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsScheduleofCashflowDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "Share-Based Compensation Expense, Discontinued Operations", "documentation": "Share-Based Compensation Expense, Discontinued Operations" } } }, "auth_ref": [] }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "presentation": [ "http://www.avanos.com/role/ShareRepurchaseProgramNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares withheld for tax withholding obligation (in shares)", "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeChangesDuringthePeriodDetails", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r21", "r109", "r113", "r114", "r200", "r229", "r230", "r231", "r247", "r248", "r249", "r251", "r256", "r258", "r260", "r274", "r304", "r305", "r330", "r404", "r457", "r458", "r461", "r462", "r463", "r465", "r470", "r471", "r480", "r481", "r482", "r483", "r484", "r485", "r488", "r511", "r512", "r513", "r514", "r515", "r516", "r519", "r520", "r524", "r553", "r567", "r568", "r569", "r576", "r634" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r247", "r248", "r249", "r274", "r520", "r531", "r574", "r577", "r587", "r588", "r589", "r590", "r591", "r592", "r595", "r598", "r599", "r600", "r601", "r602", "r604", "r605", "r606", "r607", "r609", "r610", "r611", "r612", "r613", "r615", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r634", "r718" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r247", "r248", "r249", "r274", "r300", "r520", "r531", "r574", "r577", "r587", "r588", "r589", "r590", "r591", "r592", "r595", "r598", "r599", "r600", "r601", "r602", "r604", "r605", "r606", "r607", "r609", "r610", "r611", "r612", "r613", "r615", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r634", "r718" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise or redemption of share-based awards", "label": "Stock Issued During Period, Value, Stock Options Exercised", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r21", "r109", "r113", "r114", "r153" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/ShareRepurchaseProgramNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock issued, value, stock options exercised, net of tax benefit (expense)", "label": "Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense)", "documentation": "Value of stock issued as a result of the exercise of stock options, after deduction of related income tax (expense) benefit." } } }, "auth_ref": [] }, "srt_StockRepurchaseProgramAuthorizedAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "StockRepurchaseProgramAuthorizedAmount1", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/ShareRepurchaseProgramNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock repurchase program, authorized amount", "label": "Share Repurchase Program, Authorized, Amount", "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership." } } }, "auth_ref": [ "r801" ] }, "us-gaap_StockRepurchaseProgramPeriodInForce1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRepurchaseProgramPeriodInForce1", "presentation": [ "http://www.avanos.com/role/ShareRepurchaseProgramNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repurchase program period (in years)", "label": "Share Repurchase Program, Period in Force", "documentation": "Period share may be purchased under authorized share repurchase plan, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, repurchase of stock and unit of ownership." } } }, "auth_ref": [] }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "crdr": "credit", "presentation": [ "http://www.avanos.com/role/ShareRepurchaseProgramSummaryofTreasuryStockDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Amount Remaining in Program for Purchase (in millions)", "label": "Share Repurchase Program, Remaining Authorized, Amount", "documentation": "Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership." } } }, "auth_ref": [] }, "us-gaap_StockRepurchasedDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRepurchasedDuringPeriodValue", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/ShareRepurchaseProgramNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Value of common stock repurchased", "label": "Stock Repurchased During Period, Value", "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r21", "r108", "r109", "r153", "r576", "r634", "r654", "r724" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/AccumulatedOtherComprehensiveIncomeChangesDuringthePeriodDetails", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Total Stockholders\u2019 Equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r109", "r113", "r114", "r140", "r597", "r614", "r635", "r636", "r709", "r725", "r749", "r762", "r825", "r880" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders\u2019 Equity", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.avanos.com/role/ShareRepurchaseProgram" ], "lang": { "en-us": { "role": { "terseLabel": "Share Repurchase Program", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r150", "r239", "r391", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r487", "r637", "r638", "r655" ] }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental Balance Sheet Information", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity." } } }, "auth_ref": [ "r733" ] }, "avns_SurgicalPainAndRecoveryMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "SurgicalPainAndRecoveryMember", "presentation": [ "http://www.avanos.com/role/BusinessandProductsInformationNetSalesbyProductCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Surgical pain and recovery", "label": "Surgical Pain And Recovery [Member]", "documentation": "Surgical Pain And Recovery" } } }, "auth_ref": [] }, "us-gaap_TaxesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TaxesPayableCurrent", "crdr": "credit", "calculation": { "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued taxes and other", "label": "Taxes Payable, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r100", "r101" ] }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TechnologyBasedIntangibleAssetsMember", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionIdentifiableIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Developed technology and other", "label": "Technology-Based Intangible Assets [Member]", "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights." } } }, "auth_ref": [ "r25", "r776", "r777", "r778", "r779", "r781", "r783", "r786", "r787" ] }, "avns_TermLoanFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "TermLoanFacilitiesMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan Facilities", "label": "Term Loan Facilities [Member]", "documentation": "Term Loan Facilities" } } }, "auth_ref": [] }, "avns_TermLoanFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "TermLoanFacilityMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails", "http://www.avanos.com/role/DebtSummaryofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan Facility", "label": "Term Loan Facility [Member]", "documentation": "Term Loan Facility [Member]" } } }, "auth_ref": [] }, "avns_TermLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "TermLoansMember", "presentation": [ "http://www.avanos.com/role/FairValueInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan Facility", "label": "Term Loans [Member]", "documentation": "Term Loans" } } }, "auth_ref": [] }, "us-gaap_TrademarksAndTradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TrademarksAndTradeNamesMember", "presentation": [ "http://www.avanos.com/role/BusinessAcquisitionIdentifiableIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade names and trademarks", "label": "Trademarks and Trade Names [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r59", "r776", "r777", "r778", "r779", "r780", "r781", "r783", "r785", "r786", "r787" ] }, "us-gaap_TrademarksMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TrademarksMember", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trademarks", "label": "Trademarks [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style." } } }, "auth_ref": [ "r59", "r680", "r776", "r777", "r778", "r779", "r780", "r781", "r783", "r785", "r786", "r787" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.avanos.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "avns_TransformationProcessMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "TransformationProcessMember", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transformation Process", "label": "Transformation Process [Member]", "documentation": "Transformation Process" } } }, "auth_ref": [] }, "avns_TransitionServicesAgreementTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "TransitionServicesAgreementTerm", "presentation": [ "http://www.avanos.com/role/DiscontinuedOperationsNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transition services agreement, term (in years)", "label": "Transition Services Agreement, Term", "documentation": "Transition Services Agreement, Term" } } }, "auth_ref": [] }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockAcquiredAverageCostPerShare", "presentation": [ "http://www.avanos.com/role/ShareRepurchaseProgramSummaryofTreasuryStockDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Average Price Per Share (in dollars per share)", "label": "Shares Acquired, Average Cost Per Share", "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased." } } }, "auth_ref": [ "r48" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Stock", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r48" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.avanos.com/role/ShareRepurchaseProgramSummaryofTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares repurchased, program to date (in shares)", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r48" ] }, "us-gaap_TreasuryStockCommonValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockCommonValue", "crdr": "debit", "calculation": { "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Treasury stock", "label": "Treasury Stock, Common, Value", "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r48", "r51", "r113" ] }, "us-gaap_TreasuryStockSharesAcquired": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockSharesAcquired", "presentation": [ "http://www.avanos.com/role/ShareRepurchaseProgramSummaryofTreasuryStockDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Shares Repurchased (in shares)", "label": "Treasury Stock, Shares, Acquired", "documentation": "Number of shares that have been repurchased during the period and are being held in treasury." } } }, "auth_ref": [ "r21", "r109", "r153" ] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "presentation": [ "http://www.avanos.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.avanos.com/role/ShareRepurchaseProgramSummaryofTreasuryStockDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchases of treasury stock", "terseLabel": "Aggregate Purchase Price (in millions)", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r21", "r48", "r153" ] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.avanos.com/role/RestructuringActivitiesAccrualandPaymentActivityDetails", "http://www.avanos.com/role/RestructuringActivitiesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of Restructuring [Domain]", "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r338", "r339", "r343", "r344" ] }, "us-gaap_UnsecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnsecuredDebtMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails", "http://www.avanos.com/role/DebtSummaryofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unsecured debt", "label": "Unsecured Debt [Member]", "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets." } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://www.avanos.com/role/AccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r39", "r40", "r41", "r176", "r177", "r178", "r179" ] }, "us-gaap_ValuationAllowancesAndReservesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ValuationAllowancesAndReservesDomain", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "documentation": "Valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r242", "r243", "r244", "r245", "r246" ] }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ValuationAllowancesAndReservesTypeAxis", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "documentation": "Information by valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r242", "r243", "r244", "r245", "r246" ] }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r181", "r182", "r183", "r184", "r185", "r242", "r243", "r244", "r245", "r246" ] }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ValuationAndQualifyingAccountsDisclosureTable", "presentation": [ "http://www.avanos.com/role/SupplementalBalanceSheetInformationAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "documentation": "Disclosure of information about valuation allowance and qualifying account and reserve." } } }, "auth_ref": [ "r181", "r182", "r183", "r184", "r185", "r242", "r243", "r244", "r245", "r246" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VariableRateAxis", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Axis]", "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "avns_VariableRateComponentAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "VariableRateComponentAxis", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate Component [Axis]", "label": "Variable Rate Component [Axis]", "documentation": "Variable Rate Component" } } }, "auth_ref": [] }, "avns_VariableRateComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "VariableRateComponentDomain", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate Component [Domain]", "label": "Variable Rate Component [Domain]", "documentation": "Variable Rate Component [Domain]" } } }, "auth_ref": [] }, "avns_VariableRateComponentOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "VariableRateComponentOneMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable rate component one", "label": "Variable Rate Component One [Member]", "documentation": "Variable Rate Component One" } } }, "auth_ref": [] }, "avns_VariableRateComponentThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "VariableRateComponentThreeMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable rate component three", "label": "Variable Rate Component Three [Member]", "documentation": "Variable Rate Component Three" } } }, "auth_ref": [] }, "avns_VariableRateComponentTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.avanos.com/20240930", "localname": "VariableRateComponentTwoMember", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable rate component two", "label": "Variable Rate Component Two [Member]", "documentation": "Variable Rate Component Two" } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VariableRateDomain", "presentation": [ "http://www.avanos.com/role/DebtNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Domain]", "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "calculation": { "http://www.avanos.com/role/EarningsPerShareEPSDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive effect of stock options and restricted share unit awards (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment", "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation." } } }, "auth_ref": [ "r755" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.avanos.com/role/EarningsPerShareEPSDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Diluted weighted average shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r263", "r268" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Shares Outstanding:", "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.avanos.com/role/EarningsPerShareEPSDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.avanos.com/role/EarningsPerShareEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic weighted average shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r262", "r268" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-10" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(j)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(f)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1B" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1B" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1D", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1D" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-13" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-5" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-2" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-3" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-23" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-6" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-18" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205-20/tableOfContent" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-11" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3B" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-4" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3A" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4A" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5D" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/220/tableOfContent" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/360/tableOfContent" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-9" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/805/tableOfContent" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/815/tableOfContent" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "09", "Paragraph": "Column B", "Publisher": "SEC" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "09", "Paragraph": "Column C", "Subparagraph": "(1)", "Publisher": "SEC" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "09", "Paragraph": "Column C", "Subparagraph": "(2)", "Publisher": "SEC" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "09", "Paragraph": "Column D", "Publisher": "SEC" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "09", "Paragraph": "Column E", "Publisher": "SEC" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(a)", "Footnote": "4", "Publisher": "SEC" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(b)", "Footnote": "4", "Publisher": "SEC" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column A", "Publisher": "SEC" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column B", "Publisher": "SEC" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column C", "Publisher": "SEC" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column D", "Publisher": "SEC" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column E", "Publisher": "SEC" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column F", "Publisher": "SEC" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 11", "Section": "L", "Publisher": "SEC" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 2", "Publisher": "SEC" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 4", "Publisher": "SEC" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/260/tableOfContent" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/420/tableOfContent" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EEEE", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEEE" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5C" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "940", "SubTopic": "820", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-6" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479196/954-310-45-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r660": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r661": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8" }, "r665": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r666": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15" }, "r667": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r668": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r669": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r670": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r671": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r672": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r673": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r674": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r675": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r676": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r677": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r678": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r679": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r680": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r681": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r682": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r683": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r684": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r685": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r686": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r687": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r688": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r689": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r690": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r691": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r692": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r693": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r694": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r697": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r698": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r699": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r700": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r701": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r702": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r703": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r704": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r705": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r706": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r707": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r708": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r709": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r710": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r711": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r712": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r713": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r714": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r715": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r717": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r721": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r722": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r723": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r724": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r725": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r726": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r727": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r728": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r730": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r732": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 2", "Publisher": "SEC" }, "r733": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/210/tableOfContent" }, "r734": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r735": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r741": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r742": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r743": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r744": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r745": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r746": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r747": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r748": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r749": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r750": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r751": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r752": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r753": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r754": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r755": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r756": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r757": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r758": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r759": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r760": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r761": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r762": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r763": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-20/tableOfContent" }, "r764": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r765": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r766": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r767": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r768": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r769": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r770": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r771": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r772": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r773": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A" }, "r774": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r775": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r776": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r777": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r778": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r779": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r780": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r781": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r782": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r783": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r784": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r785": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r786": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r787": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r788": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r789": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r790": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r791": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r792": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r793": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r794": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r795": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r796": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r797": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r798": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r799": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r800": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r801": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480123/805-50-15-3" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1" }, "r807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480682/815-20-25-6A" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "25", "Name": "Accounting Standards Codification", "Section": "40", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480270/815-25-40-8A" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r824": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r825": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r832": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r833": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r834": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r835": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r836": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r837": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r838": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r839": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r840": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r841": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1" }, "r842": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r843": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r844": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r845": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" } } } ZIP 90 0001606498-24-000084-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001606498-24-000084-xbrl.zip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�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end XML 91 avns-20240930_htm.xml IDEA: XBRL DOCUMENT 0001606498 2024-01-01 2024-09-30 0001606498 2024-10-23 0001606498 2024-07-01 2024-09-30 0001606498 2023-07-01 2023-09-30 0001606498 2023-01-01 2023-09-30 0001606498 2024-09-30 0001606498 2023-12-31 0001606498 us-gaap:CommonStockMember 2024-09-30 0001606498 us-gaap:CommonStockMember 2023-09-30 0001606498 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001606498 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001606498 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001606498 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001606498 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001606498 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001606498 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001606498 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001606498 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001606498 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001606498 us-gaap:RetainedEarningsMember 2024-06-30 0001606498 us-gaap:RetainedEarningsMember 2023-06-30 0001606498 us-gaap:RetainedEarningsMember 2023-12-31 0001606498 us-gaap:RetainedEarningsMember 2022-12-31 0001606498 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001606498 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001606498 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0001606498 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001606498 us-gaap:RetainedEarningsMember 2024-09-30 0001606498 us-gaap:RetainedEarningsMember 2023-09-30 0001606498 us-gaap:TreasuryStockCommonMember 2024-06-30 0001606498 us-gaap:TreasuryStockCommonMember 2023-06-30 0001606498 us-gaap:TreasuryStockCommonMember 2023-12-31 0001606498 us-gaap:TreasuryStockCommonMember 2022-12-31 0001606498 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-30 0001606498 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-09-30 0001606498 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-09-30 0001606498 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-09-30 0001606498 us-gaap:TreasuryStockCommonMember 2024-09-30 0001606498 us-gaap:TreasuryStockCommonMember 2023-09-30 0001606498 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001606498 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001606498 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001606498 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001606498 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001606498 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001606498 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0001606498 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0001606498 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001606498 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001606498 2023-09-30 0001606498 2022-12-31 0001606498 avns:RHBusinessMember 2023-10-02 2023-10-02 0001606498 avns:RHBusinessMember 2023-06-07 2023-06-07 0001606498 srt:MinimumMember avns:RHBusinessMember 2023-06-07 2023-06-07 0001606498 srt:MaximumMember avns:RHBusinessMember 2023-06-07 2023-06-07 0001606498 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember avns:RHBusinessMember 2024-09-30 0001606498 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember avns:RHBusinessMember 2023-12-31 0001606498 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember avns:RHBusinessMember 2024-07-01 2024-09-30 0001606498 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember avns:RHBusinessMember 2023-07-01 2023-09-30 0001606498 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember avns:RHBusinessMember 2024-01-01 2024-09-30 0001606498 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember avns:RHBusinessMember 2023-01-01 2023-09-30 0001606498 srt:MinimumMember avns:PostDivestitureRestructuringPlanMember 2024-09-30 0001606498 srt:MaximumMember avns:PostDivestitureRestructuringPlanMember 2024-09-30 0001606498 avns:PostDivestitureRestructuringPlanMember 2024-07-01 2024-09-30 0001606498 avns:PostDivestitureRestructuringPlanMember 2024-01-01 2024-09-30 0001606498 2023-01-01 2023-01-31 0001606498 srt:MaximumMember avns:TransformationProcessMember 2023-01-31 0001606498 srt:MinimumMember avns:ProgramManagementConsultingAndEmployeeRetentionMember 2024-09-30 0001606498 srt:MaximumMember avns:ProgramManagementConsultingAndEmployeeRetentionMember 2024-09-30 0001606498 srt:MinimumMember avns:ManufacturingAndSupplyChainImprovementsMember 2024-09-30 0001606498 srt:MaximumMember avns:ManufacturingAndSupplyChainImprovementsMember 2024-09-30 0001606498 srt:MinimumMember avns:OrganizationalDesignAlignmentAndOtherRelatedActivitiesMember 2024-09-30 0001606498 srt:MaximumMember avns:OrganizationalDesignAlignmentAndOtherRelatedActivitiesMember 2024-09-30 0001606498 avns:ProgramManagementConsultingAndEmployeeRetentionMember 2024-07-01 2024-09-30 0001606498 avns:ProgramManagementConsultingAndEmployeeRetentionMember 2024-01-01 2024-09-30 0001606498 avns:ProgramManagementConsultingAndEmployeeRetentionMember 2023-07-01 2023-09-30 0001606498 avns:ProgramManagementConsultingAndEmployeeRetentionMember 2023-01-01 2023-09-30 0001606498 avns:ProgramManagementConsultingAndEmployeeRetentionExpensesAndEmployeeSeveranceAndBenefitsMember 2024-01-01 2024-09-30 0001606498 avns:ProgramManagementConsultingAndEmployeeRetentionExpensesAndEmployeeSeveranceAndBenefitsMember 2024-07-01 2024-09-30 0001606498 avns:ProgramManagementConsultingAndEmployeeRetentionExpensesAndEmployeeSeveranceAndBenefitsMember 2024-09-30 0001606498 us-gaap:EmployeeSeveranceMember avns:MultiYearRestructuringPlanInitialPhaseMember 2023-12-31 0001606498 us-gaap:EmployeeSeveranceMember avns:MultiYearRestructuringPlanInitialPhaseMember 2024-01-01 2024-09-30 0001606498 us-gaap:EmployeeSeveranceMember avns:MultiYearRestructuringPlanInitialPhaseMember 2024-09-30 0001606498 avns:DirosTechnologyIncMember 2023-07-24 2023-07-24 0001606498 avns:DirosTechnologyIncMember 2023-06-17 2023-06-17 0001606498 avns:DirosTechnologyIncMember 2023-07-24 0001606498 avns:DirosTechnologyIncMember 2024-07-01 2024-09-30 0001606498 avns:DirosTechnologyIncMember 2024-01-01 2024-09-30 0001606498 avns:DirosTechnologyIncMember 2023-07-01 2023-09-30 0001606498 avns:DirosTechnologyIncMember 2023-01-01 2023-09-30 0001606498 2023-06-17 2024-09-30 0001606498 avns:DirosTechnologyIncMember us-gaap:TrademarksAndTradeNamesMember 2023-07-24 2023-07-24 0001606498 avns:DirosTechnologyIncMember us-gaap:CustomerRelationshipsMember 2023-07-24 2023-07-24 0001606498 avns:DirosTechnologyIncMember us-gaap:TechnologyBasedIntangibleAssetsMember 2023-07-24 2023-07-24 0001606498 avns:AllowanceForCreditLossDoubtfulAccountsMember 2024-09-30 0001606498 avns:AllowanceForCreditLossDoubtfulAccountsMember 2023-12-31 0001606498 avns:AllowanceForCreditLossSalesDiscountsMember 2024-09-30 0001606498 avns:AllowanceForCreditLossSalesDiscountsMember 2023-12-31 0001606498 us-gaap:LandMember 2024-09-30 0001606498 us-gaap:LandMember 2023-12-31 0001606498 us-gaap:BuildingMember 2024-09-30 0001606498 us-gaap:BuildingMember 2023-12-31 0001606498 us-gaap:MachineryAndEquipmentMember 2024-09-30 0001606498 us-gaap:MachineryAndEquipmentMember 2023-12-31 0001606498 us-gaap:ConstructionInProgressMember 2024-09-30 0001606498 us-gaap:ConstructionInProgressMember 2023-12-31 0001606498 us-gaap:TrademarksMember 2024-09-30 0001606498 us-gaap:TrademarksMember 2023-12-31 0001606498 us-gaap:PatentsMember 2024-09-30 0001606498 us-gaap:PatentsMember 2023-12-31 0001606498 us-gaap:OtherIntangibleAssetsMember 2024-09-30 0001606498 us-gaap:OtherIntangibleAssetsMember 2023-12-31 0001606498 us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2024-09-30 0001606498 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-09-30 0001606498 us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-12-31 0001606498 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0001606498 us-gaap:RevolvingCreditFacilityMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2024-09-30 0001606498 us-gaap:RevolvingCreditFacilityMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-09-30 0001606498 us-gaap:RevolvingCreditFacilityMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-12-31 0001606498 us-gaap:RevolvingCreditFacilityMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0001606498 avns:TermLoansMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2024-09-30 0001606498 avns:TermLoansMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-09-30 0001606498 avns:TermLoansMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-12-31 0001606498 avns:TermLoansMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0001606498 us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2024-09-30 0001606498 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-09-30 0001606498 us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-12-31 0001606498 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0001606498 us-gaap:RevolvingCreditFacilityMember us-gaap:UnsecuredDebtMember 2024-09-30 0001606498 us-gaap:RevolvingCreditFacilityMember us-gaap:UnsecuredDebtMember 2023-12-31 0001606498 avns:TermLoanFacilityMember us-gaap:UnsecuredDebtMember 2024-09-30 0001606498 avns:TermLoanFacilityMember us-gaap:UnsecuredDebtMember 2023-12-31 0001606498 avns:CreditAgreementMember 2022-06-24 0001606498 avns:TermLoanFacilityMember us-gaap:SecuredDebtMember 2022-06-24 2022-06-24 0001606498 avns:TermLoanFacilityMember us-gaap:SecuredDebtMember 2022-06-24 0001606498 us-gaap:RevolvingCreditFacilityMember avns:SeniorSecuredRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-06-24 2022-06-24 0001606498 us-gaap:RevolvingCreditFacilityMember avns:SeniorSecuredRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-06-24 0001606498 us-gaap:LetterOfCreditMember avns:SeniorSecuredRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-06-24 0001606498 srt:MinimumMember avns:CreditAgreementMember us-gaap:SecuredOvernightFinancingRateSofrMember avns:VariableRateComponentOneMember 2022-06-24 2022-06-24 0001606498 srt:MaximumMember avns:CreditAgreementMember us-gaap:SecuredOvernightFinancingRateSofrMember avns:VariableRateComponentOneMember 2022-06-24 2022-06-24 0001606498 srt:MinimumMember avns:CreditAgreementMember us-gaap:SecuredOvernightFinancingRateSofrMember avns:VariableRateComponentTwoMember 2022-06-24 2022-06-24 0001606498 srt:MaximumMember avns:CreditAgreementMember us-gaap:SecuredOvernightFinancingRateSofrMember avns:VariableRateComponentTwoMember 2022-06-24 2022-06-24 0001606498 avns:CreditAgreementMember us-gaap:FederalFundsEffectiveSwapRateMember 2022-06-24 2022-06-24 0001606498 avns:CreditAgreementMember us-gaap:SecuredOvernightFinancingRateSofrMember avns:VariableRateComponentThreeMember 2022-06-24 2022-06-24 0001606498 srt:MinimumMember avns:CreditAgreementMember us-gaap:BaseRateMember 2022-06-24 2022-06-24 0001606498 srt:MaximumMember avns:CreditAgreementMember us-gaap:BaseRateMember 2022-06-24 2022-06-24 0001606498 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember avns:SeniorSecuredRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-06-24 2022-06-24 0001606498 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember avns:SeniorSecuredRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-06-24 2022-06-24 0001606498 avns:TermLoanFacilityMember us-gaap:SecuredDebtMember 2024-09-30 0001606498 avns:DebtInstrumentPeriodicPaymentFirstEightQuartersMember 2024-01-01 2024-09-30 0001606498 avns:DebtInstrumentPeriodicPaymentSubsequentToFirstEightQuartersMember 2024-01-01 2024-09-30 0001606498 avns:TermLoanFacilitiesMember us-gaap:UnsecuredDebtMember 2024-01-01 2024-09-30 0001606498 us-gaap:RevolvingCreditFacilityMember us-gaap:UnsecuredDebtMember 2024-01-01 2024-09-30 0001606498 us-gaap:LetterOfCreditMember 2024-09-30 0001606498 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0001606498 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0001606498 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0001606498 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-09-30 0001606498 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-09-30 0001606498 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-09-30 0001606498 us-gaap:AccumulatedTranslationAdjustmentMember 2024-09-30 0001606498 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-09-30 0001606498 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-09-30 0001606498 us-gaap:EmployeeStockOptionMember 2024-07-01 2024-09-30 0001606498 us-gaap:EmployeeStockOptionMember 2023-07-01 2023-09-30 0001606498 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-09-30 0001606498 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001606498 us-gaap:RestrictedStockUnitsRSUMember 2024-07-01 2024-09-30 0001606498 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-09-30 0001606498 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-09-30 0001606498 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001606498 us-gaap:PerformanceSharesMember 2024-07-01 2024-09-30 0001606498 us-gaap:PerformanceSharesMember 2023-07-01 2023-09-30 0001606498 us-gaap:PerformanceSharesMember 2024-01-01 2024-09-30 0001606498 us-gaap:PerformanceSharesMember 2023-01-01 2023-09-30 0001606498 avns:EmployeeStockPurchaseProgramMember 2024-07-01 2024-09-30 0001606498 avns:EmployeeStockPurchaseProgramMember 2023-07-01 2023-09-30 0001606498 avns:EmployeeStockPurchaseProgramMember 2024-01-01 2024-09-30 0001606498 avns:EmployeeStockPurchaseProgramMember 2023-01-01 2023-09-30 0001606498 2021-07-06 2021-07-06 0001606498 us-gaap:ForeignExchangeForwardMember 2024-09-30 0001606498 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-30 0001606498 avns:DigestiveHealthMember 2024-07-01 2024-09-30 0001606498 avns:DigestiveHealthMember 2023-07-01 2023-09-30 0001606498 avns:DigestiveHealthMember 2024-01-01 2024-09-30 0001606498 avns:DigestiveHealthMember 2023-01-01 2023-09-30 0001606498 avns:SurgicalPainAndRecoveryMember 2024-07-01 2024-09-30 0001606498 avns:SurgicalPainAndRecoveryMember 2023-07-01 2023-09-30 0001606498 avns:SurgicalPainAndRecoveryMember 2024-01-01 2024-09-30 0001606498 avns:SurgicalPainAndRecoveryMember 2023-01-01 2023-09-30 0001606498 avns:InterventionalPainMember 2024-07-01 2024-09-30 0001606498 avns:InterventionalPainMember 2023-07-01 2023-09-30 0001606498 avns:InterventionalPainMember 2024-01-01 2024-09-30 0001606498 avns:InterventionalPainMember 2023-01-01 2023-09-30 0001606498 avns:PainManagementAndRecoveryMember 2024-07-01 2024-09-30 0001606498 avns:PainManagementAndRecoveryMember 2023-07-01 2023-09-30 0001606498 avns:PainManagementAndRecoveryMember 2024-01-01 2024-09-30 0001606498 avns:PainManagementAndRecoveryMember 2023-01-01 2023-09-30 0001606498 2023-07-28 2023-07-28 0001606498 2023-07-28 0001606498 2023-10-01 2023-12-31 0001606498 2024-01-01 2024-03-31 0001606498 2024-03-31 0001606498 2024-04-01 2024-06-30 0001606498 2024-06-30 shares iso4217:USD iso4217:USD shares avns:segment pure 0001606498 --12-31 2024 Q3 false 1 P1Y 10-Q true 2024-09-30 false 001-36440 AVANOS MEDICAL, INC. DE 46-4987888 5405 Windward Parkway Suite 100 South Alpharetta, GA 30004 (844) 428-2667 Common Stock - $0.01 Par Value AVNS NYSE Yes Yes Large Accelerated Filer false false false 45956997 170400000 171300000 508200000 500000000.0 77500000 75800000 224900000 215300000 92900000 95500000 283300000 284700000 7200000 6100000 20500000 20400000 74300000 78700000 238800000 260500000 600000 -9500000 -1700000 -10800000 12000000.0 1200000 22300000 -7000000.0 700000 900000 4300000 1900000 3200000 4700000 9400000 11700000 9500000 -2600000 17200000 -16800000 3600000 6200000 6500000 4100000 5900000 -8800000 10700000 -20900000 -1600000 5100000 -5500000 -51400000 4300000 -3700000 5200000 -72300000 0.13 -0.19 0.23 -0.45 -0.03 0.11 -0.12 -1.10 0.10 -0.08 0.11 -1.55 0.12 -0.19 0.23 -0.45 -0.03 0.11 -0.12 -1.10 0.09 -0.08 0.11 -1.55 4300000 -3700000 5200000 -72300000 300000 -4600000 -8000000.0 2800000 -100000 0 100000 0 200000 0 -1800000 0 600000 -4600000 -9900000 2800000 4900000 -8300000 -4700000 -69500000 89000000.0 87700000 131900000 142800000 161900000 163200000 15900000 28800000 73900000 64500000 472600000 487000000.0 109500000 117200000 26500000 26800000 795100000 796100000 220100000 239500000 6600000 6500000 25800000 19300000 1656200000 1692400000 9400000 8600000 13700000 12800000 54200000 56300000 82700000 93200000 52900000 63700000 212900000 234600000 152600000 159400000 26500000 28300000 23900000 23800000 10600000 10000000.0 426500000 456100000 0.01 0.01 20000000 20000000 0 0 0 0 0.01 0.01 300000000 300000000 45954931 46174337 500000 500000 1674700000 1663600000 -309700000 -314900000 98900000 85900000 -36900000 -27000000.0 1229700000 1236300000 1656200000 1692400000 500000 500000 500000 500000 1671500000 1654900000 1663600000 1646400000 600000 900000 1100000 1500000 2600000 3900000 10000000.0 11800000 1674700000 1659700000 1674700000 1659700000 -314000000.0 -321700000 -314900000 -253100000 4300000 -3700000 5200000 -72300000 -309700000 -325400000 -309700000 -325400000 -98500000 -70500000 -85900000 -66800000 400000 9200000 13000000.0 12900000 -98900000 -79700000 -98900000 -79700000 -37500000 -28400000 -27000000.0 -35800000 600000 -4600000 -9900000 2800000 -36900000 -33000000.0 -36900000 -33000000.0 1229700000 1222100000 1229700000 1222100000 5200000 -72300000 34400000 34600000 10000000.0 11800000 0 59100000 -400000 -1100000 6900000 -30000000.0 5900000 6600000 -7700000 -200000 -1200000 -16000000.0 -3700000 -19700000 2800000 -2500000 42800000 19700000 13000000.0 11900000 2100000 0 0 -47500000 9000000.0 0 -19900000 -59400000 6300000 3100000 20000000.0 55000000.0 20000000.0 20000000.0 12700000 12900000 1100000 1500000 3800000 0 -21700000 20500000 100000 -1400000 1300000 -20600000 87700000 127700000 89000000.0 107100000 Accounting Policies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Avanos Medical, Inc. is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today’s most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio. References herein to “Avanos,” “the Company,” “we,” “our” and “us” refer to Avanos Medical, Inc. and its consolidated subsidiaries. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interim Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepared the accompanying unaudited condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and the instructions to the Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements, and the condensed consolidated financial statements in this Form 10-Q should be read in conjunction with the Form 10-K. Our unaudited interim condensed consolidated financial statements contain all necessary material adjustments, which are of a normal and recurring nature, to fairly state our financial condition, results of operations and cash flows for the periods presented. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of our condensed consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Estimates are used in accounting for, among other things, certain amounts included in discontinued operations, certain amounts included in assets and liabilities held for sale, distributor rebate accruals, future cash flows associated with impairment testing for goodwill and long-lived assets, loss contingencies, and deferred tax assets and potential income tax assessments. Actual results could differ from these estimates, and the effect of any change could be material to our financial statements. Changes in these estimates are recorded when known.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test goodwill for impairment annually or more frequently whenever events or circumstances more likely than not indicate that the fair value of the reporting unit may be below its carrying value. We operate as a single reportable operating segment with one reporting unit. The fair value of our reporting unit is estimated using a combination of income (discounted cash flow analysis) and market approaches. The income approach is dependent upon several assumptions regarding future periods such as sales growth and a terminal growth rate. A weighted average cost of capital (“WACC”) was used to discount future estimated cash flows to their present values. The WACC was based on externally observable data considering market participants’ cost of equity and debt, optimal capital structure and risk factors specific to us. The market approach estimates the value of our company using a market capitalization methodology.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that the fair value of our reporting unit exceeded the net carrying amount in our most recent goodwill impairment test on July 1, 2024. However, there can be no assurance that the assumptions and estimates made for purposes of the annual goodwill impairment test will prove to be accurate. Volatility in the equity and debt markets, or increases in interest rates, could result in a higher discount rate. Changes in sales volumes, selling prices and costs of goods sold, and increases in interest rates could cause changes in our forecasted cash flows. Unfavorable changes in any of the factors described above, as well as a decline in our stock price, could result in a goodwill impairment charge in the future.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedging and Derivatives</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recorded as assets or liabilities on the balance sheet at fair value. Changes in the fair value of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">derivatives are either recorded in the income statement or other comprehensive income, as appropriate. The effective portion of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the gain or loss on derivatives designated as cash flow hedges is included in other comprehensive income in the period that</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">changes in fair value occur, and is reclassified to income in the same period that the hedged item affects income. Our policies allow the use of derivatives for risk management purposes and prohibit their use for speculation. Our policies also prohibit the use of any leveraged derivative instrument. Consistent with our policies, foreign currency derivative instruments are entered into with major financial institutions. At inception, we formally designate certain derivatives as cash flow hedges and establish how the effectiveness of these hedges will be assessed and measured. This process links the derivatives to the transactions they are hedging. See Note 11, “Derivative Financial Instruments,” for disclosures about derivative instruments and hedging activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2023, we adopted ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU pertains to acquired revenue contracts with customers in a business combination and addresses diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. Adoption of this ASU did not have a material effect on our financial position, results of operations or cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes: Improvement to Income Tax Disclosures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This ASU pertains to disaggregation of income tax disclosures and enhances annual income tax disclosures to address investor requests for more information about the tax risks and opportunities present in an entity’s worldwide operations. The two primary enhancements disaggregate existing income tax disclosures related to the effective tax rate reconciliation and income taxes paid, and requires entities to disclose a tabular reconciliation of expected tax and reported tax on income from continuing operations using both percentages and amounts, broken out into specific categories with certain reconciling items at or above 5% of the expected tax further broken out by nature and/or jurisdiction. Additionally, this ASU requires disclosure around income taxes paid (net of refunds received) broken out between federal, state, local and foreign, and income taxes paid (net of refunds received) to an individual jurisdiction when greater than 5% of total income taxes paid. This ASU will be effective for annual periods beginning after December 15, 2024, with early adoption permitted. Adoption of this ASU is not expected to have a material effect on our financial position, results of operations or cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting: Improvements to Reportable Segment Disclosures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This ASU enhances segment reporting under Topic 280 by expanding the breadth and frequency of segment disclosures, and aims to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. This ASU will be effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of this ASU will require us to expand our current disclosures around significant expenses and disclose an aggregate amount and composition of other segment items related to our single operating segment. On an annual basis, this ASU will require us to disclose the Chief Operating Decision Maker’s (CODM) title and position, as well as how the CODM uses each reported measure of segment profit or loss to assess performance and allocate resources to the segment. We will retrospectively adopt this ASU in the fiscal period ending December 31, 2024 as required by ASU No. 2023-07.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, the FASB issued ASU No. 2023-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: Joint Venture Formations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU is intended to address diversity in practice regarding accounting and provide decision-useful information related to contributions made to joint ventures and requires entities that qualify as either a joint venture or a corporate joint venture to apply a new basis of accounting upon the formation of the joint venture. Specifically, the ASU provides that a joint venture or a corporate joint venture must initially measure its assets and liabilities at fair value on the formation date. This ASU will be effective for all newly formed joint venture entities with a formation date on or after January 1, 2025, with early adoption permitted. Joint ventures formed prior to the adoption date may elect to apply the new guidance retrospectively back to their original formation date. Adoption of this ASU is not expected to have a material effect on our financial position, results of operations or cash flows.</span></div> <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Avanos Medical, Inc. is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today’s most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio. References herein to “Avanos,” “the Company,” “we,” “our” and “us” refer to Avanos Medical, Inc. and its consolidated subsidiaries. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interim Financial Statements</span></div>We prepared the accompanying unaudited condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and the instructions to the Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements, and the condensed consolidated financial statements in this Form 10-Q should be read in conjunction with the Form 10-K. Our unaudited interim condensed consolidated financial statements contain all necessary material adjustments, which are of a normal and recurring nature, to fairly state our financial condition, results of operations and cash flows for the periods presented. <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of our condensed consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Estimates are used in accounting for, among other things, certain amounts included in discontinued operations, certain amounts included in assets and liabilities held for sale, distributor rebate accruals, future cash flows associated with impairment testing for goodwill and long-lived assets, loss contingencies, and deferred tax assets and potential income tax assessments. Actual results could differ from these estimates, and the effect of any change could be material to our financial statements. Changes in these estimates are recorded when known.</span></div> <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test goodwill for impairment annually or more frequently whenever events or circumstances more likely than not indicate that the fair value of the reporting unit may be below its carrying value. We operate as a single reportable operating segment with one reporting unit. The fair value of our reporting unit is estimated using a combination of income (discounted cash flow analysis) and market approaches. The income approach is dependent upon several assumptions regarding future periods such as sales growth and a terminal growth rate. A weighted average cost of capital (“WACC”) was used to discount future estimated cash flows to their present values. The WACC was based on externally observable data considering market participants’ cost of equity and debt, optimal capital structure and risk factors specific to us. The market approach estimates the value of our company using a market capitalization methodology.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that the fair value of our reporting unit exceeded the net carrying amount in our most recent goodwill impairment test on July 1, 2024. However, there can be no assurance that the assumptions and estimates made for purposes of the annual goodwill impairment test will prove to be accurate. Volatility in the equity and debt markets, or increases in interest rates, could result in a higher discount rate. Changes in sales volumes, selling prices and costs of goods sold, and increases in interest rates could cause changes in our forecasted cash flows. Unfavorable changes in any of the factors described above, as well as a decline in our stock price, could result in a goodwill impairment charge in the future.</span></div> 1 <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedging and Derivatives</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recorded as assets or liabilities on the balance sheet at fair value. Changes in the fair value of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">derivatives are either recorded in the income statement or other comprehensive income, as appropriate. The effective portion of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the gain or loss on derivatives designated as cash flow hedges is included in other comprehensive income in the period that</span></div>changes in fair value occur, and is reclassified to income in the same period that the hedged item affects income. Our policies allow the use of derivatives for risk management purposes and prohibit their use for speculation. Our policies also prohibit the use of any leveraged derivative instrument. Consistent with our policies, foreign currency derivative instruments are entered into with major financial institutions. At inception, we formally designate certain derivatives as cash flow hedges and establish how the effectiveness of these hedges will be assessed and measured. This process links the derivatives to the transactions they are hedging. <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2023, we adopted ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU pertains to acquired revenue contracts with customers in a business combination and addresses diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. Adoption of this ASU did not have a material effect on our financial position, results of operations or cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes: Improvement to Income Tax Disclosures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This ASU pertains to disaggregation of income tax disclosures and enhances annual income tax disclosures to address investor requests for more information about the tax risks and opportunities present in an entity’s worldwide operations. The two primary enhancements disaggregate existing income tax disclosures related to the effective tax rate reconciliation and income taxes paid, and requires entities to disclose a tabular reconciliation of expected tax and reported tax on income from continuing operations using both percentages and amounts, broken out into specific categories with certain reconciling items at or above 5% of the expected tax further broken out by nature and/or jurisdiction. Additionally, this ASU requires disclosure around income taxes paid (net of refunds received) broken out between federal, state, local and foreign, and income taxes paid (net of refunds received) to an individual jurisdiction when greater than 5% of total income taxes paid. This ASU will be effective for annual periods beginning after December 15, 2024, with early adoption permitted. Adoption of this ASU is not expected to have a material effect on our financial position, results of operations or cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting: Improvements to Reportable Segment Disclosures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This ASU enhances segment reporting under Topic 280 by expanding the breadth and frequency of segment disclosures, and aims to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. This ASU will be effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of this ASU will require us to expand our current disclosures around significant expenses and disclose an aggregate amount and composition of other segment items related to our single operating segment. On an annual basis, this ASU will require us to disclose the Chief Operating Decision Maker’s (CODM) title and position, as well as how the CODM uses each reported measure of segment profit or loss to assess performance and allocate resources to the segment. We will retrospectively adopt this ASU in the fiscal period ending December 31, 2024 as required by ASU No. 2023-07.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, the FASB issued ASU No. 2023-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: Joint Venture Formations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU is intended to address diversity in practice regarding accounting and provide decision-useful information related to contributions made to joint ventures and requires entities that qualify as either a joint venture or a corporate joint venture to apply a new basis of accounting upon the formation of the joint venture. Specifically, the ASU provides that a joint venture or a corporate joint venture must initially measure its assets and liabilities at fair value on the formation date. This ASU will be effective for all newly formed joint venture entities with a formation date on or after January 1, 2025, with early adoption permitted. Joint ventures formed prior to the adoption date may elect to apply the new guidance retrospectively back to their original formation date. Adoption of this ASU is not expected to have a material effect on our financial position, results of operations or cash flows.</span></div> Discontinued Operations<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 7, 2023, we entered into a Purchase Agreement (“the Purchase Agreement”) by and among us and certain of our affiliates and SunMed Group Holdings, LLC (“Buyer”) pursuant to which Buyer agreed to purchase substantially all of the assets primarily relating to or primarily used in our Respiratory Health (“RH”) business (the “RH Divestiture”). On October 2, 2023, we closed the RH Divestiture for a total purchase price of $110 million in cash, subject to certain adjustments as provided in the Purchase Agreement based on the indebtedness and inventory transferred to Buyer at the closing and the chargebacks assumed by Buyer but that would otherwise have been payable by the Company and its subsidiaries on or after October 2, 2023 to distributors of the Company’s RH products located in the United States</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(the “Initial Closing”). </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RH Divestiture represents a key component of Avanos’ ongoing three-year transformation process, and is aimed at accelerating the Company’s efforts to focus its portfolio on markets where it is well positioned to succeed.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At or before the closing of the RH Divestiture, we and Buyer entered into various transition services agreements pursuant to which we, Buyer and each company’s respective affiliates provide to each other various transitional services, including, but not limited to, product manufacturing and distribution, facilities, order fulfillment, invoicing, quality assurance, regulatory support, audit support and other services. The services generally commenced on the closing date of the Divestiture and terminate no later than <span style="-sec-ix-hidden:f-340">one</span> to three years thereafter. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also entered into distribution agreements with Buyer under which we will remain a limited risk distributor for RH products on Buyer’s behalf for sales outside of the United States. As a result, we had $6.6 million of RH products included in “Prepaid expenses and other current assets” in the accompanying consolidated balance sheet as of September 30, 2024, compared to $11.9 million as of December 31, 2023. While our agreements with Buyer allows for limited risk distributor (“LRD”) arrangements for up to three years from the date of the Purchase Agreement, we expect the LRD arrangements to terminate by the end of this year.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the RH Divestiture, the results of operations from our RH business are reported as “Net (Loss) Income from discontinued operations, net of tax” and the related assets and liabilities are classified as “held for sale” in the condensed consolidated financial statements. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to an agreement under which we provide manufacturing services for the Buyer, certain manufacturing facilities and equipment did not transfer to the Buyer upon the Initial Closing, and remained in “Assets Held for Sale” as of September 30, 2024 with a corresponding liability representing our obligation to transfer the manufacturing facilities and equipment to the buyer at a later date. Likewise, the results of operations from these manufacturing operations continue to be classified as “Net Loss from discontinued operations, net of tax. On October 1, 2024, we finalized the RH Divestiture and completed the transfer of the manufacturing facilities and equipment to Buyer. Accordingly, we expect to finalize adjustments to our pretax loss on discontinued operations in the fourth quarter of 2024.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial results of our discontinued operations for all periods presented herein (in millions):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:46.036%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax loss on classification as discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Loss) Income from discontinued operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (provision) from discontinued operations</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (Loss) Income from discontinued operations, net of tax</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Loss) Earnings Per Share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with accounting principles generally accepted in the United States (“GAAP”), only expenses specifically identifiable and related to a business to be disposed may be allocated to discontinued operations. Accordingly, the cost of products sold, research and development, selling and general expenses and other expense, net in discontinued operations include expenses incurred directly to solely support our respiratory health business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details on assets and liabilities classified as held for sale in the accompanying consolidated balance sheets are presented in the following table (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets held for sale - discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, Plant and Equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Lease Right-of-Use Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets classified as held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities held for sale - discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Portion of Operating Lease Liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Current Operating Lease Liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities held for sale - discontinued operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities held for sale as of September 30, 2024 were classified as current since we expect the RH Divestiture to be completed within one year. </span></div><div><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides operating and investing cash flow information for our discontinued operations (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:72.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.734%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div> 110000000 P3Y P3Y 6600000 11900000 P3Y <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial results of our discontinued operations for all periods presented herein (in millions):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:46.036%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and general expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax loss on classification as discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Loss) Income from discontinued operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (provision) from discontinued operations</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (Loss) Income from discontinued operations, net of tax</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Loss) Earnings Per Share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details on assets and liabilities classified as held for sale in the accompanying consolidated balance sheets are presented in the following table (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets held for sale - discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, Plant and Equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Lease Right-of-Use Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets classified as held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities held for sale - discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Portion of Operating Lease Liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Current Operating Lease Liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities held for sale - discontinued operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides operating and investing cash flow information for our discontinued operations (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:72.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.734%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div> 10500000 31100000 41000000.0 93900000 15900000 19900000 47400000 57800000 -5400000 11200000 -6400000 36100000 0 200000 0 800000 0 4200000 0 11900000 0 0 0 -72300000 -3200000 100000 1100000 300000 -2200000 6700000 -7500000 -49200000 -600000 1600000 -2000000.0 2200000 -1600000 5100000 -5500000 -51400000 -0.03 0.11 -0.12 -1.10 -0.03 0.11 -0.12 -1.10 28200000 17500000 43000000.0 43900000 2700000 3100000 73900000 64500000 700000 800000 51300000 61300000 900000 1600000 52900000 63700000 0 2600000 0 100000 600000 3100000 Restructuring Activities<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-RH Divestiture Restructuring Plan</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2024, we initiated a post-RH Divestiture restructuring plan (the “Plan”). The Plan is intended to align our organizational structure, distribution and operational footprint with our remaining business. We expect the Plan will be substantially complete by the end of 2025 and currently expect to incur between $10.0 million and $11.0 million of cash expenses, primarily for employee termination benefits. In the three and nine months ended September 30, 2024, we incurred $2.3 million and $6.4 million, respectively, of costs related to the Plan. These costs were included in “Cost of products sold” and “Selling and general expenses” in the accompanying condensed consolidated income statements. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transformation Process</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, we initiated a three-year restructuring initiative intended to align the Company under a single commercial organization, rationalize our product portfolio, undertake additional cost management activities to enhance the Company’s operating profitability and pursue efficient capital allocation strategies (the “Transformation Process”). The RH Divestiture represents a key component of the three-year Transformation Process. We expect the Transformation Process will be substantially complete by the end of 2025. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to incur up to $30.0 million of cash expenses in connection with the Transformation Process, consisting of between $9.0 million and $12.0 million of program management consulting and employee retention expenses; between $8.0 million and $11.0 million of expenses associated with manufacturing and supply chain improvements and portfolio rationalization; and the remainder for expenses associated with</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">organization design and alignment and other related activities. These amounts include between $6.0 million and $8.0 million of employee severance and benefits costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three and nine months ended September 30, 2024, we incurred expenses of $0.7 million and $5.2 million, respectively, primarily related to employee severance and benefits costs in connection with the Transformation Process, compared to $4.3 million and $23.0 million in the three and nine months ended September 30, 2023. These costs were included in “Cost of products sold” and “Selling and general expenses” in the accompanying condensed consolidated income statements. Plan-to-</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">date we have incurred expenses of $33.4 million in connection with the Transformation Process, which includes $28.1 million of cash expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liability for costs associated with our restructuring initiatives as of September 30, 2024 is summarized below (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and transformation costs, excluding non-cash charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 10000000.0 11000000.0 2300000 6400000 P3Y P3Y 30000000.0 9000000.0 12000000.0 8000000.0 11000000.0 6000000.0 8000000.0 700000 5200000 4300000 23000000.0 33400000 33400000 28100000 <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liability for costs associated with our restructuring initiatives as of September 30, 2024 is summarized below (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and transformation costs, excluding non-cash charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2300000 10300000 9200000 3400000 Business Acquisition<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diros Technology</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2023 we entered into a definitive agreement to acquire Diros Technology Inc. (“Diros”), a leading manufacturer of innovative radiofrequency ablation (“RFA”) products used to treat chronic pain conditions. On July 24, 2023, we closed the acquisition of Diros. The total purchase price paid in connection with our acquisition of Diros was $53.0 million, consisting of $2.5 million in cash paid upon entry into the definitive agreement and $50.5 million in cash paid at closing (subject to certain working capital and other adjustments), with up to an additional $7.0 million payable in contingent cash consideration based on achievement of certain performance objectives defined in the purchase agreement (the “Diros Acquisition”). The purchase price for the Diros Acquisition was funded by proceeds from our Revolving Credit Facility. The accompanying condensed consolidated income statement includes $4.6 million and $14.4 million of net sales from Diros for the three and nine months ended September 30, 2024, respectively. The accompanying condensed consolidated income statement includes $2.4 million of net sales from Diros since the acquisition date for the three and nine months ended September 30, 2023. In the three and nine months ended September 30, 2024, we incurred $1.5 million and $2.1 million of costs in connection with the Diros Acquisition, compared to $0.6 million and $0.9 million of costs in the three and nine months ended September 30, 2023, respectively. These costs are included in “Selling and general expenses,” In the nine months ended September 30, 2024, we made contingent consideration payments of $4.6 million and to date we have made contingent consideration payments of $6.1 million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the acquisition method of accounting for business combinations, the purchase price paid is allocated to the underlying net assets in proportion to their respective fair values. Any excess of the purchase price over the estimated fair values is recorded as goodwill. Fair values of assets acquired and liabilities assumed are being determined using discounted cash flow analyses and the fair value of the contingent consideration is being estimated using a Monte Carlo simulation. Assumptions supporting the estimated fair values are based on facts and circumstances that existed on the valuation date. The purchase price allocation is shown in the table below (in millions):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets, net of cash acquired</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities, excluding contingent consideration</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncurrent liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The identifiable intangible assets relating to the Diros Acquisition include the following (in millions, except years):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identifiable Intangible Asset Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Useful Lives (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names and trademarks</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology and other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div> 53000000.0 2500000 50500000 7000000.0 4600000 14400000 2400000 2400000 1500000 2100000 600000 900000 4600000 6100000 The purchase price allocation is shown in the table below (in millions):<div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets, net of cash acquired</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities, excluding contingent consideration</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncurrent liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 7500000 7000000.0 5300000 500000 8100000 29600000 33400000 49600000 <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The identifiable intangible assets relating to the Diros Acquisition include the following (in millions, except years):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identifiable Intangible Asset Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Useful Lives (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names and trademarks</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology and other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div> 2900000 P15Y 21200000 P14Y 5500000 P13Y 29600000 Supplemental Balance Sheet Information<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable consist of the following (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances and doubtful accounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">131.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Losses on receivables are estimated based on known troubled accounts and historical experience. Receivables are considered impaired and written off when it is probable that payments due will not be collected. Allowance for doubtful accounts was $0.1 million for the three months ended September 30, 2024 and $0.2 million for the nine months ended September 30, 2024, compared to a net benefit of $0.4 million and an expense of $0.2 million for the three and nine months ended September 30, 2023, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories at the lower of cost (determined on the FIFO method) or net realizable value consists of the following (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies and other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">161.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred $2.8 million and $4.3 million of expense for inventory write-offs and obsolescence in the three and nine months ended September 30, 2024, compared to $2.0 million and $6.3 million in the three and nine months ended September 30, 2023, respectively.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consists of the following (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">185.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">246.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(137.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">109.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $5.3 million and $15.6 million for the three and nine months ended September 30, 2024, </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively, compared to $4.8 million and $14.2 million for the three and nine months ended September 30, 2023, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill are as follows (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Goodwill</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">795.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets subject to amortization consist of the following (in millions):</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(29.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and acquired technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">248.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(179.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(68.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">138.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">497.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(277.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">220.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(258.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets is included in “Cost of products sold” and “Selling and general expenses” and was $6.4 million and $18.8 million for the three and nine months ended September 30, 2024, respectively, compared to $6.2 million and $17.8 million for the three and nine months ended September 30, 2023, respectively. As of September 30, 2024 we had unrealized currency translation adjustments of $0.3 million related to our acquired intangibles from the acquisition of Diros.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for the remainder of 2024, the following four years and thereafter is estimated as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.894%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued Expenses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of the following (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates and customer incentives</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Long-Term Liabilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities consist of the following (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable consist of the following (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances and doubtful accounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">131.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 137300000 134000000.0 0 14100000 4800000 5100000 600000 200000 131900000 142800000 100000 200000 -400000 200000 <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories at the lower of cost (determined on the FIFO method) or net realizable value consists of the following (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies and other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">161.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 47400000 50300000 23200000 19800000 87900000 88500000 3400000 4600000 161900000 163200000 2800000 4300000 2000000.0 6300000 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consists of the following (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">185.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">246.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(137.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">109.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1200000 1300000 41300000 38000000.0 185400000 182800000 18800000 18000000.0 246700000 240100000 137200000 122900000 109500000 117200000 5300000 15600000 4800000 14200000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill are as follows (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Goodwill</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">795.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 796100000 1000000.0 795100000 <div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets subject to amortization consist of the following (in millions):</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(29.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and acquired technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">248.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(179.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(68.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">138.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">497.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(277.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">220.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(258.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 41600000 29700000 11900000 42000000.0 28800000 13200000 248500000 179200000 69300000 248600000 171900000 76700000 207700000 68800000 138900000 207700000 58100000 149600000 497800000 277700000 220100000 498300000 258800000 239500000 6400000 18800000 6200000 17800000 -300000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for the remainder of 2024, the following four years and thereafter is estimated as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.894%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 6700000 25000000.0 24500000 22800000 22600000 118500000 220100000 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of the following (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates and customer incentives</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities for estimated returns, rebates and incentives are presented in the table below (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.250%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued customer incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates and customer incentives</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales returns</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________________________________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Accrued sales returns are included in “Other” in the accrued expenses table in Note 5, “Supplemental Balance Sheet Information”.</span></div> 23600000 17700000 29800000 31500000 6200000 16700000 23100000 27300000 82700000 93200000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities consist of the following (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 6700000 5900000 3900000 4100000 10600000 10000000.0 Fair Value Information<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following fair value information is based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels in the hierarchy used to measure fair value are:</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Unadjusted quoted prices in active markets accessible at the reporting date for identical assets and liabilities.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Quoted prices for similar assets or liabilities in active markets. Quoted prices for identical or similar assets and liabilities in markets that are not considered active or financial instruments for which all significant inputs are observable, either directly or indirectly.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Prices or valuations that require inputs that are significant to the valuation and are unobservable.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The following table includes the fair value of our financial instruments for which disclosure of fair value is required (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">112.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">112.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration related to acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>Cash equivalents are recorded at cost, which approximates fair value due to their short-term nature. The fair value of amounts borrowed under our Revolving Credit Facility and Term Loan Facility approximates carrying value because borrowings are subject to a variable rate as described in Note 7, “Debt”. The following table includes the fair value of our financial instruments for which disclosure of fair value is required (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">112.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">112.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration related to acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 89000000.0 89000000.0 87700000 87700000 50000000.0 50000000.0 50000000.0 50000000.0 112000000.0 112000000.0 118000000.0 118000000.0 0 0 5300000 5300000 Debt<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024 and December 31, 2023, our respective debt balances were as follows (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.981%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.83 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.81 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">112.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">162.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Long-Term Debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">152.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 24, 2022, we entered into a credit agreement (the “Credit Agreement”) with certain lenders which established credit facilities in an aggregate principal amount of $500.0 million, consisting of a five-year senior secured term loan of $125.0 million (the “Term Loan Facility”) and a five-year senior secured revolving credit facility allowing borrowings of up to $375.0 million, with a letter of credit sub-facility in an amount of $75.0 million (the “Revolving Credit Facility”). </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All obligations under the Credit Agreement and certain hedging agreements and cash management arrangements thereunder are: (i) guaranteed by each of the Company’s direct and indirect, existing and future, material wholly owned domestic subsidiaries (“Guarantors”) and </span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) secured by a first priority lien on substantially all the assets of the Company and the Guarantors. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains an accordion feature that allows us to incur incremental term loans under the Term Loan Facility or under new term loan facilities or to increase the amount of the commitments under the Revolving Credit Facility, including through the establishment of one or more tranches under the Revolving Credit Facility. The Credit Agreement will mature on June 24, 2027.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Term Loan Facility and Revolving Credit Facility bear interest at our option at either: (i) an adjusted term secured overnight financing rate (“SOFR”), plus a margin ranging between 1.50% to 2.00% per annum, depending on our consolidated total leverage ratio; (ii) an adjusted daily simple SOFR rate, plus a margin ranging between 1.50% to 2.00% per annum, depending on our consolidated total leverage ratio; or (iii) a base rate (calculated as the greatest of (a) the prime rate, (b) the NYFRB rate (being the greater of the federal funds effective rate or the overnight bank funding rate) plus 0.50%, and (c) the one month adjusted term SOFR rate plus 1.00%), plus a margin ranging between 0.50% to 1.00% per annum, depending on our consolidated total leverage ratio. The unused portion of the Revolving Credit Facility will be subject to a commitment fee ranging between 0.20% to 0.25% per annum, depending on our consolidated total leverage ratio. Unamortized debt discount and issuance costs are being amortized to interest expense over the life of the Term Loan Facility using the interest method, resulting in an effective interest rate of 7.1% as of September 30, 2024.</span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement requires compliance with certain customary operational and financial covenants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of September 30, 2024, we were in compliance with these covenants. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Credit Agreement contains certain other customary limitations on our ability to, among other things: incur additional indebtedness; pay dividends on or repurchase or redeem our capital stock; make loans, investments and acquisitions; sell, transfer or otherwise dispose of assets; guarantee other obligations; create or grant liens; and enter into certain types of transactions with affiliates. Notwithstanding such limitations, the Credit Agreement allows us to pay dividends, repurchase stock and make investments up to an “Available Amount,” as defined in the Credit Agreement, provided no event of default has occurred and certain financial ratios have been achieved on a pro forma basis. We are permitted to prepay all or a portion of the Term Loan Facility and the Revolving Credit Facility at any time without premium or penalty.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Payments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement requires quarterly principal installment payments on the Term Loan Facility of 10% of the total principal borrowed for the first eight quarters following funding and then quarterly installment payments of 20% of the total principal borrowed, at which time the remaining unpaid principal amount of the Term Loan Facility is due and payable by the Company upon the maturity date of June 24, 2027. The current portion of the Term Loan Facility is $9.4 million. Interest is payable quarterly. We have the right to voluntarily prepay the Term Loan Facility in accordance with the terms of the Credit Agreement. Interest is payable at the same rates set forth above for the Revolving Credit Facility.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2024, we repaid $6.3 million of the Term Loan Facility. During the nine months ended September 30, 2024, we borrowed $20.0 million and repaid $20.0 million of the Revolving Credit Facility. As of September 30, 2024, we had letters of credit outstanding of $6.3 million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024, the aggregate amounts of long-term debt that will mature during each of the next four years are as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.894%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024 and December 31, 2023, our respective debt balances were as follows (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.981%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.83 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.81 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">112.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">162.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Long-Term Debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">152.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0.0683 50000000.0 50000000.0 0.0681 112500000 118800000 162500000 168800000 500000 800000 9400000 8600000 152600000 159400000 500000000.0 P5Y 125000000.0 P5Y 375000000.0 75000000.0 0.0150 0.0200 0.0150 0.0200 0.0050 0.0100 0.0050 0.0100 0.0020 0.0025 0.071 0.10 0.20 9400000 6300000 20000000.0 20000000.0 6300000 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024, the aggregate amounts of long-term debt that will mature during each of the next four years are as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.894%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2300000 9400000 10200000 140600000 0 162500000 Accumulated Other Comprehensive Income<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the components of Accumulated Other Comprehensive Income (“AOCI”), net of tax, are as follows (in millions):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit<br/>Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net changes in the components of AOCI, including the tax effect, are as follows (in millions):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized currency translation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension plans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension plans, net of tax</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in AOCI</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the components of Accumulated Other Comprehensive Income (“AOCI”), net of tax, are as follows (in millions):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit<br/>Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net changes in the components of AOCI, including the tax effect, are as follows (in millions):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized currency translation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension plans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension plans, net of tax</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in AOCI</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -27000000.0 0 0 -27000000.0 -8000000.0 -1800000 -100000 -9900000 -35000000.0 -1800000 -100000 -36900000 300000 -4600000 -8000000.0 2800000 -100000 0 100000 0 -100000 0 100000 0 700000 0 -1300000 0 500000 0 500000 0 200000 0 -1800000 0 600000 -4600000 -9900000 2800000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense is included in “Cost of products sold,” “Research and development,” and “Sales and general expenses.” Stock-based compensation expense for the three and nine months ended September 30, 2024 and 2023 is shown in the table below (in millions):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time-based restricted share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance-based restricted share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense is included in “Cost of products sold,” “Research and development,” and “Sales and general expenses.” Stock-based compensation expense for the three and nine months ended September 30, 2024 and 2023 is shown in the table below (in millions):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time-based restricted share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance-based restricted share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 0 0 300000 2700000 2500000 7600000 7900000 -100000 1300000 2300000 3400000 0 100000 100000 200000 2600000 3900000 10000000.0 11800000 Commitments and Contingencies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various legal proceedings, claims and governmental inspections, audits or investigations pertaining to issues such as contract disputes, product liability, tax matters, patents and trademarks, advertising, governmental regulations, employment and other matters. Under the terms of the distribution agreement we entered into with Kimberly-Clark Corporation (“Kimberly-Clark”) prior to our 2014 spin-off from Kimberly-Clark, legal proceedings, claims and other liabilities that are primarily related to our business are our responsibility and we are obligated to indemnify and hold Kimberly-Clark harmless for such matters. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Investigation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2015, we were served with a subpoena from the Department of Veterans Affairs Office of the Inspector General (“VA OIG”) seeking information related to the design, manufacture, testing, sale and promotion of MicroCool and other surgical gowns produced by the Company. In July 2015, we became aware that the VA OIG subpoena and an earlier VA OIG subpoena served on Kimberly-Clark requesting information about gown sales to the federal government were related to a United States Department of Justice (“DOJ”) investigation. In May 2016, April 2017 and September 2018, we received additional subpoenas from the DOJ seeking further information related to the Company’s surgical gowns.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 6, 2021, we entered into a Deferred Prosecution Agreement (“DPA”) with the DOJ that resolved their criminal investigation related to our MicroCool surgical gowns. Pursuant to the terms of the DPA, in July 2021 the Company made a payment of $22.2 million. The DPA term expired on July 7, 2024. Under the DPA, the DOJ has up to six months following the term’s expiration to seek dismissal of the case.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patent Litigation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in an industry characterized by extensive patent litigation. Competitors may claim that our products infringe upon their intellectual property. Resolution of patent litigation or other intellectual property claims is typically time consuming and costly and can result in significant damage awards and injunctions that could prevent the manufacture and sale of the affected products or require us to make significant royalty payments in order to continue selling the affected products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any given time, we may be involved as either a plaintiff or a defendant in a number of patent infringement actions, the outcomes of which may not be known for prolonged periods of time.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While we maintain general and professional liability, product liability and other insurance, our insurance policies may not cover all of these matters and may not fully cover liabilities arising out of these matters. In addition, we may be obligated to indemnify our directors and officers against these matters.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We record provisions in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. For any matters that are reasonably possible to result in loss and for which no possible loss or range of loss is disclosed in this Form 10-Q, management has determined that it is unable to estimate the possible loss or range of loss because, in each case, at least the following facts applied: (a) the matter is at an early stage of the proceedings; (b) the damages are indeterminate, unspecified or determined to be immaterial; and (c) significant factual issues have yet to be resolved. At present, although the results of litigation and claims cannot be predicted with certainty, we believe that the ultimate resolution of any pending legal proceeding to which we are a party will not have a material adverse effect on our business, financial condition, results of operations or liquidity.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental Compliance</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to federal, state and local environmental protection laws and regulations with respect to our business operations. We believe we are operating in compliance with, or are taking action aimed at ensuring compliance with, these laws and regulations. None of our compliance obligations with environmental protection laws and regulations, individually or in the aggregate, is expected to have a material adverse effect on our business, financial condition, results of operations or liquidity.</span></div> 22200000 Derivative Financial Instruments<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2024, we began to enter into derivative instruments to hedge a portion of forecasted cash flows denominated in Mexican pesos. The derivative instruments used to manage these exposures are designated and qualify as cash flow hedges. The derivative liability for foreign exchange contracts was $2.1 million as of September 30, 2024 and is included in the condensed consolidated balance sheet in accrued expenses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective portion of the gain or loss on a derivative instrument is initially recorded in AOCI, net of related income taxes, and recognized in earnings in the same period that the hedged exposure affects earnings. The loss recognized in earnings was not material in the three and nine months ended September 30, 2024. As of September 30, 2024, the aggregate notional values of outstanding foreign currency swap contracts designated as cash flow hedges were $17.8 million.</span></div> 2100000 17800000 Earnings Per Share (“EPS”)<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic EPS is calculated by dividing net income by the weighted average number of common shares outstanding during each period. Diluted earnings per share is calculated by dividing net income by the number of common shares outstanding and the effect of all dilutive common stock equivalents outstanding during each period, as determined using the treasury stock method. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of basic and diluted earnings (loss) per share for the three and nine months ended September 30, 2024 and 2023 is set forth in the following table (in millions, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Shares Outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and restricted share unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (Loss) Per Share</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Continuing Operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Discontinued Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic Earnings (Loss) Per Share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.55)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Continuing Operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Discontinued Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings (Loss) Per Share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.09</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.55)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted share units (“RSUs”) contain provisions allowing for the equivalent of any dividends paid on common stock during the restricted period to be reinvested into additional RSUs at the then fair market value of the common stock on the date the dividends are paid. Such awards are to be included in the EPS calculation under the two-class method. Currently, we do not anticipate any cash dividends for the foreseeable future and our outstanding RSU awards are not material in comparison to our weighted average shares outstanding. Accordingly, all EPS amounts reflect shares as if they were fully vested and the disclosures associated with the two-class method are not presented herein.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2024, $1.0 million and $1.3 million of potentially dilutive stock options and RSU awards were excluded from the computation of earnings per share as their effect would have been anti-dilutive.</span></div> <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of basic and diluted earnings (loss) per share for the three and nine months ended September 30, 2024 and 2023 is set forth in the following table (in millions, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Shares Outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and restricted share unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (Loss) Per Share</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Continuing Operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Discontinued Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic Earnings (Loss) Per Share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.55)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Continuing Operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Discontinued Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings (Loss) Per Share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.09</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.55)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 5900000 -8800000 10700000 -20900000 -1600000 5100000 -5500000 -51400000 4300000 -3700000 5200000 -72300000 46000000.0 46800000 46000000.0 46700000 600000 0 500000 0 46600000 46800000 46500000 46700000 0.13 -0.19 0.23 -0.45 -0.03 0.11 -0.12 -1.10 0.10 -0.08 0.11 -1.55 0.12 -0.19 0.23 -0.45 -0.03 0.11 -0.12 -1.10 0.09 -0.08 0.11 -1.55 1000000.0 1300000 Business and Products Information<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct our business in one operating and reportable segment that provides our medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Avanos develops, manufactures and markets its recognized brands globally and holds leading market positions in multiple categories across its portfolio. Our management evaluates net sales by product category within our single reportable segment as follows (in millions):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:45.967%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.660%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive Health</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">98.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">290.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pain Management and Recovery:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical pain and recovery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional pain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">123.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Pain Management and Recovery</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">217.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net Sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">170.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">508.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Digestive Health i</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s a portfolio of products such as our MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pain Management and Recovery </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a portfolio of products including:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interventional pain solutions, which provide minimally invasive pain relief therapies, such as our COOLIEF pain therapy, OrthogenRx’s knee osteoarthritis HA pain relief injection products and Diros’ RFA products used to treat chronic pain conditions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities for estimated returns, rebates and incentives are presented in the table below (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.250%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued customer incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates and customer incentives</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales returns</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________________________________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Accrued sales returns are included in “Other” in the accrued expenses table in Note 5, “Supplemental Balance Sheet Information”.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of our business, we receive purchase orders for products under supply agreements which are normally fulfilled within three to four weeks. Our performance obligations under purchase orders are satisfied and revenue is recognized at a point in time, which is upon shipment or upon delivery of our products, depending on shipping terms. Accordingly, we normally do not have transactions that give rise to material unfulfilled performance obligations.</span></div> 1 1 Our management evaluates net sales by product category within our single reportable segment as follows (in millions):<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:45.967%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.660%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive Health</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">98.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">290.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pain Management and Recovery:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical pain and recovery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional pain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">123.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Pain Management and Recovery</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">217.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net Sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">170.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">508.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 98200000 95000000.0 290600000 276800000 30300000 34100000 93800000 103600000 41900000 42200000 123800000 119600000 72200000 76300000 217600000 223200000 170400000 171300000 508200000 500000000.0 13700000 10400000 9900000 7300000 23600000 17700000 100000 100000 23700000 17800000 Share Repurchase Program<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2023, the Board of Directors approved a new one-year program under which we may repurchase up to $25.0 million of our common stock. Repurchases under this program will be made from time to time at management’s discretion on the open market or through privately negotiated transactions in compliance with Rule 10b-18 under the Exchange Act, subject to market conditions, applicable legal requirements and other relevant factors. We have established a pre-arranged trading plan under Rule 10b5-1 of the Exchange Act in connection with this share repurchase program. This share repurchase program does not obligate us to purchase any particular amount of common stock and may be suspended, modified or discontinued by us without prior notice. In the third quarter of 2023, we repurchased $9.2 million of our common stock and during the fourth quarter of 2023, we repurchased an additional $5.8 million of our common stock.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2024, our repurchases of our common stock were as summarized in the table below. </span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.865%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Repurchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Purchase Price<br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount Remaining in<br/>Program for Purchase<br/>(in millions)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"># of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Program to Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First quarter of 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,680 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085,333 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.45 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter of 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,571 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254,904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the share repurchase program, we withheld 140,539 shares of common stock for $2.7 million in taxes associated with stock-based compensation transactions for the nine months ended September 30, 2024.</span></div> P1Y 25000000.0 9200000 5800000 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2024, our repurchases of our common stock were as summarized in the table below. </span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.865%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Repurchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Purchase Price<br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount Remaining in<br/>Program for Purchase<br/>(in millions)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"># of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Program to Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First quarter of 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,680 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085,333 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.45 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter of 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,571 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254,904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 342680 1085333 6700000 19.45 3300000 169571 1254904 3300000 19.67 0 140539 2700000